id sid tid token lemma pos cord-313312-h607itv2 1 1 key key NN cord-313312-h607itv2 1 2 : : : cord-313312-h607itv2 2 1 cord-313312-h607itv2 cord-313312-h607itv2 NN cord-313312-h607itv2 2 2 authors author NNS cord-313312-h607itv2 2 3 : : : cord-313312-h607itv2 2 4 Mok Mok NNP cord-313312-h607itv2 2 5 , , , cord-313312-h607itv2 2 6 Darren Darren NNP cord-313312-h607itv2 2 7 Z. Z. NNP cord-313312-h607itv2 2 8 L. L. NNP cord-313312-h607itv2 2 9 ; ; : cord-313312-h607itv2 2 10 Chan Chan NNP cord-313312-h607itv2 2 11 , , , cord-313312-h607itv2 2 12 Kuan Kuan NNP cord-313312-h607itv2 2 13 Rong Rong NNP cord-313312-h607itv2 3 1 title title NN cord-313312-h607itv2 3 2 : : : cord-313312-h607itv2 4 1 The the DT cord-313312-h607itv2 4 2 Effects effect NNS cord-313312-h607itv2 4 3 of of IN cord-313312-h607itv2 4 4 Pre pre JJ cord-313312-h607itv2 4 5 - - JJ cord-313312-h607itv2 4 6 Existing existing JJ cord-313312-h607itv2 4 7 Antibodies Antibodies NNPS cord-313312-h607itv2 4 8 on on IN cord-313312-h607itv2 4 9 Live live JJ cord-313312-h607itv2 4 10 - - HYPH cord-313312-h607itv2 4 11 Attenuated attenuate VBN cord-313312-h607itv2 4 12 Viral Viral NNP cord-313312-h607itv2 4 13 Vaccines Vaccines NNPS cord-313312-h607itv2 4 14 date date NN cord-313312-h607itv2 4 15 : : : cord-313312-h607itv2 4 16 2020 2020 CD cord-313312-h607itv2 4 17 - - HYPH cord-313312-h607itv2 4 18 05 05 CD cord-313312-h607itv2 4 19 - - HYPH cord-313312-h607itv2 4 20 08 08 CD cord-313312-h607itv2 4 21 journal journal NN cord-313312-h607itv2 4 22 : : : cord-313312-h607itv2 5 1 Viruses virus NNS cord-313312-h607itv2 5 2 DOI DOI NNP cord-313312-h607itv2 5 3 : : : cord-313312-h607itv2 6 1 10.3390 10.3390 CD cord-313312-h607itv2 7 1 /v12050520 /v12050520 . cord-313312-h607itv2 8 1 sha sha NNP cord-313312-h607itv2 8 2 : : : cord-313312-h607itv2 8 3 8d12199734c818c025cda267be5fe8fe0d6641cd 8d12199734c818c025cda267be5fe8fe0d6641cd NNP cord-313312-h607itv2 8 4 doc_id doc_id CD cord-313312-h607itv2 8 5 : : : cord-313312-h607itv2 9 1 313312 313312 CD cord-313312-h607itv2 9 2 cord_uid cord_uid NN cord-313312-h607itv2 9 3 : : : cord-313312-h607itv2 10 1 h607itv2 h607itv2 NNP cord-313312-h607itv2 10 2 Live live RB cord-313312-h607itv2 10 3 - - HYPH cord-313312-h607itv2 10 4 attenuated attenuate VBN cord-313312-h607itv2 10 5 vaccines vaccine NNS cord-313312-h607itv2 10 6 ( ( -LRB- cord-313312-h607itv2 10 7 LAVs lav NNS cord-313312-h607itv2 10 8 ) ) -RRB- cord-313312-h607itv2 10 9 have have VBP cord-313312-h607itv2 10 10 achieved achieve VBN cord-313312-h607itv2 10 11 remarkable remarkable JJ cord-313312-h607itv2 10 12 successes success NNS cord-313312-h607itv2 10 13 in in IN cord-313312-h607itv2 10 14 controlling control VBG cord-313312-h607itv2 10 15 virus virus NN cord-313312-h607itv2 10 16 spread spread NN cord-313312-h607itv2 10 17 , , , cord-313312-h607itv2 10 18 as as RB cord-313312-h607itv2 10 19 well well RB cord-313312-h607itv2 10 20 as as IN cord-313312-h607itv2 10 21 for for IN cord-313312-h607itv2 10 22 other other JJ cord-313312-h607itv2 10 23 applications application NNS cord-313312-h607itv2 10 24 such such JJ cord-313312-h607itv2 10 25 as as IN cord-313312-h607itv2 10 26 cancer cancer NN cord-313312-h607itv2 10 27 immunotherapy immunotherapy NN cord-313312-h607itv2 10 28 . . . cord-313312-h607itv2 11 1 However however RB cord-313312-h607itv2 11 2 , , , cord-313312-h607itv2 11 3 with with IN cord-313312-h607itv2 11 4 rapid rapid JJ cord-313312-h607itv2 11 5 increases increase NNS cord-313312-h607itv2 11 6 in in IN cord-313312-h607itv2 11 7 international international JJ cord-313312-h607itv2 11 8 travel travel NN cord-313312-h607itv2 11 9 , , , cord-313312-h607itv2 11 10 globalization globalization NN cord-313312-h607itv2 11 11 , , , cord-313312-h607itv2 11 12 geographic geographic JJ cord-313312-h607itv2 11 13 spread spread NN cord-313312-h607itv2 11 14 of of IN cord-313312-h607itv2 11 15 viral viral JJ cord-313312-h607itv2 11 16 vectors vector NNS cord-313312-h607itv2 11 17 , , , cord-313312-h607itv2 11 18 and and CC cord-313312-h607itv2 11 19 widespread widespread JJ cord-313312-h607itv2 11 20 use use NN cord-313312-h607itv2 11 21 of of IN cord-313312-h607itv2 11 22 vaccines vaccine NNS cord-313312-h607itv2 11 23 , , , cord-313312-h607itv2 11 24 there there EX cord-313312-h607itv2 11 25 is be VBZ cord-313312-h607itv2 11 26 an an DT cord-313312-h607itv2 11 27 increasing increase VBG cord-313312-h607itv2 11 28 need need NN cord-313312-h607itv2 11 29 to to TO cord-313312-h607itv2 11 30 consider consider VB cord-313312-h607itv2 11 31 how how WRB cord-313312-h607itv2 11 32 pre pre JJ cord-313312-h607itv2 11 33 - - NN cord-313312-h607itv2 11 34 exposure exposure NN cord-313312-h607itv2 11 35 to to IN cord-313312-h607itv2 11 36 viruses virus NNS cord-313312-h607itv2 11 37 which which WDT cord-313312-h607itv2 11 38 share share VBP cord-313312-h607itv2 11 39 similar similar JJ cord-313312-h607itv2 11 40 antigenic antigenic JJ cord-313312-h607itv2 11 41 regions region NNS cord-313312-h607itv2 11 42 can can MD cord-313312-h607itv2 11 43 impact impact VB cord-313312-h607itv2 11 44 vaccine vaccine NN cord-313312-h607itv2 11 45 efficacy efficacy NN cord-313312-h607itv2 11 46 . . . cord-313312-h607itv2 12 1 Pre pre JJ cord-313312-h607itv2 12 2 - - JJ cord-313312-h607itv2 12 3 existing existing JJ cord-313312-h607itv2 12 4 antibodies antibody NNS cord-313312-h607itv2 12 5 , , , cord-313312-h607itv2 12 6 derived derive VBN cord-313312-h607itv2 12 7 from from IN cord-313312-h607itv2 12 8 either either CC cord-313312-h607itv2 12 9 from from IN cord-313312-h607itv2 12 10 maternal maternal JJ cord-313312-h607itv2 12 11 – – : cord-313312-h607itv2 12 12 fetal fetal JJ cord-313312-h607itv2 12 13 transmission transmission NN cord-313312-h607itv2 12 14 , , , cord-313312-h607itv2 12 15 or or CC cord-313312-h607itv2 12 16 by by IN cord-313312-h607itv2 12 17 previous previous JJ cord-313312-h607itv2 12 18 infection infection NN cord-313312-h607itv2 12 19 or or CC cord-313312-h607itv2 12 20 vaccination vaccination NN cord-313312-h607itv2 12 21 , , , cord-313312-h607itv2 12 22 have have VBP cord-313312-h607itv2 12 23 been be VBN cord-313312-h607itv2 12 24 demonstrated demonstrate VBN cord-313312-h607itv2 12 25 to to TO cord-313312-h607itv2 12 26 interfere interfere VB cord-313312-h607itv2 12 27 with with IN cord-313312-h607itv2 12 28 vaccine vaccine NN cord-313312-h607itv2 12 29 immunogenicity immunogenicity NN cord-313312-h607itv2 12 30 of of IN cord-313312-h607itv2 12 31 measles measle NNS cord-313312-h607itv2 12 32 , , , cord-313312-h607itv2 12 33 adenovirus adenovirus NN cord-313312-h607itv2 12 34 , , , cord-313312-h607itv2 12 35 and and CC cord-313312-h607itv2 12 36 influenza influenza NN cord-313312-h607itv2 12 37 LAVs lav NNS cord-313312-h607itv2 12 38 . . . cord-313312-h607itv2 13 1 Immune immune JJ cord-313312-h607itv2 13 2 interference interference NN cord-313312-h607itv2 13 3 of of IN cord-313312-h607itv2 13 4 LAVs lav NNS cord-313312-h607itv2 13 5 can can MD cord-313312-h607itv2 13 6 be be VB cord-313312-h607itv2 13 7 caused cause VBN cord-313312-h607itv2 13 8 by by IN cord-313312-h607itv2 13 9 the the DT cord-313312-h607itv2 13 10 formation formation NN cord-313312-h607itv2 13 11 of of IN cord-313312-h607itv2 13 12 virus virus NN cord-313312-h607itv2 13 13 – – : cord-313312-h607itv2 13 14 antibody antibody NN cord-313312-h607itv2 13 15 complexes complex NNS cord-313312-h607itv2 13 16 that that WDT cord-313312-h607itv2 13 17 neutralize neutralize VBP cord-313312-h607itv2 13 18 virus virus NN cord-313312-h607itv2 13 19 infection infection NN cord-313312-h607itv2 13 20 in in IN cord-313312-h607itv2 13 21 antigen antigen NN cord-313312-h607itv2 13 22 - - HYPH cord-313312-h607itv2 13 23 presenting present VBG cord-313312-h607itv2 13 24 cells cell NNS cord-313312-h607itv2 13 25 , , , cord-313312-h607itv2 13 26 or or CC cord-313312-h607itv2 13 27 by by IN cord-313312-h607itv2 13 28 the the DT cord-313312-h607itv2 13 29 cross cross NN cord-313312-h607itv2 13 30 - - NN cord-313312-h607itv2 13 31 linking linking NN cord-313312-h607itv2 13 32 of of IN cord-313312-h607itv2 13 33 the the DT cord-313312-h607itv2 13 34 B b NN cord-313312-h607itv2 13 35 - - HYPH cord-313312-h607itv2 13 36 cell cell NN cord-313312-h607itv2 13 37 receptor receptor NN cord-313312-h607itv2 13 38 with with IN cord-313312-h607itv2 13 39 the the DT cord-313312-h607itv2 13 40 inhibitory inhibitory JJ cord-313312-h607itv2 13 41 receptor receptor NN cord-313312-h607itv2 13 42 , , , cord-313312-h607itv2 13 43 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 13 44 . . . cord-313312-h607itv2 14 1 On on IN cord-313312-h607itv2 14 2 the the DT cord-313312-h607itv2 14 3 other other JJ cord-313312-h607itv2 14 4 hand hand NN cord-313312-h607itv2 14 5 , , , cord-313312-h607itv2 14 6 pre pre VB cord-313312-h607itv2 14 7 - - JJ cord-313312-h607itv2 14 8 existing existing JJ cord-313312-h607itv2 14 9 antibodies antibody NNS cord-313312-h607itv2 14 10 can can MD cord-313312-h607itv2 14 11 augment augment VB cord-313312-h607itv2 14 12 flaviviral flaviviral NNP cord-313312-h607itv2 14 13 LAV LAV NNP cord-313312-h607itv2 14 14 efficacy efficacy NN cord-313312-h607itv2 14 15 such such JJ cord-313312-h607itv2 14 16 as as IN cord-313312-h607itv2 14 17 that that DT cord-313312-h607itv2 14 18 of of IN cord-313312-h607itv2 14 19 dengue dengue NN cord-313312-h607itv2 14 20 and and CC cord-313312-h607itv2 14 21 yellow yellow JJ cord-313312-h607itv2 14 22 fever fever NN cord-313312-h607itv2 14 23 virus virus NN cord-313312-h607itv2 14 24 , , , cord-313312-h607itv2 14 25 especially especially RB cord-313312-h607itv2 14 26 when when WRB cord-313312-h607itv2 14 27 pre pre JJ cord-313312-h607itv2 14 28 - - JJ cord-313312-h607itv2 14 29 existing existing JJ cord-313312-h607itv2 14 30 antibodies antibody NNS cord-313312-h607itv2 14 31 are be VBP cord-313312-h607itv2 14 32 present present JJ cord-313312-h607itv2 14 33 at at IN cord-313312-h607itv2 14 34 sub sub NN cord-313312-h607itv2 14 35 - - JJ cord-313312-h607itv2 14 36 neutralizing neutralize VBG cord-313312-h607itv2 14 37 levels level NNS cord-313312-h607itv2 14 38 . . . cord-313312-h607itv2 15 1 The the DT cord-313312-h607itv2 15 2 increased increased JJ cord-313312-h607itv2 15 3 vaccine vaccine NN cord-313312-h607itv2 15 4 immunogenicity immunogenicity NN cord-313312-h607itv2 15 5 can can MD cord-313312-h607itv2 15 6 be be VB cord-313312-h607itv2 15 7 facilitated facilitate VBN cord-313312-h607itv2 15 8 by by IN cord-313312-h607itv2 15 9 antibody antibody NN cord-313312-h607itv2 15 10 - - HYPH cord-313312-h607itv2 15 11 dependent dependent JJ cord-313312-h607itv2 15 12 enhancement enhancement NN cord-313312-h607itv2 15 13 of of IN cord-313312-h607itv2 15 14 virus virus NN cord-313312-h607itv2 15 15 infection infection NN cord-313312-h607itv2 15 16 , , , cord-313312-h607itv2 15 17 enhancing enhance VBG cord-313312-h607itv2 15 18 virus virus NN cord-313312-h607itv2 15 19 uptake uptake NN cord-313312-h607itv2 15 20 in in IN cord-313312-h607itv2 15 21 antigen antigen NN cord-313312-h607itv2 15 22 - - HYPH cord-313312-h607itv2 15 23 presenting present VBG cord-313312-h607itv2 15 24 cells cell NNS cord-313312-h607itv2 15 25 , , , cord-313312-h607itv2 15 26 and and CC cord-313312-h607itv2 15 27 robust robust JJ cord-313312-h607itv2 15 28 induction induction NN cord-313312-h607itv2 15 29 of of IN cord-313312-h607itv2 15 30 innate innate JJ cord-313312-h607itv2 15 31 immune immune JJ cord-313312-h607itv2 15 32 responses response NNS cord-313312-h607itv2 15 33 that that WDT cord-313312-h607itv2 15 34 promote promote VBP cord-313312-h607itv2 15 35 vaccine vaccine NN cord-313312-h607itv2 15 36 immunogenicity immunogenicity NN cord-313312-h607itv2 15 37 . . . cord-313312-h607itv2 16 1 This this DT cord-313312-h607itv2 16 2 review review NN cord-313312-h607itv2 16 3 examines examine VBZ cord-313312-h607itv2 16 4 the the DT cord-313312-h607itv2 16 5 literature literature NN cord-313312-h607itv2 16 6 on on IN cord-313312-h607itv2 16 7 this this DT cord-313312-h607itv2 16 8 topic topic NN cord-313312-h607itv2 16 9 and and CC cord-313312-h607itv2 16 10 examines examine VBZ cord-313312-h607itv2 16 11 the the DT cord-313312-h607itv2 16 12 circumstances circumstance NNS cord-313312-h607itv2 16 13 where where WRB cord-313312-h607itv2 16 14 pre pre JJ cord-313312-h607itv2 16 15 - - JJ cord-313312-h607itv2 16 16 existing existing JJ cord-313312-h607itv2 16 17 antibodies antibody NNS cord-313312-h607itv2 16 18 can can MD cord-313312-h607itv2 16 19 inhibit inhibit VB cord-313312-h607itv2 16 20 or or CC cord-313312-h607itv2 16 21 enhance enhance VB cord-313312-h607itv2 16 22 LAV LAV NNP cord-313312-h607itv2 16 23 efficacy efficacy NN cord-313312-h607itv2 16 24 . . . cord-313312-h607itv2 17 1 A a DT cord-313312-h607itv2 17 2 better well JJR cord-313312-h607itv2 17 3 knowledge knowledge NN cord-313312-h607itv2 17 4 of of IN cord-313312-h607itv2 17 5 the the DT cord-313312-h607itv2 17 6 underlying underlie VBG cord-313312-h607itv2 17 7 mechanisms mechanism NNS cord-313312-h607itv2 17 8 involved involve VBN cord-313312-h607itv2 17 9 could could MD cord-313312-h607itv2 17 10 allow allow VB cord-313312-h607itv2 17 11 us -PRON- PRP cord-313312-h607itv2 17 12 to to TO cord-313312-h607itv2 17 13 better better RB cord-313312-h607itv2 17 14 manage manage VB cord-313312-h607itv2 17 15 immunization immunization NN cord-313312-h607itv2 17 16 in in IN cord-313312-h607itv2 17 17 seropositive seropositive JJ cord-313312-h607itv2 17 18 individuals individual NNS cord-313312-h607itv2 17 19 and and CC cord-313312-h607itv2 17 20 even even RB cord-313312-h607itv2 17 21 identify identify VB cord-313312-h607itv2 17 22 possibilities possibility NNS cord-313312-h607itv2 17 23 that that WDT cord-313312-h607itv2 17 24 could could MD cord-313312-h607itv2 17 25 allow allow VB cord-313312-h607itv2 17 26 us -PRON- PRP cord-313312-h607itv2 17 27 to to TO cord-313312-h607itv2 17 28 exploit exploit VB cord-313312-h607itv2 17 29 pre pre JJ cord-313312-h607itv2 17 30 - - JJ cord-313312-h607itv2 17 31 existing existing JJ cord-313312-h607itv2 17 32 antibodies antibody NNS cord-313312-h607itv2 17 33 to to TO cord-313312-h607itv2 17 34 boost boost VB cord-313312-h607itv2 17 35 vaccine vaccine NN cord-313312-h607itv2 17 36 - - HYPH cord-313312-h607itv2 17 37 induced induce VBN cord-313312-h607itv2 17 38 responses response NNS cord-313312-h607itv2 17 39 for for IN cord-313312-h607itv2 17 40 improved improved JJ cord-313312-h607itv2 17 41 vaccine vaccine NN cord-313312-h607itv2 17 42 efficacy efficacy NN cord-313312-h607itv2 17 43 . . . cord-313312-h607itv2 18 1 " " `` cord-313312-h607itv2 18 2 It -PRON- PRP cord-313312-h607itv2 18 3 's be VBZ cord-313312-h607itv2 18 4 time time NN cord-313312-h607itv2 18 5 to to TO cord-313312-h607itv2 18 6 close close VB cord-313312-h607itv2 18 7 the the DT cord-313312-h607itv2 18 8 book book NN cord-313312-h607itv2 18 9 on on IN cord-313312-h607itv2 18 10 infectious infectious JJ cord-313312-h607itv2 18 11 diseases disease NNS cord-313312-h607itv2 18 12 , , , cord-313312-h607itv2 18 13 declare declare VB cord-313312-h607itv2 18 14 the the DT cord-313312-h607itv2 18 15 war war NN cord-313312-h607itv2 18 16 against against IN cord-313312-h607itv2 18 17 pestilence pestilence NN cord-313312-h607itv2 18 18 won win VBD cord-313312-h607itv2 18 19 , , , cord-313312-h607itv2 18 20 and and CC cord-313312-h607itv2 18 21 shift shift VB cord-313312-h607itv2 18 22 national national JJ cord-313312-h607itv2 18 23 resources resource NNS cord-313312-h607itv2 18 24 to to IN cord-313312-h607itv2 18 25 such such JJ cord-313312-h607itv2 18 26 chronic chronic JJ cord-313312-h607itv2 18 27 problems problem NNS cord-313312-h607itv2 18 28 as as IN cord-313312-h607itv2 18 29 cancer cancer NN cord-313312-h607itv2 18 30 and and CC cord-313312-h607itv2 18 31 heart heart NN cord-313312-h607itv2 18 32 disease disease NN cord-313312-h607itv2 18 33 " " '' cord-313312-h607itv2 18 34 [ [ -LRB- cord-313312-h607itv2 18 35 1 1 CD cord-313312-h607itv2 18 36 ] ] -RRB- cord-313312-h607itv2 18 37 . . . cord-313312-h607itv2 19 1 Contrary contrary JJ cord-313312-h607itv2 19 2 to to IN cord-313312-h607itv2 19 3 this this DT cord-313312-h607itv2 19 4 infamous infamous JJ cord-313312-h607itv2 19 5 statement statement NN cord-313312-h607itv2 19 6 , , , cord-313312-h607itv2 19 7 long long RB cord-313312-h607itv2 19 8 misattributed misattribute VBN cord-313312-h607itv2 19 9 to to IN cord-313312-h607itv2 19 10 the the DT cord-313312-h607itv2 19 11 former former JJ cord-313312-h607itv2 19 12 US US NNP cord-313312-h607itv2 19 13 Surgeon Surgeon NNP cord-313312-h607itv2 19 14 General General NNP cord-313312-h607itv2 19 15 Dr. Dr. NNP cord-313312-h607itv2 19 16 William William NNP cord-313312-h607itv2 19 17 H. H. NNP cord-313312-h607itv2 19 18 Stewart Stewart NNP cord-313312-h607itv2 19 19 , , , cord-313312-h607itv2 19 20 and and CC cord-313312-h607itv2 19 21 despite despite IN cord-313312-h607itv2 19 22 advances advance NNS cord-313312-h607itv2 19 23 in in IN cord-313312-h607itv2 19 24 healthcare healthcare NN cord-313312-h607itv2 19 25 and and CC cord-313312-h607itv2 19 26 technology technology NN cord-313312-h607itv2 19 27 , , , cord-313312-h607itv2 19 28 we -PRON- PRP cord-313312-h607itv2 19 29 remain remain VBP cord-313312-h607itv2 19 30 extremely extremely RB cord-313312-h607itv2 19 31 vulnerable vulnerable JJ cord-313312-h607itv2 19 32 to to IN cord-313312-h607itv2 19 33 the the DT cord-313312-h607itv2 19 34 threat threat NN cord-313312-h607itv2 19 35 of of IN cord-313312-h607itv2 19 36 communicable communicable JJ cord-313312-h607itv2 19 37 diseases disease NNS cord-313312-h607itv2 19 38 . . . cord-313312-h607itv2 20 1 In in IN cord-313312-h607itv2 20 2 the the DT cord-313312-h607itv2 20 3 last last JJ cord-313312-h607itv2 20 4 ten ten CD cord-313312-h607itv2 20 5 years year NNS cord-313312-h607itv2 20 6 alone alone RB cord-313312-h607itv2 20 7 , , , cord-313312-h607itv2 20 8 we -PRON- PRP cord-313312-h607itv2 20 9 have have VBP cord-313312-h607itv2 20 10 experienced experience VBN cord-313312-h607itv2 20 11 the the DT cord-313312-h607itv2 20 12 pandemic pandemic NN cord-313312-h607itv2 20 13 spread spread NN cord-313312-h607itv2 20 14 of of IN cord-313312-h607itv2 20 15 swine swine NN cord-313312-h607itv2 20 16 - - HYPH cord-313312-h607itv2 20 17 origin origin NN cord-313312-h607itv2 20 18 H1N1 H1N1 NNP cord-313312-h607itv2 20 19 influenza influenza NN cord-313312-h607itv2 20 20 , , , cord-313312-h607itv2 20 21 the the DT cord-313312-h607itv2 20 22 West west JJ cord-313312-h607itv2 20 23 African African NNP cord-313312-h607itv2 20 24 Ebola Ebola NNP cord-313312-h607itv2 20 25 epidemic epidemic NN cord-313312-h607itv2 20 26 , , , cord-313312-h607itv2 20 27 the the DT cord-313312-h607itv2 20 28 resurgence resurgence NN cord-313312-h607itv2 20 29 of of IN cord-313312-h607itv2 20 30 yellow yellow JJ cord-313312-h607itv2 20 31 fever fever NN cord-313312-h607itv2 20 32 , , , cord-313312-h607itv2 20 33 the the DT cord-313312-h607itv2 20 34 Zika Zika NNP cord-313312-h607itv2 20 35 virus virus NN cord-313312-h607itv2 20 36 emergency emergency NN cord-313312-h607itv2 20 37 , , , cord-313312-h607itv2 20 38 and and CC cord-313312-h607itv2 20 39 the the DT cord-313312-h607itv2 20 40 return return NN cord-313312-h607itv2 20 41 of of IN cord-313312-h607itv2 20 42 a a DT cord-313312-h607itv2 20 43 global global JJ cord-313312-h607itv2 20 44 coronavirus coronavirus NN cord-313312-h607itv2 20 45 threat threat NN cord-313312-h607itv2 20 46 [ [ -LRB- cord-313312-h607itv2 20 47 2 2 CD cord-313312-h607itv2 20 48 ] ] -RRB- cord-313312-h607itv2 20 49 [ [ -LRB- cord-313312-h607itv2 20 50 3 3 CD cord-313312-h607itv2 20 51 ] ] -RRB- cord-313312-h607itv2 20 52 [ [ -LRB- cord-313312-h607itv2 20 53 4 4 CD cord-313312-h607itv2 20 54 ] ] -RRB- cord-313312-h607itv2 20 55 [ [ -LRB- cord-313312-h607itv2 20 56 5 5 CD cord-313312-h607itv2 20 57 ] ] -RRB- cord-313312-h607itv2 20 58 [ [ -LRB- cord-313312-h607itv2 20 59 6 6 CD cord-313312-h607itv2 20 60 ] ] -RRB- cord-313312-h607itv2 20 61 . . . cord-313312-h607itv2 21 1 With with IN cord-313312-h607itv2 21 2 the the DT cord-313312-h607itv2 21 3 continued continued JJ cord-313312-h607itv2 21 4 emergence emergence NN cord-313312-h607itv2 21 5 and and CC cord-313312-h607itv2 21 6 re re NN cord-313312-h607itv2 21 7 - - NN cord-313312-h607itv2 21 8 emergence emergence NN cord-313312-h607itv2 21 9 of of IN cord-313312-h607itv2 21 10 new new JJ cord-313312-h607itv2 21 11 and and CC cord-313312-h607itv2 21 12 current current JJ cord-313312-h607itv2 21 13 viral viral JJ cord-313312-h607itv2 21 14 pathogens pathogen NNS cord-313312-h607itv2 21 15 , , , cord-313312-h607itv2 21 16 it -PRON- PRP cord-313312-h607itv2 21 17 is be VBZ cord-313312-h607itv2 21 18 imperative imperative JJ cord-313312-h607itv2 21 19 that that IN cord-313312-h607itv2 21 20 we -PRON- PRP cord-313312-h607itv2 21 21 continue continue VBP cord-313312-h607itv2 21 22 to to TO cord-313312-h607itv2 21 23 design design VB cord-313312-h607itv2 21 24 new new JJ cord-313312-h607itv2 21 25 strategies strategy NNS cord-313312-h607itv2 21 26 to to TO cord-313312-h607itv2 21 27 combat combat VB cord-313312-h607itv2 21 28 their -PRON- PRP$ cord-313312-h607itv2 21 29 spread spread NN cord-313312-h607itv2 21 30 and and CC cord-313312-h607itv2 21 31 prevent prevent VB cord-313312-h607itv2 21 32 human human JJ cord-313312-h607itv2 21 33 disease disease NN cord-313312-h607itv2 21 34 . . . cord-313312-h607itv2 22 1 Among among IN cord-313312-h607itv2 22 2 the the DT cord-313312-h607itv2 22 3 various various JJ cord-313312-h607itv2 22 4 methods method NNS cord-313312-h607itv2 22 5 to to TO cord-313312-h607itv2 22 6 impede impede VB cord-313312-h607itv2 22 7 viral viral JJ cord-313312-h607itv2 22 8 transmission transmission NN cord-313312-h607itv2 22 9 , , , cord-313312-h607itv2 22 10 vaccines vaccine NNS cord-313312-h607itv2 22 11 are be VBP cord-313312-h607itv2 22 12 widely widely RB cord-313312-h607itv2 22 13 heralded herald VBN cord-313312-h607itv2 22 14 as as IN cord-313312-h607itv2 22 15 one one CD cord-313312-h607itv2 22 16 of of IN cord-313312-h607itv2 22 17 the the DT cord-313312-h607itv2 22 18 most most RBS cord-313312-h607itv2 22 19 effective effective JJ cord-313312-h607itv2 22 20 medical medical JJ cord-313312-h607itv2 22 21 interventions intervention NNS cord-313312-h607itv2 22 22 . . . cord-313312-h607itv2 23 1 Indeed indeed RB cord-313312-h607itv2 23 2 , , , cord-313312-h607itv2 23 3 since since IN cord-313312-h607itv2 23 4 the the DT cord-313312-h607itv2 23 5 pivotal pivotal JJ cord-313312-h607itv2 23 6 discovery discovery NN cord-313312-h607itv2 23 7 by by IN cord-313312-h607itv2 23 8 Edward Edward NNP cord-313312-h607itv2 23 9 Jenner Jenner NNP cord-313312-h607itv2 23 10 over over IN cord-313312-h607itv2 23 11 two two CD cord-313312-h607itv2 23 12 hundred hundred CD cord-313312-h607itv2 23 13 years year NNS cord-313312-h607itv2 23 14 ago ago RB cord-313312-h607itv2 23 15 , , , cord-313312-h607itv2 23 16 vaccination vaccination NN cord-313312-h607itv2 23 17 has have VBZ cord-313312-h607itv2 23 18 seen see VBN cord-313312-h607itv2 23 19 tremendous tremendous JJ cord-313312-h607itv2 23 20 success success NN cord-313312-h607itv2 23 21 in in IN cord-313312-h607itv2 23 22 reducing reduce VBG cord-313312-h607itv2 23 23 the the DT cord-313312-h607itv2 23 24 burden burden NN cord-313312-h607itv2 23 25 of of IN cord-313312-h607itv2 23 26 viral viral JJ cord-313312-h607itv2 23 27 diseases disease NNS cord-313312-h607itv2 23 28 against against IN cord-313312-h607itv2 23 29 wild wild JJ cord-313312-h607itv2 23 30 - - HYPH cord-313312-h607itv2 23 31 type type NN cord-313312-h607itv2 23 32 virus virus NN cord-313312-h607itv2 23 33 infections infection NNS cord-313312-h607itv2 23 34 and and CC cord-313312-h607itv2 23 35 not not RB cord-313312-h607itv2 23 36 cause cause VB cord-313312-h607itv2 23 37 worse bad JJR cord-313312-h607itv2 23 38 disease disease NN cord-313312-h607itv2 23 39 outcomes outcome NNS cord-313312-h607itv2 23 40 . . . cord-313312-h607itv2 24 1 For for IN cord-313312-h607itv2 24 2 vaccines vaccine NNS cord-313312-h607itv2 24 3 that that WDT cord-313312-h607itv2 24 4 are be VBP cord-313312-h607itv2 24 5 administered administer VBN cord-313312-h607itv2 24 6 to to IN cord-313312-h607itv2 24 7 neonates neonate NNS cord-313312-h607itv2 24 8 , , , cord-313312-h607itv2 24 9 the the DT cord-313312-h607itv2 24 10 presence presence NN cord-313312-h607itv2 24 11 of of IN cord-313312-h607itv2 24 12 passively passively RB cord-313312-h607itv2 24 13 acquired acquire VBN cord-313312-h607itv2 24 14 maternal maternal JJ cord-313312-h607itv2 24 15 antibodies antibody NNS cord-313312-h607itv2 24 16 within within IN cord-313312-h607itv2 24 17 the the DT cord-313312-h607itv2 24 18 first first JJ cord-313312-h607itv2 24 19 six six CD cord-313312-h607itv2 24 20 months month NNS cord-313312-h607itv2 24 21 may may MD cord-313312-h607itv2 24 22 also also RB cord-313312-h607itv2 24 23 interfere interfere VB cord-313312-h607itv2 24 24 with with IN cord-313312-h607itv2 24 25 vaccination vaccination NN cord-313312-h607itv2 24 26 [ [ -LRB- cord-313312-h607itv2 24 27 21 21 CD cord-313312-h607itv2 24 28 , , , cord-313312-h607itv2 24 29 22 22 CD cord-313312-h607itv2 24 30 ] ] -RRB- cord-313312-h607itv2 24 31 . . . cord-313312-h607itv2 25 1 The the DT cord-313312-h607itv2 25 2 potential potential JJ cord-313312-h607itv2 25 3 effects effect NNS cord-313312-h607itv2 25 4 of of IN cord-313312-h607itv2 25 5 pre pre JJ cord-313312-h607itv2 25 6 - - JJ cord-313312-h607itv2 25 7 existing existing JJ cord-313312-h607itv2 25 8 antibodies antibody NNS cord-313312-h607itv2 25 9 on on IN cord-313312-h607itv2 25 10 LAV LAV NNP cord-313312-h607itv2 25 11 and and CC cord-313312-h607itv2 25 12 virally virally RB cord-313312-h607itv2 25 13 vectored vectore VBN cord-313312-h607itv2 25 14 antigens antigen NNS cord-313312-h607itv2 25 15 will will MD cord-313312-h607itv2 25 16 hence hence RB cord-313312-h607itv2 25 17 be be VB cord-313312-h607itv2 25 18 the the DT cord-313312-h607itv2 25 19 focus focus NN cord-313312-h607itv2 25 20 of of IN cord-313312-h607itv2 25 21 this this DT cord-313312-h607itv2 25 22 review review NN cord-313312-h607itv2 25 23 . . . cord-313312-h607itv2 26 1 In in IN cord-313312-h607itv2 26 2 this this DT cord-313312-h607itv2 26 3 review review NN cord-313312-h607itv2 26 4 , , , cord-313312-h607itv2 26 5 we -PRON- PRP cord-313312-h607itv2 26 6 examine examine VBP cord-313312-h607itv2 26 7 the the DT cord-313312-h607itv2 26 8 scenarios scenario NNS cord-313312-h607itv2 26 9 in in IN cord-313312-h607itv2 26 10 which which WDT cord-313312-h607itv2 26 11 pre pre JJ cord-313312-h607itv2 26 12 - - JJ cord-313312-h607itv2 26 13 existing existing JJ cord-313312-h607itv2 26 14 antibodies antibody NNS cord-313312-h607itv2 26 15 can can MD cord-313312-h607itv2 26 16 either either CC cord-313312-h607itv2 26 17 enhance enhance VB cord-313312-h607itv2 26 18 or or CC cord-313312-h607itv2 26 19 inhibit inhibit VB cord-313312-h607itv2 26 20 LAV LAV NNP cord-313312-h607itv2 26 21 efficacy efficacy NN cord-313312-h607itv2 26 22 , , , cord-313312-h607itv2 26 23 as as RB cord-313312-h607itv2 26 24 well well RB cord-313312-h607itv2 26 25 as as IN cord-313312-h607itv2 26 26 the the DT cord-313312-h607itv2 26 27 underlying underlie VBG cord-313312-h607itv2 26 28 mechanisms mechanism NNS cord-313312-h607itv2 26 29 involved involve VBN cord-313312-h607itv2 26 30 . . . cord-313312-h607itv2 27 1 A a DT cord-313312-h607itv2 27 2 better well JJR cord-313312-h607itv2 27 3 understanding understanding NN cord-313312-h607itv2 27 4 will will MD cord-313312-h607itv2 27 5 allow allow VB cord-313312-h607itv2 27 6 us -PRON- PRP cord-313312-h607itv2 27 7 to to TO cord-313312-h607itv2 27 8 tailor tailor VB cord-313312-h607itv2 27 9 our -PRON- PRP$ cord-313312-h607itv2 27 10 vaccination vaccination NN cord-313312-h607itv2 27 11 schedules schedule NNS cord-313312-h607itv2 27 12 or or CC cord-313312-h607itv2 27 13 vaccine vaccine NN cord-313312-h607itv2 27 14 doses dose NNS cord-313312-h607itv2 27 15 , , , cord-313312-h607itv2 27 16 to to TO cord-313312-h607itv2 27 17 ensure ensure VB cord-313312-h607itv2 27 18 that that IN cord-313312-h607itv2 27 19 LAV LAV NNP cord-313312-h607itv2 27 20 efficacy efficacy NN cord-313312-h607itv2 27 21 will will MD cord-313312-h607itv2 27 22 not not RB cord-313312-h607itv2 27 23 be be VB cord-313312-h607itv2 27 24 compromised compromise VBN cord-313312-h607itv2 27 25 by by IN cord-313312-h607itv2 27 26 the the DT cord-313312-h607itv2 27 27 presence presence NN cord-313312-h607itv2 27 28 of of IN cord-313312-h607itv2 27 29 pre pre JJ cord-313312-h607itv2 27 30 - - JJ cord-313312-h607itv2 27 31 existing existing JJ cord-313312-h607itv2 27 32 immunity immunity NN cord-313312-h607itv2 27 33 . . . cord-313312-h607itv2 28 1 Prior prior RB cord-313312-h607itv2 28 2 to to IN cord-313312-h607itv2 28 3 the the DT cord-313312-h607itv2 28 4 advent advent NN cord-313312-h607itv2 28 5 of of IN cord-313312-h607itv2 28 6 vaccination vaccination NN cord-313312-h607itv2 28 7 , , , cord-313312-h607itv2 28 8 the the DT cord-313312-h607itv2 28 9 incidence incidence NN cord-313312-h607itv2 28 10 rate rate NN cord-313312-h607itv2 28 11 of of IN cord-313312-h607itv2 28 12 measles measle NNS cord-313312-h607itv2 28 13 was be VBD cord-313312-h607itv2 28 14 so so RB cord-313312-h607itv2 28 15 high high JJ cord-313312-h607itv2 28 16 that that DT cord-313312-h607itv2 28 17 infection infection NN cord-313312-h607itv2 28 18 by by IN cord-313312-h607itv2 28 19 the the DT cord-313312-h607itv2 28 20 measles measle NNS cord-313312-h607itv2 28 21 virus virus NN cord-313312-h607itv2 28 22 was be VBD cord-313312-h607itv2 28 23 basically basically RB cord-313312-h607itv2 28 24 considered consider VBN cord-313312-h607itv2 28 25 an an DT cord-313312-h607itv2 28 26 inevitability inevitability NN cord-313312-h607itv2 28 27 [ [ -LRB- cord-313312-h607itv2 28 28 23 23 CD cord-313312-h607itv2 28 29 , , , cord-313312-h607itv2 28 30 24 24 CD cord-313312-h607itv2 28 31 ] ] -RRB- cord-313312-h607itv2 28 32 . . . cord-313312-h607itv2 29 1 The the DT cord-313312-h607itv2 29 2 virus virus NN cord-313312-h607itv2 29 3 , , , cord-313312-h607itv2 29 4 which which WDT cord-313312-h607itv2 29 5 is be VBZ cord-313312-h607itv2 29 6 spread spread VBN cord-313312-h607itv2 29 7 by by IN cord-313312-h607itv2 29 8 the the DT cord-313312-h607itv2 29 9 respiratory respiratory JJ cord-313312-h607itv2 29 10 route route NN cord-313312-h607itv2 29 11 , , , cord-313312-h607itv2 29 12 is be VBZ cord-313312-h607itv2 29 13 highly highly RB cord-313312-h607itv2 29 14 contagious contagious JJ cord-313312-h607itv2 29 15 and and CC cord-313312-h607itv2 29 16 infects infect VBZ cord-313312-h607itv2 29 17 over over IN cord-313312-h607itv2 29 18 90 90 CD cord-313312-h607itv2 29 19 % % NN cord-313312-h607itv2 29 20 of of IN cord-313312-h607itv2 29 21 individuals individual NNS cord-313312-h607itv2 29 22 by by IN cord-313312-h607itv2 29 23 age age NN cord-313312-h607itv2 29 24 18 18 CD cord-313312-h607itv2 29 25 in in IN cord-313312-h607itv2 29 26 the the DT cord-313312-h607itv2 29 27 pre pre JJ cord-313312-h607itv2 29 28 - - JJ cord-313312-h607itv2 29 29 vaccination vaccination JJ cord-313312-h607itv2 29 30 era era NN cord-313312-h607itv2 29 31 [ [ -LRB- cord-313312-h607itv2 29 32 24 24 CD cord-313312-h607itv2 29 33 , , , cord-313312-h607itv2 29 34 25 25 CD cord-313312-h607itv2 29 35 ] ] -RRB- cord-313312-h607itv2 29 36 . . . cord-313312-h607itv2 30 1 About about RB cord-313312-h607itv2 30 2 seven seven CD cord-313312-h607itv2 30 3 to to TO cord-313312-h607itv2 30 4 eight eight CD cord-313312-h607itv2 30 5 million million CD cord-313312-h607itv2 30 6 children child NNS cord-313312-h607itv2 30 7 were be VBD cord-313312-h607itv2 30 8 estimated estimate VBN cord-313312-h607itv2 30 9 to to TO cord-313312-h607itv2 30 10 have have VB cord-313312-h607itv2 30 11 died die VBN cord-313312-h607itv2 30 12 from from IN cord-313312-h607itv2 30 13 measles measles NN cord-313312-h607itv2 30 14 infection infection NN cord-313312-h607itv2 30 15 each each DT cord-313312-h607itv2 30 16 year year NN cord-313312-h607itv2 30 17 during during IN cord-313312-h607itv2 30 18 this this DT cord-313312-h607itv2 30 19 period period NN cord-313312-h607itv2 30 20 , , , cord-313312-h607itv2 30 21 with with IN cord-313312-h607itv2 30 22 many many JJ cord-313312-h607itv2 30 23 others other NNS cord-313312-h607itv2 30 24 suffering suffer VBG cord-313312-h607itv2 30 25 from from IN cord-313312-h607itv2 30 26 disease disease NN cord-313312-h607itv2 30 27 complications complication NNS cord-313312-h607itv2 30 28 [ [ -LRB- cord-313312-h607itv2 30 29 26 26 CD cord-313312-h607itv2 30 30 ] ] -RRB- cord-313312-h607itv2 30 31 . . . cord-313312-h607itv2 31 1 However however RB cord-313312-h607itv2 31 2 , , , cord-313312-h607itv2 31 3 in in IN cord-313312-h607itv2 31 4 1936 1936 CD cord-313312-h607itv2 31 5 , , , cord-313312-h607itv2 31 6 society society NN cord-313312-h607itv2 31 7 experienced experience VBD cord-313312-h607itv2 31 8 a a DT cord-313312-h607itv2 31 9 turning turning NN cord-313312-h607itv2 31 10 point point NN cord-313312-h607itv2 31 11 in in IN cord-313312-h607itv2 31 12 the the DT cord-313312-h607itv2 31 13 fight fight NN cord-313312-h607itv2 31 14 against against IN cord-313312-h607itv2 31 15 measles measle NNS cord-313312-h607itv2 31 16 with with IN cord-313312-h607itv2 31 17 the the DT cord-313312-h607itv2 31 18 development development NN cord-313312-h607itv2 31 19 of of IN cord-313312-h607itv2 31 20 the the DT cord-313312-h607itv2 31 21 first first JJ cord-313312-h607itv2 31 22 live live RB cord-313312-h607itv2 31 23 - - HYPH cord-313312-h607itv2 31 24 attenuated attenuate VBN cord-313312-h607itv2 31 25 measles measle NNS cord-313312-h607itv2 31 26 vaccine vaccine NN cord-313312-h607itv2 31 27 ( ( -LRB- cord-313312-h607itv2 31 28 MV MV NNP cord-313312-h607itv2 31 29 ) ) -RRB- cord-313312-h607itv2 31 30 [ [ -LRB- cord-313312-h607itv2 31 31 27 27 CD cord-313312-h607itv2 31 32 ] ] -RRB- cord-313312-h607itv2 31 33 . . . cord-313312-h607itv2 32 1 The the DT cord-313312-h607itv2 32 2 live live RB cord-313312-h607itv2 32 3 - - HYPH cord-313312-h607itv2 32 4 attenuated attenuated JJ cord-313312-h607itv2 32 5 MV MV NNP cord-313312-h607itv2 32 6 is be VBZ cord-313312-h607itv2 32 7 one one CD cord-313312-h607itv2 32 8 example example NN cord-313312-h607itv2 32 9 of of IN cord-313312-h607itv2 32 10 a a DT cord-313312-h607itv2 32 11 highly highly RB cord-313312-h607itv2 32 12 successful successful JJ cord-313312-h607itv2 32 13 LAV LAV NNP cord-313312-h607itv2 32 14 , , , cord-313312-h607itv2 32 15 and and CC cord-313312-h607itv2 32 16 its -PRON- PRP$ cord-313312-h607itv2 32 17 introduction introduction NN cord-313312-h607itv2 32 18 has have VBZ cord-313312-h607itv2 32 19 transformed transform VBN cord-313312-h607itv2 32 20 measles measle NNS cord-313312-h607itv2 32 21 from from IN cord-313312-h607itv2 32 22 a a DT cord-313312-h607itv2 32 23 complicated complicated JJ cord-313312-h607itv2 32 24 disease disease NN cord-313312-h607itv2 32 25 into into IN cord-313312-h607itv2 32 26 a a DT cord-313312-h607itv2 32 27 triviality triviality NN cord-313312-h607itv2 32 28 in in IN cord-313312-h607itv2 32 29 most most RBS cord-313312-h607itv2 32 30 developed developed JJ cord-313312-h607itv2 32 31 countries country NNS cord-313312-h607itv2 32 32 , , , cord-313312-h607itv2 32 33 although although IN cord-313312-h607itv2 32 34 measles measle NNS cord-313312-h607itv2 32 35 still still RB cord-313312-h607itv2 32 36 forms form VBZ cord-313312-h607itv2 32 37 a a DT cord-313312-h607itv2 32 38 significant significant JJ cord-313312-h607itv2 32 39 disease disease NN cord-313312-h607itv2 32 40 burden burden NN cord-313312-h607itv2 32 41 in in IN cord-313312-h607itv2 32 42 developing develop VBG cord-313312-h607itv2 32 43 nations nation NNS cord-313312-h607itv2 32 44 [ [ -LRB- cord-313312-h607itv2 32 45 28 28 CD cord-313312-h607itv2 32 46 ] ] -RRB- cord-313312-h607itv2 32 47 [ [ -LRB- cord-313312-h607itv2 32 48 29 29 CD cord-313312-h607itv2 32 49 ] ] -RRB- cord-313312-h607itv2 32 50 [ [ -LRB- cord-313312-h607itv2 32 51 30 30 CD cord-313312-h607itv2 32 52 ] ] -RRB- cord-313312-h607itv2 32 53 . . . cord-313312-h607itv2 33 1 The the DT cord-313312-h607itv2 33 2 wild wild JJ cord-313312-h607itv2 33 3 - - HYPH cord-313312-h607itv2 33 4 type type NN cord-313312-h607itv2 33 5 virus virus NN cord-313312-h607itv2 33 6 was be VBD cord-313312-h607itv2 33 7 first first RB cord-313312-h607itv2 33 8 isolated isolate VBN cord-313312-h607itv2 33 9 in in IN cord-313312-h607itv2 33 10 1954 1954 CD cord-313312-h607itv2 33 11 by by IN cord-313312-h607itv2 33 12 Dr. Dr. NNP cord-313312-h607itv2 33 13 John John NNP cord-313312-h607itv2 33 14 F. F. NNP cord-313312-h607itv2 33 15 Enders Enders NNP cord-313312-h607itv2 33 16 and and CC cord-313312-h607itv2 33 17 his -PRON- PRP$ cord-313312-h607itv2 33 18 team team NN cord-313312-h607itv2 33 19 from from IN cord-313312-h607itv2 33 20 the the DT cord-313312-h607itv2 33 21 blood blood NN cord-313312-h607itv2 33 22 of of IN cord-313312-h607itv2 33 23 an an DT cord-313312-h607itv2 33 24 11-year 11-year JJ cord-313312-h607itv2 33 25 - - HYPH cord-313312-h607itv2 33 26 old old JJ cord-313312-h607itv2 33 27 boy boy NN cord-313312-h607itv2 33 28 named name VBN cord-313312-h607itv2 33 29 David David NNP cord-313312-h607itv2 33 30 Edmonston Edmonston NNP cord-313312-h607itv2 33 31 , , , cord-313312-h607itv2 33 32 who who WP cord-313312-h607itv2 33 33 became become VBD cord-313312-h607itv2 33 34 the the DT cord-313312-h607itv2 33 35 namesake namesake NN cord-313312-h607itv2 33 36 of of IN cord-313312-h607itv2 33 37 the the DT cord-313312-h607itv2 33 38 viral viral JJ cord-313312-h607itv2 33 39 strain strain NN cord-313312-h607itv2 33 40 that that WDT cord-313312-h607itv2 33 41 would would MD cord-313312-h607itv2 33 42 eventually eventually RB cord-313312-h607itv2 33 43 become become VB cord-313312-h607itv2 33 44 the the DT cord-313312-h607itv2 33 45 first first JJ cord-313312-h607itv2 33 46 measles measles NN cord-313312-h607itv2 33 47 vaccine vaccine NN cord-313312-h607itv2 33 48 [ [ -LRB- cord-313312-h607itv2 33 49 31 31 CD cord-313312-h607itv2 33 50 ] ] -RRB- cord-313312-h607itv2 33 51 . . . cord-313312-h607itv2 34 1 Serial serial JJ cord-313312-h607itv2 34 2 passage passage NN cord-313312-h607itv2 34 3 of of IN cord-313312-h607itv2 34 4 the the DT cord-313312-h607itv2 34 5 wild wild JJ cord-313312-h607itv2 34 6 - - HYPH cord-313312-h607itv2 34 7 type type NN cord-313312-h607itv2 34 8 Edmonston Edmonston NNP cord-313312-h607itv2 34 9 strain strain NN cord-313312-h607itv2 34 10 in in IN cord-313312-h607itv2 34 11 human human JJ cord-313312-h607itv2 34 12 and and CC cord-313312-h607itv2 34 13 chicken chicken NN cord-313312-h607itv2 34 14 embryo embryo NN cord-313312-h607itv2 34 15 fibroblast fibroblast NN cord-313312-h607itv2 34 16 tissue tissue NN cord-313312-h607itv2 34 17 culture culture NN cord-313312-h607itv2 34 18 resulted result VBD cord-313312-h607itv2 34 19 in in IN cord-313312-h607itv2 34 20 a a DT cord-313312-h607itv2 34 21 virus virus NN cord-313312-h607itv2 34 22 with with IN cord-313312-h607itv2 34 23 reduced reduce VBN cord-313312-h607itv2 34 24 virulence virulence NN cord-313312-h607itv2 34 25 . . . cord-313312-h607itv2 35 1 However however RB cord-313312-h607itv2 35 2 , , , cord-313312-h607itv2 35 3 the the DT cord-313312-h607itv2 35 4 ability ability NN cord-313312-h607itv2 35 5 of of IN cord-313312-h607itv2 35 6 the the DT cord-313312-h607itv2 35 7 parental parental JJ cord-313312-h607itv2 35 8 strain strain NN cord-313312-h607itv2 35 9 to to TO cord-313312-h607itv2 35 10 induce induce VB cord-313312-h607itv2 35 11 protective protective JJ cord-313312-h607itv2 35 12 immunity immunity NN cord-313312-h607itv2 35 13 is be VBZ cord-313312-h607itv2 35 14 retained retain VBN cord-313312-h607itv2 35 15 . . . cord-313312-h607itv2 36 1 The the DT cord-313312-h607itv2 36 2 MV MV NNP cord-313312-h607itv2 36 3 is be VBZ cord-313312-h607itv2 36 4 highly highly RB cord-313312-h607itv2 36 5 immunogenic immunogenic JJ cord-313312-h607itv2 36 6 , , , cord-313312-h607itv2 36 7 inducing induce VBG cord-313312-h607itv2 36 8 both both CC cord-313312-h607itv2 36 9 humoral humoral JJ cord-313312-h607itv2 36 10 and and CC cord-313312-h607itv2 36 11 cellular cellular JJ cord-313312-h607itv2 36 12 immunity immunity NN cord-313312-h607itv2 36 13 at at IN cord-313312-h607itv2 36 14 magnitudes magnitude NNS cord-313312-h607itv2 36 15 comparable comparable JJ cord-313312-h607itv2 36 16 to to IN cord-313312-h607itv2 36 17 that that DT cord-313312-h607itv2 36 18 of of IN cord-313312-h607itv2 36 19 a a DT cord-313312-h607itv2 36 20 natural natural JJ cord-313312-h607itv2 36 21 infection infection NN cord-313312-h607itv2 36 22 , , , cord-313312-h607itv2 36 23 although although IN cord-313312-h607itv2 36 24 antibody antibody NN cord-313312-h607itv2 36 25 titers titer NNS cord-313312-h607itv2 36 26 induced induce VBN cord-313312-h607itv2 36 27 are be VBP cord-313312-h607itv2 36 28 often often RB cord-313312-h607itv2 36 29 lower low JJR cord-313312-h607itv2 36 30 [ [ -LRB- cord-313312-h607itv2 36 31 32 32 CD cord-313312-h607itv2 36 32 , , , cord-313312-h607itv2 36 33 33 33 CD cord-313312-h607itv2 36 34 ] ] -RRB- cord-313312-h607itv2 36 35 . . . cord-313312-h607itv2 37 1 Investigators investigator NNS cord-313312-h607itv2 37 2 have have VBP cord-313312-h607itv2 37 3 demonstrated demonstrate VBN cord-313312-h607itv2 37 4 that that IN cord-313312-h607itv2 37 5 this this DT cord-313312-h607itv2 37 6 protection protection NN cord-313312-h607itv2 37 7 is be VBZ cord-313312-h607itv2 37 8 highly highly RB cord-313312-h607itv2 37 9 robust robust JJ cord-313312-h607itv2 37 10 , , , cord-313312-h607itv2 37 11 and and CC cord-313312-h607itv2 37 12 could could MD cord-313312-h607itv2 37 13 last last VB cord-313312-h607itv2 37 14 for for IN cord-313312-h607itv2 37 15 as as RB cord-313312-h607itv2 37 16 long long JJ cord-313312-h607itv2 37 17 as as IN cord-313312-h607itv2 37 18 20 20 CD cord-313312-h607itv2 37 19 years year NNS cord-313312-h607itv2 37 20 after after IN cord-313312-h607itv2 37 21 vaccine vaccine NN cord-313312-h607itv2 37 22 administration administration NN cord-313312-h607itv2 37 23 [ [ -LRB- cord-313312-h607itv2 37 24 34 34 CD cord-313312-h607itv2 37 25 ] ] -RRB- cord-313312-h607itv2 37 26 . . . cord-313312-h607itv2 38 1 Its -PRON- PRP$ cord-313312-h607itv2 38 2 excellent excellent JJ cord-313312-h607itv2 38 3 safety safety NN cord-313312-h607itv2 38 4 profile profile NN cord-313312-h607itv2 38 5 , , , cord-313312-h607itv2 38 6 highly highly RB cord-313312-h607itv2 38 7 immunogenic immunogenic JJ cord-313312-h607itv2 38 8 nature nature NN cord-313312-h607itv2 38 9 , , , cord-313312-h607itv2 38 10 and and CC cord-313312-h607itv2 38 11 low low JJ cord-313312-h607itv2 38 12 possibility possibility NN cord-313312-h607itv2 38 13 of of IN cord-313312-h607itv2 38 14 reversion reversion NN cord-313312-h607itv2 38 15 to to IN cord-313312-h607itv2 38 16 virulence virulence NN cord-313312-h607itv2 38 17 has have VBZ cord-313312-h607itv2 38 18 also also RB cord-313312-h607itv2 38 19 placed place VBN cord-313312-h607itv2 38 20 it -PRON- PRP cord-313312-h607itv2 38 21 as as IN cord-313312-h607itv2 38 22 a a DT cord-313312-h607itv2 38 23 promising promising JJ cord-313312-h607itv2 38 24 candidate candidate NN cord-313312-h607itv2 38 25 for for IN cord-313312-h607itv2 38 26 use use NN cord-313312-h607itv2 38 27 as as IN cord-313312-h607itv2 38 28 a a DT cord-313312-h607itv2 38 29 viral viral JJ cord-313312-h607itv2 38 30 vector vector NN cord-313312-h607itv2 38 31 to to TO cord-313312-h607itv2 38 32 deliver deliver VB cord-313312-h607itv2 38 33 heterologous heterologous JJ cord-313312-h607itv2 38 34 antigens antigen NNS cord-313312-h607itv2 38 35 [ [ -LRB- cord-313312-h607itv2 38 36 35 35 CD cord-313312-h607itv2 38 37 ] ] -RRB- cord-313312-h607itv2 38 38 . . . cord-313312-h607itv2 39 1 Some some DT cord-313312-h607itv2 39 2 of of IN cord-313312-h607itv2 39 3 the the DT cord-313312-h607itv2 39 4 first first JJ cord-313312-h607itv2 39 5 evidence evidence NN cord-313312-h607itv2 39 6 that that WDT cord-313312-h607itv2 39 7 describes describe VBZ cord-313312-h607itv2 39 8 the the DT cord-313312-h607itv2 39 9 role role NN cord-313312-h607itv2 39 10 of of IN cord-313312-h607itv2 39 11 pre pre JJ cord-313312-h607itv2 39 12 - - JJ cord-313312-h607itv2 39 13 existing existing JJ cord-313312-h607itv2 39 14 immunity immunity NN cord-313312-h607itv2 39 15 on on IN cord-313312-h607itv2 39 16 live live JJ cord-313312-h607itv2 39 17 vaccines vaccine NNS cord-313312-h607itv2 39 18 comes come VBZ cord-313312-h607itv2 39 19 from from IN cord-313312-h607itv2 39 20 the the DT cord-313312-h607itv2 39 21 measles measle NNS cord-313312-h607itv2 39 22 vaccine vaccine NN cord-313312-h607itv2 39 23 . . . cord-313312-h607itv2 40 1 The the DT cord-313312-h607itv2 40 2 efficacy efficacy NN cord-313312-h607itv2 40 3 of of IN cord-313312-h607itv2 40 4 live live JJ cord-313312-h607itv2 40 5 MV MV NNP cord-313312-h607itv2 40 6 was be VBD cord-313312-h607itv2 40 7 found find VBN cord-313312-h607itv2 40 8 to to TO cord-313312-h607itv2 40 9 be be VB cord-313312-h607itv2 40 10 often often RB cord-313312-h607itv2 40 11 hampered hamper VBN cord-313312-h607itv2 40 12 by by IN cord-313312-h607itv2 40 13 pre pre JJ cord-313312-h607itv2 40 14 - - JJ cord-313312-h607itv2 40 15 existing existing JJ cord-313312-h607itv2 40 16 immunity immunity NN cord-313312-h607itv2 40 17 at at IN cord-313312-h607itv2 40 18 the the DT cord-313312-h607itv2 40 19 time time NN cord-313312-h607itv2 40 20 of of IN cord-313312-h607itv2 40 21 vaccination vaccination NN cord-313312-h607itv2 40 22 , , , cord-313312-h607itv2 40 23 and and CC cord-313312-h607itv2 40 24 this this DT cord-313312-h607itv2 40 25 effect effect NN cord-313312-h607itv2 40 26 is be VBZ cord-313312-h607itv2 40 27 best well RBS cord-313312-h607itv2 40 28 illustrated illustrate VBN cord-313312-h607itv2 40 29 in in IN cord-313312-h607itv2 40 30 infants infant NNS cord-313312-h607itv2 40 31 who who WP cord-313312-h607itv2 40 32 are be VBP cord-313312-h607itv2 40 33 born bear VBN cord-313312-h607itv2 40 34 to to IN cord-313312-h607itv2 40 35 measles measles NN cord-313312-h607itv2 40 36 - - HYPH cord-313312-h607itv2 40 37 immune immune JJ cord-313312-h607itv2 40 38 mothers mother NNS cord-313312-h607itv2 40 39 . . . cord-313312-h607itv2 41 1 During during IN cord-313312-h607itv2 41 2 gestation gestation NN cord-313312-h607itv2 41 3 , , , cord-313312-h607itv2 41 4 infants infant NNS cord-313312-h607itv2 41 5 acquire acquire VBP cord-313312-h607itv2 41 6 protective protective JJ cord-313312-h607itv2 41 7 antibodies antibody NNS cord-313312-h607itv2 41 8 as as IN cord-313312-h607itv2 41 9 a a DT cord-313312-h607itv2 41 10 result result NN cord-313312-h607itv2 41 11 of of IN cord-313312-h607itv2 41 12 transplacental transplacental NNP cord-313312-h607itv2 41 13 transfer transfer NN cord-313312-h607itv2 41 14 of of IN cord-313312-h607itv2 41 15 maternal maternal JJ cord-313312-h607itv2 41 16 IgG IgG NNP cord-313312-h607itv2 41 17 antibodies antibody NNS cord-313312-h607itv2 41 18 [ [ -LRB- cord-313312-h607itv2 41 19 36 36 CD cord-313312-h607itv2 41 20 ] ] -RRB- cord-313312-h607itv2 41 21 . . . cord-313312-h607itv2 42 1 These these DT cord-313312-h607itv2 42 2 antibodies antibody NNS cord-313312-h607itv2 42 3 , , , cord-313312-h607itv2 42 4 while while IN cord-313312-h607itv2 42 5 protective protective JJ cord-313312-h607itv2 42 6 against against IN cord-313312-h607itv2 42 7 infection infection NN cord-313312-h607itv2 42 8 , , , cord-313312-h607itv2 42 9 can can MD cord-313312-h607itv2 42 10 also also RB cord-313312-h607itv2 42 11 suppress suppress VB cord-313312-h607itv2 42 12 infant infant NN cord-313312-h607itv2 42 13 responses response NNS cord-313312-h607itv2 42 14 to to IN cord-313312-h607itv2 42 15 immunization immunization NN cord-313312-h607itv2 42 16 . . . cord-313312-h607itv2 43 1 Indeed indeed RB cord-313312-h607itv2 43 2 , , , cord-313312-h607itv2 43 3 studies study NNS cord-313312-h607itv2 43 4 have have VBP cord-313312-h607itv2 43 5 shown show VBN cord-313312-h607itv2 43 6 that that IN cord-313312-h607itv2 43 7 vaccinating vaccinate VBG cord-313312-h607itv2 43 8 infants infant NNS cord-313312-h607itv2 43 9 born bear VBN cord-313312-h607itv2 43 10 to to IN cord-313312-h607itv2 43 11 measles measles NN cord-313312-h607itv2 43 12 - - HYPH cord-313312-h607itv2 43 13 immune immune JJ cord-313312-h607itv2 43 14 mothers mother NNS cord-313312-h607itv2 43 15 before before IN cord-313312-h607itv2 43 16 or or CC cord-313312-h607itv2 43 17 at at IN cord-313312-h607itv2 43 18 the the DT cord-313312-h607itv2 43 19 age age NN cord-313312-h607itv2 43 20 of of IN cord-313312-h607itv2 43 21 six six CD cord-313312-h607itv2 43 22 months month NNS cord-313312-h607itv2 43 23 often often RB cord-313312-h607itv2 43 24 results result VBZ cord-313312-h607itv2 43 25 in in IN cord-313312-h607itv2 43 26 seroconversion seroconversion NN cord-313312-h607itv2 43 27 failure failure NN cord-313312-h607itv2 43 28 [ [ -LRB- cord-313312-h607itv2 43 29 37 37 CD cord-313312-h607itv2 43 30 , , , cord-313312-h607itv2 43 31 38 38 CD cord-313312-h607itv2 43 32 ] ] -RRB- cord-313312-h607itv2 43 33 . . . cord-313312-h607itv2 44 1 By by IN cord-313312-h607itv2 44 2 contrast contrast NN cord-313312-h607itv2 44 3 , , , cord-313312-h607itv2 44 4 immunization immunization NN cord-313312-h607itv2 44 5 campaigns campaign NNS cord-313312-h607itv2 44 6 with with IN cord-313312-h607itv2 44 7 MV MV NNP cord-313312-h607itv2 44 8 between between IN cord-313312-h607itv2 44 9 9 9 CD cord-313312-h607itv2 44 10 to to TO cord-313312-h607itv2 44 11 12 12 CD cord-313312-h607itv2 44 12 months month NNS cord-313312-h607itv2 44 13 of of IN cord-313312-h607itv2 44 14 age age NN cord-313312-h607itv2 44 15 are be VBP cord-313312-h607itv2 44 16 relatively relatively RB cord-313312-h607itv2 44 17 successful successful JJ cord-313312-h607itv2 44 18 [ [ -LRB- cord-313312-h607itv2 44 19 39 39 CD cord-313312-h607itv2 44 20 , , , cord-313312-h607itv2 44 21 40 40 CD cord-313312-h607itv2 44 22 ] ] -RRB- cord-313312-h607itv2 44 23 . . . cord-313312-h607itv2 45 1 This this DT cord-313312-h607itv2 45 2 is be VBZ cord-313312-h607itv2 45 3 likely likely RB cord-313312-h607itv2 45 4 explained explain VBN cord-313312-h607itv2 45 5 by by IN cord-313312-h607itv2 45 6 waning wane VBG cord-313312-h607itv2 45 7 maternal maternal JJ cord-313312-h607itv2 45 8 antibody antibody NN cord-313312-h607itv2 45 9 levels level NNS cord-313312-h607itv2 45 10 over over IN cord-313312-h607itv2 45 11 the the DT cord-313312-h607itv2 45 12 period period NN cord-313312-h607itv2 45 13 of of IN cord-313312-h607itv2 45 14 6 6 CD cord-313312-h607itv2 45 15 to to TO cord-313312-h607itv2 45 16 12 12 CD cord-313312-h607itv2 45 17 months month NNS cord-313312-h607itv2 45 18 , , , cord-313312-h607itv2 45 19 where where WRB cord-313312-h607itv2 45 20 antibody antibody NN cord-313312-h607itv2 45 21 titers titer NNS cord-313312-h607itv2 45 22 fall fall VBP cord-313312-h607itv2 45 23 below below IN cord-313312-h607itv2 45 24 the the DT cord-313312-h607itv2 45 25 inhibitory inhibitory JJ cord-313312-h607itv2 45 26 threshold threshold NN cord-313312-h607itv2 45 27 required require VBN cord-313312-h607itv2 45 28 for for IN cord-313312-h607itv2 45 29 successful successful JJ cord-313312-h607itv2 45 30 vaccination vaccination NN cord-313312-h607itv2 45 31 [ [ -LRB- cord-313312-h607itv2 45 32 41 41 CD cord-313312-h607itv2 45 33 ] ] -RRB- cord-313312-h607itv2 45 34 . . . cord-313312-h607itv2 46 1 Moreover moreover RB cord-313312-h607itv2 46 2 , , , cord-313312-h607itv2 46 3 the the DT cord-313312-h607itv2 46 4 claims claim NNS cord-313312-h607itv2 46 5 that that WDT cord-313312-h607itv2 46 6 pre pre JJ cord-313312-h607itv2 46 7 - - JJ cord-313312-h607itv2 46 8 existing existing JJ cord-313312-h607itv2 46 9 antibody antibody NN cord-313312-h607itv2 46 10 titers titer NNS cord-313312-h607itv2 46 11 can can MD cord-313312-h607itv2 46 12 impact impact VB cord-313312-h607itv2 46 13 MV MV NNP cord-313312-h607itv2 46 14 efficacy efficacy NN cord-313312-h607itv2 46 15 are be VBP cord-313312-h607itv2 46 16 further further RB cord-313312-h607itv2 46 17 supported support VBN cord-313312-h607itv2 46 18 by by IN cord-313312-h607itv2 46 19 animal animal NN cord-313312-h607itv2 46 20 studies study NNS cord-313312-h607itv2 46 21 . . . cord-313312-h607itv2 47 1 For for IN cord-313312-h607itv2 47 2 instance instance NN cord-313312-h607itv2 47 3 , , , cord-313312-h607itv2 47 4 following follow VBG cord-313312-h607itv2 47 5 the the DT cord-313312-h607itv2 47 6 intravenous intravenous JJ cord-313312-h607itv2 47 7 transfer transfer NN cord-313312-h607itv2 47 8 of of IN cord-313312-h607itv2 47 9 varying vary VBG cord-313312-h607itv2 47 10 titers titer NNS cord-313312-h607itv2 47 11 of of IN cord-313312-h607itv2 47 12 MV MV NNP cord-313312-h607itv2 47 13 neutralizing neutralize VBG cord-313312-h607itv2 47 14 antibodies antibody NNS cord-313312-h607itv2 47 15 , , , cord-313312-h607itv2 47 16 immunization immunization NN cord-313312-h607itv2 47 17 of of IN cord-313312-h607itv2 47 18 mice mouse NNS cord-313312-h607itv2 47 19 with with IN cord-313312-h607itv2 47 20 a a DT cord-313312-h607itv2 47 21 recombinant recombinant JJ cord-313312-h607itv2 47 22 measles measle NNS cord-313312-h607itv2 47 23 vaccine vaccine NN cord-313312-h607itv2 47 24 ( ( -LRB- cord-313312-h607itv2 47 25 rMV rMV NNP cord-313312-h607itv2 47 26 ) ) -RRB- cord-313312-h607itv2 47 27 expressing express VBG cord-313312-h607itv2 48 1 Simian simian JJ cord-313312-h607itv2 48 2 Immunodeficiency Immunodeficiency NNP cord-313312-h607itv2 48 3 Virus Virus NNP cord-313312-h607itv2 48 4 ( ( -LRB- cord-313312-h607itv2 48 5 SIV SIV NNP cord-313312-h607itv2 48 6 ) ) -RRB- cord-313312-h607itv2 48 7 gag gag NN cord-313312-h607itv2 48 8 protein protein NN cord-313312-h607itv2 48 9 was be VBD cord-313312-h607itv2 48 10 significantly significantly RB cord-313312-h607itv2 48 11 inhibited inhibit VBN cord-313312-h607itv2 48 12 when when WRB cord-313312-h607itv2 48 13 pre pre JJ cord-313312-h607itv2 48 14 - - JJ cord-313312-h607itv2 48 15 existing existing JJ cord-313312-h607itv2 48 16 antibody antibody NN cord-313312-h607itv2 48 17 titers titer NNS cord-313312-h607itv2 48 18 were be VBD cord-313312-h607itv2 48 19 above above IN cord-313312-h607itv2 48 20 500mIU 500miu CD cord-313312-h607itv2 48 21 / / SYM cord-313312-h607itv2 48 22 mL ml NN cord-313312-h607itv2 48 23 of of IN cord-313312-h607itv2 48 24 serum serum NN cord-313312-h607itv2 48 25 [ [ -LRB- cord-313312-h607itv2 48 26 35 35 CD cord-313312-h607itv2 48 27 ] ] -RRB- cord-313312-h607itv2 48 28 . . . cord-313312-h607itv2 49 1 Likewise likewise RB cord-313312-h607itv2 49 2 , , , cord-313312-h607itv2 49 3 investigations investigation NNS cord-313312-h607itv2 49 4 in in IN cord-313312-h607itv2 49 5 cynomolgus cynomolgus JJ cord-313312-h607itv2 49 6 macaques macaque NNS cord-313312-h607itv2 49 7 by by IN cord-313312-h607itv2 49 8 van van NNP cord-313312-h607itv2 49 9 Binnendijk Binnendijk NNP cord-313312-h607itv2 49 10 et et NNP cord-313312-h607itv2 49 11 al al NNP cord-313312-h607itv2 49 12 . . NNP cord-313312-h607itv2 49 13 revealed reveal VBD cord-313312-h607itv2 49 14 that that IN cord-313312-h607itv2 49 15 pre pre JJ cord-313312-h607itv2 49 16 - - JJ cord-313312-h607itv2 49 17 existing existing JJ cord-313312-h607itv2 49 18 antibody antibody NN cord-313312-h607itv2 49 19 titers titer NNS cord-313312-h607itv2 49 20 as as RB cord-313312-h607itv2 49 21 low low JJ cord-313312-h607itv2 49 22 as as IN cord-313312-h607itv2 49 23 0.1IU 0.1iu CD cord-313312-h607itv2 50 1 /mL /mL NFP cord-313312-h607itv2 50 2 abrogated abrogate VBD cord-313312-h607itv2 50 3 the the DT cord-313312-h607itv2 50 4 development development NN cord-313312-h607itv2 50 5 of of IN cord-313312-h607itv2 50 6 antibodies antibody NNS cord-313312-h607itv2 50 7 following follow VBG cord-313312-h607itv2 50 8 vaccination vaccination NN cord-313312-h607itv2 50 9 with with IN cord-313312-h607itv2 50 10 MV MV NNP cord-313312-h607itv2 50 11 or or CC cord-313312-h607itv2 50 12 a a DT cord-313312-h607itv2 50 13 recombinant recombinant JJ cord-313312-h607itv2 50 14 vaccinia vaccinia NN cord-313312-h607itv2 50 15 virus virus NN cord-313312-h607itv2 50 16 vector vector NN cord-313312-h607itv2 50 17 expressing express VBG cord-313312-h607itv2 50 18 measles measles NN cord-313312-h607itv2 50 19 antigens antigen NNS cord-313312-h607itv2 50 20 [ [ -LRB- cord-313312-h607itv2 50 21 42 42 CD cord-313312-h607itv2 50 22 ] ] -RRB- cord-313312-h607itv2 50 23 . . . cord-313312-h607itv2 51 1 Interestingly interestingly RB cord-313312-h607itv2 51 2 , , , cord-313312-h607itv2 51 3 while while IN cord-313312-h607itv2 51 4 antibody antibody NN cord-313312-h607itv2 51 5 induction induction NN cord-313312-h607itv2 51 6 by by IN cord-313312-h607itv2 51 7 MV MV NNP cord-313312-h607itv2 51 8 is be VBZ cord-313312-h607itv2 51 9 negatively negatively RB cord-313312-h607itv2 51 10 impacted impact VBN cord-313312-h607itv2 51 11 by by IN cord-313312-h607itv2 51 12 pre pre JJ cord-313312-h607itv2 51 13 - - JJ cord-313312-h607itv2 51 14 existing existing JJ cord-313312-h607itv2 51 15 immunity immunity NN cord-313312-h607itv2 51 16 , , , cord-313312-h607itv2 51 17 the the DT cord-313312-h607itv2 51 18 effect effect NN cord-313312-h607itv2 51 19 on on IN cord-313312-h607itv2 51 20 cellular cellular JJ cord-313312-h607itv2 51 21 responses response NNS cord-313312-h607itv2 51 22 seem seem VBP cord-313312-h607itv2 51 23 unaffected unaffected JJ cord-313312-h607itv2 51 24 . . . cord-313312-h607itv2 52 1 For for IN cord-313312-h607itv2 52 2 example example NN cord-313312-h607itv2 52 3 , , , cord-313312-h607itv2 52 4 infants infant NNS cord-313312-h607itv2 52 5 vaccinated vaccinate VBN cord-313312-h607itv2 52 6 with with IN cord-313312-h607itv2 52 7 MV MV NNP cord-313312-h607itv2 52 8 at at IN cord-313312-h607itv2 52 9 age age NN cord-313312-h607itv2 52 10 6 6 CD cord-313312-h607itv2 52 11 or or CC cord-313312-h607itv2 52 12 9 9 CD cord-313312-h607itv2 52 13 months month NNS cord-313312-h607itv2 52 14 followed follow VBN cord-313312-h607itv2 52 15 by by IN cord-313312-h607itv2 52 16 the the DT cord-313312-h607itv2 52 17 measles measles NN cord-313312-h607itv2 52 18 - - HYPH cord-313312-h607itv2 52 19 mumps mumps NN cord-313312-h607itv2 52 20 - - HYPH cord-313312-h607itv2 52 21 rubella rubella NN cord-313312-h607itv2 52 22 ( ( -LRB- cord-313312-h607itv2 52 23 MMR MMR NNP cord-313312-h607itv2 52 24 ) ) -RRB- cord-313312-h607itv2 52 25 vaccine vaccine NN cord-313312-h607itv2 52 26 at at IN cord-313312-h607itv2 52 27 12 12 CD cord-313312-h607itv2 52 28 months month NNS cord-313312-h607itv2 52 29 generated generate VBN cord-313312-h607itv2 52 30 equivalent equivalent JJ cord-313312-h607itv2 52 31 T t NN cord-313312-h607itv2 52 32 - - HYPH cord-313312-h607itv2 52 33 cell cell NN cord-313312-h607itv2 52 34 responses response NNS cord-313312-h607itv2 52 35 to to TO cord-313312-h607itv2 52 36 control control VB cord-313312-h607itv2 52 37 infants infant NNS cord-313312-h607itv2 52 38 given give VBN cord-313312-h607itv2 52 39 only only RB cord-313312-h607itv2 52 40 MMR MMR NNP cord-313312-h607itv2 52 41 at at IN cord-313312-h607itv2 52 42 age age NN cord-313312-h607itv2 52 43 12 12 CD cord-313312-h607itv2 52 44 months month NNS cord-313312-h607itv2 52 45 [ [ -LRB- cord-313312-h607itv2 52 46 43 43 CD cord-313312-h607itv2 52 47 ] ] -RRB- cord-313312-h607itv2 52 48 . . . cord-313312-h607itv2 53 1 Thus thus RB cord-313312-h607itv2 53 2 , , , cord-313312-h607itv2 53 3 experimental experimental JJ cord-313312-h607itv2 53 4 models model NNS cord-313312-h607itv2 53 5 and and CC cord-313312-h607itv2 53 6 clinical clinical JJ cord-313312-h607itv2 53 7 data data NN cord-313312-h607itv2 53 8 support support NN cord-313312-h607itv2 53 9 that that IN cord-313312-h607itv2 53 10 the the DT cord-313312-h607itv2 53 11 inhibition inhibition NN cord-313312-h607itv2 53 12 of of IN cord-313312-h607itv2 53 13 MV MV NNP cord-313312-h607itv2 53 14 vaccination vaccination NN cord-313312-h607itv2 53 15 in in IN cord-313312-h607itv2 53 16 neonates neonate NNS cord-313312-h607itv2 53 17 is be VBZ cord-313312-h607itv2 53 18 more more RBR cord-313312-h607itv2 53 19 likely likely JJ cord-313312-h607itv2 53 20 due due IN cord-313312-h607itv2 53 21 to to IN cord-313312-h607itv2 53 22 interference interference NN cord-313312-h607itv2 53 23 from from IN cord-313312-h607itv2 53 24 maternal maternal JJ cord-313312-h607itv2 53 25 antibodies antibody NNS cord-313312-h607itv2 53 26 rather rather RB cord-313312-h607itv2 53 27 than than IN cord-313312-h607itv2 53 28 the the DT cord-313312-h607itv2 53 29 immaturity immaturity NN cord-313312-h607itv2 53 30 of of IN cord-313312-h607itv2 53 31 the the DT cord-313312-h607itv2 53 32 neonatal neonatal JJ cord-313312-h607itv2 53 33 system system NN cord-313312-h607itv2 53 34 . . . cord-313312-h607itv2 54 1 Adenoviruses adenovirus NNS cord-313312-h607itv2 54 2 ( ( -LRB- cord-313312-h607itv2 54 3 AdV AdV NNP cord-313312-h607itv2 54 4 ) ) -RRB- cord-313312-h607itv2 54 5 and and CC cord-313312-h607itv2 54 6 adeno adeno NN cord-313312-h607itv2 54 7 - - HYPH cord-313312-h607itv2 54 8 associated associate VBN cord-313312-h607itv2 54 9 viruses virus NNS cord-313312-h607itv2 54 10 have have VBP cord-313312-h607itv2 54 11 been be VBN cord-313312-h607itv2 54 12 widely widely RB cord-313312-h607itv2 54 13 studied study VBN cord-313312-h607itv2 54 14 as as IN cord-313312-h607itv2 54 15 a a DT cord-313312-h607itv2 54 16 potential potential JJ cord-313312-h607itv2 54 17 viral viral JJ cord-313312-h607itv2 54 18 vector vector NN cord-313312-h607itv2 54 19 for for IN cord-313312-h607itv2 54 20 cancer cancer NN cord-313312-h607itv2 54 21 gene gene NN cord-313312-h607itv2 54 22 therapy therapy NN cord-313312-h607itv2 54 23 and and CC cord-313312-h607itv2 54 24 infectious infectious JJ cord-313312-h607itv2 54 25 diseases disease NNS cord-313312-h607itv2 54 26 . . . cord-313312-h607itv2 55 1 This this DT cord-313312-h607itv2 55 2 double double RB cord-313312-h607itv2 55 3 - - HYPH cord-313312-h607itv2 55 4 stranded strand VBN cord-313312-h607itv2 55 5 DNA dna NN cord-313312-h607itv2 55 6 virus virus NN cord-313312-h607itv2 55 7 holds hold VBZ cord-313312-h607itv2 55 8 several several JJ cord-313312-h607itv2 55 9 advantages advantage NNS cord-313312-h607itv2 55 10 as as IN cord-313312-h607itv2 55 11 a a DT cord-313312-h607itv2 55 12 vector vector NN cord-313312-h607itv2 55 13 , , , cord-313312-h607itv2 55 14 including include VBG cord-313312-h607itv2 55 15 but but CC cord-313312-h607itv2 55 16 not not RB cord-313312-h607itv2 55 17 limited limited JJ cord-313312-h607itv2 55 18 to to IN cord-313312-h607itv2 55 19 the the DT cord-313312-h607itv2 55 20 ability ability NN cord-313312-h607itv2 55 21 to to TO cord-313312-h607itv2 55 22 induce induce VB cord-313312-h607itv2 55 23 robust robust JJ cord-313312-h607itv2 55 24 cellular cellular JJ cord-313312-h607itv2 55 25 and and CC cord-313312-h607itv2 55 26 humoral humoral JJ cord-313312-h607itv2 55 27 responses response NNS cord-313312-h607itv2 55 28 , , , cord-313312-h607itv2 55 29 high high JJ cord-313312-h607itv2 55 30 expression expression NN cord-313312-h607itv2 55 31 of of IN cord-313312-h607itv2 55 32 transgenes transgene NNS cord-313312-h607itv2 55 33 , , , cord-313312-h607itv2 55 34 favorable favorable JJ cord-313312-h607itv2 55 35 safety safety NN cord-313312-h607itv2 55 36 profiles profile NNS cord-313312-h607itv2 55 37 , , , cord-313312-h607itv2 55 38 and and CC cord-313312-h607itv2 55 39 no no DT cord-313312-h607itv2 55 40 risk risk NN cord-313312-h607itv2 55 41 of of IN cord-313312-h607itv2 55 42 integration integration NN cord-313312-h607itv2 55 43 into into IN cord-313312-h607itv2 55 44 the the DT cord-313312-h607itv2 55 45 host host NN cord-313312-h607itv2 55 46 genome genome NN cord-313312-h607itv2 55 47 . . . cord-313312-h607itv2 56 1 The the DT cord-313312-h607itv2 56 2 most most RBS cord-313312-h607itv2 56 3 commonly commonly RB cord-313312-h607itv2 56 4 used use VBN cord-313312-h607itv2 56 5 adenoviral adenoviral JJ cord-313312-h607itv2 56 6 vector vector NN cord-313312-h607itv2 56 7 is be VBZ cord-313312-h607itv2 56 8 AdV adv NN cord-313312-h607itv2 56 9 serotype serotype NN cord-313312-h607itv2 56 10 5 5 CD cord-313312-h607itv2 56 11 ( ( -LRB- cord-313312-h607itv2 56 12 Ad5 Ad5 NNP cord-313312-h607itv2 56 13 ) ) -RRB- cord-313312-h607itv2 56 14 and and CC cord-313312-h607itv2 56 15 has have VBZ cord-313312-h607itv2 56 16 been be VBN cord-313312-h607itv2 56 17 tested test VBN cord-313312-h607itv2 56 18 in in IN cord-313312-h607itv2 56 19 more more JJR cord-313312-h607itv2 56 20 than than IN cord-313312-h607itv2 56 21 400 400 CD cord-313312-h607itv2 56 22 gene gene NN cord-313312-h607itv2 56 23 therapy therapy NN cord-313312-h607itv2 56 24 trials trial NNS cord-313312-h607itv2 56 25 . . . cord-313312-h607itv2 57 1 However however RB cord-313312-h607itv2 57 2 , , , cord-313312-h607itv2 57 3 the the DT cord-313312-h607itv2 57 4 large large JJ cord-313312-h607itv2 57 5 majority majority NN cord-313312-h607itv2 57 6 of of IN cord-313312-h607itv2 57 7 the the DT cord-313312-h607itv2 57 8 human human JJ cord-313312-h607itv2 57 9 population population NN cord-313312-h607itv2 57 10 having have VBG cord-313312-h607itv2 57 11 pre pre JJ cord-313312-h607itv2 57 12 - - JJ cord-313312-h607itv2 57 13 existing existing JJ cord-313312-h607itv2 57 14 immunity immunity NN cord-313312-h607itv2 57 15 to to IN cord-313312-h607itv2 57 16 AdV adv NN cord-313312-h607itv2 57 17 limits limit VBZ cord-313312-h607itv2 57 18 its -PRON- PRP$ cord-313312-h607itv2 57 19 widespread widespread JJ cord-313312-h607itv2 57 20 use use NN cord-313312-h607itv2 57 21 in in IN cord-313312-h607itv2 57 22 the the DT cord-313312-h607itv2 57 23 clinics clinic NNS cord-313312-h607itv2 57 24 . . . cord-313312-h607itv2 58 1 Indeed indeed RB cord-313312-h607itv2 58 2 , , , cord-313312-h607itv2 58 3 a a DT cord-313312-h607itv2 58 4 recent recent JJ cord-313312-h607itv2 58 5 international international JJ cord-313312-h607itv2 58 6 cross cross JJ cord-313312-h607itv2 58 7 - - JJ cord-313312-h607itv2 58 8 sectional sectional JJ cord-313312-h607itv2 58 9 serological serological JJ cord-313312-h607itv2 58 10 survey survey NN cord-313312-h607itv2 58 11 demonstrated demonstrate VBD cord-313312-h607itv2 58 12 that that IN cord-313312-h607itv2 58 13 greater great JJR cord-313312-h607itv2 58 14 than than IN cord-313312-h607itv2 58 15 80 80 CD cord-313312-h607itv2 58 16 % % NN cord-313312-h607itv2 58 17 of of IN cord-313312-h607itv2 58 18 the the DT cord-313312-h607itv2 58 19 study study NN cord-313312-h607itv2 58 20 participants participant NNS cord-313312-h607itv2 58 21 possessed possess VBD cord-313312-h607itv2 58 22 neutralizing neutralize VBG cord-313312-h607itv2 58 23 antibodies antibody NNS cord-313312-h607itv2 58 24 against against IN cord-313312-h607itv2 58 25 Ad5 ad5 CD cord-313312-h607itv2 58 26 [ [ -LRB- cord-313312-h607itv2 58 27 44 44 CD cord-313312-h607itv2 58 28 ] ] -RRB- cord-313312-h607itv2 58 29 . . . cord-313312-h607itv2 59 1 In in IN cord-313312-h607itv2 59 2 a a DT cord-313312-h607itv2 59 3 similar similar JJ cord-313312-h607itv2 59 4 line line NN cord-313312-h607itv2 59 5 of of IN cord-313312-h607itv2 59 6 investigation investigation NN cord-313312-h607itv2 59 7 , , , cord-313312-h607itv2 59 8 Mast Mast NNP cord-313312-h607itv2 59 9 et et NNP cord-313312-h607itv2 59 10 al al NNP cord-313312-h607itv2 59 11 . . NNP cord-313312-h607itv2 59 12 found find VBD cord-313312-h607itv2 59 13 that that IN cord-313312-h607itv2 59 14 85.2 85.2 CD cord-313312-h607itv2 59 15 % % NN cord-313312-h607itv2 59 16 of of IN cord-313312-h607itv2 59 17 their -PRON- PRP$ cord-313312-h607itv2 59 18 study study NN cord-313312-h607itv2 59 19 participants participant NNS cord-313312-h607itv2 59 20 from from IN cord-313312-h607itv2 59 21 the the DT cord-313312-h607itv2 59 22 US US NNP cord-313312-h607itv2 59 23 , , , cord-313312-h607itv2 59 24 Europe Europe NNP cord-313312-h607itv2 59 25 , , , cord-313312-h607itv2 59 26 Thailand Thailand NNP cord-313312-h607itv2 59 27 , , , cord-313312-h607itv2 59 28 Africa Africa NNP cord-313312-h607itv2 59 29 , , , cord-313312-h607itv2 59 30 and and CC cord-313312-h607itv2 59 31 Brazil Brazil NNP cord-313312-h607itv2 59 32 were be VBD cord-313312-h607itv2 59 33 seropositive seropositive JJ cord-313312-h607itv2 59 34 for for IN cord-313312-h607itv2 59 35 anti anti JJ cord-313312-h607itv2 59 36 - - JJ cord-313312-h607itv2 59 37 Ad5 ad5 JJ cord-313312-h607itv2 59 38 neutralizing neutralize VBG cord-313312-h607itv2 59 39 antibodies antibody NNS cord-313312-h607itv2 59 40 [ [ -LRB- cord-313312-h607itv2 59 41 45 45 CD cord-313312-h607itv2 59 42 ] ] -RRB- cord-313312-h607itv2 59 43 . . . cord-313312-h607itv2 60 1 These these DT cord-313312-h607itv2 60 2 pre pre JJ cord-313312-h607itv2 60 3 - - JJ cord-313312-h607itv2 60 4 existing existing JJ cord-313312-h607itv2 60 5 antibodies antibody NNS cord-313312-h607itv2 60 6 have have VBP cord-313312-h607itv2 60 7 been be VBN cord-313312-h607itv2 60 8 shown show VBN cord-313312-h607itv2 60 9 to to TO cord-313312-h607itv2 60 10 neutralize neutralize VB cord-313312-h607itv2 60 11 the the DT cord-313312-h607itv2 60 12 Ad5 Ad5 NNP cord-313312-h607itv2 60 13 vectors vector NNS cord-313312-h607itv2 60 14 after after IN cord-313312-h607itv2 60 15 administration administration NN cord-313312-h607itv2 60 16 , , , cord-313312-h607itv2 60 17 thereby thereby RB cord-313312-h607itv2 60 18 lowering lower VBG cord-313312-h607itv2 60 19 their -PRON- PRP$ cord-313312-h607itv2 60 20 efficacy efficacy NN cord-313312-h607itv2 60 21 and and CC cord-313312-h607itv2 60 22 transgene transgene NN cord-313312-h607itv2 60 23 expression expression NN cord-313312-h607itv2 60 24 . . . cord-313312-h607itv2 61 1 The the DT cord-313312-h607itv2 61 2 most most RBS cord-313312-h607itv2 61 3 convincing convincing JJ cord-313312-h607itv2 61 4 evidence evidence NN cord-313312-h607itv2 61 5 is be VBZ cord-313312-h607itv2 61 6 from from IN cord-313312-h607itv2 61 7 the the DT cord-313312-h607itv2 61 8 large large JJ cord-313312-h607itv2 61 9 - - HYPH cord-313312-h607itv2 61 10 scale scale NN cord-313312-h607itv2 61 11 clinical clinical JJ cord-313312-h607itv2 61 12 trial trial NN cord-313312-h607itv2 61 13 ( ( -LRB- cord-313312-h607itv2 61 14 STEP STEP NNP cord-313312-h607itv2 61 15 ) ) -RRB- cord-313312-h607itv2 61 16 that that WDT cord-313312-h607itv2 61 17 tested test VBD cord-313312-h607itv2 61 18 an an DT cord-313312-h607itv2 61 19 Ad5-based Ad5-based NNP cord-313312-h607itv2 61 20 HIV-1 HIV-1 NNP cord-313312-h607itv2 61 21 vaccine vaccine NN cord-313312-h607itv2 61 22 , , , cord-313312-h607itv2 61 23 where where WRB cord-313312-h607itv2 61 24 reduced reduce VBN cord-313312-h607itv2 61 25 efficacy efficacy NN cord-313312-h607itv2 61 26 of of IN cord-313312-h607itv2 61 27 Ad5 Ad5 NNP cord-313312-h607itv2 61 28 was be VBD cord-313312-h607itv2 61 29 found find VBN cord-313312-h607itv2 61 30 to to TO cord-313312-h607itv2 61 31 be be VB cord-313312-h607itv2 61 32 associated associate VBN cord-313312-h607itv2 61 33 with with IN cord-313312-h607itv2 61 34 subjects subject NNS cord-313312-h607itv2 61 35 who who WP cord-313312-h607itv2 61 36 had have VBD cord-313312-h607itv2 61 37 pre pre VBN cord-313312-h607itv2 61 38 - - JJ cord-313312-h607itv2 61 39 existing existing JJ cord-313312-h607itv2 61 40 immunity immunity NN cord-313312-h607itv2 61 41 to to IN cord-313312-h607itv2 61 42 Ad5 Ad5 NNP cord-313312-h607itv2 61 43 [ [ -LRB- cord-313312-h607itv2 61 44 46 46 CD cord-313312-h607itv2 61 45 ] ] -RRB- cord-313312-h607itv2 61 46 . . . cord-313312-h607itv2 62 1 In in IN cord-313312-h607itv2 62 2 support support NN cord-313312-h607itv2 62 3 of of IN cord-313312-h607itv2 62 4 this this DT cord-313312-h607itv2 62 5 theory theory NN cord-313312-h607itv2 62 6 , , , cord-313312-h607itv2 62 7 the the DT cord-313312-h607itv2 62 8 clinical clinical JJ cord-313312-h607itv2 62 9 trial trial NN cord-313312-h607itv2 62 10 for for IN cord-313312-h607itv2 62 11 the the DT cord-313312-h607itv2 62 12 Ad5-based Ad5-based NNP cord-313312-h607itv2 62 13 Ebola Ebola NNP cord-313312-h607itv2 62 14 vaccine vaccine NN cord-313312-h607itv2 62 15 showed show VBD cord-313312-h607itv2 62 16 that that IN cord-313312-h607itv2 62 17 the the DT cord-313312-h607itv2 62 18 low low JJ cord-313312-h607itv2 62 19 - - HYPH cord-313312-h607itv2 62 20 dose dose NN cord-313312-h607itv2 62 21 vaccine vaccine NN cord-313312-h607itv2 62 22 of of IN cord-313312-h607itv2 62 23 4.0 4.0 CD cord-313312-h607itv2 62 24 × × CD cord-313312-h607itv2 62 25 10 10 CD cord-313312-h607itv2 62 26 10 10 CD cord-313312-h607itv2 62 27 viral viral JJ cord-313312-h607itv2 62 28 particles particle NNS cord-313312-h607itv2 62 29 was be VBD cord-313312-h607itv2 62 30 weakened weaken VBN cord-313312-h607itv2 62 31 by by IN cord-313312-h607itv2 62 32 pre pre JJ cord-313312-h607itv2 62 33 - - JJ cord-313312-h607itv2 62 34 existing existing JJ cord-313312-h607itv2 62 35 immunity immunity NN cord-313312-h607itv2 62 36 , , , cord-313312-h607itv2 62 37 whereas whereas IN cord-313312-h607itv2 62 38 immunogenicity immunogenicity NN cord-313312-h607itv2 62 39 was be VBD cord-313312-h607itv2 62 40 enhanced enhance VBN cord-313312-h607itv2 62 41 at at IN cord-313312-h607itv2 62 42 a a DT cord-313312-h607itv2 62 43 higher high JJR cord-313312-h607itv2 62 44 dose dose NN cord-313312-h607itv2 62 45 of of IN cord-313312-h607itv2 62 46 8.0 8.0 CD cord-313312-h607itv2 62 47 × × NN cord-313312-h607itv2 62 48 10 10 CD cord-313312-h607itv2 62 49 10 10 CD cord-313312-h607itv2 62 50 -1.6 -1.6 CD cord-313312-h607itv2 62 51 × × NN cord-313312-h607itv2 62 52 10 10 CD cord-313312-h607itv2 62 53 11 11 CD cord-313312-h607itv2 62 54 viral viral JJ cord-313312-h607itv2 62 55 particles particle NNS cord-313312-h607itv2 62 56 . . . cord-313312-h607itv2 63 1 In in IN cord-313312-h607itv2 63 2 a a DT cord-313312-h607itv2 63 3 mouse mouse NN cord-313312-h607itv2 63 4 model model NN cord-313312-h607itv2 63 5 , , , cord-313312-h607itv2 63 6 pre pre JJ cord-313312-h607itv2 63 7 - - JJ cord-313312-h607itv2 63 8 existing existing JJ cord-313312-h607itv2 63 9 anti anti JJ cord-313312-h607itv2 63 10 - - JJ cord-313312-h607itv2 63 11 Ad5 ad5 JJ cord-313312-h607itv2 63 12 neutralizing neutralize VBG cord-313312-h607itv2 63 13 antibodies antibody NNS cord-313312-h607itv2 63 14 were be VBD cord-313312-h607itv2 63 15 observed observe VBN cord-313312-h607itv2 63 16 to to TO cord-313312-h607itv2 63 17 severely severely RB cord-313312-h607itv2 63 18 hamper hamper VB cord-313312-h607itv2 63 19 the the DT cord-313312-h607itv2 63 20 induction induction NN cord-313312-h607itv2 63 21 of of IN cord-313312-h607itv2 63 22 both both CC cord-313312-h607itv2 63 23 cellular cellular JJ cord-313312-h607itv2 63 24 and and CC cord-313312-h607itv2 63 25 humoral humoral JJ cord-313312-h607itv2 63 26 responses response NNS cord-313312-h607itv2 63 27 by by IN cord-313312-h607itv2 63 28 a a DT cord-313312-h607itv2 63 29 recombinant recombinant JJ cord-313312-h607itv2 63 30 Ad5-Ebolavirus ad5-ebolavirus NN cord-313312-h607itv2 63 31 glycoprotein glycoprotein NN cord-313312-h607itv2 63 32 vaccine vaccine NN cord-313312-h607itv2 63 33 [ [ -LRB- cord-313312-h607itv2 63 34 47 47 CD cord-313312-h607itv2 63 35 ] ] -RRB- cord-313312-h607itv2 63 36 . . . cord-313312-h607itv2 64 1 Likewise likewise RB cord-313312-h607itv2 64 2 , , , cord-313312-h607itv2 64 3 a a DT cord-313312-h607itv2 64 4 recombinant recombinant JJ cord-313312-h607itv2 64 5 Ad5 ad5 CD cord-313312-h607itv2 64 6 vector vector NN cord-313312-h607itv2 64 7 expressing express VBG cord-313312-h607itv2 64 8 the the DT cord-313312-h607itv2 64 9 Human Human NNP cord-313312-h607itv2 64 10 Immunodeficiency Immunodeficiency NNP cord-313312-h607itv2 64 11 Virus-1 Virus-1 NNP cord-313312-h607itv2 64 12 ( ( -LRB- cord-313312-h607itv2 64 13 HIV HIV NNP cord-313312-h607itv2 64 14 ) ) -RRB- cord-313312-h607itv2 64 15 gag gag NN cord-313312-h607itv2 64 16 gene gene NN cord-313312-h607itv2 64 17 showed show VBD cord-313312-h607itv2 64 18 diminished diminish VBN cord-313312-h607itv2 64 19 , , , cord-313312-h607itv2 64 20 but but CC cord-313312-h607itv2 64 21 not not RB cord-313312-h607itv2 64 22 complete complete JJ cord-313312-h607itv2 64 23 , , , cord-313312-h607itv2 64 24 abrogation abrogation NN cord-313312-h607itv2 64 25 of of IN cord-313312-h607itv2 64 26 gag gag NN cord-313312-h607itv2 64 27 - - HYPH cord-313312-h607itv2 64 28 specific specific JJ cord-313312-h607itv2 64 29 cellular cellular JJ cord-313312-h607itv2 64 30 immune immune JJ cord-313312-h607itv2 64 31 responses response NNS cord-313312-h607itv2 64 32 following follow VBG cord-313312-h607itv2 64 33 the the DT cord-313312-h607itv2 64 34 vaccination vaccination NN cord-313312-h607itv2 64 35 of of IN cord-313312-h607itv2 64 36 rhesus rhesu NNS cord-313312-h607itv2 64 37 monkeys monkey NNS cord-313312-h607itv2 64 38 pre pre VBP cord-313312-h607itv2 64 39 - - VBD cord-313312-h607itv2 64 40 exposed expose VBN cord-313312-h607itv2 64 41 to to IN cord-313312-h607itv2 64 42 an an DT cord-313312-h607itv2 64 43 empty empty JJ cord-313312-h607itv2 64 44 Ad5 ad5 CD cord-313312-h607itv2 64 45 vector vector NN cord-313312-h607itv2 64 46 [ [ -LRB- cord-313312-h607itv2 64 47 48 48 CD cord-313312-h607itv2 64 48 ] ] -RRB- cord-313312-h607itv2 64 49 . . . cord-313312-h607itv2 65 1 Nonetheless nonetheless RB cord-313312-h607itv2 65 2 , , , cord-313312-h607itv2 65 3 there there EX cord-313312-h607itv2 65 4 exists exist VBZ cord-313312-h607itv2 65 5 conflicting conflict VBG cord-313312-h607itv2 65 6 data datum NNS cord-313312-h607itv2 65 7 that that WDT cord-313312-h607itv2 65 8 pre pre JJ cord-313312-h607itv2 65 9 - - JJ cord-313312-h607itv2 65 10 existing existing JJ cord-313312-h607itv2 65 11 anti anti JJ cord-313312-h607itv2 65 12 - - JJ cord-313312-h607itv2 65 13 Ad5 ad5 JJ cord-313312-h607itv2 65 14 may may MD cord-313312-h607itv2 65 15 not not RB cord-313312-h607itv2 65 16 affect affect VB cord-313312-h607itv2 65 17 the the DT cord-313312-h607itv2 65 18 induction induction NN cord-313312-h607itv2 65 19 of of IN cord-313312-h607itv2 65 20 cytotoxic cytotoxic JJ cord-313312-h607itv2 65 21 T t NN cord-313312-h607itv2 65 22 - - HYPH cord-313312-h607itv2 65 23 cell cell NN cord-313312-h607itv2 65 24 responses response NNS cord-313312-h607itv2 65 25 , , , cord-313312-h607itv2 65 26 indicating indicate VBG cord-313312-h607itv2 65 27 that that IN cord-313312-h607itv2 65 28 more more JJR cord-313312-h607itv2 65 29 studies study NNS cord-313312-h607itv2 65 30 may may MD cord-313312-h607itv2 65 31 be be VB cord-313312-h607itv2 65 32 required require VBN cord-313312-h607itv2 65 33 to to TO cord-313312-h607itv2 65 34 resolve resolve VB cord-313312-h607itv2 65 35 these these DT cord-313312-h607itv2 65 36 discrepancies discrepancy NNS cord-313312-h607itv2 65 37 [ [ -LRB- cord-313312-h607itv2 65 38 49 49 CD cord-313312-h607itv2 65 39 ] ] -RRB- cord-313312-h607itv2 65 40 . . . cord-313312-h607itv2 66 1 The the DT cord-313312-h607itv2 66 2 high high JJ cord-313312-h607itv2 66 3 seroprevalence seroprevalence NN cord-313312-h607itv2 66 4 of of IN cord-313312-h607itv2 66 5 anti anti JJ cord-313312-h607itv2 66 6 - - JJ cord-313312-h607itv2 66 7 Ad5 ad5 JJ cord-313312-h607itv2 66 8 immunity immunity NN cord-313312-h607itv2 66 9 has have VBZ cord-313312-h607itv2 66 10 pivoted pivot VBN cord-313312-h607itv2 66 11 the the DT cord-313312-h607itv2 66 12 development development NN cord-313312-h607itv2 66 13 of of IN cord-313312-h607itv2 66 14 genetically genetically RB cord-313312-h607itv2 66 15 - - HYPH cord-313312-h607itv2 66 16 modified modify VBN cord-313312-h607itv2 66 17 AdV adv NN cord-313312-h607itv2 66 18 and and CC cord-313312-h607itv2 66 19 the the DT cord-313312-h607itv2 66 20 search search NN cord-313312-h607itv2 66 21 of of IN cord-313312-h607itv2 66 22 rarer rare JJR cord-313312-h607itv2 66 23 AdV adv NN cord-313312-h607itv2 66 24 serotypes serotype NNS cord-313312-h607itv2 66 25 for for IN cord-313312-h607itv2 66 26 use use NN cord-313312-h607itv2 66 27 as as IN cord-313312-h607itv2 66 28 vectors vector NNS cord-313312-h607itv2 66 29 , , , cord-313312-h607itv2 66 30 in in IN cord-313312-h607itv2 66 31 hopes hope NNS cord-313312-h607itv2 66 32 that that IN cord-313312-h607itv2 66 33 these these DT cord-313312-h607itv2 66 34 viruses virus NNS cord-313312-h607itv2 66 35 may may MD cord-313312-h607itv2 66 36 circumvent circumvent VB cord-313312-h607itv2 66 37 the the DT cord-313312-h607itv2 66 38 effects effect NNS cord-313312-h607itv2 66 39 of of IN cord-313312-h607itv2 66 40 pre pre JJ cord-313312-h607itv2 66 41 - - JJ cord-313312-h607itv2 66 42 existing existing JJ cord-313312-h607itv2 66 43 anti anti JJ cord-313312-h607itv2 66 44 - - JJ cord-313312-h607itv2 66 45 Ad5 ad5 JJ cord-313312-h607itv2 66 46 immunity immunity NN cord-313312-h607itv2 66 47 [ [ -LRB- cord-313312-h607itv2 66 48 50 50 CD cord-313312-h607itv2 66 49 , , , cord-313312-h607itv2 66 50 51 51 CD cord-313312-h607itv2 66 51 ] ] -RRB- cord-313312-h607itv2 66 52 . . . cord-313312-h607itv2 67 1 However however RB cord-313312-h607itv2 67 2 , , , cord-313312-h607itv2 67 3 there there EX cord-313312-h607itv2 67 4 remains remain VBZ cord-313312-h607itv2 67 5 the the DT cord-313312-h607itv2 67 6 possibility possibility NN cord-313312-h607itv2 67 7 of of IN cord-313312-h607itv2 67 8 cross cross NN cord-313312-h607itv2 67 9 - - NN cord-313312-h607itv2 67 10 reactivity reactivity NN cord-313312-h607itv2 67 11 between between IN cord-313312-h607itv2 67 12 antibodies antibody NNS cord-313312-h607itv2 67 13 against against IN cord-313312-h607itv2 67 14 the the DT cord-313312-h607itv2 67 15 different different JJ cord-313312-h607itv2 67 16 AdV adv NN cord-313312-h607itv2 67 17 serotypes serotype NNS cord-313312-h607itv2 67 18 , , , cord-313312-h607itv2 67 19 which which WDT cord-313312-h607itv2 67 20 could could MD cord-313312-h607itv2 67 21 in in IN cord-313312-h607itv2 67 22 turn turn NN cord-313312-h607itv2 67 23 potentially potentially RB cord-313312-h607itv2 67 24 influence influence VB cord-313312-h607itv2 67 25 the the DT cord-313312-h607itv2 67 26 efficacy efficacy NN cord-313312-h607itv2 67 27 of of IN cord-313312-h607itv2 67 28 these these DT cord-313312-h607itv2 67 29 rarer rare JJR cord-313312-h607itv2 67 30 AdV adv NN cord-313312-h607itv2 67 31 as as IN cord-313312-h607itv2 67 32 vaccine vaccine NN cord-313312-h607itv2 67 33 vectors vector NNS cord-313312-h607itv2 67 34 . . . cord-313312-h607itv2 68 1 Indeed indeed RB cord-313312-h607itv2 68 2 , , , cord-313312-h607itv2 68 3 investigations investigation NNS cord-313312-h607itv2 68 4 by by IN cord-313312-h607itv2 68 5 Heemskerk Heemskerk NNP cord-313312-h607itv2 68 6 et et NNP cord-313312-h607itv2 68 7 al al NNP cord-313312-h607itv2 68 8 . . NNP cord-313312-h607itv2 68 9 have have VBP cord-313312-h607itv2 68 10 shown show VBN cord-313312-h607itv2 68 11 that that IN cord-313312-h607itv2 68 12 Ad5-specific Ad5-specific NNP cord-313312-h607itv2 68 13 CD4 CD4 NNP cord-313312-h607itv2 68 14 + + CC cord-313312-h607itv2 68 15 T T NNP cord-313312-h607itv2 68 16 - - HYPH cord-313312-h607itv2 68 17 cells cell NNS cord-313312-h607itv2 68 18 could could MD cord-313312-h607itv2 68 19 cross cross VB cord-313312-h607itv2 68 20 - - VB cord-313312-h607itv2 68 21 react react VB cord-313312-h607itv2 68 22 with with IN cord-313312-h607itv2 68 23 other other JJ cord-313312-h607itv2 68 24 AdV adv NN cord-313312-h607itv2 68 25 serotypes serotype NNS cord-313312-h607itv2 68 26 including include VBG cord-313312-h607itv2 68 27 but but CC cord-313312-h607itv2 68 28 not not RB cord-313312-h607itv2 68 29 limited limited JJ cord-313312-h607itv2 68 30 to to IN cord-313312-h607itv2 68 31 Ad1 ad1 NN cord-313312-h607itv2 68 32 , , , cord-313312-h607itv2 68 33 Ad3 ad3 CD cord-313312-h607itv2 68 34 , , , cord-313312-h607itv2 68 35 Ad7 ad7 NN cord-313312-h607itv2 68 36 , , , cord-313312-h607itv2 68 37 and and CC cord-313312-h607itv2 68 38 Ad35 Ad35 NNP cord-313312-h607itv2 68 39 , , , cord-313312-h607itv2 68 40 suggesting suggest VBG cord-313312-h607itv2 68 41 that that IN cord-313312-h607itv2 68 42 the the DT cord-313312-h607itv2 68 43 different different JJ cord-313312-h607itv2 68 44 AdV adv NN cord-313312-h607itv2 68 45 serotypes serotype NNS cord-313312-h607itv2 68 46 share share VBP cord-313312-h607itv2 68 47 similar similar JJ cord-313312-h607itv2 68 48 T t NN cord-313312-h607itv2 68 49 - - HYPH cord-313312-h607itv2 68 50 cell cell NN cord-313312-h607itv2 68 51 epitopes epitope NNS cord-313312-h607itv2 68 52 [ [ -LRB- cord-313312-h607itv2 68 53 52 52 CD cord-313312-h607itv2 68 54 ] ] -RRB- cord-313312-h607itv2 68 55 . . . cord-313312-h607itv2 69 1 Several several JJ cord-313312-h607itv2 69 2 studies study NNS cord-313312-h607itv2 69 3 have have VBP cord-313312-h607itv2 69 4 attempted attempt VBN cord-313312-h607itv2 69 5 to to TO cord-313312-h607itv2 69 6 further further RB cord-313312-h607itv2 69 7 explore explore VB cord-313312-h607itv2 69 8 this this DT cord-313312-h607itv2 69 9 school school NN cord-313312-h607itv2 69 10 of of IN cord-313312-h607itv2 69 11 thought thought NN cord-313312-h607itv2 69 12 , , , cord-313312-h607itv2 69 13 and and CC cord-313312-h607itv2 69 14 their -PRON- PRP$ cord-313312-h607itv2 69 15 results result NNS cord-313312-h607itv2 69 16 have have VBP cord-313312-h607itv2 69 17 provided provide VBN cord-313312-h607itv2 69 18 greater great JJR cord-313312-h607itv2 69 19 insight insight NN cord-313312-h607itv2 69 20 into into IN cord-313312-h607itv2 69 21 this this DT cord-313312-h607itv2 69 22 particular particular JJ cord-313312-h607itv2 69 23 topic topic NN cord-313312-h607itv2 69 24 . . . cord-313312-h607itv2 70 1 Ad35 Ad35 NNP cord-313312-h607itv2 70 2 is be VBZ cord-313312-h607itv2 70 3 one one CD cord-313312-h607itv2 70 4 of of IN cord-313312-h607itv2 70 5 the the DT cord-313312-h607itv2 70 6 rarest rare JJS cord-313312-h607itv2 70 7 human human JJ cord-313312-h607itv2 70 8 AdV adv NN cord-313312-h607itv2 70 9 serotypes serotype NNS cord-313312-h607itv2 70 10 , , , cord-313312-h607itv2 70 11 with with IN cord-313312-h607itv2 70 12 a a DT cord-313312-h607itv2 70 13 seroprevalence seroprevalence NN cord-313312-h607itv2 70 14 of of IN cord-313312-h607itv2 70 15 less less JJR cord-313312-h607itv2 70 16 than than IN cord-313312-h607itv2 70 17 7 7 CD cord-313312-h607itv2 70 18 % % NN cord-313312-h607itv2 70 19 in in IN cord-313312-h607itv2 70 20 the the DT cord-313312-h607itv2 70 21 population population NN cord-313312-h607itv2 70 22 . . . cord-313312-h607itv2 71 1 In in IN cord-313312-h607itv2 71 2 an an DT cord-313312-h607itv2 71 3 attempt attempt NN cord-313312-h607itv2 71 4 to to TO cord-313312-h607itv2 71 5 determine determine VB cord-313312-h607itv2 71 6 its -PRON- PRP$ cord-313312-h607itv2 71 7 potential potential NN cord-313312-h607itv2 71 8 as as IN cord-313312-h607itv2 71 9 an an DT cord-313312-h607itv2 71 10 alternative alternative JJ cord-313312-h607itv2 71 11 vector vector NN cord-313312-h607itv2 71 12 to to IN cord-313312-h607itv2 71 13 Ad5 ad5 CD cord-313312-h607itv2 71 14 , , , cord-313312-h607itv2 71 15 Barouch Barouch NNP cord-313312-h607itv2 71 16 et et NNP cord-313312-h607itv2 71 17 al al NNP cord-313312-h607itv2 71 18 . . . cord-313312-h607itv2 72 1 compared compare VBN cord-313312-h607itv2 72 2 the the DT cord-313312-h607itv2 72 3 immunogenicity immunogenicity NN cord-313312-h607itv2 72 4 of of IN cord-313312-h607itv2 72 5 a a DT cord-313312-h607itv2 72 6 rAd35 rad35 NN cord-313312-h607itv2 72 7 vaccine vaccine NN cord-313312-h607itv2 72 8 expressing express VBG cord-313312-h607itv2 72 9 Simian Simian NNP cord-313312-h607itv2 72 10 Immunodeficiency Immunodeficiency NNP cord-313312-h607itv2 72 11 Virus virus NN cord-313312-h607itv2 72 12 ( ( -LRB- cord-313312-h607itv2 72 13 SIV)-Gag SIV)-Gag NNP cord-313312-h607itv2 72 14 versus versus IN cord-313312-h607itv2 72 15 a a DT cord-313312-h607itv2 72 16 rAd5 rad5 PRP$ cord-313312-h607itv2 72 17 SIV SIV NNP cord-313312-h607itv2 72 18 - - HYPH cord-313312-h607itv2 72 19 Gag Gag NNP cord-313312-h607itv2 72 20 vaccine vaccine NN cord-313312-h607itv2 72 21 in in IN cord-313312-h607itv2 72 22 Ad5 ad5 CD cord-313312-h607itv2 72 23 immune immune JJ cord-313312-h607itv2 72 24 C57 C57 NNP cord-313312-h607itv2 72 25 / / SYM cord-313312-h607itv2 72 26 BL6 BL6 NNP cord-313312-h607itv2 72 27 mice mouse NNS cord-313312-h607itv2 72 28 [ [ -LRB- cord-313312-h607itv2 72 29 53 53 CD cord-313312-h607itv2 72 30 ] ] -RRB- cord-313312-h607itv2 72 31 . . . cord-313312-h607itv2 73 1 Indeed indeed RB cord-313312-h607itv2 73 2 , , , cord-313312-h607itv2 73 3 the the DT cord-313312-h607itv2 73 4 efficacy efficacy NN cord-313312-h607itv2 73 5 of of IN cord-313312-h607itv2 73 6 the the DT cord-313312-h607itv2 73 7 rAd35-Gag rAd35-Gag NNP cord-313312-h607itv2 73 8 vaccine vaccine NN cord-313312-h607itv2 73 9 was be VBD cord-313312-h607itv2 73 10 unaffected unaffected JJ cord-313312-h607itv2 73 11 even even RB cord-313312-h607itv2 73 12 by by IN cord-313312-h607itv2 73 13 high high JJ cord-313312-h607itv2 73 14 levels level NNS cord-313312-h607itv2 73 15 of of IN cord-313312-h607itv2 73 16 pre pre JJ cord-313312-h607itv2 73 17 - - JJ cord-313312-h607itv2 73 18 existing existing JJ cord-313312-h607itv2 73 19 Ad5 ad5 CD cord-313312-h607itv2 73 20 immunity immunity NN cord-313312-h607itv2 73 21 , , , cord-313312-h607itv2 73 22 indicating indicate VBG cord-313312-h607itv2 73 23 the the DT cord-313312-h607itv2 73 24 absence absence NN cord-313312-h607itv2 73 25 of of IN cord-313312-h607itv2 73 26 a a DT cord-313312-h607itv2 73 27 cross cross JJ cord-313312-h607itv2 73 28 - - JJ cord-313312-h607itv2 73 29 reactive reactive JJ cord-313312-h607itv2 73 30 response response NN cord-313312-h607itv2 73 31 between between IN cord-313312-h607itv2 73 32 Ad5 ad5 CD cord-313312-h607itv2 73 33 and and CC cord-313312-h607itv2 73 34 Ad35 Ad35 NNP cord-313312-h607itv2 73 35 . . . cord-313312-h607itv2 74 1 Likewise likewise RB cord-313312-h607itv2 74 2 , , , cord-313312-h607itv2 74 3 the the DT cord-313312-h607itv2 74 4 presence presence NN cord-313312-h607itv2 74 5 of of IN cord-313312-h607itv2 74 6 anti anti JJ cord-313312-h607itv2 74 7 - - JJ cord-313312-h607itv2 74 8 Ad5 ad5 JJ cord-313312-h607itv2 74 9 immunity immunity NN cord-313312-h607itv2 74 10 did do VBD cord-313312-h607itv2 74 11 not not RB cord-313312-h607itv2 74 12 affect affect VB cord-313312-h607itv2 74 13 the the DT cord-313312-h607itv2 74 14 efficacy efficacy NN cord-313312-h607itv2 74 15 of of IN cord-313312-h607itv2 74 16 a a DT cord-313312-h607itv2 74 17 rAd11-Gag rad11-gag CD cord-313312-h607itv2 74 18 vector vector NN cord-313312-h607itv2 74 19 vaccine vaccine NN cord-313312-h607itv2 74 20 in in IN cord-313312-h607itv2 74 21 mice mouse NNS cord-313312-h607itv2 74 22 . . . cord-313312-h607itv2 75 1 Interestingly interestingly RB cord-313312-h607itv2 75 2 , , , cord-313312-h607itv2 75 3 pre pre JJ cord-313312-h607itv2 75 4 - - JJ cord-313312-h607itv2 75 5 existing existing JJ cord-313312-h607itv2 75 6 anti anti JJ cord-313312-h607itv2 75 7 - - JJ cord-313312-h607itv2 75 8 Ad11 ad11 JJ cord-313312-h607itv2 75 9 immunity immunity NN cord-313312-h607itv2 75 10 could could MD cord-313312-h607itv2 75 11 suppress suppress VB cord-313312-h607itv2 75 12 cellular cellular JJ cord-313312-h607itv2 75 13 immune immune JJ cord-313312-h607itv2 75 14 responses response NNS cord-313312-h607itv2 75 15 elicited elicit VBN cord-313312-h607itv2 75 16 by by IN cord-313312-h607itv2 75 17 the the DT cord-313312-h607itv2 75 18 rAd35-Gag rAd35-Gag NNP cord-313312-h607itv2 75 19 vaccine vaccine NN cord-313312-h607itv2 75 20 , , , cord-313312-h607itv2 75 21 suggesting suggest VBG cord-313312-h607itv2 75 22 some some DT cord-313312-h607itv2 75 23 cross cross NN cord-313312-h607itv2 75 24 - - NN cord-313312-h607itv2 75 25 reactivity reactivity NN cord-313312-h607itv2 75 26 between between IN cord-313312-h607itv2 75 27 Ad11 Ad11 NNP cord-313312-h607itv2 75 28 and and CC cord-313312-h607itv2 75 29 Ad35 Ad35 NNP cord-313312-h607itv2 75 30 immune immune JJ cord-313312-h607itv2 75 31 responses response NNS cord-313312-h607itv2 75 32 [ [ -LRB- cord-313312-h607itv2 75 33 54 54 CD cord-313312-h607itv2 75 34 ] ] -RRB- cord-313312-h607itv2 75 35 . . . cord-313312-h607itv2 76 1 The the DT cord-313312-h607itv2 76 2 inhibitory inhibitory JJ cord-313312-h607itv2 76 3 effect effect NN cord-313312-h607itv2 76 4 of of IN cord-313312-h607itv2 76 5 pre pre JJ cord-313312-h607itv2 76 6 - - JJ cord-313312-h607itv2 76 7 existing existing JJ cord-313312-h607itv2 76 8 antibodies antibody NNS cord-313312-h607itv2 76 9 to to TO cord-313312-h607itv2 76 10 AdV adv NN cord-313312-h607itv2 76 11 remains remain VBZ cord-313312-h607itv2 76 12 a a DT cord-313312-h607itv2 76 13 challenge challenge NN cord-313312-h607itv2 76 14 for for IN cord-313312-h607itv2 76 15 their -PRON- PRP$ cord-313312-h607itv2 76 16 use use NN cord-313312-h607itv2 76 17 as as IN cord-313312-h607itv2 76 18 viral viral JJ cord-313312-h607itv2 76 19 vectors vector NNS cord-313312-h607itv2 76 20 , , , cord-313312-h607itv2 76 21 and and CC cord-313312-h607itv2 76 22 the the DT cord-313312-h607itv2 76 23 development development NN cord-313312-h607itv2 76 24 of of IN cord-313312-h607itv2 76 25 alternative alternative JJ cord-313312-h607itv2 76 26 serotypes serotype NNS cord-313312-h607itv2 76 27 remains remain VBZ cord-313312-h607itv2 76 28 to to TO cord-313312-h607itv2 76 29 be be VB cord-313312-h607itv2 76 30 one one CD cord-313312-h607itv2 76 31 of of IN cord-313312-h607itv2 76 32 the the DT cord-313312-h607itv2 76 33 best good JJS cord-313312-h607itv2 76 34 strategies strategy NNS cord-313312-h607itv2 76 35 to to TO cord-313312-h607itv2 76 36 circumvent circumvent VB cord-313312-h607itv2 76 37 this this DT cord-313312-h607itv2 76 38 limitation limitation NN cord-313312-h607itv2 76 39 . . . cord-313312-h607itv2 77 1 The the DT cord-313312-h607itv2 77 2 history history NN cord-313312-h607itv2 77 3 of of IN cord-313312-h607itv2 77 4 mankind mankind NN cord-313312-h607itv2 77 5 is be VBZ cord-313312-h607itv2 77 6 intricately intricately RB cord-313312-h607itv2 77 7 intertwined intertwine VBN cord-313312-h607itv2 77 8 with with IN cord-313312-h607itv2 77 9 that that DT cord-313312-h607itv2 77 10 of of IN cord-313312-h607itv2 77 11 influenza influenza NN cord-313312-h607itv2 77 12 , , , cord-313312-h607itv2 77 13 and and CC cord-313312-h607itv2 77 14 the the DT cord-313312-h607itv2 77 15 virus virus NN cord-313312-h607itv2 77 16 remains remain VBZ cord-313312-h607itv2 77 17 one one CD cord-313312-h607itv2 77 18 of of IN cord-313312-h607itv2 77 19 the the DT cord-313312-h607itv2 77 20 top top JJ cord-313312-h607itv2 77 21 10 10 CD cord-313312-h607itv2 77 22 threats threat NNS cord-313312-h607itv2 77 23 to to IN cord-313312-h607itv2 77 24 global global JJ cord-313312-h607itv2 77 25 health health NN cord-313312-h607itv2 77 26 . . . cord-313312-h607itv2 78 1 Estimates estimate NNS cord-313312-h607itv2 78 2 indicate indicate VBP cord-313312-h607itv2 78 3 that that IN cord-313312-h607itv2 78 4 there there EX cord-313312-h607itv2 78 5 are be VBP cord-313312-h607itv2 78 6 approximately approximately RB cord-313312-h607itv2 78 7 1 1 CD cord-313312-h607itv2 78 8 billion billion CD cord-313312-h607itv2 78 9 cases case NNS cord-313312-h607itv2 78 10 globally globally RB cord-313312-h607itv2 78 11 each each DT cord-313312-h607itv2 78 12 year year NN cord-313312-h607itv2 78 13 , , , cord-313312-h607itv2 78 14 of of IN cord-313312-h607itv2 78 15 which which WDT cord-313312-h607itv2 78 16 3 3 CD cord-313312-h607itv2 78 17 to to IN cord-313312-h607itv2 78 18 5 5 CD cord-313312-h607itv2 78 19 million million CD cord-313312-h607itv2 78 20 are be VBP cord-313312-h607itv2 78 21 severe severe JJ cord-313312-h607itv2 78 22 cases case NNS cord-313312-h607itv2 78 23 and and CC cord-313312-h607itv2 78 24 up up IN cord-313312-h607itv2 78 25 to to TO cord-313312-h607itv2 78 26 650,000 650,000 CD cord-313312-h607itv2 78 27 eventually eventually RB cord-313312-h607itv2 78 28 succumb succumb VB cord-313312-h607itv2 78 29 to to IN cord-313312-h607itv2 78 30 the the DT cord-313312-h607itv2 78 31 disease disease NN cord-313312-h607itv2 78 32 [ [ -LRB- cord-313312-h607itv2 78 33 55 55 CD cord-313312-h607itv2 78 34 ] ] -RRB- cord-313312-h607itv2 78 35 . . . cord-313312-h607itv2 79 1 Combined combine VBN cord-313312-h607itv2 79 2 with with IN cord-313312-h607itv2 79 3 the the DT cord-313312-h607itv2 79 4 economic economic JJ cord-313312-h607itv2 79 5 impact impact NN cord-313312-h607itv2 79 6 from from IN cord-313312-h607itv2 79 7 the the DT cord-313312-h607itv2 79 8 loss loss NN cord-313312-h607itv2 79 9 of of IN cord-313312-h607itv2 79 10 work work NN cord-313312-h607itv2 79 11 productivity productivity NN cord-313312-h607itv2 79 12 , , , cord-313312-h607itv2 79 13 a a DT cord-313312-h607itv2 79 14 proper proper JJ cord-313312-h607itv2 79 15 and and CC cord-313312-h607itv2 79 16 robust robust JJ cord-313312-h607itv2 79 17 framework framework NN cord-313312-h607itv2 79 18 is be VBZ cord-313312-h607itv2 79 19 required require VBN cord-313312-h607itv2 79 20 to to TO cord-313312-h607itv2 79 21 counter counter VB cord-313312-h607itv2 79 22 this this DT cord-313312-h607itv2 79 23 threat threat NN cord-313312-h607itv2 79 24 . . . cord-313312-h607itv2 80 1 The the DT cord-313312-h607itv2 80 2 2019 2019 CD cord-313312-h607itv2 80 3 Global Global NNP cord-313312-h607itv2 80 4 Influenza Influenza NNP cord-313312-h607itv2 80 5 Strategies Strategies NNPS cord-313312-h607itv2 80 6 recommend recommend VBP cord-313312-h607itv2 80 7 vaccination vaccination NN cord-313312-h607itv2 80 8 as as IN cord-313312-h607itv2 80 9 the the DT cord-313312-h607itv2 80 10 most most RBS cord-313312-h607itv2 80 11 effective effective JJ cord-313312-h607itv2 80 12 intervention intervention NN cord-313312-h607itv2 80 13 to to TO cord-313312-h607itv2 80 14 mitigate mitigate VB cord-313312-h607itv2 80 15 the the DT cord-313312-h607itv2 80 16 impact impact NN cord-313312-h607itv2 80 17 of of IN cord-313312-h607itv2 80 18 influenza influenza NN cord-313312-h607itv2 80 19 [ [ -LRB- cord-313312-h607itv2 80 20 56 56 CD cord-313312-h607itv2 80 21 ] ] -RRB- cord-313312-h607itv2 80 22 . . . cord-313312-h607itv2 81 1 Three three CD cord-313312-h607itv2 81 2 types type NNS cord-313312-h607itv2 81 3 of of IN cord-313312-h607itv2 81 4 influenza influenza NN cord-313312-h607itv2 81 5 vaccines vaccine NNS cord-313312-h607itv2 81 6 are be VBP cord-313312-h607itv2 81 7 licensed license VBN cord-313312-h607itv2 81 8 for for IN cord-313312-h607itv2 81 9 use use NN cord-313312-h607itv2 81 10 : : : cord-313312-h607itv2 81 11 ( ( -LRB- cord-313312-h607itv2 81 12 1 1 LS cord-313312-h607itv2 81 13 ) ) -RRB- cord-313312-h607itv2 81 14 recombinant recombinant NN cord-313312-h607itv2 81 15 , , , cord-313312-h607itv2 81 16 ( ( -LRB- cord-313312-h607itv2 81 17 2 2 LS cord-313312-h607itv2 81 18 ) ) -RRB- cord-313312-h607itv2 81 19 inactivated inactivate VBN cord-313312-h607itv2 81 20 , , , cord-313312-h607itv2 81 21 and and CC cord-313312-h607itv2 81 22 ( ( -LRB- cord-313312-h607itv2 81 23 3 3 LS cord-313312-h607itv2 81 24 ) ) -RRB- cord-313312-h607itv2 81 25 live live RB cord-313312-h607itv2 81 26 - - HYPH cord-313312-h607itv2 81 27 attenuated attenuated JJ cord-313312-h607itv2 81 28 . . . cord-313312-h607itv2 82 1 The the DT cord-313312-h607itv2 82 2 three three CD cord-313312-h607itv2 82 3 vaccines vaccine NNS cord-313312-h607itv2 82 4 are be VBP cord-313312-h607itv2 82 5 multivalent multivalent JJ cord-313312-h607itv2 82 6 and and CC cord-313312-h607itv2 82 7 provide provide VB cord-313312-h607itv2 82 8 protection protection NN cord-313312-h607itv2 82 9 against against IN cord-313312-h607itv2 82 10 selected select VBN cord-313312-h607itv2 82 11 influenza influenza NN cord-313312-h607itv2 82 12 type type NN cord-313312-h607itv2 82 13 A a NN cord-313312-h607itv2 82 14 and and CC cord-313312-h607itv2 82 15 type type NN cord-313312-h607itv2 82 16 B b NN cord-313312-h607itv2 82 17 strains strain NNS cord-313312-h607itv2 82 18 that that WDT cord-313312-h607itv2 82 19 are be VBP cord-313312-h607itv2 82 20 predicted predict VBN cord-313312-h607itv2 82 21 to to TO cord-313312-h607itv2 82 22 spread spread VB cord-313312-h607itv2 82 23 in in IN cord-313312-h607itv2 82 24 the the DT cord-313312-h607itv2 82 25 upcoming upcoming JJ cord-313312-h607itv2 82 26 season season NN cord-313312-h607itv2 82 27 [ [ -LRB- cord-313312-h607itv2 82 28 57 57 CD cord-313312-h607itv2 82 29 ] ] -RRB- cord-313312-h607itv2 82 30 . . . cord-313312-h607itv2 83 1 The the DT cord-313312-h607itv2 83 2 former former JJ cord-313312-h607itv2 83 3 two two CD cord-313312-h607itv2 83 4 are be VBP cord-313312-h607itv2 83 5 capable capable JJ cord-313312-h607itv2 83 6 of of IN cord-313312-h607itv2 83 7 inducing induce VBG cord-313312-h607itv2 83 8 only only RB cord-313312-h607itv2 83 9 IgG igg NN cord-313312-h607itv2 83 10 responses response NNS cord-313312-h607itv2 83 11 [ [ -LRB- cord-313312-h607itv2 83 12 57 57 CD cord-313312-h607itv2 83 13 , , , cord-313312-h607itv2 83 14 58 58 CD cord-313312-h607itv2 83 15 ] ] -RRB- cord-313312-h607itv2 83 16 . . . cord-313312-h607itv2 84 1 By by IN cord-313312-h607itv2 84 2 contrast contrast NN cord-313312-h607itv2 84 3 , , , cord-313312-h607itv2 84 4 the the DT cord-313312-h607itv2 84 5 live live RB cord-313312-h607itv2 84 6 - - HYPH cord-313312-h607itv2 84 7 attenuated attenuate VBN cord-313312-h607itv2 84 8 influenza influenza NN cord-313312-h607itv2 84 9 vaccine vaccine NN cord-313312-h607itv2 84 10 ( ( -LRB- cord-313312-h607itv2 84 11 LAIV LAIV NNP cord-313312-h607itv2 84 12 ) ) -RRB- cord-313312-h607itv2 84 13 can can MD cord-313312-h607itv2 84 14 generate generate VB cord-313312-h607itv2 84 15 strain strain NN cord-313312-h607itv2 84 16 - - HYPH cord-313312-h607itv2 84 17 specific specific JJ cord-313312-h607itv2 84 18 IgG igg NN cord-313312-h607itv2 84 19 antibodies antibody NNS cord-313312-h607itv2 84 20 as as RB cord-313312-h607itv2 84 21 well well RB cord-313312-h607itv2 84 22 as as IN cord-313312-h607itv2 84 23 mucosal mucosal JJ cord-313312-h607itv2 84 24 IgA IgA NNP cord-313312-h607itv2 84 25 immunity immunity NN cord-313312-h607itv2 84 26 and and CC cord-313312-h607itv2 84 27 T t NN cord-313312-h607itv2 84 28 - - HYPH cord-313312-h607itv2 84 29 cell cell NN cord-313312-h607itv2 84 30 responses response NNS cord-313312-h607itv2 84 31 that that WDT cord-313312-h607itv2 84 32 are be VBP cord-313312-h607itv2 84 33 associated associate VBN cord-313312-h607itv2 84 34 with with IN cord-313312-h607itv2 84 35 protection protection NN cord-313312-h607itv2 84 36 from from IN cord-313312-h607itv2 84 37 influenza influenza NN cord-313312-h607itv2 84 38 illness illness NN cord-313312-h607itv2 84 39 [ [ -LRB- cord-313312-h607itv2 84 40 59 59 CD cord-313312-h607itv2 84 41 , , , cord-313312-h607itv2 84 42 60 60 CD cord-313312-h607itv2 84 43 ] ] -RRB- cord-313312-h607itv2 84 44 . . . cord-313312-h607itv2 85 1 Indeed indeed RB cord-313312-h607itv2 85 2 , , , cord-313312-h607itv2 85 3 a a DT cord-313312-h607itv2 85 4 meta meta NN cord-313312-h607itv2 85 5 - - HYPH cord-313312-h607itv2 85 6 analysis analysis NN cord-313312-h607itv2 85 7 by by IN cord-313312-h607itv2 85 8 Ambrose Ambrose NNP cord-313312-h607itv2 85 9 et et NNP cord-313312-h607itv2 85 10 al al NNP cord-313312-h607itv2 85 11 . . . cord-313312-h607itv2 86 1 on on IN cord-313312-h607itv2 86 2 the the DT cord-313312-h607itv2 86 3 efficacy efficacy NN cord-313312-h607itv2 86 4 of of IN cord-313312-h607itv2 86 5 LAIV LAIV NNP cord-313312-h607itv2 86 6 in in IN cord-313312-h607itv2 86 7 children child NNS cord-313312-h607itv2 86 8 showed show VBD cord-313312-h607itv2 86 9 that that IN cord-313312-h607itv2 86 10 recipients recipient NNS cord-313312-h607itv2 86 11 of of IN cord-313312-h607itv2 86 12 the the DT cord-313312-h607itv2 86 13 live live JJ cord-313312-h607itv2 86 14 vaccine vaccine NN cord-313312-h607itv2 86 15 demonstrated demonstrate VBD cord-313312-h607itv2 86 16 a a DT cord-313312-h607itv2 86 17 44 44 CD cord-313312-h607itv2 86 18 % % NN cord-313312-h607itv2 86 19 reduction reduction NN cord-313312-h607itv2 86 20 in in IN cord-313312-h607itv2 86 21 influenza influenza NN cord-313312-h607itv2 86 22 cases case NNS cord-313312-h607itv2 86 23 compared compare VBN cord-313312-h607itv2 86 24 to to IN cord-313312-h607itv2 86 25 those those DT cord-313312-h607itv2 86 26 who who WP cord-313312-h607itv2 86 27 received receive VBD cord-313312-h607itv2 86 28 the the DT cord-313312-h607itv2 86 29 trivalent trivalent JJ cord-313312-h607itv2 86 30 inactivated inactivate VBN cord-313312-h607itv2 86 31 vaccine vaccine NN cord-313312-h607itv2 86 32 ( ( -LRB- cord-313312-h607itv2 86 33 TIV TIV NNP cord-313312-h607itv2 86 34 ) ) -RRB- cord-313312-h607itv2 87 1 [ [ -LRB- cord-313312-h607itv2 87 2 61 61 CD cord-313312-h607itv2 87 3 ] ] -RRB- cord-313312-h607itv2 87 4 . . . cord-313312-h607itv2 88 1 Put put VB cord-313312-h607itv2 88 2 together together RB cord-313312-h607itv2 88 3 , , , cord-313312-h607itv2 88 4 these these DT cord-313312-h607itv2 88 5 studies study NNS cord-313312-h607itv2 88 6 demonstrate demonstrate VBP cord-313312-h607itv2 88 7 the the DT cord-313312-h607itv2 88 8 potential potential NN cord-313312-h607itv2 88 9 of of IN cord-313312-h607itv2 88 10 LAIV LAIV NNP cord-313312-h607itv2 88 11 as as IN cord-313312-h607itv2 88 12 a a DT cord-313312-h607itv2 88 13 highly highly RB cord-313312-h607itv2 88 14 efficacious efficacious JJ cord-313312-h607itv2 88 15 vaccine vaccine NN cord-313312-h607itv2 88 16 . . . cord-313312-h607itv2 89 1 Yet yet RB cord-313312-h607itv2 89 2 , , , cord-313312-h607itv2 89 3 efforts effort NNS cord-313312-h607itv2 89 4 to to TO cord-313312-h607itv2 89 5 develop develop VB cord-313312-h607itv2 89 6 such such PDT cord-313312-h607itv2 89 7 a a DT cord-313312-h607itv2 89 8 vaccine vaccine NN cord-313312-h607itv2 89 9 have have VBP cord-313312-h607itv2 89 10 been be VBN cord-313312-h607itv2 89 11 stymied stymie VBN cord-313312-h607itv2 89 12 by by IN cord-313312-h607itv2 89 13 the the DT cord-313312-h607itv2 89 14 presence presence NN cord-313312-h607itv2 89 15 of of IN cord-313312-h607itv2 89 16 pre pre JJ cord-313312-h607itv2 89 17 - - JJ cord-313312-h607itv2 89 18 existing existing JJ cord-313312-h607itv2 89 19 immunity immunity NN cord-313312-h607itv2 89 20 gained gain VBD cord-313312-h607itv2 89 21 over over IN cord-313312-h607itv2 89 22 a a DT cord-313312-h607itv2 89 23 lifetime lifetime NN cord-313312-h607itv2 89 24 of of IN cord-313312-h607itv2 89 25 exposure exposure NN cord-313312-h607itv2 89 26 to to IN cord-313312-h607itv2 89 27 different different JJ cord-313312-h607itv2 89 28 viral viral JJ cord-313312-h607itv2 89 29 strains strain NNS cord-313312-h607itv2 89 30 either either CC cord-313312-h607itv2 89 31 from from IN cord-313312-h607itv2 89 32 natural natural JJ cord-313312-h607itv2 89 33 infection infection NN cord-313312-h607itv2 89 34 or or CC cord-313312-h607itv2 89 35 vaccination vaccination NN cord-313312-h607itv2 89 36 . . . cord-313312-h607itv2 90 1 Indeed indeed RB cord-313312-h607itv2 90 2 , , , cord-313312-h607itv2 90 3 several several JJ cord-313312-h607itv2 90 4 observational observational JJ cord-313312-h607itv2 90 5 studies study NNS cord-313312-h607itv2 90 6 point point VBP cord-313312-h607itv2 90 7 to to IN cord-313312-h607itv2 90 8 the the DT cord-313312-h607itv2 90 9 possibility possibility NN cord-313312-h607itv2 90 10 that that IN cord-313312-h607itv2 90 11 pre pre JJ cord-313312-h607itv2 90 12 - - JJ cord-313312-h607itv2 90 13 existing existing JJ cord-313312-h607itv2 90 14 immunity immunity NN cord-313312-h607itv2 90 15 can can MD cord-313312-h607itv2 90 16 reduce reduce VB cord-313312-h607itv2 90 17 the the DT cord-313312-h607itv2 90 18 efficacy efficacy NN cord-313312-h607itv2 90 19 of of IN cord-313312-h607itv2 90 20 both both CC cord-313312-h607itv2 90 21 inactivated inactivated JJ cord-313312-h607itv2 90 22 and and CC cord-313312-h607itv2 90 23 life life NN cord-313312-h607itv2 90 24 - - HYPH cord-313312-h607itv2 90 25 attenuated attenuate VBN cord-313312-h607itv2 90 26 influenza influenza NN cord-313312-h607itv2 90 27 vaccine vaccine NN cord-313312-h607itv2 90 28 [ [ -LRB- cord-313312-h607itv2 90 29 62 62 CD cord-313312-h607itv2 90 30 ] ] -RRB- cord-313312-h607itv2 90 31 [ [ -LRB- cord-313312-h607itv2 90 32 63 63 CD cord-313312-h607itv2 90 33 ] ] -RRB- cord-313312-h607itv2 90 34 [ [ -LRB- cord-313312-h607itv2 90 35 64 64 CD cord-313312-h607itv2 90 36 ] ] -RRB- cord-313312-h607itv2 91 1 [ [ -LRB- cord-313312-h607itv2 91 2 65 65 CD cord-313312-h607itv2 91 3 ] ] -RRB- cord-313312-h607itv2 92 1 [ [ -LRB- cord-313312-h607itv2 92 2 66 66 CD cord-313312-h607itv2 92 3 ] ] -RRB- cord-313312-h607itv2 93 1 [ [ -LRB- cord-313312-h607itv2 93 2 67 67 CD cord-313312-h607itv2 93 3 ] ] -RRB- cord-313312-h607itv2 93 4 [ [ -LRB- cord-313312-h607itv2 93 5 68 68 CD cord-313312-h607itv2 93 6 ] ] -RRB- cord-313312-h607itv2 93 7 . . . cord-313312-h607itv2 94 1 For for IN cord-313312-h607itv2 94 2 example example NN cord-313312-h607itv2 94 3 , , , cord-313312-h607itv2 94 4 Saito Saito NNP cord-313312-h607itv2 94 5 et et NNP cord-313312-h607itv2 94 6 al al NNP cord-313312-h607itv2 94 7 . . NNP cord-313312-h607itv2 94 8 found find VBD cord-313312-h607itv2 94 9 that that IN cord-313312-h607itv2 94 10 children child NNS cord-313312-h607itv2 94 11 who who WP cord-313312-h607itv2 94 12 received receive VBD cord-313312-h607itv2 94 13 TIV TIV NNP cord-313312-h607itv2 94 14 for for IN cord-313312-h607itv2 94 15 a a DT cord-313312-h607itv2 94 16 previous previous JJ cord-313312-h607itv2 94 17 season season NN cord-313312-h607itv2 94 18 had have VBD cord-313312-h607itv2 94 19 reduced reduce VBN cord-313312-h607itv2 94 20 vaccine vaccine NN cord-313312-h607itv2 94 21 effectiveness effectiveness NN cord-313312-h607itv2 94 22 for for IN cord-313312-h607itv2 94 23 the the DT cord-313312-h607itv2 94 24 current current JJ cord-313312-h607itv2 94 25 seasonal seasonal JJ cord-313312-h607itv2 94 26 vaccine vaccine NN cord-313312-h607itv2 94 27 compared compare VBN cord-313312-h607itv2 94 28 to to IN cord-313312-h607itv2 94 29 unvaccinated unvaccinated JJ cord-313312-h607itv2 94 30 children child NNS cord-313312-h607itv2 94 31 [ [ -LRB- cord-313312-h607itv2 94 32 66 66 CD cord-313312-h607itv2 94 33 ] ] -RRB- cord-313312-h607itv2 94 34 . . . cord-313312-h607itv2 95 1 Likewise likewise RB cord-313312-h607itv2 95 2 , , , cord-313312-h607itv2 95 3 Sasaki Sasaki NNP cord-313312-h607itv2 95 4 et et NNP cord-313312-h607itv2 95 5 al al NNP cord-313312-h607itv2 95 6 . . . cord-313312-h607itv2 96 1 showed show VBD cord-313312-h607itv2 96 2 lower low JJR cord-313312-h607itv2 96 3 antibody antibody NN cord-313312-h607itv2 96 4 induction induction NN cord-313312-h607itv2 96 5 by by IN cord-313312-h607itv2 96 6 a a DT cord-313312-h607itv2 96 7 LAIV LAIV NNP cord-313312-h607itv2 96 8 in in IN cord-313312-h607itv2 96 9 individuals individual NNS cord-313312-h607itv2 96 10 who who WP cord-313312-h607itv2 96 11 had have VBD cord-313312-h607itv2 96 12 prior prior JJ cord-313312-h607itv2 96 13 year year NN cord-313312-h607itv2 96 14 TIV TIV NNP cord-313312-h607itv2 96 15 vaccination vaccination NN cord-313312-h607itv2 96 16 [ [ -LRB- cord-313312-h607itv2 96 17 67 67 CD cord-313312-h607itv2 96 18 ] ] -RRB- cord-313312-h607itv2 96 19 . . . cord-313312-h607itv2 97 1 Furthermore furthermore RB cord-313312-h607itv2 97 2 , , , cord-313312-h607itv2 97 3 Coelingh Coelingh NNP cord-313312-h607itv2 97 4 et et NNP cord-313312-h607itv2 97 5 al al NNP cord-313312-h607itv2 97 6 . . NNP cord-313312-h607itv2 97 7 demonstrated demonstrate VBD cord-313312-h607itv2 97 8 that that IN cord-313312-h607itv2 97 9 younger young JJR cord-313312-h607itv2 97 10 children child NNS cord-313312-h607itv2 97 11 aged age VBN cord-313312-h607itv2 97 12 two two CD cord-313312-h607itv2 97 13 to to TO cord-313312-h607itv2 97 14 eight eight CD cord-313312-h607itv2 97 15 as as RB cord-313312-h607itv2 97 16 well well RB cord-313312-h607itv2 97 17 as as IN cord-313312-h607itv2 97 18 baseline baseline JJ cord-313312-h607itv2 97 19 seronegative seronegative JJ cord-313312-h607itv2 97 20 adults adult NNS cord-313312-h607itv2 97 21 had have VBD cord-313312-h607itv2 97 22 higher high JJR cord-313312-h607itv2 97 23 fold fold NN cord-313312-h607itv2 97 24 - - HYPH cord-313312-h607itv2 97 25 induction induction NN cord-313312-h607itv2 97 26 of of IN cord-313312-h607itv2 97 27 serum serum NN cord-313312-h607itv2 97 28 hemagglutinin hemagglutinin NN cord-313312-h607itv2 97 29 inhibition inhibition NN cord-313312-h607itv2 97 30 ( ( -LRB- cord-313312-h607itv2 97 31 HAI HAI NNP cord-313312-h607itv2 97 32 ) ) -RRB- cord-313312-h607itv2 97 33 antibody antibody NN cord-313312-h607itv2 97 34 titers titer NNS cord-313312-h607itv2 97 35 post post VBP cord-313312-h607itv2 97 36 - - JJ cord-313312-h607itv2 97 37 LAIV LAIV NNP cord-313312-h607itv2 97 38 vaccination vaccination NN cord-313312-h607itv2 97 39 [ [ -LRB- cord-313312-h607itv2 97 40 69 69 CD cord-313312-h607itv2 97 41 ] ] -RRB- cord-313312-h607itv2 97 42 . . . cord-313312-h607itv2 98 1 However however RB cord-313312-h607itv2 98 2 , , , cord-313312-h607itv2 98 3 given give VBN cord-313312-h607itv2 98 4 how how WRB cord-313312-h607itv2 98 5 complicated complicated JJ cord-313312-h607itv2 98 6 it -PRON- PRP cord-313312-h607itv2 98 7 is be VBZ cord-313312-h607itv2 98 8 to to TO cord-313312-h607itv2 98 9 trace trace VB cord-313312-h607itv2 98 10 the the DT cord-313312-h607itv2 98 11 history history NN cord-313312-h607itv2 98 12 of of IN cord-313312-h607itv2 98 13 an an DT cord-313312-h607itv2 98 14 individual individual NN cord-313312-h607itv2 98 15 's 's POS cord-313312-h607itv2 98 16 exposure exposure NN cord-313312-h607itv2 98 17 to to IN cord-313312-h607itv2 98 18 influenza influenza NN cord-313312-h607itv2 98 19 strains strain NNS cord-313312-h607itv2 98 20 , , , cord-313312-h607itv2 98 21 it -PRON- PRP cord-313312-h607itv2 98 22 is be VBZ cord-313312-h607itv2 98 23 difficult difficult JJ cord-313312-h607itv2 98 24 to to TO cord-313312-h607itv2 98 25 tease tease VB cord-313312-h607itv2 98 26 out out RP cord-313312-h607itv2 98 27 the the DT cord-313312-h607itv2 98 28 exact exact JJ cord-313312-h607itv2 98 29 impact impact NN cord-313312-h607itv2 98 30 that that WDT cord-313312-h607itv2 98 31 pre pre JJ cord-313312-h607itv2 98 32 - - JJ cord-313312-h607itv2 98 33 existing existing JJ cord-313312-h607itv2 98 34 immunity immunity NN cord-313312-h607itv2 98 35 has have VBZ cord-313312-h607itv2 98 36 on on IN cord-313312-h607itv2 98 37 vaccine vaccine NN cord-313312-h607itv2 98 38 efficacy efficacy NN cord-313312-h607itv2 98 39 in in IN cord-313312-h607itv2 98 40 human human JJ cord-313312-h607itv2 98 41 samples sample NNS cord-313312-h607itv2 98 42 . . . cord-313312-h607itv2 99 1 Perhaps perhaps RB cord-313312-h607itv2 99 2 then then RB cord-313312-h607itv2 99 3 , , , cord-313312-h607itv2 99 4 by by IN cord-313312-h607itv2 99 5 establishing establish VBG cord-313312-h607itv2 99 6 a a DT cord-313312-h607itv2 99 7 good good JJ cord-313312-h607itv2 99 8 animal animal NN cord-313312-h607itv2 99 9 model model NN cord-313312-h607itv2 99 10 with with IN cord-313312-h607itv2 99 11 controlled control VBN cord-313312-h607itv2 99 12 infection infection NN cord-313312-h607itv2 99 13 histories history NNS cord-313312-h607itv2 99 14 , , , cord-313312-h607itv2 99 15 we -PRON- PRP cord-313312-h607itv2 99 16 will will MD cord-313312-h607itv2 99 17 be be VB cord-313312-h607itv2 99 18 able able JJ cord-313312-h607itv2 99 19 to to TO cord-313312-h607itv2 99 20 better well RBR cord-313312-h607itv2 99 21 understand understand VB cord-313312-h607itv2 99 22 these these DT cord-313312-h607itv2 99 23 complexities complexity NNS cord-313312-h607itv2 99 24 . . . cord-313312-h607itv2 100 1 Flaviviruses flavivirus NNS cord-313312-h607itv2 100 2 include include VBP cord-313312-h607itv2 100 3 a a DT cord-313312-h607itv2 100 4 number number NN cord-313312-h607itv2 100 5 of of IN cord-313312-h607itv2 100 6 clinically clinically RB cord-313312-h607itv2 100 7 important important JJ cord-313312-h607itv2 100 8 pathogens pathogen NNS cord-313312-h607itv2 100 9 that that WDT cord-313312-h607itv2 100 10 are be VBP cord-313312-h607itv2 100 11 either either RB cord-313312-h607itv2 100 12 transmitted transmit VBN cord-313312-h607itv2 100 13 by by IN cord-313312-h607itv2 100 14 mosquitoes mosquito NNS cord-313312-h607itv2 100 15 ( ( -LRB- cord-313312-h607itv2 100 16 dengue dengue NN cord-313312-h607itv2 100 17 , , , cord-313312-h607itv2 100 18 Zika Zika NNP cord-313312-h607itv2 100 19 , , , cord-313312-h607itv2 100 20 yellow yellow JJ cord-313312-h607itv2 100 21 fever fever NN cord-313312-h607itv2 100 22 , , , cord-313312-h607itv2 100 23 West West NNP cord-313312-h607itv2 100 24 Nile Nile NNP cord-313312-h607itv2 100 25 , , , cord-313312-h607itv2 100 26 and and CC cord-313312-h607itv2 100 27 Japanese japanese JJ cord-313312-h607itv2 100 28 encephalitis encephalitis NN cord-313312-h607itv2 100 29 virus virus NN cord-313312-h607itv2 100 30 ) ) -RRB- cord-313312-h607itv2 100 31 or or CC cord-313312-h607itv2 100 32 by by IN cord-313312-h607itv2 100 33 ticks tick NNS cord-313312-h607itv2 100 34 ( ( -LRB- cord-313312-h607itv2 100 35 tick tick VB cord-313312-h607itv2 100 36 - - HYPH cord-313312-h607itv2 100 37 borne bear VBN cord-313312-h607itv2 100 38 encephalitis encephalitis RB cord-313312-h607itv2 100 39 , , , cord-313312-h607itv2 100 40 Powassan Powassan NNP cord-313312-h607itv2 100 41 virus virus NN cord-313312-h607itv2 100 42 ) ) -RRB- cord-313312-h607itv2 100 43 [ [ -LRB- cord-313312-h607itv2 100 44 70 70 CD cord-313312-h607itv2 100 45 ] ] -RRB- cord-313312-h607itv2 100 46 . . . cord-313312-h607itv2 101 1 The the DT cord-313312-h607itv2 101 2 recent recent JJ cord-313312-h607itv2 101 3 Zika Zika NNP cord-313312-h607itv2 101 4 pandemic pandemic NN cord-313312-h607itv2 101 5 witnessed witness VBD cord-313312-h607itv2 101 6 more more JJR cord-313312-h607itv2 101 7 than than IN cord-313312-h607itv2 101 8 3700 3700 CD cord-313312-h607itv2 101 9 cases case NNS cord-313312-h607itv2 101 10 of of IN cord-313312-h607itv2 101 11 congenital congenital JJ cord-313312-h607itv2 101 12 birth birth NN cord-313312-h607itv2 101 13 defects defect NNS cord-313312-h607itv2 101 14 linked link VBN cord-313312-h607itv2 101 15 to to IN cord-313312-h607itv2 101 16 Zika Zika NNP cord-313312-h607itv2 101 17 virus virus NN cord-313312-h607itv2 101 18 infection infection NN cord-313312-h607itv2 101 19 in in IN cord-313312-h607itv2 101 20 the the DT cord-313312-h607itv2 101 21 Americas Americas NNPS cord-313312-h607itv2 101 22 and and CC cord-313312-h607itv2 101 23 was be VBD cord-313312-h607itv2 101 24 declared declare VBN cord-313312-h607itv2 101 25 by by IN cord-313312-h607itv2 101 26 the the DT cord-313312-h607itv2 101 27 World World NNP cord-313312-h607itv2 101 28 Health Health NNP cord-313312-h607itv2 101 29 Organization Organization NNP cord-313312-h607itv2 101 30 in in IN cord-313312-h607itv2 101 31 February February NNP cord-313312-h607itv2 101 32 2016 2016 CD cord-313312-h607itv2 101 33 to to TO cord-313312-h607itv2 101 34 be be VB cord-313312-h607itv2 101 35 a a DT cord-313312-h607itv2 101 36 public public JJ cord-313312-h607itv2 101 37 health health NN cord-313312-h607itv2 101 38 emergency emergency NN cord-313312-h607itv2 101 39 [ [ -LRB- cord-313312-h607itv2 101 40 71 71 CD cord-313312-h607itv2 101 41 ] ] -RRB- cord-313312-h607itv2 101 42 . . . cord-313312-h607itv2 102 1 Dengue dengue NN cord-313312-h607itv2 102 2 infections infection NNS cord-313312-h607itv2 102 3 , , , cord-313312-h607itv2 102 4 on on IN cord-313312-h607itv2 102 5 the the DT cord-313312-h607itv2 102 6 other other JJ cord-313312-h607itv2 102 7 hand hand NN cord-313312-h607itv2 102 8 , , , cord-313312-h607itv2 102 9 account account VBP cord-313312-h607itv2 102 10 for for IN cord-313312-h607itv2 102 11 390 390 CD cord-313312-h607itv2 102 12 million million CD cord-313312-h607itv2 102 13 infections infection NNS cord-313312-h607itv2 102 14 annually annually RB cord-313312-h607itv2 102 15 , , , cord-313312-h607itv2 102 16 of of IN cord-313312-h607itv2 102 17 which which WDT cord-313312-h607itv2 102 18 96 96 CD cord-313312-h607itv2 102 19 million million CD cord-313312-h607itv2 102 20 infections infection NNS cord-313312-h607itv2 102 21 are be VBP cord-313312-h607itv2 102 22 symptomatic symptomatic JJ cord-313312-h607itv2 102 23 [ [ -LRB- cord-313312-h607itv2 102 24 72 72 CD cord-313312-h607itv2 102 25 ] ] -RRB- cord-313312-h607itv2 102 26 . . . cord-313312-h607itv2 103 1 The the DT cord-313312-h607itv2 103 2 antigenic antigenic JJ cord-313312-h607itv2 103 3 closeness closeness NN cord-313312-h607itv2 103 4 between between IN cord-313312-h607itv2 103 5 flaviviruses flavivirus NNS cord-313312-h607itv2 103 6 is be VBZ cord-313312-h607itv2 103 7 such such JJ cord-313312-h607itv2 103 8 that that DT cord-313312-h607itv2 103 9 infection infection NN cord-313312-h607itv2 103 10 with with IN cord-313312-h607itv2 103 11 one one CD cord-313312-h607itv2 103 12 flavivirus flavivirus NN cord-313312-h607itv2 103 13 induces induce VBZ cord-313312-h607itv2 103 14 species species NN cord-313312-h607itv2 103 15 - - HYPH cord-313312-h607itv2 103 16 specific specific JJ cord-313312-h607itv2 103 17 immunity immunity NN cord-313312-h607itv2 103 18 , , , cord-313312-h607itv2 103 19 as as RB cord-313312-h607itv2 103 20 well well RB cord-313312-h607itv2 103 21 as as IN cord-313312-h607itv2 103 22 cross cross JJ cord-313312-h607itv2 103 23 - - JJ cord-313312-h607itv2 103 24 reactive reactive JJ cord-313312-h607itv2 103 25 antibodies antibody NNS cord-313312-h607itv2 103 26 against against IN cord-313312-h607itv2 103 27 related relate VBN cord-313312-h607itv2 103 28 serocomplexes serocomplexe NNS cord-313312-h607itv2 103 29 [ [ -LRB- cord-313312-h607itv2 103 30 73 73 CD cord-313312-h607itv2 103 31 , , , cord-313312-h607itv2 103 32 74 74 CD cord-313312-h607itv2 103 33 ] ] -RRB- cord-313312-h607itv2 103 34 . . . cord-313312-h607itv2 104 1 However however RB cord-313312-h607itv2 104 2 , , , cord-313312-h607itv2 104 3 these these DT cord-313312-h607itv2 104 4 cross cross JJ cord-313312-h607itv2 104 5 - - JJ cord-313312-h607itv2 104 6 reactive reactive JJ cord-313312-h607itv2 104 7 antibodies antibody NNS cord-313312-h607itv2 104 8 do do VBP cord-313312-h607itv2 104 9 not not RB cord-313312-h607itv2 104 10 necessarily necessarily RB cord-313312-h607itv2 104 11 cross cross VB cord-313312-h607itv2 104 12 - - JJ cord-313312-h607itv2 104 13 protect protect JJ cord-313312-h607itv2 104 14 . . . cord-313312-h607itv2 105 1 Initial initial JJ cord-313312-h607itv2 105 2 insights insight NNS cord-313312-h607itv2 105 3 come come VBP cord-313312-h607itv2 105 4 from from IN cord-313312-h607itv2 105 5 human human JJ cord-313312-h607itv2 105 6 dengue dengue NN cord-313312-h607itv2 105 7 challenge challenge NN cord-313312-h607itv2 105 8 studies study NNS cord-313312-h607itv2 105 9 by by IN cord-313312-h607itv2 105 10 Albert Albert NNP cord-313312-h607itv2 105 11 Sabin Sabin NNP cord-313312-h607itv2 105 12 , , , cord-313312-h607itv2 105 13 who who WP cord-313312-h607itv2 105 14 provided provide VBD cord-313312-h607itv2 105 15 evidence evidence NN cord-313312-h607itv2 105 16 that that IN cord-313312-h607itv2 105 17 a a DT cord-313312-h607itv2 105 18 homologous homologous JJ cord-313312-h607itv2 105 19 challenge challenge NN cord-313312-h607itv2 105 20 in in IN cord-313312-h607itv2 105 21 humans human NNS cord-313312-h607itv2 105 22 with with IN cord-313312-h607itv2 105 23 the the DT cord-313312-h607itv2 105 24 same same JJ cord-313312-h607itv2 105 25 dengue dengue NN cord-313312-h607itv2 105 26 virus virus NN cord-313312-h607itv2 105 27 ( ( -LRB- cord-313312-h607itv2 105 28 DENV DENV NNP cord-313312-h607itv2 105 29 ) ) -RRB- cord-313312-h607itv2 105 30 serotype serotype NN cord-313312-h607itv2 105 31 protects protect VBZ cord-313312-h607itv2 105 32 against against IN cord-313312-h607itv2 105 33 re re NN cord-313312-h607itv2 105 34 - - NN cord-313312-h607itv2 105 35 infection infection NN cord-313312-h607itv2 105 36 , , , cord-313312-h607itv2 105 37 but but CC cord-313312-h607itv2 105 38 only only RB cord-313312-h607itv2 105 39 short short JJ cord-313312-h607itv2 105 40 - - HYPH cord-313312-h607itv2 105 41 term term NN cord-313312-h607itv2 105 42 protection protection NN cord-313312-h607itv2 105 43 against against IN cord-313312-h607itv2 105 44 the the DT cord-313312-h607itv2 105 45 heterologous heterologous NNP cord-313312-h607itv2 105 46 DENV DENV NNP cord-313312-h607itv2 105 47 serotype serotype NN cord-313312-h607itv2 105 48 challenge challenge NN cord-313312-h607itv2 105 49 for for IN cord-313312-h607itv2 105 50 up up IN cord-313312-h607itv2 105 51 to to TO cord-313312-h607itv2 105 52 six six CD cord-313312-h607itv2 105 53 months month NNS cord-313312-h607itv2 105 54 [ [ -LRB- cord-313312-h607itv2 105 55 75 75 CD cord-313312-h607itv2 105 56 , , , cord-313312-h607itv2 105 57 76 76 CD cord-313312-h607itv2 105 58 ] ] -RRB- cord-313312-h607itv2 105 59 . . . cord-313312-h607itv2 106 1 Moreover moreover RB cord-313312-h607itv2 106 2 , , , cord-313312-h607itv2 106 3 when when WRB cord-313312-h607itv2 106 4 cross cross JJ cord-313312-h607itv2 106 5 - - JJ cord-313312-h607itv2 106 6 reactive reactive JJ cord-313312-h607itv2 106 7 antibodies antibody NNS cord-313312-h607itv2 106 8 decline decline VBP cord-313312-h607itv2 106 9 to to TO cord-313312-h607itv2 106 10 sub sub VB cord-313312-h607itv2 106 11 - - JJ cord-313312-h607itv2 106 12 neutralizing neutralize VBG cord-313312-h607itv2 106 13 levels level NNS cord-313312-h607itv2 106 14 , , , cord-313312-h607itv2 106 15 these these DT cord-313312-h607itv2 106 16 antibodies antibody NNS cord-313312-h607itv2 106 17 can can MD cord-313312-h607itv2 106 18 opsonize opsonize VB cord-313312-h607itv2 106 19 dengue dengue NN cord-313312-h607itv2 106 20 virus virus NN cord-313312-h607itv2 106 21 infection infection NN cord-313312-h607itv2 106 22 , , , cord-313312-h607itv2 106 23 resulting result VBG cord-313312-h607itv2 106 24 in in IN cord-313312-h607itv2 106 25 enhanced enhanced JJ cord-313312-h607itv2 106 26 virus virus NN cord-313312-h607itv2 106 27 burden burden NN cord-313312-h607itv2 106 28 and and CC cord-313312-h607itv2 106 29 risk risk NN cord-313312-h607itv2 106 30 of of IN cord-313312-h607itv2 106 31 severe severe JJ cord-313312-h607itv2 106 32 dengue dengue NN cord-313312-h607itv2 106 33 in in IN cord-313312-h607itv2 106 34 patients patient NNS cord-313312-h607itv2 106 35 experiencing experience VBG cord-313312-h607itv2 106 36 secondary secondary JJ cord-313312-h607itv2 106 37 infection infection NN cord-313312-h607itv2 106 38 [ [ -LRB- cord-313312-h607itv2 106 39 77 77 CD cord-313312-h607itv2 106 40 ] ] -RRB- cord-313312-h607itv2 106 41 . . . cord-313312-h607itv2 107 1 Indeed indeed RB cord-313312-h607itv2 107 2 , , , cord-313312-h607itv2 107 3 recent recent JJ cord-313312-h607itv2 107 4 cohort cohort NN cord-313312-h607itv2 107 5 studies study NNS cord-313312-h607itv2 107 6 conducted conduct VBN cord-313312-h607itv2 107 7 in in IN cord-313312-h607itv2 107 8 Nicaragua Nicaragua NNP cord-313312-h607itv2 107 9 and and CC cord-313312-h607itv2 107 10 Thailand Thailand NNP cord-313312-h607itv2 107 11 provide provide VBP cord-313312-h607itv2 107 12 clinical clinical JJ cord-313312-h607itv2 107 13 evidence evidence NN cord-313312-h607itv2 107 14 that that IN cord-313312-h607itv2 107 15 a a DT cord-313312-h607itv2 107 16 specific specific JJ cord-313312-h607itv2 107 17 range range NN cord-313312-h607itv2 107 18 of of IN cord-313312-h607itv2 107 19 antibody antibody NN cord-313312-h607itv2 107 20 titers titer NNS cord-313312-h607itv2 107 21 is be VBZ cord-313312-h607itv2 107 22 associated associate VBN cord-313312-h607itv2 107 23 with with IN cord-313312-h607itv2 107 24 an an DT cord-313312-h607itv2 107 25 increased increase VBN cord-313312-h607itv2 107 26 risk risk NN cord-313312-h607itv2 107 27 of of IN cord-313312-h607itv2 107 28 severe severe JJ cord-313312-h607itv2 107 29 dengue dengue NN cord-313312-h607itv2 107 30 [ [ -LRB- cord-313312-h607itv2 107 31 78 78 CD cord-313312-h607itv2 107 32 , , , cord-313312-h607itv2 107 33 79 79 CD cord-313312-h607itv2 107 34 ] ] -RRB- cord-313312-h607itv2 107 35 . . . cord-313312-h607itv2 108 1 The the DT cord-313312-h607itv2 108 2 presence presence NN cord-313312-h607itv2 108 3 of of IN cord-313312-h607itv2 108 4 waning wane VBG cord-313312-h607itv2 108 5 maternal maternal JJ cord-313312-h607itv2 108 6 anti anti JJ cord-313312-h607itv2 108 7 - - JJ cord-313312-h607itv2 108 8 dengue dengue JJ cord-313312-h607itv2 108 9 antibodies antibody NNS cord-313312-h607itv2 108 10 can can MD cord-313312-h607itv2 108 11 also also RB cord-313312-h607itv2 108 12 predispose predispose VB cord-313312-h607itv2 108 13 children child NNS cord-313312-h607itv2 108 14 to to TO cord-313312-h607itv2 108 15 dengue dengue VB cord-313312-h607itv2 108 16 hemorrhagic hemorrhagic JJ cord-313312-h607itv2 108 17 fever fever NN cord-313312-h607itv2 108 18 , , , cord-313312-h607itv2 108 19 reinforcing reinforce VBG cord-313312-h607itv2 108 20 the the DT cord-313312-h607itv2 108 21 concept concept NN cord-313312-h607itv2 108 22 that that IN cord-313312-h607itv2 108 23 pre pre JJ cord-313312-h607itv2 108 24 - - JJ cord-313312-h607itv2 108 25 existing existing JJ cord-313312-h607itv2 108 26 antibodies antibody NNS cord-313312-h607itv2 108 27 can can MD cord-313312-h607itv2 108 28 promote promote VB cord-313312-h607itv2 108 29 disease disease NN cord-313312-h607itv2 108 30 pathogenesis pathogenesis NN cord-313312-h607itv2 108 31 [ [ -LRB- cord-313312-h607itv2 108 32 80 80 CD cord-313312-h607itv2 108 33 ] ] -RRB- cord-313312-h607itv2 108 34 . . . cord-313312-h607itv2 109 1 Consistent consistent JJ cord-313312-h607itv2 109 2 with with IN cord-313312-h607itv2 109 3 the the DT cord-313312-h607itv2 109 4 notion notion NN cord-313312-h607itv2 109 5 that that IN cord-313312-h607itv2 109 6 sub sub NN cord-313312-h607itv2 109 7 - - JJ cord-313312-h607itv2 109 8 neutralizing neutralize VBG cord-313312-h607itv2 109 9 cross cross JJ cord-313312-h607itv2 109 10 - - JJ cord-313312-h607itv2 109 11 reactive reactive JJ cord-313312-h607itv2 109 12 antibodies antibody NNS cord-313312-h607itv2 109 13 can can MD cord-313312-h607itv2 109 14 promote promote VB cord-313312-h607itv2 109 15 viral viral JJ cord-313312-h607itv2 109 16 infection infection NN cord-313312-h607itv2 109 17 , , , cord-313312-h607itv2 109 18 the the DT cord-313312-h607itv2 109 19 presence presence NN cord-313312-h607itv2 109 20 of of IN cord-313312-h607itv2 109 21 pre pre JJ cord-313312-h607itv2 109 22 - - JJ cord-313312-h607itv2 109 23 existing existing JJ cord-313312-h607itv2 109 24 cross cross JJ cord-313312-h607itv2 109 25 - - JJ cord-313312-h607itv2 109 26 reactive reactive JJ cord-313312-h607itv2 109 27 antibodies antibody NNS cord-313312-h607itv2 109 28 can can MD cord-313312-h607itv2 109 29 also also RB cord-313312-h607itv2 109 30 increase increase VB cord-313312-h607itv2 109 31 the the DT cord-313312-h607itv2 109 32 immunogenicity immunogenicity NN cord-313312-h607itv2 109 33 of of IN cord-313312-h607itv2 109 34 flaviviral flaviviral FW cord-313312-h607itv2 109 35 LAVs lav NNS cord-313312-h607itv2 109 36 . . . cord-313312-h607itv2 110 1 As as IN cord-313312-h607itv2 110 2 demonstrated demonstrate VBN cord-313312-h607itv2 110 3 in in IN cord-313312-h607itv2 110 4 both both DT cord-313312-h607itv2 110 5 Dengvaxia Dengvaxia NNP cord-313312-h607itv2 110 6 ® ® NNP cord-313312-h607itv2 110 7 and and CC cord-313312-h607itv2 110 8 Takaeda Takaeda NNP cord-313312-h607itv2 110 9 ® ® POS cord-313312-h607itv2 110 10 dengue dengue NN cord-313312-h607itv2 110 11 vaccine vaccine NN cord-313312-h607itv2 110 12 trials trial NNS cord-313312-h607itv2 110 13 , , , cord-313312-h607itv2 110 14 seropositive seropositive JJ cord-313312-h607itv2 110 15 individuals individual NNS cord-313312-h607itv2 110 16 produced produce VBD cord-313312-h607itv2 110 17 greater great JJR cord-313312-h607itv2 110 18 neutralizing neutralize VBG cord-313312-h607itv2 110 19 antibody antibody NN cord-313312-h607itv2 110 20 responses response NNS cord-313312-h607itv2 110 21 and and CC cord-313312-h607itv2 110 22 protection protection NN cord-313312-h607itv2 110 23 against against IN cord-313312-h607itv2 110 24 the the DT cord-313312-h607itv2 110 25 wild wild JJ cord-313312-h607itv2 110 26 - - HYPH cord-313312-h607itv2 110 27 type type NN cord-313312-h607itv2 110 28 DENV DENV NNP cord-313312-h607itv2 110 29 infection infection NN cord-313312-h607itv2 110 30 compared compare VBN cord-313312-h607itv2 110 31 to to IN cord-313312-h607itv2 110 32 seronegative seronegative JJ cord-313312-h607itv2 110 33 vaccinees vaccinee NNS cord-313312-h607itv2 110 34 [ [ -LRB- cord-313312-h607itv2 110 35 19 19 CD cord-313312-h607itv2 110 36 , , , cord-313312-h607itv2 110 37 81 81 CD cord-313312-h607itv2 110 38 , , , cord-313312-h607itv2 110 39 82 82 CD cord-313312-h607itv2 110 40 ] ] -RRB- cord-313312-h607itv2 110 41 . . . cord-313312-h607itv2 111 1 These these DT cord-313312-h607itv2 111 2 studies study NNS cord-313312-h607itv2 111 3 were be VBD cord-313312-h607itv2 111 4 also also RB cord-313312-h607itv2 111 5 supported support VBN cord-313312-h607itv2 111 6 by by IN cord-313312-h607itv2 111 7 in in IN cord-313312-h607itv2 111 8 vivo vivo NNP cord-313312-h607itv2 111 9 studies study NNS cord-313312-h607itv2 111 10 showing show VBG cord-313312-h607itv2 111 11 that that IN cord-313312-h607itv2 111 12 sequential sequential JJ cord-313312-h607itv2 111 13 immunization immunization NN cord-313312-h607itv2 111 14 for for IN cord-313312-h607itv2 111 15 flaviviruses flavivirus NNS cord-313312-h607itv2 111 16 with with IN cord-313312-h607itv2 111 17 shared share VBN cord-313312-h607itv2 111 18 CD4 CD4 NNP cord-313312-h607itv2 111 19 epitopes epitope NNS cord-313312-h607itv2 111 20 that that WDT cord-313312-h607itv2 111 21 could could MD cord-313312-h607itv2 111 22 enhance enhance VB cord-313312-h607itv2 111 23 protection protection NN cord-313312-h607itv2 111 24 during during IN cord-313312-h607itv2 111 25 subsequent subsequent JJ cord-313312-h607itv2 111 26 heterologous heterologous JJ cord-313312-h607itv2 111 27 infection infection NN cord-313312-h607itv2 111 28 [ [ -LRB- cord-313312-h607itv2 111 29 83 83 CD cord-313312-h607itv2 111 30 ] ] -RRB- cord-313312-h607itv2 111 31 . . . cord-313312-h607itv2 112 1 However however RB cord-313312-h607itv2 112 2 , , , cord-313312-h607itv2 112 3 in in IN cord-313312-h607itv2 112 4 another another DT cord-313312-h607itv2 112 5 study study NN cord-313312-h607itv2 112 6 , , , cord-313312-h607itv2 112 7 pre pre JJ cord-313312-h607itv2 112 8 - - JJ cord-313312-h607itv2 112 9 existing existing JJ cord-313312-h607itv2 112 10 antibodies antibody NNS cord-313312-h607itv2 112 11 from from IN cord-313312-h607itv2 112 12 yellow yellow JJ cord-313312-h607itv2 112 13 fever fever NN cord-313312-h607itv2 112 14 vaccination vaccination NN cord-313312-h607itv2 112 15 can can MD cord-313312-h607itv2 112 16 cause cause VB cord-313312-h607itv2 112 17 impairment impairment NN cord-313312-h607itv2 112 18 of of IN cord-313312-h607itv2 112 19 neutralizing neutralize VBG cord-313312-h607itv2 112 20 antibody antibody NN cord-313312-h607itv2 112 21 responses response NNS cord-313312-h607itv2 112 22 to to TO cord-313312-h607itv2 112 23 tick tick VB cord-313312-h607itv2 112 24 - - HYPH cord-313312-h607itv2 112 25 borne bear VBN cord-313312-h607itv2 112 26 encephalitis encephalitis JJ cord-313312-h607itv2 112 27 vaccination vaccination NN cord-313312-h607itv2 112 28 [ [ -LRB- cord-313312-h607itv2 112 29 84 84 CD cord-313312-h607itv2 112 30 ] ] -RRB- cord-313312-h607itv2 112 31 . . . cord-313312-h607itv2 113 1 The the DT cord-313312-h607itv2 113 2 clinical clinical JJ cord-313312-h607itv2 113 3 trial trial NN cord-313312-h607itv2 113 4 finding finding NN cord-313312-h607itv2 113 5 that that IN cord-313312-h607itv2 113 6 subjects subject NNS cord-313312-h607itv2 113 7 with with IN cord-313312-h607itv2 113 8 a a DT cord-313312-h607itv2 113 9 limited limited JJ cord-313312-h607itv2 113 10 range range NN cord-313312-h607itv2 113 11 of of IN cord-313312-h607itv2 113 12 cross cross JJ cord-313312-h607itv2 113 13 - - JJ cord-313312-h607itv2 113 14 reactive reactive JJ cord-313312-h607itv2 113 15 antibodies antibody NNS cord-313312-h607itv2 113 16 from from IN cord-313312-h607itv2 113 17 a a DT cord-313312-h607itv2 113 18 prior prior JJ cord-313312-h607itv2 113 19 Japanese japanese JJ cord-313312-h607itv2 113 20 Encephalitis Encephalitis NNP cord-313312-h607itv2 113 21 vaccine vaccine NN cord-313312-h607itv2 113 22 were be VBD cord-313312-h607itv2 113 23 able able JJ cord-313312-h607itv2 113 24 to to TO cord-313312-h607itv2 113 25 enhance enhance VB cord-313312-h607itv2 113 26 yellow yellow JJ cord-313312-h607itv2 113 27 fever fever NN cord-313312-h607itv2 113 28 vaccination vaccination NN cord-313312-h607itv2 113 29 , , , cord-313312-h607itv2 113 30 by by IN cord-313312-h607itv2 113 31 prolonging prolong VBG cord-313312-h607itv2 113 32 vaccine vaccine NN cord-313312-h607itv2 113 33 viremia viremia NN cord-313312-h607itv2 113 34 duration duration NN cord-313312-h607itv2 113 35 that that WDT cord-313312-h607itv2 113 36 leads lead VBZ cord-313312-h607itv2 113 37 to to IN cord-313312-h607itv2 113 38 higher high JJR cord-313312-h607itv2 113 39 antibody antibody NN cord-313312-h607itv2 113 40 titers titer NNS cord-313312-h607itv2 113 41 , , , cord-313312-h607itv2 113 42 thus thus RB cord-313312-h607itv2 113 43 hints hint VBZ cord-313312-h607itv2 113 44 at at IN cord-313312-h607itv2 113 45 the the DT cord-313312-h607itv2 113 46 possibility possibility NN cord-313312-h607itv2 113 47 that that IN cord-313312-h607itv2 113 48 whether whether IN cord-313312-h607itv2 113 49 pre pre JJ cord-313312-h607itv2 113 50 - - JJ cord-313312-h607itv2 113 51 existing existing JJ cord-313312-h607itv2 113 52 antibodies antibody NNS cord-313312-h607itv2 113 53 inhibit inhibit VBP cord-313312-h607itv2 113 54 or or CC cord-313312-h607itv2 113 55 augment augment VB cord-313312-h607itv2 113 56 flavivirus flavivirus JJ cord-313312-h607itv2 113 57 infection infection NN cord-313312-h607itv2 113 58 will will MD cord-313312-h607itv2 113 59 depend depend VB cord-313312-h607itv2 113 60 on on IN cord-313312-h607itv2 113 61 both both DT cord-313312-h607itv2 113 62 antibody antibody NN cord-313312-h607itv2 113 63 titers titer NNS cord-313312-h607itv2 113 64 and and CC cord-313312-h607itv2 113 65 the the DT cord-313312-h607itv2 113 66 type type NN cord-313312-h607itv2 113 67 / / SYM cord-313312-h607itv2 113 68 specificity specificity NN cord-313312-h607itv2 113 69 of of IN cord-313312-h607itv2 113 70 antibodies antibody NNS cord-313312-h607itv2 113 71 produced produce VBD cord-313312-h607itv2 113 72 [ [ -LRB- cord-313312-h607itv2 113 73 85 85 CD cord-313312-h607itv2 113 74 ] ] -RRB- cord-313312-h607itv2 113 75 . . . cord-313312-h607itv2 114 1 The the DT cord-313312-h607itv2 114 2 plausible plausible JJ cord-313312-h607itv2 114 3 mechanisms mechanism NNS cord-313312-h607itv2 114 4 involved involve VBN cord-313312-h607itv2 114 5 are be VBP cord-313312-h607itv2 114 6 as as RB cord-313312-h607itv2 114 7 elaborated elaborate VBN cord-313312-h607itv2 114 8 below below RB cord-313312-h607itv2 114 9 . . . cord-313312-h607itv2 115 1 The the DT cord-313312-h607itv2 115 2 primary primary JJ cord-313312-h607itv2 115 3 role role NN cord-313312-h607itv2 115 4 of of IN cord-313312-h607itv2 115 5 antibodies antibody NNS cord-313312-h607itv2 115 6 is be VBZ cord-313312-h607itv2 115 7 antigen antigen NN cord-313312-h607itv2 115 8 binding bind VBG cord-313312-h607itv2 115 9 and and CC cord-313312-h607itv2 115 10 interacting interact VBG cord-313312-h607itv2 115 11 with with IN cord-313312-h607itv2 115 12 Fc Fc NNP cord-313312-h607itv2 115 13 - - HYPH cord-313312-h607itv2 115 14 gamma gamma NN cord-313312-h607itv2 115 15 receptors receptor NNS cord-313312-h607itv2 115 16 ( ( -LRB- cord-313312-h607itv2 115 17 FcγRs FcγRs NNP cord-313312-h607itv2 115 18 ) ) -RRB- cord-313312-h607itv2 115 19 to to TO cord-313312-h607itv2 115 20 modulate modulate VB cord-313312-h607itv2 115 21 subsequent subsequent JJ cord-313312-h607itv2 115 22 immune immune JJ cord-313312-h607itv2 115 23 responses response NNS cord-313312-h607itv2 115 24 . . . cord-313312-h607itv2 116 1 The the DT cord-313312-h607itv2 116 2 integration integration NN cord-313312-h607itv2 116 3 of of IN cord-313312-h607itv2 116 4 both both CC cord-313312-h607itv2 116 5 activating activate VBG cord-313312-h607itv2 116 6 and and CC cord-313312-h607itv2 116 7 inhibiting inhibit VBG cord-313312-h607itv2 116 8 signals signal NNS cord-313312-h607itv2 116 9 is be VBZ cord-313312-h607itv2 116 10 critical critical JJ cord-313312-h607itv2 116 11 for for IN cord-313312-h607itv2 116 12 the the DT cord-313312-h607itv2 116 13 generation generation NN cord-313312-h607itv2 116 14 of of IN cord-313312-h607itv2 116 15 an an DT cord-313312-h607itv2 116 16 effective effective JJ cord-313312-h607itv2 116 17 immune immune JJ cord-313312-h607itv2 116 18 response response NN cord-313312-h607itv2 116 19 . . . cord-313312-h607itv2 117 1 In in IN cord-313312-h607itv2 117 2 this this DT cord-313312-h607itv2 117 3 aspect aspect NN cord-313312-h607itv2 117 4 , , , cord-313312-h607itv2 117 5 FcγRs FcγRs NNP cord-313312-h607itv2 117 6 are be VBP cord-313312-h607itv2 117 7 an an DT cord-313312-h607itv2 117 8 archetype archetype NN cord-313312-h607itv2 117 9 of of IN cord-313312-h607itv2 117 10 how how WRB cord-313312-h607itv2 117 11 such such JJ cord-313312-h607itv2 117 12 signals signal NNS cord-313312-h607itv2 117 13 influence influence VBP cord-313312-h607itv2 117 14 both both DT cord-313312-h607itv2 117 15 innate innate JJ cord-313312-h607itv2 117 16 and and CC cord-313312-h607itv2 117 17 adaptive adaptive JJ cord-313312-h607itv2 117 18 immune immune JJ cord-313312-h607itv2 117 19 functions function NNS cord-313312-h607itv2 117 20 . . . cord-313312-h607itv2 118 1 Functionally functionally RB cord-313312-h607itv2 118 2 , , , cord-313312-h607itv2 118 3 FcγRs FcγRs NNP cord-313312-h607itv2 118 4 can can MD cord-313312-h607itv2 118 5 be be VB cord-313312-h607itv2 118 6 classified classify VBN cord-313312-h607itv2 118 7 into into IN cord-313312-h607itv2 118 8 either either CC cord-313312-h607itv2 118 9 activating activate VBG cord-313312-h607itv2 118 10 or or CC cord-313312-h607itv2 118 11 inhibiting inhibit VBG cord-313312-h607itv2 118 12 receptors receptor NNS cord-313312-h607itv2 118 13 depending depend VBG cord-313312-h607itv2 118 14 on on IN cord-313312-h607itv2 118 15 the the DT cord-313312-h607itv2 118 16 pathway pathway NN cord-313312-h607itv2 119 1 they -PRON- PRP cord-313312-h607itv2 119 2 initiate initiate VBP cord-313312-h607itv2 119 3 [ [ -LRB- cord-313312-h607itv2 119 4 86 86 CD cord-313312-h607itv2 119 5 ] ] -RRB- cord-313312-h607itv2 119 6 . . . cord-313312-h607itv2 120 1 Activating activate VBG cord-313312-h607itv2 120 2 FcγRs FcγRs NNP cord-313312-h607itv2 120 3 possess possess VBP cord-313312-h607itv2 120 4 an an DT cord-313312-h607itv2 120 5 immunoreceptor immunoreceptor JJ cord-313312-h607itv2 120 6 tyrosine tyrosine NN cord-313312-h607itv2 120 7 - - HYPH cord-313312-h607itv2 120 8 based base VBN cord-313312-h607itv2 120 9 activation activation NN cord-313312-h607itv2 120 10 ( ( -LRB- cord-313312-h607itv2 120 11 ITAM ITAM NNP cord-313312-h607itv2 120 12 ) ) -RRB- cord-313312-h607itv2 120 13 motif motif NN cord-313312-h607itv2 120 14 in in IN cord-313312-h607itv2 120 15 their -PRON- PRP$ cord-313312-h607itv2 120 16 cytosolic cytosolic JJ cord-313312-h607itv2 120 17 domain domain NN cord-313312-h607itv2 120 18 , , , cord-313312-h607itv2 120 19 or or CC cord-313312-h607itv2 120 20 in in IN cord-313312-h607itv2 120 21 the the DT cord-313312-h607itv2 120 22 case case NN cord-313312-h607itv2 120 23 of of IN cord-313312-h607itv2 120 24 FcγRI FcγRI NNP cord-313312-h607itv2 120 25 and and CC cord-313312-h607itv2 120 26 FcγRIIIA FcγRIIIA NNP cord-313312-h607itv2 120 27 , , , cord-313312-h607itv2 120 28 associate associate VBP cord-313312-h607itv2 120 29 with with IN cord-313312-h607itv2 120 30 an an DT cord-313312-h607itv2 120 31 ITAM ITAM NNP cord-313312-h607itv2 120 32 - - HYPH cord-313312-h607itv2 120 33 containing contain VBG cord-313312-h607itv2 120 34 γ γ NN cord-313312-h607itv2 120 35 - - HYPH cord-313312-h607itv2 120 36 chain chain NN cord-313312-h607itv2 120 37 . . . cord-313312-h607itv2 121 1 Engagement engagement NN cord-313312-h607itv2 121 2 of of IN cord-313312-h607itv2 121 3 activating activate VBG cord-313312-h607itv2 121 4 FcγRs FcγRs NNP cord-313312-h607itv2 121 5 by by IN cord-313312-h607itv2 121 6 immune immune JJ cord-313312-h607itv2 121 7 complexes complex NNS cord-313312-h607itv2 121 8 results result NNS cord-313312-h607itv2 121 9 in in IN cord-313312-h607itv2 121 10 the the DT cord-313312-h607itv2 121 11 phosphorylation phosphorylation NN cord-313312-h607itv2 121 12 of of IN cord-313312-h607itv2 121 13 the the DT cord-313312-h607itv2 121 14 γ γ NN cord-313312-h607itv2 121 15 - - HYPH cord-313312-h607itv2 121 16 chain chain NN cord-313312-h607itv2 121 17 by by IN cord-313312-h607itv2 121 18 SRC SRC NNP cord-313312-h607itv2 121 19 - - HYPH cord-313312-h607itv2 121 20 family family NN cord-313312-h607itv2 121 21 kinases kinase NNS cord-313312-h607itv2 121 22 in in IN cord-313312-h607itv2 121 23 order order NN cord-313312-h607itv2 121 24 to to TO cord-313312-h607itv2 121 25 create create VB cord-313312-h607itv2 121 26 a a DT cord-313312-h607itv2 121 27 docking docking NN cord-313312-h607itv2 121 28 site site NN cord-313312-h607itv2 121 29 for for IN cord-313312-h607itv2 121 30 spleen spleen NN cord-313312-h607itv2 121 31 tyrosine tyrosine NN cord-313312-h607itv2 121 32 kinase kinase NN cord-313312-h607itv2 121 33 ( ( -LRB- cord-313312-h607itv2 121 34 SYK SYK NNP cord-313312-h607itv2 121 35 ) ) -RRB- cord-313312-h607itv2 121 36 . . . cord-313312-h607itv2 122 1 Subsequent subsequent JJ cord-313312-h607itv2 122 2 activation activation NN cord-313312-h607itv2 122 3 of of IN cord-313312-h607itv2 122 4 SYK SYK NNP cord-313312-h607itv2 122 5 results result NNS cord-313312-h607itv2 122 6 in in IN cord-313312-h607itv2 122 7 a a DT cord-313312-h607itv2 122 8 signaling signal VBG cord-313312-h607itv2 122 9 cascade cascade NN cord-313312-h607itv2 122 10 , , , cord-313312-h607itv2 122 11 leading lead VBG cord-313312-h607itv2 122 12 to to IN cord-313312-h607itv2 122 13 the the DT cord-313312-h607itv2 122 14 induction induction NN cord-313312-h607itv2 122 15 of of IN cord-313312-h607itv2 122 16 pro pro JJ cord-313312-h607itv2 122 17 - - JJ cord-313312-h607itv2 122 18 inflammatory inflammatory JJ cord-313312-h607itv2 122 19 responses response NNS cord-313312-h607itv2 122 20 and and CC cord-313312-h607itv2 122 21 activation activation NN cord-313312-h607itv2 122 22 of of IN cord-313312-h607itv2 122 23 innate innate JJ cord-313312-h607itv2 122 24 immune immune JJ cord-313312-h607itv2 122 25 effector effector NN cord-313312-h607itv2 122 26 cells cell NNS cord-313312-h607itv2 122 27 [ [ -LRB- cord-313312-h607itv2 122 28 87 87 CD cord-313312-h607itv2 122 29 , , , cord-313312-h607itv2 122 30 88 88 CD cord-313312-h607itv2 122 31 ] ] -RRB- cord-313312-h607itv2 122 32 . . . cord-313312-h607itv2 123 1 By by IN cord-313312-h607itv2 123 2 contrast contrast NN cord-313312-h607itv2 123 3 , , , cord-313312-h607itv2 123 4 the the DT cord-313312-h607itv2 123 5 inhibitory inhibitory JJ cord-313312-h607itv2 123 6 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 123 7 receptor receptor NN cord-313312-h607itv2 123 8 contains contain VBZ cord-313312-h607itv2 123 9 an an DT cord-313312-h607itv2 123 10 immunoreceptor immunoreceptor JJ cord-313312-h607itv2 123 11 tyrosine tyrosine NN cord-313312-h607itv2 123 12 - - HYPH cord-313312-h607itv2 123 13 based base VBN cord-313312-h607itv2 123 14 inhibition inhibition NN cord-313312-h607itv2 123 15 ( ( -LRB- cord-313312-h607itv2 123 16 ITIM ITIM NNP cord-313312-h607itv2 123 17 ) ) -RRB- cord-313312-h607itv2 123 18 motif motif NN cord-313312-h607itv2 123 19 within within IN cord-313312-h607itv2 123 20 its -PRON- PRP$ cord-313312-h607itv2 123 21 intracellular intracellular JJ cord-313312-h607itv2 123 22 domain domain NN cord-313312-h607itv2 123 23 . . . cord-313312-h607itv2 124 1 Cross cross NN cord-313312-h607itv2 124 2 - - NN cord-313312-h607itv2 124 3 linking linking NN cord-313312-h607itv2 124 4 of of IN cord-313312-h607itv2 124 5 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 124 6 enables enable VBZ cord-313312-h607itv2 124 7 the the DT cord-313312-h607itv2 124 8 recruitment recruitment NN cord-313312-h607itv2 124 9 of of IN cord-313312-h607itv2 124 10 SH2 SH2 NNP cord-313312-h607itv2 124 11 domain domain NN cord-313312-h607itv2 124 12 - - HYPH cord-313312-h607itv2 124 13 containing contain VBG cord-313312-h607itv2 124 14 inositol inositol NN cord-313312-h607itv2 124 15 polyphosphate polyphosphate NN cord-313312-h607itv2 124 16 5 5 CD cord-313312-h607itv2 124 17 phosphatase phosphatase NN cord-313312-h607itv2 124 18 ( ( -LRB- cord-313312-h607itv2 124 19 SHIP ship NN cord-313312-h607itv2 124 20 ) ) -RRB- cord-313312-h607itv2 124 21 and and CC cord-313312-h607itv2 124 22 SH2 SH2 NNP cord-313312-h607itv2 124 23 domain domain NN cord-313312-h607itv2 124 24 - - HYPH cord-313312-h607itv2 124 25 containing contain VBG cord-313312-h607itv2 124 26 protein protein NN cord-313312-h607itv2 124 27 tyrosine tyrosine NN cord-313312-h607itv2 124 28 phosphatase phosphatase NN cord-313312-h607itv2 124 29 1 1 CD cord-313312-h607itv2 124 30 ( ( -LRB- cord-313312-h607itv2 124 31 SHP1 SHP1 NNP cord-313312-h607itv2 124 32 ) ) -RRB- cord-313312-h607itv2 124 33 to to TO cord-313312-h607itv2 124 34 modulate modulate VB cord-313312-h607itv2 124 35 signals signal NNS cord-313312-h607itv2 124 36 generated generate VBN cord-313312-h607itv2 124 37 by by IN cord-313312-h607itv2 124 38 activating activate VBG cord-313312-h607itv2 124 39 FcγRs FcγRs NNP cord-313312-h607itv2 124 40 , , , cord-313312-h607itv2 124 41 thereby thereby RB cord-313312-h607itv2 124 42 regulating regulate VBG cord-313312-h607itv2 124 43 the the DT cord-313312-h607itv2 124 44 magnitude magnitude NN cord-313312-h607itv2 124 45 of of IN cord-313312-h607itv2 124 46 inflammatory inflammatory JJ cord-313312-h607itv2 124 47 responses response NNS cord-313312-h607itv2 124 48 . . . cord-313312-h607itv2 125 1 Furthermore furthermore RB cord-313312-h607itv2 125 2 , , , cord-313312-h607itv2 125 3 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 125 4 is be VBZ cord-313312-h607itv2 125 5 important important JJ cord-313312-h607itv2 125 6 for for IN cord-313312-h607itv2 125 7 controlling control VBG cord-313312-h607itv2 125 8 B b NN cord-313312-h607itv2 125 9 - - HYPH cord-313312-h607itv2 125 10 cell cell NN cord-313312-h607itv2 125 11 development development NN cord-313312-h607itv2 125 12 [ [ -LRB- cord-313312-h607itv2 125 13 89 89 CD cord-313312-h607itv2 125 14 ] ] -RRB- cord-313312-h607itv2 126 1 [ [ -LRB- cord-313312-h607itv2 126 2 90 90 CD cord-313312-h607itv2 126 3 ] ] -RRB- cord-313312-h607itv2 126 4 [ [ -LRB- cord-313312-h607itv2 126 5 91 91 CD cord-313312-h607itv2 126 6 ] ] -RRB- cord-313312-h607itv2 126 7 [ [ -LRB- cord-313312-h607itv2 126 8 92 92 CD cord-313312-h607itv2 126 9 ] ] -RRB- cord-313312-h607itv2 127 1 [ [ -LRB- cord-313312-h607itv2 127 2 93 93 CD cord-313312-h607itv2 127 3 ] ] -RRB- cord-313312-h607itv2 127 4 [ [ -LRB- cord-313312-h607itv2 127 5 94 94 CD cord-313312-h607itv2 127 6 ] ] -RRB- cord-313312-h607itv2 127 7 . . . cord-313312-h607itv2 128 1 Indeed indeed RB cord-313312-h607itv2 128 2 , , , cord-313312-h607itv2 128 3 B b NN cord-313312-h607itv2 128 4 - - HYPH cord-313312-h607itv2 128 5 cells cell NNS cord-313312-h607itv2 128 6 express express VBP cord-313312-h607itv2 128 7 FcγRIIB fcγriib NN cord-313312-h607itv2 128 8 as as IN cord-313312-h607itv2 128 9 the the DT cord-313312-h607itv2 128 10 only only JJ cord-313312-h607itv2 128 11 FcγR fcγr NN cord-313312-h607itv2 128 12 on on IN cord-313312-h607itv2 128 13 their -PRON- PRP$ cord-313312-h607itv2 128 14 cell cell NN cord-313312-h607itv2 128 15 surface surface NN cord-313312-h607itv2 128 16 , , , cord-313312-h607itv2 128 17 and and CC cord-313312-h607itv2 128 18 cross cross NN cord-313312-h607itv2 128 19 - - NN cord-313312-h607itv2 128 20 linking linking NN cord-313312-h607itv2 128 21 of of IN cord-313312-h607itv2 128 22 FcγRIIB fcγriib NN cord-313312-h607itv2 128 23 on on IN cord-313312-h607itv2 128 24 naïve naïve JJ cord-313312-h607itv2 128 25 B b NN cord-313312-h607itv2 128 26 - - HYPH cord-313312-h607itv2 128 27 cells cell NNS cord-313312-h607itv2 128 28 could could MD cord-313312-h607itv2 128 29 inhibit inhibit VB cord-313312-h607itv2 128 30 their -PRON- PRP$ cord-313312-h607itv2 128 31 proliferation proliferation NN cord-313312-h607itv2 128 32 and and CC cord-313312-h607itv2 128 33 differentiation differentiation NN cord-313312-h607itv2 128 34 into into IN cord-313312-h607itv2 128 35 plasma plasma NN cord-313312-h607itv2 128 36 cells cell NNS cord-313312-h607itv2 128 37 [ [ -LRB- cord-313312-h607itv2 128 38 95 95 CD cord-313312-h607itv2 128 39 ] ] -RRB- cord-313312-h607itv2 128 40 . . . cord-313312-h607itv2 129 1 Likewise likewise RB cord-313312-h607itv2 129 2 , , , cord-313312-h607itv2 129 3 cross cross NN cord-313312-h607itv2 129 4 - - NN cord-313312-h607itv2 129 5 linking linking NN cord-313312-h607itv2 129 6 of of IN cord-313312-h607itv2 129 7 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 129 8 induces induce VBZ cord-313312-h607itv2 129 9 apoptosis apoptosis NN cord-313312-h607itv2 129 10 in in IN cord-313312-h607itv2 129 11 bone bone NN cord-313312-h607itv2 129 12 marrow marrow NN cord-313312-h607itv2 129 13 plasma plasma NN cord-313312-h607itv2 129 14 cells cell NNS cord-313312-h607itv2 129 15 , , , cord-313312-h607itv2 129 16 suggesting suggest VBG cord-313312-h607itv2 129 17 that that IN cord-313312-h607itv2 129 18 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 129 19 may may MD cord-313312-h607itv2 129 20 influence influence VB cord-313312-h607itv2 129 21 the the DT cord-313312-h607itv2 129 22 lifespan lifespan NN cord-313312-h607itv2 129 23 of of IN cord-313312-h607itv2 129 24 these these DT cord-313312-h607itv2 129 25 antibody antibody NN cord-313312-h607itv2 129 26 - - HYPH cord-313312-h607itv2 129 27 producing produce VBG cord-313312-h607itv2 129 28 cells cell NNS cord-313312-h607itv2 129 29 [ [ -LRB- cord-313312-h607itv2 129 30 89 89 CD cord-313312-h607itv2 129 31 ] ] -RRB- cord-313312-h607itv2 129 32 . . . cord-313312-h607itv2 130 1 The the DT cord-313312-h607itv2 130 2 signaling signal VBG cord-313312-h607itv2 130 3 responses response NNS cord-313312-h607itv2 130 4 triggered trigger VBN cord-313312-h607itv2 130 5 by by IN cord-313312-h607itv2 130 6 virus virus NN cord-313312-h607itv2 130 7 - - HYPH cord-313312-h607itv2 130 8 antibody antibody NN cord-313312-h607itv2 130 9 complexes complex NNS cord-313312-h607itv2 130 10 are be VBP cord-313312-h607itv2 130 11 thus thus RB cord-313312-h607itv2 130 12 highly highly RB cord-313312-h607itv2 130 13 dependent dependent JJ cord-313312-h607itv2 130 14 on on IN cord-313312-h607itv2 130 15 the the DT cord-313312-h607itv2 130 16 type type NN cord-313312-h607itv2 130 17 of of IN cord-313312-h607itv2 130 18 FcγRs FcγRs NNP cord-313312-h607itv2 130 19 with with IN cord-313312-h607itv2 130 20 which which WDT cord-313312-h607itv2 130 21 the the DT cord-313312-h607itv2 130 22 immune immune JJ cord-313312-h607itv2 130 23 complexes complex NNS cord-313312-h607itv2 130 24 interact interact VBP cord-313312-h607itv2 130 25 , , , cord-313312-h607itv2 130 26 which which WDT cord-313312-h607itv2 130 27 can can MD cord-313312-h607itv2 130 28 result result VB cord-313312-h607itv2 130 29 in in IN cord-313312-h607itv2 130 30 either either DT cord-313312-h607itv2 130 31 virus virus NN cord-313312-h607itv2 130 32 inhibition inhibition NN cord-313312-h607itv2 130 33 or or CC cord-313312-h607itv2 130 34 enhancement enhancement NN cord-313312-h607itv2 130 35 of of IN cord-313312-h607itv2 130 36 virus virus NN cord-313312-h607itv2 130 37 infection infection NN cord-313312-h607itv2 130 38 . . . cord-313312-h607itv2 131 1 Virus virus NN cord-313312-h607itv2 131 2 neutralization neutralization NN cord-313312-h607itv2 131 3 occurs occur VBZ cord-313312-h607itv2 131 4 when when WRB cord-313312-h607itv2 131 5 virions virion NNS cord-313312-h607itv2 131 6 are be VBP cord-313312-h607itv2 131 7 bound bind VBN cord-313312-h607itv2 131 8 by by IN cord-313312-h607itv2 131 9 antibodies antibody NNS cord-313312-h607itv2 131 10 with with IN cord-313312-h607itv2 131 11 stoichiometry stoichiometry NN cord-313312-h607itv2 131 12 exceeding exceed VBG cord-313312-h607itv2 131 13 a a DT cord-313312-h607itv2 131 14 required require VBN cord-313312-h607itv2 131 15 threshold threshold NN cord-313312-h607itv2 131 16 . . . cord-313312-h607itv2 132 1 Hence hence RB cord-313312-h607itv2 132 2 , , , cord-313312-h607itv2 132 3 one one CD cord-313312-h607itv2 132 4 of of IN cord-313312-h607itv2 132 5 the the DT cord-313312-h607itv2 132 6 popular popular JJ cord-313312-h607itv2 132 7 explanations explanation NNS cord-313312-h607itv2 132 8 to to TO cord-313312-h607itv2 132 9 explain explain VB cord-313312-h607itv2 132 10 the the DT cord-313312-h607itv2 132 11 lack lack NN cord-313312-h607itv2 132 12 of of IN cord-313312-h607itv2 132 13 LAV LAV NNP cord-313312-h607itv2 132 14 efficacy efficacy NN cord-313312-h607itv2 132 15 in in IN cord-313312-h607itv2 132 16 the the DT cord-313312-h607itv2 132 17 presence presence NN cord-313312-h607itv2 132 18 of of IN cord-313312-h607itv2 132 19 pre pre JJ cord-313312-h607itv2 132 20 - - JJ cord-313312-h607itv2 132 21 existing existing JJ cord-313312-h607itv2 132 22 antibodies antibody NNS cord-313312-h607itv2 132 23 is be VBZ cord-313312-h607itv2 132 24 the the DT cord-313312-h607itv2 132 25 neutralization neutralization NN cord-313312-h607itv2 132 26 of of IN cord-313312-h607itv2 132 27 the the DT cord-313312-h607itv2 132 28 LAV LAV NNP cord-313312-h607itv2 132 29 , , , cord-313312-h607itv2 132 30 which which WDT cord-313312-h607itv2 132 31 could could MD cord-313312-h607itv2 132 32 consequently consequently RB cord-313312-h607itv2 132 33 decrease decrease VB cord-313312-h607itv2 132 34 the the DT cord-313312-h607itv2 132 35 amount amount NN cord-313312-h607itv2 132 36 of of IN cord-313312-h607itv2 132 37 viral viral JJ cord-313312-h607itv2 132 38 antigens antigen NNS cord-313312-h607itv2 132 39 to to IN cord-313312-h607itv2 132 40 levels level NNS cord-313312-h607itv2 132 41 that that WDT cord-313312-h607itv2 132 42 are be VBP cord-313312-h607itv2 132 43 below below IN cord-313312-h607itv2 132 44 the the DT cord-313312-h607itv2 132 45 threshold threshold NN cord-313312-h607itv2 132 46 for for IN cord-313312-h607itv2 132 47 immune immune JJ cord-313312-h607itv2 132 48 detection detection NN cord-313312-h607itv2 132 49 and and CC cord-313312-h607itv2 132 50 recognition recognition NN cord-313312-h607itv2 132 51 . . . cord-313312-h607itv2 133 1 Antibody antibody NN cord-313312-h607itv2 133 2 concentrations concentration NNS cord-313312-h607itv2 133 3 , , , cord-313312-h607itv2 133 4 affinity affinity NN cord-313312-h607itv2 133 5 , , , cord-313312-h607itv2 133 6 and and CC cord-313312-h607itv2 133 7 epitope epitope NN cord-313312-h607itv2 133 8 accessibility accessibility NN cord-313312-h607itv2 133 9 are be VBP cord-313312-h607itv2 133 10 critical critical JJ cord-313312-h607itv2 133 11 determinants determinant NNS cord-313312-h607itv2 133 12 for for IN cord-313312-h607itv2 133 13 virus virus NN cord-313312-h607itv2 133 14 neutralization neutralization NN cord-313312-h607itv2 133 15 [ [ -LRB- cord-313312-h607itv2 133 16 96 96 CD cord-313312-h607itv2 133 17 ] ] -RRB- cord-313312-h607itv2 134 1 [ [ -LRB- cord-313312-h607itv2 134 2 97 97 CD cord-313312-h607itv2 134 3 ] ] -RRB- cord-313312-h607itv2 134 4 [ [ -LRB- cord-313312-h607itv2 134 5 98 98 CD cord-313312-h607itv2 134 6 ] ] -RRB- cord-313312-h607itv2 134 7 . . . cord-313312-h607itv2 135 1 Antibody antibody NN cord-313312-h607itv2 135 2 affinity affinity NN cord-313312-h607itv2 135 3 , , , cord-313312-h607itv2 135 4 defined define VBN cord-313312-h607itv2 135 5 as as IN cord-313312-h607itv2 135 6 the the DT cord-313312-h607itv2 135 7 fraction fraction NN cord-313312-h607itv2 135 8 of of IN cord-313312-h607itv2 135 9 epitopes epitope NNS cord-313312-h607itv2 135 10 that that WDT cord-313312-h607itv2 135 11 are be VBP cord-313312-h607itv2 135 12 bound bind VBN cord-313312-h607itv2 135 13 by by IN cord-313312-h607itv2 135 14 antibodies antibody NNS cord-313312-h607itv2 135 15 at at IN cord-313312-h607itv2 135 16 non non JJ cord-313312-h607itv2 135 17 - - JJ cord-313312-h607itv2 135 18 saturating saturating JJ cord-313312-h607itv2 135 19 concentrations concentration NNS cord-313312-h607itv2 135 20 , , , cord-313312-h607itv2 135 21 has have VBZ cord-313312-h607itv2 135 22 been be VBN cord-313312-h607itv2 135 23 shown show VBN cord-313312-h607itv2 135 24 to to TO cord-313312-h607itv2 135 25 correlate correlate VB cord-313312-h607itv2 135 26 with with IN cord-313312-h607itv2 135 27 neutralizing neutralize VBG cord-313312-h607itv2 135 28 activity activity NN cord-313312-h607itv2 135 29 in in IN cord-313312-h607itv2 135 30 vitro vitro FW cord-313312-h607itv2 135 31 . . . cord-313312-h607itv2 136 1 On on IN cord-313312-h607itv2 136 2 the the DT cord-313312-h607itv2 136 3 other other JJ cord-313312-h607itv2 136 4 hand hand NN cord-313312-h607itv2 136 5 , , , cord-313312-h607itv2 136 6 epitope epitope NN cord-313312-h607itv2 136 7 accessibility accessibility NN cord-313312-h607itv2 136 8 is be VBZ cord-313312-h607itv2 136 9 defined define VBN cord-313312-h607itv2 136 10 as as IN cord-313312-h607itv2 136 11 the the DT cord-313312-h607itv2 136 12 number number NN cord-313312-h607itv2 136 13 of of IN cord-313312-h607itv2 136 14 epitopes epitope NNS cord-313312-h607itv2 136 15 on on IN cord-313312-h607itv2 136 16 viruses virus NNS cord-313312-h607itv2 136 17 that that WDT cord-313312-h607itv2 136 18 are be VBP cord-313312-h607itv2 136 19 available available JJ cord-313312-h607itv2 136 20 for for IN cord-313312-h607itv2 136 21 binding bind VBG cord-313312-h607itv2 136 22 and and CC cord-313312-h607itv2 136 23 can can MD cord-313312-h607itv2 136 24 be be VB cord-313312-h607itv2 136 25 affected affect VBN cord-313312-h607itv2 136 26 by by IN cord-313312-h607itv2 136 27 virus virus NN cord-313312-h607itv2 136 28 structure structure NN cord-313312-h607itv2 136 29 , , , cord-313312-h607itv2 136 30 structural structural JJ cord-313312-h607itv2 136 31 dynamics dynamic NNS cord-313312-h607itv2 136 32 of of IN cord-313312-h607itv2 136 33 virus virus NN cord-313312-h607itv2 136 34 , , , cord-313312-h607itv2 136 35 and and CC cord-313312-h607itv2 136 36 virus virus NN cord-313312-h607itv2 136 37 maturation maturation NN cord-313312-h607itv2 136 38 states state NNS cord-313312-h607itv2 136 39 [ [ -LRB- cord-313312-h607itv2 136 40 99 99 CD cord-313312-h607itv2 136 41 ] ] -RRB- cord-313312-h607itv2 136 42 . . . cord-313312-h607itv2 137 1 The the DT cord-313312-h607itv2 137 2 epitope epitope NN cord-313312-h607itv2 137 3 availability availability NN cord-313312-h607itv2 137 4 would would MD cord-313312-h607itv2 137 5 thus thus RB cord-313312-h607itv2 137 6 affect affect VB cord-313312-h607itv2 137 7 the the DT cord-313312-h607itv2 137 8 fraction fraction NN cord-313312-h607itv2 137 9 of of IN cord-313312-h607itv2 137 10 epitope epitope NN cord-313312-h607itv2 137 11 occupancy occupancy NN cord-313312-h607itv2 137 12 that that WDT cord-313312-h607itv2 137 13 will will MD cord-313312-h607itv2 137 14 be be VB cord-313312-h607itv2 137 15 required require VBN cord-313312-h607itv2 137 16 for for IN cord-313312-h607itv2 137 17 virus virus NN cord-313312-h607itv2 137 18 neutralization neutralization NN cord-313312-h607itv2 137 19 . . . cord-313312-h607itv2 138 1 Taken take VBN cord-313312-h607itv2 138 2 together together RB cord-313312-h607itv2 138 3 , , , cord-313312-h607itv2 138 4 cross cross JJ cord-313312-h607itv2 138 5 - - JJ cord-313312-h607itv2 138 6 reactive reactive JJ cord-313312-h607itv2 138 7 antibodies antibody NNS cord-313312-h607itv2 138 8 that that WDT cord-313312-h607itv2 138 9 can can MD cord-313312-h607itv2 138 10 neutralize neutralize VB cord-313312-h607itv2 138 11 virus virus NN cord-313312-h607itv2 138 12 infection infection NN cord-313312-h607itv2 138 13 are be VBP cord-313312-h607itv2 138 14 likely likely RB cord-313312-h607itv2 138 15 those those DT cord-313312-h607itv2 138 16 that that WDT cord-313312-h607itv2 138 17 can can MD cord-313312-h607itv2 138 18 bind bind VB cord-313312-h607itv2 138 19 to to IN cord-313312-h607itv2 138 20 accessible accessible JJ cord-313312-h607itv2 138 21 epitopes epitope NNS cord-313312-h607itv2 138 22 with with IN cord-313312-h607itv2 138 23 considerable considerable JJ cord-313312-h607itv2 138 24 affinity affinity NN cord-313312-h607itv2 138 25 . . . cord-313312-h607itv2 139 1 Conversely conversely RB cord-313312-h607itv2 139 2 , , , cord-313312-h607itv2 139 3 antibodies antibody NNS cord-313312-h607itv2 139 4 that that WDT cord-313312-h607itv2 139 5 bind bind VBP cord-313312-h607itv2 139 6 weakly weakly RB cord-313312-h607itv2 139 7 and and CC cord-313312-h607itv2 139 8 target target VB cord-313312-h607itv2 139 9 epitopes epitope NNS cord-313312-h607itv2 139 10 with with IN cord-313312-h607itv2 139 11 reduced reduce VBN cord-313312-h607itv2 139 12 accessibility accessibility NN cord-313312-h607itv2 139 13 are be VBP cord-313312-h607itv2 139 14 unlikely unlikely JJ cord-313312-h607itv2 139 15 to to TO cord-313312-h607itv2 139 16 neutralize neutralize VB cord-313312-h607itv2 139 17 viruses virus NNS cord-313312-h607itv2 139 18 , , , cord-313312-h607itv2 139 19 and and CC cord-313312-h607itv2 139 20 may may MD cord-313312-h607itv2 139 21 instead instead RB cord-313312-h607itv2 139 22 enhance enhance VB cord-313312-h607itv2 139 23 viral viral JJ cord-313312-h607itv2 139 24 infection infection NN cord-313312-h607itv2 139 25 via via IN cord-313312-h607itv2 139 26 FcγR fcγr RB cord-313312-h607itv2 139 27 - - HYPH cord-313312-h607itv2 139 28 mediated mediate VBN cord-313312-h607itv2 139 29 uptake uptake NN cord-313312-h607itv2 139 30 . . . cord-313312-h607itv2 140 1 Antibodies antibody NNS cord-313312-h607itv2 140 2 can can MD cord-313312-h607itv2 140 3 neutralize neutralize VB cord-313312-h607itv2 140 4 LAV LAV NNP cord-313312-h607itv2 140 5 strains strain NNS cord-313312-h607itv2 140 6 in in IN cord-313312-h607itv2 140 7 a a DT cord-313312-h607itv2 140 8 variety variety NN cord-313312-h607itv2 140 9 of of IN cord-313312-h607itv2 140 10 ways way NNS cord-313312-h607itv2 140 11 , , , cord-313312-h607itv2 140 12 as as IN cord-313312-h607itv2 140 13 summarized summarize VBN cord-313312-h607itv2 140 14 in in IN cord-313312-h607itv2 140 15 Figure Figure NNP cord-313312-h607itv2 140 16 1 1 CD cord-313312-h607itv2 140 17 . . . cord-313312-h607itv2 141 1 They -PRON- PRP cord-313312-h607itv2 141 2 may may MD cord-313312-h607itv2 141 3 block block VB cord-313312-h607itv2 141 4 virus virus NN cord-313312-h607itv2 141 5 attachment attachment NN cord-313312-h607itv2 141 6 and and CC cord-313312-h607itv2 141 7 entry entry NN cord-313312-h607itv2 141 8 by by IN cord-313312-h607itv2 141 9 either either DT cord-313312-h607itv2 141 10 binding bind VBG cord-313312-h607itv2 141 11 to to IN cord-313312-h607itv2 141 12 epitopes epitope NNS cord-313312-h607itv2 141 13 that that WDT cord-313312-h607itv2 141 14 are be VBP cord-313312-h607itv2 141 15 directly directly RB cord-313312-h607itv2 141 16 involved involve VBN cord-313312-h607itv2 141 17 in in IN cord-313312-h607itv2 141 18 virus virus NN cord-313312-h607itv2 141 19 - - HYPH cord-313312-h607itv2 141 20 receptor receptor NN cord-313312-h607itv2 141 21 interactions interaction NNS cord-313312-h607itv2 141 22 or or CC cord-313312-h607itv2 141 23 by by IN cord-313312-h607itv2 141 24 imposing impose VBG cord-313312-h607itv2 141 25 steric steric JJ cord-313312-h607itv2 141 26 hindrance hindrance NN cord-313312-h607itv2 141 27 that that WDT cord-313312-h607itv2 141 28 prevent prevent VBP cord-313312-h607itv2 141 29 virus virus NN cord-313312-h607itv2 141 30 interaction interaction NN cord-313312-h607itv2 141 31 with with IN cord-313312-h607itv2 141 32 host host NN cord-313312-h607itv2 141 33 receptors receptor NNS cord-313312-h607itv2 141 34 . . . cord-313312-h607itv2 142 1 As as IN cord-313312-h607itv2 142 2 most most JJS cord-313312-h607itv2 142 3 virus virus NN cord-313312-h607itv2 142 4 structures structure NNS cord-313312-h607itv2 142 5 are be VBP cord-313312-h607itv2 142 6 dynamic dynamic JJ cord-313312-h607itv2 142 7 and and CC cord-313312-h607itv2 142 8 can can MD cord-313312-h607itv2 142 9 change change VB cord-313312-h607itv2 142 10 structural structural JJ cord-313312-h607itv2 142 11 conformations conformation NNS cord-313312-h607itv2 142 12 at at IN cord-313312-h607itv2 142 13 different different JJ cord-313312-h607itv2 142 14 temperatures temperature NNS cord-313312-h607itv2 142 15 , , , cord-313312-h607itv2 142 16 it -PRON- PRP cord-313312-h607itv2 142 17 is be VBZ cord-313312-h607itv2 142 18 thought think VBN cord-313312-h607itv2 142 19 that that IN cord-313312-h607itv2 142 20 antibody antibody NN cord-313312-h607itv2 142 21 binding bind VBG cord-313312-h607itv2 142 22 to to IN cord-313312-h607itv2 142 23 these these DT cord-313312-h607itv2 142 24 dynamic dynamic JJ cord-313312-h607itv2 142 25 structures structure NNS cord-313312-h607itv2 142 26 may may MD cord-313312-h607itv2 142 27 cause cause VB cord-313312-h607itv2 142 28 structural structural JJ cord-313312-h607itv2 142 29 changes change NNS cord-313312-h607itv2 142 30 that that WDT cord-313312-h607itv2 142 31 can can MD cord-313312-h607itv2 142 32 impair impair VB cord-313312-h607itv2 142 33 virus virus NN cord-313312-h607itv2 142 34 attachment attachment NN cord-313312-h607itv2 142 35 , , , cord-313312-h607itv2 142 36 thereby thereby RB cord-313312-h607itv2 142 37 causing cause VBG cord-313312-h607itv2 142 38 virus virus NN cord-313312-h607itv2 142 39 neutralization neutralization NN cord-313312-h607itv2 142 40 [ [ -LRB- cord-313312-h607itv2 142 41 100 100 CD cord-313312-h607itv2 142 42 ] ] -RRB- cord-313312-h607itv2 142 43 . . . cord-313312-h607itv2 143 1 However however RB cord-313312-h607itv2 143 2 , , , cord-313312-h607itv2 143 3 the the DT cord-313312-h607itv2 143 4 blockade blockade NN cord-313312-h607itv2 143 5 of of IN cord-313312-h607itv2 143 6 virus virus NN cord-313312-h607itv2 143 7 - - HYPH cord-313312-h607itv2 143 8 receptor receptor NN cord-313312-h607itv2 143 9 interactions interaction NNS cord-313312-h607itv2 143 10 alone alone RB cord-313312-h607itv2 143 11 may may MD cord-313312-h607itv2 143 12 not not RB cord-313312-h607itv2 143 13 be be VB cord-313312-h607itv2 143 14 able able JJ cord-313312-h607itv2 143 15 to to TO cord-313312-h607itv2 143 16 completely completely RB cord-313312-h607itv2 143 17 neutralize neutralize VB cord-313312-h607itv2 143 18 the the DT cord-313312-h607itv2 143 19 viruses virus NNS cord-313312-h607itv2 143 20 , , , cord-313312-h607itv2 143 21 especially especially RB cord-313312-h607itv2 143 22 in in IN cord-313312-h607itv2 143 23 FcγR fcγr NN cord-313312-h607itv2 143 24 - - HYPH cord-313312-h607itv2 143 25 bearing bear VBG cord-313312-h607itv2 143 26 cells cell NNS cord-313312-h607itv2 143 27 , , , cord-313312-h607itv2 143 28 as as IN cord-313312-h607itv2 143 29 activating activate VBG cord-313312-h607itv2 143 30 FcγRs FcγRs NNP cord-313312-h607itv2 143 31 can can MD cord-313312-h607itv2 143 32 enable enable VB cord-313312-h607itv2 143 33 entry entry NN cord-313312-h607itv2 143 34 of of IN cord-313312-h607itv2 143 35 virus virus NN cord-313312-h607itv2 143 36 - - HYPH cord-313312-h607itv2 143 37 antibody antibody NN cord-313312-h607itv2 143 38 complexes complex NNS cord-313312-h607itv2 143 39 by by IN cord-313312-h607itv2 143 40 FcγR fcγr NN cord-313312-h607itv2 143 41 - - HYPH cord-313312-h607itv2 143 42 mediated mediate VBN cord-313312-h607itv2 143 43 uptake uptake NN cord-313312-h607itv2 143 44 . . . cord-313312-h607itv2 144 1 Thus thus RB cord-313312-h607itv2 144 2 , , , cord-313312-h607itv2 144 3 pre pre JJ cord-313312-h607itv2 144 4 - - JJ cord-313312-h607itv2 144 5 existing existing JJ cord-313312-h607itv2 144 6 antibodies antibody NNS cord-313312-h607itv2 144 7 that that WDT cord-313312-h607itv2 144 8 can can MD cord-313312-h607itv2 144 9 block block VB cord-313312-h607itv2 144 10 viral viral JJ cord-313312-h607itv2 144 11 fusion fusion NN cord-313312-h607itv2 144 12 and and CC cord-313312-h607itv2 144 13 uncoating uncoating NN cord-313312-h607itv2 144 14 will will MD cord-313312-h607itv2 144 15 likely likely RB cord-313312-h607itv2 144 16 be be VB cord-313312-h607itv2 144 17 more more RBR cord-313312-h607itv2 144 18 efficient efficient JJ cord-313312-h607itv2 144 19 in in IN cord-313312-h607itv2 144 20 virus virus NN cord-313312-h607itv2 144 21 neutralization neutralization NN cord-313312-h607itv2 144 22 . . . cord-313312-h607itv2 145 1 In in IN cord-313312-h607itv2 145 2 situations situation NNS cord-313312-h607itv2 145 3 where where WRB cord-313312-h607itv2 145 4 pre pre JJ cord-313312-h607itv2 145 5 - - JJ cord-313312-h607itv2 145 6 existing existing JJ cord-313312-h607itv2 145 7 cross cross JJ cord-313312-h607itv2 145 8 - - JJ cord-313312-h607itv2 145 9 reactive reactive JJ cord-313312-h607itv2 145 10 antibodies antibody NNS cord-313312-h607itv2 145 11 are be VBP cord-313312-h607itv2 145 12 unable unable JJ cord-313312-h607itv2 145 13 to to TO cord-313312-h607itv2 145 14 inhibit inhibit VB cord-313312-h607itv2 145 15 viral viral JJ cord-313312-h607itv2 145 16 fusion fusion NN cord-313312-h607itv2 145 17 processes process NNS cord-313312-h607itv2 145 18 intracellularly intracellularly RB cord-313312-h607itv2 145 19 , , , cord-313312-h607itv2 145 20 high high JJ cord-313312-h607itv2 145 21 concentrations concentration NNS cord-313312-h607itv2 145 22 of of IN cord-313312-h607itv2 145 23 antibodies antibody NNS cord-313312-h607itv2 145 24 may may MD cord-313312-h607itv2 145 25 enable enable VB cord-313312-h607itv2 145 26 the the DT cord-313312-h607itv2 145 27 formation formation NN cord-313312-h607itv2 145 28 of of IN cord-313312-h607itv2 145 29 viral viral JJ cord-313312-h607itv2 145 30 immune immune JJ cord-313312-h607itv2 145 31 aggregates aggregate NNS cord-313312-h607itv2 145 32 that that WDT cord-313312-h607itv2 145 33 influence influence VBP cord-313312-h607itv2 145 34 the the DT cord-313312-h607itv2 145 35 types type NNS cord-313312-h607itv2 145 36 of of IN cord-313312-h607itv2 145 37 FcγRs FcγRs NNP cord-313312-h607itv2 145 38 engaged engage VBD cord-313312-h607itv2 145 39 . . . cord-313312-h607itv2 146 1 These these DT cord-313312-h607itv2 146 2 large large JJ cord-313312-h607itv2 146 3 viral viral JJ cord-313312-h607itv2 146 4 aggregates aggregate NNS cord-313312-h607itv2 146 5 can can MD cord-313312-h607itv2 146 6 then then RB cord-313312-h607itv2 146 7 inhibit inhibit VB cord-313312-h607itv2 146 8 phagocytosis phagocytosis NN cord-313312-h607itv2 146 9 by by IN cord-313312-h607itv2 146 10 co co NN cord-313312-h607itv2 146 11 - - JJ cord-313312-h607itv2 146 12 ligating ligate VBG cord-313312-h607itv2 146 13 the the DT cord-313312-h607itv2 146 14 lowly lowly JJ cord-313312-h607itv2 146 15 expressed express VBN cord-313312-h607itv2 146 16 inhibitory inhibitory JJ cord-313312-h607itv2 146 17 receptor receptor NN cord-313312-h607itv2 146 18 FcγRIIB fcγriib NN cord-313312-h607itv2 146 19 that that WDT cord-313312-h607itv2 146 20 inhibit inhibit VBP cord-313312-h607itv2 146 21 phagocytosis phagocytosis NN cord-313312-h607itv2 146 22 [ [ -LRB- cord-313312-h607itv2 146 23 101 101 CD cord-313312-h607itv2 146 24 , , , cord-313312-h607itv2 146 25 102 102 CD cord-313312-h607itv2 146 26 ] ] -RRB- cord-313312-h607itv2 146 27 . . . cord-313312-h607itv2 147 1 Finally finally RB cord-313312-h607itv2 147 2 , , , cord-313312-h607itv2 147 3 there there EX cord-313312-h607itv2 147 4 have have VBP cord-313312-h607itv2 147 5 been be VBN cord-313312-h607itv2 147 6 theories theory NNS cord-313312-h607itv2 147 7 suggesting suggest VBG cord-313312-h607itv2 147 8 that that IN cord-313312-h607itv2 147 9 FcγR fcγr JJ cord-313312-h607itv2 147 10 cross cross NN cord-313312-h607itv2 147 11 - - NN cord-313312-h607itv2 147 12 linking link VBG cord-313312-h607itv2 147 13 by by IN cord-313312-h607itv2 147 14 virus virus NN cord-313312-h607itv2 147 15 immune immune JJ cord-313312-h607itv2 147 16 complexes complex NNS cord-313312-h607itv2 147 17 may may MD cord-313312-h607itv2 147 18 increase increase VB cord-313312-h607itv2 147 19 the the DT cord-313312-h607itv2 147 20 production production NN cord-313312-h607itv2 147 21 of of IN cord-313312-h607itv2 147 22 IL-10 IL-10 NNP cord-313312-h607itv2 147 23 that that WDT cord-313312-h607itv2 147 24 abolishes abolish VBZ cord-313312-h607itv2 147 25 innate innate JJ cord-313312-h607itv2 147 26 immune immune JJ cord-313312-h607itv2 147 27 responses response NNS cord-313312-h607itv2 147 28 [ [ -LRB- cord-313312-h607itv2 147 29 103 103 CD cord-313312-h607itv2 147 30 ] ] -RRB- cord-313312-h607itv2 147 31 . . . cord-313312-h607itv2 148 1 However however RB cord-313312-h607itv2 148 2 , , , cord-313312-h607itv2 148 3 more more JJR cord-313312-h607itv2 148 4 experimental experimental JJ cord-313312-h607itv2 148 5 evidence evidence NN cord-313312-h607itv2 148 6 will will MD cord-313312-h607itv2 148 7 be be VB cord-313312-h607itv2 148 8 required require VBN cord-313312-h607itv2 148 9 to to TO cord-313312-h607itv2 148 10 support support VB cord-313312-h607itv2 148 11 this this DT cord-313312-h607itv2 148 12 theory theory NN cord-313312-h607itv2 148 13 . . . cord-313312-h607itv2 149 1 Viruses virus NNS cord-313312-h607itv2 149 2 2020 2020 CD cord-313312-h607itv2 149 3 , , , cord-313312-h607itv2 149 4 12 12 CD cord-313312-h607itv2 149 5 , , , cord-313312-h607itv2 149 6 x x NN cord-313312-h607itv2 149 7 FOR for IN cord-313312-h607itv2 149 8 PEER PEER NNP cord-313312-h607itv2 149 9 REVIEW REVIEW NNP cord-313312-h607itv2 149 10 7 7 CD cord-313312-h607itv2 149 11 of of IN cord-313312-h607itv2 149 12 17 17 CD cord-313312-h607itv2 149 13 virus virus NN cord-313312-h607itv2 149 14 maturation maturation NN cord-313312-h607itv2 149 15 states state NNS cord-313312-h607itv2 149 16 [ [ -LRB- cord-313312-h607itv2 149 17 99 99 CD cord-313312-h607itv2 149 18 ] ] -RRB- cord-313312-h607itv2 149 19 . . . cord-313312-h607itv2 150 1 The the DT cord-313312-h607itv2 150 2 epitope epitope NN cord-313312-h607itv2 150 3 availability availability NN cord-313312-h607itv2 150 4 would would MD cord-313312-h607itv2 150 5 thus thus RB cord-313312-h607itv2 150 6 affect affect VB cord-313312-h607itv2 150 7 the the DT cord-313312-h607itv2 150 8 fraction fraction NN cord-313312-h607itv2 150 9 of of IN cord-313312-h607itv2 150 10 epitope epitope NN cord-313312-h607itv2 150 11 occupancy occupancy NN cord-313312-h607itv2 150 12 that that WDT cord-313312-h607itv2 150 13 will will MD cord-313312-h607itv2 150 14 be be VB cord-313312-h607itv2 150 15 required require VBN cord-313312-h607itv2 150 16 for for IN cord-313312-h607itv2 150 17 virus virus NN cord-313312-h607itv2 150 18 neutralization neutralization NN cord-313312-h607itv2 150 19 . . . cord-313312-h607itv2 151 1 Taken take VBN cord-313312-h607itv2 151 2 together together RB cord-313312-h607itv2 151 3 , , , cord-313312-h607itv2 151 4 cross cross JJ cord-313312-h607itv2 151 5 - - JJ cord-313312-h607itv2 151 6 reactive reactive JJ cord-313312-h607itv2 151 7 antibodies antibody NNS cord-313312-h607itv2 151 8 that that WDT cord-313312-h607itv2 151 9 can can MD cord-313312-h607itv2 151 10 neutralize neutralize VB cord-313312-h607itv2 151 11 virus virus NN cord-313312-h607itv2 151 12 infection infection NN cord-313312-h607itv2 151 13 are be VBP cord-313312-h607itv2 151 14 likely likely RB cord-313312-h607itv2 151 15 those those DT cord-313312-h607itv2 151 16 that that WDT cord-313312-h607itv2 151 17 can can MD cord-313312-h607itv2 151 18 bind bind VB cord-313312-h607itv2 151 19 to to IN cord-313312-h607itv2 151 20 accessible accessible JJ cord-313312-h607itv2 151 21 epitopes epitope NNS cord-313312-h607itv2 151 22 with with IN cord-313312-h607itv2 151 23 considerable considerable JJ cord-313312-h607itv2 151 24 affinity affinity NN cord-313312-h607itv2 151 25 . . . cord-313312-h607itv2 152 1 Conversely conversely RB cord-313312-h607itv2 152 2 , , , cord-313312-h607itv2 152 3 antibodies antibody NNS cord-313312-h607itv2 152 4 that that WDT cord-313312-h607itv2 152 5 bind bind VBP cord-313312-h607itv2 152 6 weakly weakly RB cord-313312-h607itv2 152 7 and and CC cord-313312-h607itv2 152 8 target target VB cord-313312-h607itv2 152 9 epitopes epitope NNS cord-313312-h607itv2 152 10 with with IN cord-313312-h607itv2 152 11 reduced reduce VBN cord-313312-h607itv2 152 12 accessibility accessibility NN cord-313312-h607itv2 152 13 are be VBP cord-313312-h607itv2 152 14 unlikely unlikely JJ cord-313312-h607itv2 152 15 to to TO cord-313312-h607itv2 152 16 neutralize neutralize VB cord-313312-h607itv2 152 17 viruses virus NNS cord-313312-h607itv2 152 18 , , , cord-313312-h607itv2 152 19 and and CC cord-313312-h607itv2 152 20 may may MD cord-313312-h607itv2 152 21 instead instead RB cord-313312-h607itv2 152 22 enhance enhance VB cord-313312-h607itv2 152 23 viral viral JJ cord-313312-h607itv2 152 24 infection infection NN cord-313312-h607itv2 152 25 via via IN cord-313312-h607itv2 152 26 FcγRmediated fcγrmediated JJ cord-313312-h607itv2 152 27 uptake uptake NN cord-313312-h607itv2 152 28 . . . cord-313312-h607itv2 153 1 Antibodies antibody NNS cord-313312-h607itv2 153 2 can can MD cord-313312-h607itv2 153 3 neutralize neutralize VB cord-313312-h607itv2 153 4 LAV LAV NNP cord-313312-h607itv2 153 5 strains strain NNS cord-313312-h607itv2 153 6 in in IN cord-313312-h607itv2 153 7 a a DT cord-313312-h607itv2 153 8 variety variety NN cord-313312-h607itv2 153 9 of of IN cord-313312-h607itv2 153 10 ways way NNS cord-313312-h607itv2 153 11 , , , cord-313312-h607itv2 153 12 as as IN cord-313312-h607itv2 153 13 summarized summarize VBN cord-313312-h607itv2 153 14 in in IN cord-313312-h607itv2 153 15 Figure Figure NNP cord-313312-h607itv2 153 16 1 1 CD cord-313312-h607itv2 153 17 . . . cord-313312-h607itv2 154 1 They -PRON- PRP cord-313312-h607itv2 154 2 may may MD cord-313312-h607itv2 154 3 block block VB cord-313312-h607itv2 154 4 virus virus NN cord-313312-h607itv2 154 5 attachment attachment NN cord-313312-h607itv2 154 6 and and CC cord-313312-h607itv2 154 7 entry entry NN cord-313312-h607itv2 154 8 by by IN cord-313312-h607itv2 154 9 either either DT cord-313312-h607itv2 154 10 binding bind VBG cord-313312-h607itv2 154 11 to to IN cord-313312-h607itv2 154 12 epitopes epitope NNS cord-313312-h607itv2 154 13 that that WDT cord-313312-h607itv2 154 14 are be VBP cord-313312-h607itv2 154 15 directly directly RB cord-313312-h607itv2 154 16 involved involve VBN cord-313312-h607itv2 154 17 in in IN cord-313312-h607itv2 154 18 virus virus NN cord-313312-h607itv2 154 19 - - HYPH cord-313312-h607itv2 154 20 receptor receptor NN cord-313312-h607itv2 154 21 interactions interaction NNS cord-313312-h607itv2 154 22 or or CC cord-313312-h607itv2 154 23 by by IN cord-313312-h607itv2 154 24 imposing impose VBG cord-313312-h607itv2 154 25 steric steric JJ cord-313312-h607itv2 154 26 hindrance hindrance NN cord-313312-h607itv2 154 27 that that WDT cord-313312-h607itv2 154 28 prevent prevent VBP cord-313312-h607itv2 154 29 virus virus NN cord-313312-h607itv2 154 30 interaction interaction NN cord-313312-h607itv2 154 31 with with IN cord-313312-h607itv2 154 32 host host NN cord-313312-h607itv2 154 33 receptors receptor NNS cord-313312-h607itv2 154 34 . . . cord-313312-h607itv2 155 1 As as IN cord-313312-h607itv2 155 2 most most JJS cord-313312-h607itv2 155 3 virus virus NN cord-313312-h607itv2 155 4 structures structure NNS cord-313312-h607itv2 155 5 are be VBP cord-313312-h607itv2 155 6 dynamic dynamic JJ cord-313312-h607itv2 155 7 and and CC cord-313312-h607itv2 155 8 can can MD cord-313312-h607itv2 155 9 change change VB cord-313312-h607itv2 155 10 structural structural JJ cord-313312-h607itv2 155 11 conformations conformation NNS cord-313312-h607itv2 155 12 at at IN cord-313312-h607itv2 155 13 different different JJ cord-313312-h607itv2 155 14 temperatures temperature NNS cord-313312-h607itv2 155 15 , , , cord-313312-h607itv2 155 16 it -PRON- PRP cord-313312-h607itv2 155 17 is be VBZ cord-313312-h607itv2 155 18 thought think VBN cord-313312-h607itv2 155 19 that that IN cord-313312-h607itv2 155 20 antibody antibody NN cord-313312-h607itv2 155 21 binding bind VBG cord-313312-h607itv2 155 22 to to IN cord-313312-h607itv2 155 23 these these DT cord-313312-h607itv2 155 24 dynamic dynamic JJ cord-313312-h607itv2 155 25 structures structure NNS cord-313312-h607itv2 155 26 may may MD cord-313312-h607itv2 155 27 cause cause VB cord-313312-h607itv2 155 28 structural structural JJ cord-313312-h607itv2 155 29 changes change NNS cord-313312-h607itv2 155 30 that that WDT cord-313312-h607itv2 155 31 can can MD cord-313312-h607itv2 155 32 impair impair VB cord-313312-h607itv2 155 33 virus virus NN cord-313312-h607itv2 155 34 attachment attachment NN cord-313312-h607itv2 155 35 , , , cord-313312-h607itv2 155 36 thereby thereby RB cord-313312-h607itv2 155 37 causing cause VBG cord-313312-h607itv2 155 38 virus virus NN cord-313312-h607itv2 155 39 neutralization neutralization NN cord-313312-h607itv2 155 40 [ [ -LRB- cord-313312-h607itv2 155 41 100 100 CD cord-313312-h607itv2 155 42 ] ] -RRB- cord-313312-h607itv2 155 43 . . . cord-313312-h607itv2 156 1 However however RB cord-313312-h607itv2 156 2 , , , cord-313312-h607itv2 156 3 the the DT cord-313312-h607itv2 156 4 blockade blockade NN cord-313312-h607itv2 156 5 of of IN cord-313312-h607itv2 156 6 virus virus NN cord-313312-h607itv2 156 7 - - HYPH cord-313312-h607itv2 156 8 receptor receptor NN cord-313312-h607itv2 156 9 interactions interaction NNS cord-313312-h607itv2 156 10 alone alone RB cord-313312-h607itv2 156 11 may may MD cord-313312-h607itv2 156 12 not not RB cord-313312-h607itv2 156 13 be be VB cord-313312-h607itv2 156 14 able able JJ cord-313312-h607itv2 156 15 to to TO cord-313312-h607itv2 156 16 completely completely RB cord-313312-h607itv2 156 17 neutralize neutralize VB cord-313312-h607itv2 156 18 the the DT cord-313312-h607itv2 156 19 viruses virus NNS cord-313312-h607itv2 156 20 , , , cord-313312-h607itv2 156 21 especially especially RB cord-313312-h607itv2 156 22 in in IN cord-313312-h607itv2 156 23 FcγR fcγr NN cord-313312-h607itv2 156 24 - - HYPH cord-313312-h607itv2 156 25 bearing bear VBG cord-313312-h607itv2 156 26 cells cell NNS cord-313312-h607itv2 156 27 , , , cord-313312-h607itv2 156 28 as as IN cord-313312-h607itv2 156 29 activating activate VBG cord-313312-h607itv2 156 30 FcγRs FcγRs NNP cord-313312-h607itv2 156 31 can can MD cord-313312-h607itv2 156 32 enable enable VB cord-313312-h607itv2 156 33 entry entry NN cord-313312-h607itv2 156 34 of of IN cord-313312-h607itv2 156 35 virus virus NN cord-313312-h607itv2 156 36 - - HYPH cord-313312-h607itv2 156 37 antibody antibody NN cord-313312-h607itv2 156 38 complexes complex NNS cord-313312-h607itv2 156 39 by by IN cord-313312-h607itv2 156 40 FcγR fcγr NN cord-313312-h607itv2 156 41 - - HYPH cord-313312-h607itv2 156 42 mediated mediate VBN cord-313312-h607itv2 156 43 uptake uptake NN cord-313312-h607itv2 156 44 . . . cord-313312-h607itv2 157 1 Thus thus RB cord-313312-h607itv2 157 2 , , , cord-313312-h607itv2 157 3 pre pre JJ cord-313312-h607itv2 157 4 - - JJ cord-313312-h607itv2 157 5 existing existing JJ cord-313312-h607itv2 157 6 antibodies antibody NNS cord-313312-h607itv2 157 7 that that WDT cord-313312-h607itv2 157 8 can can MD cord-313312-h607itv2 157 9 block block VB cord-313312-h607itv2 157 10 viral viral JJ cord-313312-h607itv2 157 11 fusion fusion NN cord-313312-h607itv2 157 12 and and CC cord-313312-h607itv2 157 13 uncoating uncoating NN cord-313312-h607itv2 157 14 will will MD cord-313312-h607itv2 157 15 likely likely RB cord-313312-h607itv2 157 16 be be VB cord-313312-h607itv2 157 17 more more RBR cord-313312-h607itv2 157 18 efficient efficient JJ cord-313312-h607itv2 157 19 in in IN cord-313312-h607itv2 157 20 virus virus NN cord-313312-h607itv2 157 21 neutralization neutralization NN cord-313312-h607itv2 157 22 . . . cord-313312-h607itv2 158 1 In in IN cord-313312-h607itv2 158 2 situations situation NNS cord-313312-h607itv2 158 3 where where WRB cord-313312-h607itv2 158 4 pre pre JJ cord-313312-h607itv2 158 5 - - JJ cord-313312-h607itv2 158 6 existing existing JJ cord-313312-h607itv2 158 7 cross cross JJ cord-313312-h607itv2 158 8 - - JJ cord-313312-h607itv2 158 9 reactive reactive JJ cord-313312-h607itv2 158 10 antibodies antibody NNS cord-313312-h607itv2 158 11 are be VBP cord-313312-h607itv2 158 12 unable unable JJ cord-313312-h607itv2 158 13 to to TO cord-313312-h607itv2 158 14 inhibit inhibit VB cord-313312-h607itv2 158 15 viral viral JJ cord-313312-h607itv2 158 16 fusion fusion NN cord-313312-h607itv2 158 17 processes process NNS cord-313312-h607itv2 158 18 intracellularly intracellularly RB cord-313312-h607itv2 158 19 , , , cord-313312-h607itv2 158 20 high high JJ cord-313312-h607itv2 158 21 concentrations concentration NNS cord-313312-h607itv2 158 22 of of IN cord-313312-h607itv2 158 23 antibodies antibody NNS cord-313312-h607itv2 158 24 may may MD cord-313312-h607itv2 158 25 enable enable VB cord-313312-h607itv2 158 26 the the DT cord-313312-h607itv2 158 27 formation formation NN cord-313312-h607itv2 158 28 of of IN cord-313312-h607itv2 158 29 viral viral JJ cord-313312-h607itv2 158 30 immune immune JJ cord-313312-h607itv2 158 31 aggregates aggregate NNS cord-313312-h607itv2 158 32 that that WDT cord-313312-h607itv2 158 33 influence influence VBP cord-313312-h607itv2 158 34 the the DT cord-313312-h607itv2 158 35 types type NNS cord-313312-h607itv2 158 36 of of IN cord-313312-h607itv2 158 37 FcγRs FcγRs NNP cord-313312-h607itv2 158 38 engaged engage VBD cord-313312-h607itv2 158 39 . . . cord-313312-h607itv2 159 1 These these DT cord-313312-h607itv2 159 2 large large JJ cord-313312-h607itv2 159 3 viral viral JJ cord-313312-h607itv2 159 4 aggregates aggregate NNS cord-313312-h607itv2 159 5 can can MD cord-313312-h607itv2 159 6 then then RB cord-313312-h607itv2 159 7 inhibit inhibit VB cord-313312-h607itv2 159 8 phagocytosis phagocytosis NN cord-313312-h607itv2 159 9 by by IN cord-313312-h607itv2 159 10 co co NN cord-313312-h607itv2 159 11 - - JJ cord-313312-h607itv2 159 12 ligating ligate VBG cord-313312-h607itv2 159 13 the the DT cord-313312-h607itv2 159 14 lowly lowly JJ cord-313312-h607itv2 159 15 expressed express VBN cord-313312-h607itv2 159 16 inhibitory inhibitory JJ cord-313312-h607itv2 159 17 receptor receptor NN cord-313312-h607itv2 159 18 FcγRIIB fcγriib NN cord-313312-h607itv2 159 19 that that WDT cord-313312-h607itv2 159 20 inhibit inhibit VBP cord-313312-h607itv2 159 21 phagocytosis phagocytosis NN cord-313312-h607itv2 159 22 [ [ -LRB- cord-313312-h607itv2 159 23 101 101 CD cord-313312-h607itv2 159 24 , , , cord-313312-h607itv2 159 25 102 102 CD cord-313312-h607itv2 159 26 ] ] -RRB- cord-313312-h607itv2 159 27 . . . cord-313312-h607itv2 160 1 Finally finally RB cord-313312-h607itv2 160 2 , , , cord-313312-h607itv2 160 3 there there EX cord-313312-h607itv2 160 4 have have VBP cord-313312-h607itv2 160 5 been be VBN cord-313312-h607itv2 160 6 theories theory NNS cord-313312-h607itv2 160 7 suggesting suggest VBG cord-313312-h607itv2 160 8 that that IN cord-313312-h607itv2 160 9 FcγR fcγr JJ cord-313312-h607itv2 160 10 cross cross NN cord-313312-h607itv2 160 11 - - NN cord-313312-h607itv2 160 12 linking link VBG cord-313312-h607itv2 160 13 by by IN cord-313312-h607itv2 160 14 virus virus NN cord-313312-h607itv2 160 15 immune immune JJ cord-313312-h607itv2 160 16 complexes complex NNS cord-313312-h607itv2 160 17 may may MD cord-313312-h607itv2 160 18 increase increase VB cord-313312-h607itv2 160 19 the the DT cord-313312-h607itv2 160 20 production production NN cord-313312-h607itv2 160 21 of of IN cord-313312-h607itv2 160 22 IL-10 IL-10 NNP cord-313312-h607itv2 160 23 that that WDT cord-313312-h607itv2 160 24 abolishes abolish VBZ cord-313312-h607itv2 160 25 innate innate JJ cord-313312-h607itv2 160 26 immune immune JJ cord-313312-h607itv2 160 27 responses response NNS cord-313312-h607itv2 160 28 [ [ -LRB- cord-313312-h607itv2 160 29 103 103 CD cord-313312-h607itv2 160 30 ] ] -RRB- cord-313312-h607itv2 160 31 . . . cord-313312-h607itv2 161 1 However however RB cord-313312-h607itv2 161 2 , , , cord-313312-h607itv2 161 3 more more JJR cord-313312-h607itv2 161 4 experimental experimental JJ cord-313312-h607itv2 161 5 evidence evidence NN cord-313312-h607itv2 161 6 will will MD cord-313312-h607itv2 161 7 be be VB cord-313312-h607itv2 161 8 required require VBN cord-313312-h607itv2 161 9 to to TO cord-313312-h607itv2 161 10 support support VB cord-313312-h607itv2 161 11 this this DT cord-313312-h607itv2 161 12 theory theory NN cord-313312-h607itv2 161 13 . . . cord-313312-h607itv2 161 14 _SP cord-313312-h607itv2 162 1 Unlike unlike IN cord-313312-h607itv2 162 2 myeloid myeloid NN cord-313312-h607itv2 162 3 cells cell NNS cord-313312-h607itv2 162 4 , , , cord-313312-h607itv2 162 5 B b NN cord-313312-h607itv2 162 6 - - HYPH cord-313312-h607itv2 162 7 cells cell NNS cord-313312-h607itv2 162 8 exclusively exclusively RB cord-313312-h607itv2 162 9 express express VBP cord-313312-h607itv2 162 10 FcγRIIB fcγriib NN cord-313312-h607itv2 162 11 but but CC cord-313312-h607itv2 162 12 not not RB cord-313312-h607itv2 162 13 the the DT cord-313312-h607itv2 162 14 activating activate VBG cord-313312-h607itv2 162 15 FcγRs FcγRs NNP cord-313312-h607itv2 162 16 [ [ -LRB- cord-313312-h607itv2 162 17 86 86 CD cord-313312-h607itv2 162 18 ] ] -RRB- cord-313312-h607itv2 162 19 . . . cord-313312-h607itv2 163 1 Therefore therefore RB cord-313312-h607itv2 163 2 , , , cord-313312-h607itv2 163 3 cross cross NN cord-313312-h607itv2 163 4 - - NN cord-313312-h607itv2 163 5 linking linking NN cord-313312-h607itv2 163 6 of of IN cord-313312-h607itv2 163 7 the the DT cord-313312-h607itv2 163 8 B b NN cord-313312-h607itv2 163 9 - - HYPH cord-313312-h607itv2 163 10 cell cell NN cord-313312-h607itv2 163 11 receptor receptor NN cord-313312-h607itv2 163 12 ( ( -LRB- cord-313312-h607itv2 163 13 BCR BCR NNP cord-313312-h607itv2 163 14 ) ) -RRB- cord-313312-h607itv2 163 15 with with IN cord-313312-h607itv2 163 16 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 163 17 mediated mediate VBN cord-313312-h607itv2 163 18 by by IN cord-313312-h607itv2 163 19 virus virus NN cord-313312-h607itv2 163 20 immune immune JJ cord-313312-h607itv2 163 21 complexes complex NNS cord-313312-h607itv2 163 22 can can MD cord-313312-h607itv2 163 23 lead lead VB cord-313312-h607itv2 163 24 to to IN cord-313312-h607itv2 163 25 the the DT cord-313312-h607itv2 163 26 inhibition inhibition NN cord-313312-h607itv2 163 27 of of IN cord-313312-h607itv2 163 28 B b NN cord-313312-h607itv2 163 29 - - HYPH cord-313312-h607itv2 163 30 cell cell NN cord-313312-h607itv2 163 31 activation activation NN cord-313312-h607itv2 163 32 ( ( -LRB- cord-313312-h607itv2 163 33 Figure figure NN cord-313312-h607itv2 163 34 2a 2a CD cord-313312-h607itv2 163 35 ) ) -RRB- cord-313312-h607itv2 163 36 . . . cord-313312-h607itv2 164 1 Indeed indeed RB cord-313312-h607itv2 164 2 , , , cord-313312-h607itv2 164 3 by by IN cord-313312-h607itv2 164 4 adding add VBG cord-313312-h607itv2 164 5 sheep sheep NNS cord-313312-h607itv2 164 6 red red JJ cord-313312-h607itv2 164 7 blood blood NN cord-313312-h607itv2 164 8 cell cell NN cord-313312-h607itv2 164 9 - - HYPH cord-313312-h607itv2 164 10 specific specific JJ cord-313312-h607itv2 164 11 ( ( -LRB- cord-313312-h607itv2 164 12 SBRC SBRC NNP cord-313312-h607itv2 164 13 ) ) -RRB- cord-313312-h607itv2 164 14 IgG IgG NNP cord-313312-h607itv2 164 15 to to TO cord-313312-h607itv2 164 16 SRBCs SRBCs NNP cord-313312-h607itv2 164 17 , , , cord-313312-h607itv2 164 18 B b NN cord-313312-h607itv2 164 19 - - HYPH cord-313312-h607itv2 164 20 cell cell NN cord-313312-h607itv2 164 21 antibody antibody NN cord-313312-h607itv2 164 22 secretion secretion NN cord-313312-h607itv2 164 23 is be VBZ cord-313312-h607itv2 164 24 reduced reduce VBN cord-313312-h607itv2 164 25 [ [ -LRB- cord-313312-h607itv2 164 26 104 104 CD cord-313312-h607itv2 164 27 ] ] -RRB- cord-313312-h607itv2 164 28 . . . cord-313312-h607itv2 165 1 Similarly similarly RB cord-313312-h607itv2 165 2 , , , cord-313312-h607itv2 165 3 using use VBG cord-313312-h607itv2 165 4 the the DT cord-313312-h607itv2 165 5 cotton cotton NN cord-313312-h607itv2 165 6 rat rat NN cord-313312-h607itv2 165 7 model model NN cord-313312-h607itv2 165 8 of of IN cord-313312-h607itv2 165 9 MV MV NNP cord-313312-h607itv2 165 10 vaccination vaccination NN cord-313312-h607itv2 165 11 , , , cord-313312-h607itv2 165 12 maternal maternal JJ cord-313312-h607itv2 165 13 antibodies antibody NNS cord-313312-h607itv2 165 14 were be VBD cord-313312-h607itv2 165 15 demonstrated demonstrate VBN cord-313312-h607itv2 165 16 to to TO cord-313312-h607itv2 165 17 inhibit inhibit VB cord-313312-h607itv2 165 18 B b NN cord-313312-h607itv2 165 19 - - HYPH cord-313312-h607itv2 165 20 cells cell NNS cord-313312-h607itv2 165 21 by by IN cord-313312-h607itv2 165 22 the the DT cord-313312-h607itv2 165 23 cross cross NN cord-313312-h607itv2 165 24 - - JJ cord-313312-h607itv2 165 25 linking linking NN cord-313312-h607itv2 165 26 of of IN cord-313312-h607itv2 165 27 BCR BCR NNP cord-313312-h607itv2 165 28 and and CC cord-313312-h607itv2 165 29 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 165 30 [ [ -LRB- cord-313312-h607itv2 165 31 105 105 CD cord-313312-h607itv2 165 32 ] ] -RRB- cord-313312-h607itv2 165 33 . . . cord-313312-h607itv2 166 1 However however RB cord-313312-h607itv2 166 2 , , , cord-313312-h607itv2 166 3 this this DT cord-313312-h607itv2 166 4 mechanism mechanism NN cord-313312-h607itv2 166 5 of of IN cord-313312-h607itv2 166 6 inhibition inhibition NN cord-313312-h607itv2 166 7 has have VBZ cord-313312-h607itv2 166 8 not not RB cord-313312-h607itv2 166 9 been be VBN cord-313312-h607itv2 166 10 demonstrated demonstrate VBN cord-313312-h607itv2 166 11 for for IN cord-313312-h607itv2 166 12 other other JJ cord-313312-h607itv2 166 13 viruses virus NNS cord-313312-h607itv2 166 14 . . . cord-313312-h607itv2 167 1 It -PRON- PRP cord-313312-h607itv2 167 2 is be VBZ cord-313312-h607itv2 167 3 conceivable conceivable JJ cord-313312-h607itv2 167 4 that that IN cord-313312-h607itv2 167 5 this this DT cord-313312-h607itv2 167 6 mode mode NN cord-313312-h607itv2 167 7 of of IN cord-313312-h607itv2 167 8 inhibition inhibition NN cord-313312-h607itv2 167 9 is be VBZ cord-313312-h607itv2 167 10 dependent dependent JJ cord-313312-h607itv2 167 11 on on IN cord-313312-h607itv2 167 12 the the DT cord-313312-h607itv2 167 13 size size NN cord-313312-h607itv2 167 14 of of IN cord-313312-h607itv2 167 15 the the DT cord-313312-h607itv2 167 16 virus virus NN cord-313312-h607itv2 167 17 - - HYPH cord-313312-h607itv2 167 18 antibody antibody NN cord-313312-h607itv2 167 19 immune immune JJ cord-313312-h607itv2 167 20 complexes complex NNS cord-313312-h607itv2 167 21 , , , cord-313312-h607itv2 167 22 as as IN cord-313312-h607itv2 167 23 immunization immunization NN cord-313312-h607itv2 167 24 of of IN cord-313312-h607itv2 167 25 small small JJ cord-313312-h607itv2 167 26 polypeptides polypeptide NNS cord-313312-h607itv2 167 27 can can MD cord-313312-h607itv2 167 28 escape escape VB cord-313312-h607itv2 167 29 maternal maternal JJ cord-313312-h607itv2 167 30 antibody antibody NN cord-313312-h607itv2 167 31 inhibition inhibition NN cord-313312-h607itv2 167 32 [ [ -LRB- cord-313312-h607itv2 167 33 106 106 CD cord-313312-h607itv2 167 34 ] ] -RRB- cord-313312-h607itv2 167 35 . . . cord-313312-h607itv2 168 1 More More JJR cord-313312-h607itv2 168 2 mechanistic mechanistic JJ cord-313312-h607itv2 168 3 studies study NNS cord-313312-h607itv2 168 4 will will MD cord-313312-h607itv2 168 5 hence hence RB cord-313312-h607itv2 168 6 be be VB cord-313312-h607itv2 168 7 required require VBN cord-313312-h607itv2 168 8 to to TO cord-313312-h607itv2 168 9 evaluate evaluate VB cord-313312-h607itv2 168 10 the the DT cord-313312-h607itv2 168 11 conditions condition NNS cord-313312-h607itv2 168 12 that that WDT cord-313312-h607itv2 168 13 need need VBP cord-313312-h607itv2 168 14 to to TO cord-313312-h607itv2 168 15 be be VB cord-313312-h607itv2 168 16 satisfied satisfied JJ cord-313312-h607itv2 168 17 to to TO cord-313312-h607itv2 168 18 cause cause VB cord-313312-h607itv2 168 19 B b NN cord-313312-h607itv2 168 20 - - HYPH cord-313312-h607itv2 168 21 cell cell NN cord-313312-h607itv2 168 22 inhibition inhibition NN cord-313312-h607itv2 168 23 . . . cord-313312-h607itv2 169 1 Viruses virus NNS cord-313312-h607itv2 169 2 2020 2020 CD cord-313312-h607itv2 169 3 , , , cord-313312-h607itv2 169 4 12 12 CD cord-313312-h607itv2 169 5 , , , cord-313312-h607itv2 169 6 x x NN cord-313312-h607itv2 169 7 FOR for IN cord-313312-h607itv2 169 8 PEER PEER NNP cord-313312-h607itv2 169 9 REVIEW REVIEW NNP cord-313312-h607itv2 169 10 8 8 CD cord-313312-h607itv2 169 11 of of IN cord-313312-h607itv2 169 12 17 17 CD cord-313312-h607itv2 170 1 Unlike unlike IN cord-313312-h607itv2 170 2 myeloid myeloid NN cord-313312-h607itv2 170 3 cells cell NNS cord-313312-h607itv2 170 4 , , , cord-313312-h607itv2 170 5 B b NN cord-313312-h607itv2 170 6 - - HYPH cord-313312-h607itv2 170 7 cells cell NNS cord-313312-h607itv2 170 8 exclusively exclusively RB cord-313312-h607itv2 170 9 express express VBP cord-313312-h607itv2 170 10 FcγRIIB fcγriib NN cord-313312-h607itv2 170 11 but but CC cord-313312-h607itv2 170 12 not not RB cord-313312-h607itv2 170 13 the the DT cord-313312-h607itv2 170 14 activating activate VBG cord-313312-h607itv2 170 15 FcγRs FcγRs NNP cord-313312-h607itv2 170 16 [ [ -LRB- cord-313312-h607itv2 170 17 86 86 CD cord-313312-h607itv2 170 18 ] ] -RRB- cord-313312-h607itv2 170 19 . . . cord-313312-h607itv2 171 1 Therefore therefore RB cord-313312-h607itv2 171 2 , , , cord-313312-h607itv2 171 3 cross cross NN cord-313312-h607itv2 171 4 - - NN cord-313312-h607itv2 171 5 linking linking NN cord-313312-h607itv2 171 6 of of IN cord-313312-h607itv2 171 7 the the DT cord-313312-h607itv2 171 8 B b NN cord-313312-h607itv2 171 9 - - HYPH cord-313312-h607itv2 171 10 cell cell NN cord-313312-h607itv2 171 11 receptor receptor NN cord-313312-h607itv2 171 12 ( ( -LRB- cord-313312-h607itv2 171 13 BCR BCR NNP cord-313312-h607itv2 171 14 ) ) -RRB- cord-313312-h607itv2 171 15 with with IN cord-313312-h607itv2 171 16 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 171 17 mediated mediate VBN cord-313312-h607itv2 171 18 by by IN cord-313312-h607itv2 171 19 virus virus NN cord-313312-h607itv2 171 20 immune immune JJ cord-313312-h607itv2 171 21 complexes complex NNS cord-313312-h607itv2 171 22 can can MD cord-313312-h607itv2 171 23 lead lead VB cord-313312-h607itv2 171 24 to to IN cord-313312-h607itv2 171 25 the the DT cord-313312-h607itv2 171 26 inhibition inhibition NN cord-313312-h607itv2 171 27 of of IN cord-313312-h607itv2 171 28 B b NN cord-313312-h607itv2 171 29 - - HYPH cord-313312-h607itv2 171 30 cell cell NN cord-313312-h607itv2 171 31 activation activation NN cord-313312-h607itv2 171 32 ( ( -LRB- cord-313312-h607itv2 171 33 Figure figure NN cord-313312-h607itv2 171 34 2a 2a CD cord-313312-h607itv2 171 35 ) ) -RRB- cord-313312-h607itv2 171 36 . . . cord-313312-h607itv2 172 1 Indeed indeed RB cord-313312-h607itv2 172 2 , , , cord-313312-h607itv2 172 3 by by IN cord-313312-h607itv2 172 4 adding add VBG cord-313312-h607itv2 172 5 sheep sheep NNS cord-313312-h607itv2 172 6 red red JJ cord-313312-h607itv2 172 7 blood blood NN cord-313312-h607itv2 172 8 cell cell NN cord-313312-h607itv2 172 9 - - HYPH cord-313312-h607itv2 172 10 specific specific JJ cord-313312-h607itv2 172 11 ( ( -LRB- cord-313312-h607itv2 172 12 SBRC SBRC NNP cord-313312-h607itv2 172 13 ) ) -RRB- cord-313312-h607itv2 172 14 IgG IgG NNP cord-313312-h607itv2 172 15 to to TO cord-313312-h607itv2 172 16 SRBCs SRBCs NNP cord-313312-h607itv2 172 17 , , , cord-313312-h607itv2 172 18 B b NN cord-313312-h607itv2 172 19 - - HYPH cord-313312-h607itv2 172 20 cell cell NN cord-313312-h607itv2 172 21 antibody antibody NN cord-313312-h607itv2 172 22 secretion secretion NN cord-313312-h607itv2 172 23 is be VBZ cord-313312-h607itv2 172 24 reduced reduce VBN cord-313312-h607itv2 172 25 [ [ -LRB- cord-313312-h607itv2 172 26 104 104 CD cord-313312-h607itv2 172 27 ] ] -RRB- cord-313312-h607itv2 172 28 . . . cord-313312-h607itv2 173 1 Similarly similarly RB cord-313312-h607itv2 173 2 , , , cord-313312-h607itv2 173 3 using use VBG cord-313312-h607itv2 173 4 the the DT cord-313312-h607itv2 173 5 cotton cotton NN cord-313312-h607itv2 173 6 rat rat NN cord-313312-h607itv2 173 7 model model NN cord-313312-h607itv2 173 8 of of IN cord-313312-h607itv2 173 9 MV MV NNP cord-313312-h607itv2 173 10 vaccination vaccination NN cord-313312-h607itv2 173 11 , , , cord-313312-h607itv2 173 12 maternal maternal JJ cord-313312-h607itv2 173 13 antibodies antibody NNS cord-313312-h607itv2 173 14 were be VBD cord-313312-h607itv2 173 15 demonstrated demonstrate VBN cord-313312-h607itv2 173 16 to to TO cord-313312-h607itv2 173 17 inhibit inhibit VB cord-313312-h607itv2 173 18 B b NN cord-313312-h607itv2 173 19 - - HYPH cord-313312-h607itv2 173 20 cells cell NNS cord-313312-h607itv2 173 21 by by IN cord-313312-h607itv2 173 22 the the DT cord-313312-h607itv2 173 23 cross cross NN cord-313312-h607itv2 173 24 - - JJ cord-313312-h607itv2 173 25 linking linking NN cord-313312-h607itv2 173 26 of of IN cord-313312-h607itv2 173 27 BCR BCR NNP cord-313312-h607itv2 173 28 and and CC cord-313312-h607itv2 173 29 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 173 30 [ [ -LRB- cord-313312-h607itv2 173 31 105 105 CD cord-313312-h607itv2 173 32 ] ] -RRB- cord-313312-h607itv2 173 33 . . . cord-313312-h607itv2 174 1 However however RB cord-313312-h607itv2 174 2 , , , cord-313312-h607itv2 174 3 this this DT cord-313312-h607itv2 174 4 mechanism mechanism NN cord-313312-h607itv2 174 5 of of IN cord-313312-h607itv2 174 6 inhibition inhibition NN cord-313312-h607itv2 174 7 has have VBZ cord-313312-h607itv2 174 8 not not RB cord-313312-h607itv2 174 9 been be VBN cord-313312-h607itv2 174 10 demonstrated demonstrate VBN cord-313312-h607itv2 174 11 for for IN cord-313312-h607itv2 174 12 other other JJ cord-313312-h607itv2 174 13 viruses virus NNS cord-313312-h607itv2 174 14 . . . cord-313312-h607itv2 175 1 It -PRON- PRP cord-313312-h607itv2 175 2 is be VBZ cord-313312-h607itv2 175 3 conceivable conceivable JJ cord-313312-h607itv2 175 4 that that IN cord-313312-h607itv2 175 5 this this DT cord-313312-h607itv2 175 6 mode mode NN cord-313312-h607itv2 175 7 of of IN cord-313312-h607itv2 175 8 inhibition inhibition NN cord-313312-h607itv2 175 9 is be VBZ cord-313312-h607itv2 175 10 dependent dependent JJ cord-313312-h607itv2 175 11 on on IN cord-313312-h607itv2 175 12 the the DT cord-313312-h607itv2 175 13 size size NN cord-313312-h607itv2 175 14 of of IN cord-313312-h607itv2 175 15 the the DT cord-313312-h607itv2 175 16 virus virus NN cord-313312-h607itv2 175 17 - - HYPH cord-313312-h607itv2 175 18 antibody antibody NN cord-313312-h607itv2 175 19 immune immune JJ cord-313312-h607itv2 175 20 complexes complex NNS cord-313312-h607itv2 175 21 , , , cord-313312-h607itv2 175 22 as as IN cord-313312-h607itv2 175 23 immunization immunization NN cord-313312-h607itv2 175 24 of of IN cord-313312-h607itv2 175 25 small small JJ cord-313312-h607itv2 175 26 polypeptides polypeptide NNS cord-313312-h607itv2 175 27 can can MD cord-313312-h607itv2 175 28 escape escape VB cord-313312-h607itv2 175 29 maternal maternal JJ cord-313312-h607itv2 175 30 antibody antibody NN cord-313312-h607itv2 175 31 inhibition inhibition NN cord-313312-h607itv2 175 32 [ [ -LRB- cord-313312-h607itv2 175 33 106 106 CD cord-313312-h607itv2 175 34 ] ] -RRB- cord-313312-h607itv2 175 35 . . . cord-313312-h607itv2 176 1 More More JJR cord-313312-h607itv2 176 2 mechanistic mechanistic JJ cord-313312-h607itv2 176 3 studies study NNS cord-313312-h607itv2 176 4 will will MD cord-313312-h607itv2 176 5 hence hence RB cord-313312-h607itv2 176 6 be be VB cord-313312-h607itv2 176 7 required require VBN cord-313312-h607itv2 176 8 to to TO cord-313312-h607itv2 176 9 evaluate evaluate VB cord-313312-h607itv2 176 10 the the DT cord-313312-h607itv2 176 11 conditions condition NNS cord-313312-h607itv2 176 12 that that WDT cord-313312-h607itv2 176 13 need need VBP cord-313312-h607itv2 176 14 to to TO cord-313312-h607itv2 176 15 be be VB cord-313312-h607itv2 176 16 satisfied satisfied JJ cord-313312-h607itv2 176 17 to to TO cord-313312-h607itv2 176 18 cause cause VB cord-313312-h607itv2 176 19 B b NN cord-313312-h607itv2 176 20 - - HYPH cord-313312-h607itv2 176 21 cell cell NN cord-313312-h607itv2 176 22 inhibition inhibition NN cord-313312-h607itv2 176 23 . . . cord-313312-h607itv2 177 1 Another another DT cord-313312-h607itv2 177 2 way way NN cord-313312-h607itv2 177 3 in in IN cord-313312-h607itv2 177 4 which which WDT cord-313312-h607itv2 177 5 antibodies antibody NNS cord-313312-h607itv2 177 6 can can MD cord-313312-h607itv2 177 7 inhibit inhibit VB cord-313312-h607itv2 177 8 B b NN cord-313312-h607itv2 177 9 - - HYPH cord-313312-h607itv2 177 10 cell cell NN cord-313312-h607itv2 177 11 responses response NNS cord-313312-h607itv2 177 12 is be VBZ cord-313312-h607itv2 177 13 through through IN cord-313312-h607itv2 177 14 epitope epitope NN cord-313312-h607itv2 177 15 masking masking NN cord-313312-h607itv2 177 16 . . . cord-313312-h607itv2 178 1 This this DT cord-313312-h607itv2 178 2 hypothesis hypothesis NN cord-313312-h607itv2 178 3 postulates postulate VBZ cord-313312-h607itv2 178 4 that that IN cord-313312-h607itv2 178 5 the the DT cord-313312-h607itv2 178 6 presence presence NN cord-313312-h607itv2 178 7 of of IN cord-313312-h607itv2 178 8 pre pre JJ cord-313312-h607itv2 178 9 - - JJ cord-313312-h607itv2 178 10 existing existing JJ cord-313312-h607itv2 178 11 antibodies antibody NNS cord-313312-h607itv2 178 12 can can MD cord-313312-h607itv2 178 13 mask mask VB cord-313312-h607itv2 178 14 the the DT cord-313312-h607itv2 178 15 exposure exposure NN cord-313312-h607itv2 178 16 of of IN cord-313312-h607itv2 178 17 epitopes epitope NNS cord-313312-h607itv2 178 18 , , , cord-313312-h607itv2 178 19 thereby thereby RB cord-313312-h607itv2 178 20 prohibiting prohibit VBG cord-313312-h607itv2 178 21 recognition recognition NN cord-313312-h607itv2 178 22 by by IN cord-313312-h607itv2 178 23 the the DT cord-313312-h607itv2 178 24 B b NN cord-313312-h607itv2 178 25 - - HYPH cord-313312-h607itv2 178 26 cell cell NN cord-313312-h607itv2 178 27 . . . cord-313312-h607itv2 179 1 This this DT cord-313312-h607itv2 179 2 is be VBZ cord-313312-h607itv2 179 3 also also RB cord-313312-h607itv2 179 4 termed term VBN cord-313312-h607itv2 179 5 as as IN cord-313312-h607itv2 179 6 epitope epitope NN cord-313312-h607itv2 179 7 - - HYPH cord-313312-h607itv2 179 8 specific specific JJ cord-313312-h607itv2 179 9 suppression suppression NN cord-313312-h607itv2 179 10 , , , cord-313312-h607itv2 179 11 whereby whereby WRB cord-313312-h607itv2 179 12 epitopes epitope NNS cord-313312-h607itv2 179 13 covered cover VBN cord-313312-h607itv2 179 14 by by IN cord-313312-h607itv2 179 15 these these DT cord-313312-h607itv2 179 16 antibodies antibody NNS cord-313312-h607itv2 179 17 are be VBP cord-313312-h607itv2 179 18 unable unable JJ cord-313312-h607itv2 179 19 to to TO cord-313312-h607itv2 179 20 be be VB cord-313312-h607itv2 179 21 recognized recognize VBN cord-313312-h607itv2 179 22 by by IN cord-313312-h607itv2 179 23 B b NN cord-313312-h607itv2 179 24 - - HYPH cord-313312-h607itv2 179 25 cells cell NNS cord-313312-h607itv2 179 26 ( ( -LRB- cord-313312-h607itv2 179 27 Figure figure NN cord-313312-h607itv2 179 28 2b 2b CD cord-313312-h607itv2 179 29 ) ) -RRB- cord-313312-h607itv2 179 30 . . . cord-313312-h607itv2 180 1 Interestingly interestingly RB cord-313312-h607itv2 180 2 , , , cord-313312-h607itv2 180 3 there there EX cord-313312-h607itv2 180 4 have have VBP cord-313312-h607itv2 180 5 been be VBN cord-313312-h607itv2 180 6 reports report NNS cord-313312-h607itv2 180 7 of of IN cord-313312-h607itv2 180 8 epitope epitope NN cord-313312-h607itv2 180 9 unspecific unspecific JJ cord-313312-h607itv2 180 10 suppression suppression NN cord-313312-h607itv2 180 11 , , , cord-313312-h607itv2 180 12 where where WRB cord-313312-h607itv2 180 13 monoclonal monoclonal JJ cord-313312-h607itv2 180 14 antibodies antibody NNS cord-313312-h607itv2 180 15 that that WDT cord-313312-h607itv2 180 16 target target VBP cord-313312-h607itv2 180 17 only only RB cord-313312-h607itv2 180 18 one one CD cord-313312-h607itv2 180 19 specific specific JJ cord-313312-h607itv2 180 20 epitope epitope NN cord-313312-h607itv2 180 21 can can MD cord-313312-h607itv2 180 22 suppress suppress VB cord-313312-h607itv2 180 23 B b NN cord-313312-h607itv2 180 24 - - HYPH cord-313312-h607itv2 180 25 cell cell NN cord-313312-h607itv2 180 26 recognition recognition NN cord-313312-h607itv2 180 27 of of IN cord-313312-h607itv2 180 28 a a DT cord-313312-h607itv2 180 29 whole whole JJ cord-313312-h607itv2 180 30 antigen antigen NN cord-313312-h607itv2 180 31 , , , cord-313312-h607itv2 180 32 suggesting suggest VBG cord-313312-h607itv2 180 33 the the DT cord-313312-h607itv2 180 34 possibility possibility NN cord-313312-h607itv2 180 35 that that IN cord-313312-h607itv2 180 36 steric steric JJ cord-313312-h607itv2 180 37 hindrance hindrance NN cord-313312-h607itv2 180 38 or or CC cord-313312-h607itv2 180 39 obstruction obstruction NN cord-313312-h607itv2 180 40 by by IN cord-313312-h607itv2 180 41 high high JJ cord-313312-h607itv2 180 42 concentrations concentration NNS cord-313312-h607itv2 180 43 of of IN cord-313312-h607itv2 180 44 antibodies antibody NNS cord-313312-h607itv2 180 45 can can MD cord-313312-h607itv2 180 46 also also RB cord-313312-h607itv2 180 47 lead lead VB cord-313312-h607itv2 180 48 to to IN cord-313312-h607itv2 180 49 overall overall JJ cord-313312-h607itv2 180 50 suppression suppression NN cord-313312-h607itv2 180 51 B b NN cord-313312-h607itv2 180 52 - - HYPH cord-313312-h607itv2 180 53 cell cell NN cord-313312-h607itv2 180 54 recognition recognition NN cord-313312-h607itv2 180 55 [ [ -LRB- cord-313312-h607itv2 180 56 107 107 CD cord-313312-h607itv2 180 57 , , , cord-313312-h607itv2 180 58 108 108 CD cord-313312-h607itv2 180 59 ] ] -RRB- cord-313312-h607itv2 180 60 . . . cord-313312-h607itv2 181 1 Antibody antibody NN cord-313312-h607itv2 181 2 - - HYPH cord-313312-h607itv2 181 3 dependent dependent JJ cord-313312-h607itv2 181 4 enhancement enhancement NN cord-313312-h607itv2 181 5 ( ( -LRB- cord-313312-h607itv2 181 6 ADE ADE NNP cord-313312-h607itv2 181 7 ) ) -RRB- cord-313312-h607itv2 181 8 of of IN cord-313312-h607itv2 181 9 viral viral JJ cord-313312-h607itv2 181 10 infection infection NN cord-313312-h607itv2 181 11 has have VBZ cord-313312-h607itv2 181 12 been be VBN cord-313312-h607itv2 181 13 documented document VBN cord-313312-h607itv2 181 14 for for IN cord-313312-h607itv2 181 15 many many JJ cord-313312-h607itv2 181 16 viruses virus NNS cord-313312-h607itv2 181 17 , , , cord-313312-h607itv2 181 18 including include VBG cord-313312-h607itv2 181 19 flaviviruses flavivirus NNS cord-313312-h607itv2 181 20 , , , cord-313312-h607itv2 181 21 influenza influenza NN cord-313312-h607itv2 181 22 , , , cord-313312-h607itv2 181 23 MV MV NNP cord-313312-h607itv2 181 24 , , , cord-313312-h607itv2 181 25 Ross Ross NNP cord-313312-h607itv2 181 26 river river NN cord-313312-h607itv2 181 27 viruses virus NNS cord-313312-h607itv2 181 28 , , , cord-313312-h607itv2 181 29 HIV HIV NNP cord-313312-h607itv2 181 30 , , , cord-313312-h607itv2 181 31 and and CC cord-313312-h607itv2 181 32 coronaviruses coronaviruse NNS cord-313312-h607itv2 181 33 [ [ -LRB- cord-313312-h607itv2 181 34 109 109 CD cord-313312-h607itv2 181 35 ] ] -RRB- cord-313312-h607itv2 181 36 . . . cord-313312-h607itv2 182 1 ADE ADE NNP cord-313312-h607itv2 182 2 can can MD cord-313312-h607itv2 182 3 occur occur VB cord-313312-h607itv2 182 4 when when WRB cord-313312-h607itv2 182 5 sub sub NN cord-313312-h607itv2 182 6 - - JJ cord-313312-h607itv2 182 7 neutralizing neutralize VBG cord-313312-h607itv2 182 8 levels level NNS cord-313312-h607itv2 182 9 of of IN cord-313312-h607itv2 182 10 cross cross JJ cord-313312-h607itv2 182 11 - - JJ cord-313312-h607itv2 182 12 reactive reactive JJ cord-313312-h607itv2 182 13 antibodies antibody NNS cord-313312-h607itv2 182 14 form form VBP cord-313312-h607itv2 182 15 immune immune JJ cord-313312-h607itv2 182 16 complexes complex NNS cord-313312-h607itv2 182 17 with with IN cord-313312-h607itv2 182 18 viruses virus NNS cord-313312-h607itv2 182 19 , , , cord-313312-h607itv2 182 20 opsonizing opsonize VBG cord-313312-h607itv2 182 21 viral viral JJ cord-313312-h607itv2 182 22 infection infection NN cord-313312-h607itv2 182 23 in in IN cord-313312-h607itv2 182 24 FcγR fcγr NN cord-313312-h607itv2 182 25 - - HYPH cord-313312-h607itv2 182 26 bearing bear VBG cord-313312-h607itv2 182 27 myeloid myeloid NN cord-313312-h607itv2 182 28 cells cell NNS cord-313312-h607itv2 182 29 including include VBG cord-313312-h607itv2 182 30 monocytes monocyte NNS cord-313312-h607itv2 182 31 , , , cord-313312-h607itv2 182 32 macrophages macrophage NNS cord-313312-h607itv2 182 33 , , , cord-313312-h607itv2 182 34 and and CC cord-313312-h607itv2 182 35 dendritic dendritic JJ cord-313312-h607itv2 182 36 cells cell NNS cord-313312-h607itv2 182 37 via via IN cord-313312-h607itv2 182 38 activating activate VBG cord-313312-h607itv2 182 39 FcγR fcγr NN cord-313312-h607itv2 182 40 - - HYPH cord-313312-h607itv2 182 41 mediated mediate VBN cord-313312-h607itv2 182 42 uptake uptake NN cord-313312-h607itv2 182 43 . . . cord-313312-h607itv2 183 1 The the DT cord-313312-h607itv2 183 2 majority majority NN cord-313312-h607itv2 183 3 of of IN cord-313312-h607itv2 183 4 the the DT cord-313312-h607itv2 183 5 mechanistic mechanistic JJ cord-313312-h607itv2 183 6 insights insight NNS cord-313312-h607itv2 183 7 about about IN cord-313312-h607itv2 183 8 ADE ADE NNP cord-313312-h607itv2 183 9 of of IN cord-313312-h607itv2 183 10 viral viral JJ cord-313312-h607itv2 183 11 infection infection NN cord-313312-h607itv2 183 12 are be VBP cord-313312-h607itv2 183 13 gathered gather VBN cord-313312-h607itv2 183 14 from from IN cord-313312-h607itv2 183 15 dengue dengue NN cord-313312-h607itv2 183 16 , , , cord-313312-h607itv2 183 17 as as IN cord-313312-h607itv2 183 18 waning wane VBG cord-313312-h607itv2 183 19 cross cross JJ cord-313312-h607itv2 183 20 - - JJ cord-313312-h607itv2 183 21 reactive reactive JJ cord-313312-h607itv2 183 22 antibodies antibody NNS cord-313312-h607itv2 183 23 that that WDT cord-313312-h607itv2 183 24 are be VBP cord-313312-h607itv2 183 25 acquired acquire VBN cord-313312-h607itv2 183 26 from from IN cord-313312-h607itv2 183 27 a a DT cord-313312-h607itv2 183 28 heterotypic heterotypic NNP cord-313312-h607itv2 183 29 DENV DENV NNP cord-313312-h607itv2 183 30 infection infection NN cord-313312-h607itv2 183 31 or or CC cord-313312-h607itv2 183 32 through through IN cord-313312-h607itv2 183 33 maternal maternal JJ cord-313312-h607itv2 183 34 - - HYPH cord-313312-h607itv2 183 35 fetal fetal JJ cord-313312-h607itv2 183 36 transmission transmission NN cord-313312-h607itv2 183 37 can can MD cord-313312-h607itv2 183 38 result result VB cord-313312-h607itv2 183 39 in in IN cord-313312-h607itv2 183 40 a a DT cord-313312-h607itv2 183 41 heightened heightened JJ cord-313312-h607itv2 183 42 risk risk NN cord-313312-h607itv2 183 43 of of IN cord-313312-h607itv2 183 44 severe severe JJ cord-313312-h607itv2 183 45 dengue dengue NN cord-313312-h607itv2 183 46 that that WDT cord-313312-h607itv2 183 47 can can MD cord-313312-h607itv2 183 48 be be VB cord-313312-h607itv2 183 49 life life NN cord-313312-h607itv2 183 50 - - HYPH cord-313312-h607itv2 183 51 threatening threaten VBG cord-313312-h607itv2 183 52 [ [ -LRB- cord-313312-h607itv2 183 53 78 78 CD cord-313312-h607itv2 183 54 ] ] -RRB- cord-313312-h607itv2 183 55 [ [ -LRB- cord-313312-h607itv2 183 56 79 79 CD cord-313312-h607itv2 183 57 ] ] -RRB- cord-313312-h607itv2 183 58 [ [ -LRB- cord-313312-h607itv2 183 59 80 80 CD cord-313312-h607itv2 183 60 ] ] -RRB- cord-313312-h607itv2 183 61 . . . cord-313312-h607itv2 184 1 Both both DT cord-313312-h607itv2 184 2 activating activate VBG cord-313312-h607itv2 184 3 FcγRI FcγRI NNP cord-313312-h607itv2 184 4 and and CC cord-313312-h607itv2 184 5 FcγRIIA FcγRIIA NNP cord-313312-h607itv2 184 6 have have VBP cord-313312-h607itv2 184 7 been be VBN cord-313312-h607itv2 184 8 shown show VBN cord-313312-h607itv2 184 9 to to TO cord-313312-h607itv2 184 10 be be VB cord-313312-h607itv2 184 11 involved involve VBN cord-313312-h607itv2 184 12 in in IN cord-313312-h607itv2 184 13 ADE ade NN cord-313312-h607itv2 184 14 - - HYPH cord-313312-h607itv2 184 15 mediated mediate VBN cord-313312-h607itv2 184 16 infection infection NN cord-313312-h607itv2 184 17 , , , cord-313312-h607itv2 184 18 although although IN cord-313312-h607itv2 184 19 increasing increase VBG cord-313312-h607itv2 184 20 studies study NNS cord-313312-h607itv2 184 21 indicate indicate VBP cord-313312-h607itv2 184 22 that that IN cord-313312-h607itv2 184 23 FcγRIIA FcγRIIA NNP cord-313312-h607itv2 184 24 could could MD cord-313312-h607itv2 184 25 be be VB cord-313312-h607itv2 184 26 more more RBR cord-313312-h607itv2 184 27 important important JJ cord-313312-h607itv2 184 28 than than IN cord-313312-h607itv2 184 29 FcγRI FcγRI NNP cord-313312-h607itv2 184 30 in in IN cord-313312-h607itv2 184 31 enhancing enhance VBG cord-313312-h607itv2 184 32 viral viral JJ cord-313312-h607itv2 184 33 infection infection NN cord-313312-h607itv2 184 34 [ [ -LRB- cord-313312-h607itv2 184 35 110 110 CD cord-313312-h607itv2 184 36 , , , cord-313312-h607itv2 184 37 111 111 CD cord-313312-h607itv2 184 38 ] ] -RRB- cord-313312-h607itv2 184 39 . . . cord-313312-h607itv2 185 1 While while IN cord-313312-h607itv2 185 2 the the DT cord-313312-h607itv2 185 3 precise precise JJ cord-313312-h607itv2 185 4 mechanisms mechanism NNS cord-313312-h607itv2 185 5 involved involve VBN cord-313312-h607itv2 185 6 remain remain VBP cord-313312-h607itv2 185 7 unclear unclear JJ cord-313312-h607itv2 185 8 , , , cord-313312-h607itv2 185 9 it -PRON- PRP cord-313312-h607itv2 185 10 is be VBZ cord-313312-h607itv2 185 11 possible possible JJ cord-313312-h607itv2 185 12 that that IN cord-313312-h607itv2 185 13 the the DT cord-313312-h607itv2 185 14 trafficking trafficking NN cord-313312-h607itv2 185 15 of of IN cord-313312-h607itv2 185 16 immune immune JJ cord-313312-h607itv2 185 17 complexes complex NNS cord-313312-h607itv2 185 18 through through IN cord-313312-h607itv2 185 19 FcγRIIA fcγriia NN cord-313312-h607itv2 185 20 - - HYPH cord-313312-h607itv2 185 21 mediated mediate VBN cord-313312-h607itv2 185 22 uptake uptake NN cord-313312-h607itv2 185 23 is be VBZ cord-313312-h607itv2 185 24 slower slow JJR cord-313312-h607itv2 185 25 , , , cord-313312-h607itv2 185 26 thereby thereby RB cord-313312-h607itv2 185 27 allowing allow VBG cord-313312-h607itv2 185 28 more more JJR cord-313312-h607itv2 185 29 viral viral JJ cord-313312-h607itv2 185 30 fusion fusion NN cord-313312-h607itv2 185 31 and and CC cord-313312-h607itv2 185 32 infection infection NN cord-313312-h607itv2 185 33 [ [ -LRB- cord-313312-h607itv2 185 34 112 112 CD cord-313312-h607itv2 185 35 , , , cord-313312-h607itv2 185 36 113 113 CD cord-313312-h607itv2 185 37 ] ] -RRB- cord-313312-h607itv2 185 38 . . . cord-313312-h607itv2 186 1 The the DT cord-313312-h607itv2 186 2 activation activation NN cord-313312-h607itv2 186 3 of of IN cord-313312-h607itv2 186 4 FcγRI FcγRI NNP cord-313312-h607itv2 186 5 , , , cord-313312-h607itv2 186 6 however however RB cord-313312-h607itv2 186 7 , , , cord-313312-h607itv2 186 8 may may MD cord-313312-h607itv2 186 9 aid aid VB cord-313312-h607itv2 186 10 to to TO cord-313312-h607itv2 186 11 further further RB cord-313312-h607itv2 186 12 enhance enhance VB cord-313312-h607itv2 186 13 immunogenic immunogenic JJ cord-313312-h607itv2 186 14 responses response NNS cord-313312-h607itv2 186 15 to to IN cord-313312-h607itv2 186 16 viral viral JJ cord-313312-h607itv2 186 17 antigens antigen NNS cord-313312-h607itv2 186 18 by by IN cord-313312-h607itv2 186 19 targeting target VBG cord-313312-h607itv2 186 20 virus virus NN cord-313312-h607itv2 186 21 immune immune JJ cord-313312-h607itv2 186 22 complexes complex NNS cord-313312-h607itv2 186 23 to to IN cord-313312-h607itv2 186 24 the the DT cord-313312-h607itv2 186 25 late late JJ cord-313312-h607itv2 186 26 endosomes endosome NNS cord-313312-h607itv2 186 27 or or CC cord-313312-h607itv2 186 28 lysosomes lysosome NNS cord-313312-h607itv2 186 29 for for IN cord-313312-h607itv2 186 30 enhanced enhance VBN cord-313312-h607itv2 186 31 antigen antigen NN cord-313312-h607itv2 186 32 processing processing NN cord-313312-h607itv2 186 33 and and CC cord-313312-h607itv2 186 34 antigen antigen NN cord-313312-h607itv2 186 35 presentation presentation NN cord-313312-h607itv2 186 36 to to IN cord-313312-h607itv2 186 37 the the DT cord-313312-h607itv2 186 38 CD4 CD4 NNP cord-313312-h607itv2 186 39 + + CC cord-313312-h607itv2 186 40 T T NNP cord-313312-h607itv2 186 41 - - HYPH cord-313312-h607itv2 186 42 cells cell NNS cord-313312-h607itv2 186 43 , , , cord-313312-h607itv2 186 44 thereby thereby RB cord-313312-h607itv2 186 45 increasing increase VBG cord-313312-h607itv2 186 46 B b NN cord-313312-h607itv2 186 47 - - HYPH cord-313312-h607itv2 186 48 cell cell NN cord-313312-h607itv2 186 49 responses response NNS cord-313312-h607itv2 186 50 [ [ -LRB- cord-313312-h607itv2 186 51 112 112 CD cord-313312-h607itv2 186 52 ] ] -RRB- cord-313312-h607itv2 186 53 . . . cord-313312-h607itv2 187 1 Overall overall RB cord-313312-h607itv2 187 2 , , , cord-313312-h607itv2 187 3 at at IN cord-313312-h607itv2 187 4 sub sub NN cord-313312-h607itv2 187 5 - - JJ cord-313312-h607itv2 187 6 neutralizing neutralize VBG cord-313312-h607itv2 187 7 antibody antibody NN cord-313312-h607itv2 187 8 levels level NNS cord-313312-h607itv2 187 9 , , , cord-313312-h607itv2 187 10 the the DT cord-313312-h607itv2 187 11 presence presence NN cord-313312-h607itv2 187 12 of of IN cord-313312-h607itv2 187 13 pre pre JJ cord-313312-h607itv2 187 14 - - JJ cord-313312-h607itv2 187 15 existing existing JJ cord-313312-h607itv2 187 16 antibodies antibody NNS cord-313312-h607itv2 187 17 can can MD cord-313312-h607itv2 187 18 activate activate VB cord-313312-h607itv2 187 19 both both DT cord-313312-h607itv2 187 20 FcγRI FcγRI NNP cord-313312-h607itv2 187 21 and and CC cord-313312-h607itv2 187 22 FcγRIIA FcγRIIA NNP cord-313312-h607itv2 187 23 , , , cord-313312-h607itv2 187 24 which which WDT cord-313312-h607itv2 187 25 promotes promote VBZ cord-313312-h607itv2 187 26 virus virus NN cord-313312-h607itv2 187 27 uptake uptake NN cord-313312-h607itv2 187 28 , , , cord-313312-h607itv2 187 29 replication replication NN cord-313312-h607itv2 187 30 , , , cord-313312-h607itv2 187 31 and and CC cord-313312-h607itv2 187 32 antigen antigen NN cord-313312-h607itv2 187 33 presentation presentation NN cord-313312-h607itv2 187 34 that that WDT cord-313312-h607itv2 187 35 consequently consequently RB cord-313312-h607itv2 187 36 augments augment VBZ cord-313312-h607itv2 187 37 vaccine vaccine NN cord-313312-h607itv2 187 38 immunogenicity immunogenicity NN cord-313312-h607itv2 187 39 . . . cord-313312-h607itv2 188 1 Besides besides IN cord-313312-h607itv2 188 2 promoting promote VBG cord-313312-h607itv2 188 3 viral viral JJ cord-313312-h607itv2 188 4 entry entry NN cord-313312-h607itv2 188 5 and and CC cord-313312-h607itv2 188 6 antigen antigen NN cord-313312-h607itv2 188 7 presentation presentation NN cord-313312-h607itv2 188 8 , , , cord-313312-h607itv2 188 9 the the DT cord-313312-h607itv2 188 10 cross cross NN cord-313312-h607itv2 188 11 - - NN cord-313312-h607itv2 188 12 linking linking NN cord-313312-h607itv2 188 13 of of IN cord-313312-h607itv2 188 14 FcγRs FcγRs NNP cord-313312-h607itv2 188 15 may may MD cord-313312-h607itv2 188 16 also also RB cord-313312-h607itv2 188 17 modulate modulate VB cord-313312-h607itv2 188 18 cellular cellular JJ cord-313312-h607itv2 188 19 and and CC cord-313312-h607itv2 188 20 host host NN cord-313312-h607itv2 188 21 responses response NNS cord-313312-h607itv2 188 22 that that WDT cord-313312-h607itv2 188 23 promote promote VBP cord-313312-h607itv2 188 24 viral viral JJ cord-313312-h607itv2 188 25 replication replication NN cord-313312-h607itv2 188 26 and and CC cord-313312-h607itv2 188 27 LAV LAV NNP cord-313312-h607itv2 188 28 immunogenicity immunogenicity NN cord-313312-h607itv2 188 29 ( ( -LRB- cord-313312-h607itv2 188 30 Figure figure NN cord-313312-h607itv2 188 31 3 3 CD cord-313312-h607itv2 188 32 ) ) -RRB- cord-313312-h607itv2 188 33 . . . cord-313312-h607itv2 189 1 Some some DT cord-313312-h607itv2 189 2 insights insight NNS cord-313312-h607itv2 189 3 can can MD cord-313312-h607itv2 189 4 be be VB cord-313312-h607itv2 189 5 obtained obtain VBN cord-313312-h607itv2 189 6 from from IN cord-313312-h607itv2 189 7 our -PRON- PRP$ cord-313312-h607itv2 189 8 clinical clinical JJ cord-313312-h607itv2 189 9 trial trial NN cord-313312-h607itv2 189 10 , , , cord-313312-h607itv2 189 11 where where WRB cord-313312-h607itv2 189 12 subjects subject NNS cord-313312-h607itv2 189 13 were be VBD cord-313312-h607itv2 189 14 sequentially sequentially RB cord-313312-h607itv2 189 15 vaccinated vaccinate VBN cord-313312-h607itv2 189 16 with with IN cord-313312-h607itv2 189 17 the the DT cord-313312-h607itv2 189 18 inactivated inactivate VBN cord-313312-h607itv2 189 19 Japanese Japanese NNP cord-313312-h607itv2 189 20 Encephalitis Encephalitis NNP cord-313312-h607itv2 189 21 virus virus NN cord-313312-h607itv2 189 22 vaccine vaccine NN cord-313312-h607itv2 189 23 followed follow VBN cord-313312-h607itv2 189 24 by by IN cord-313312-h607itv2 189 25 the the DT cord-313312-h607itv2 189 26 yellow yellow JJ cord-313312-h607itv2 189 27 fever fever NNP cord-313312-h607itv2 189 28 vaccine vaccine NN cord-313312-h607itv2 189 29 . . . cord-313312-h607itv2 190 1 Subjects subject NNS cord-313312-h607itv2 190 2 within within IN cord-313312-h607itv2 190 3 a a DT cord-313312-h607itv2 190 4 restricted restricted JJ cord-313312-h607itv2 190 5 range range NN cord-313312-h607itv2 190 6 of of IN cord-313312-h607itv2 190 7 cross cross JJ cord-313312-h607itv2 190 8 - - JJ cord-313312-h607itv2 190 9 reactive reactive JJ cord-313312-h607itv2 190 10 antibodies antibody NNS cord-313312-h607itv2 190 11 resulted result VBD cord-313312-h607itv2 190 12 in in IN cord-313312-h607itv2 190 13 increased increase VBN cord-313312-h607itv2 190 14 antibody antibody NN cord-313312-h607itv2 190 15 responses response NNS cord-313312-h607itv2 190 16 , , , cord-313312-h607itv2 190 17 whereas whereas IN cord-313312-h607itv2 190 18 too too RB cord-313312-h607itv2 190 19 many many JJ cord-313312-h607itv2 190 20 or or CC cord-313312-h607itv2 190 21 too too RB cord-313312-h607itv2 190 22 few few JJ cord-313312-h607itv2 190 23 antibodies antibody NNS cord-313312-h607itv2 190 24 resulted result VBD cord-313312-h607itv2 190 25 in in IN cord-313312-h607itv2 190 26 reduced reduce VBN cord-313312-h607itv2 190 27 antibody antibody NN cord-313312-h607itv2 190 28 responses response NNS cord-313312-h607itv2 190 29 , , , cord-313312-h607itv2 190 30 indicating indicate VBG cord-313312-h607itv2 190 31 the the DT cord-313312-h607itv2 190 32 possible possible JJ cord-313312-h607itv2 190 33 role role NN cord-313312-h607itv2 190 34 of of IN cord-313312-h607itv2 190 35 ADE ADE NNP cord-313312-h607itv2 190 36 in in IN cord-313312-h607itv2 190 37 augmented augment VBN cord-313312-h607itv2 190 38 vaccine vaccine NN cord-313312-h607itv2 190 39 antibody antibody NN cord-313312-h607itv2 190 40 responses response NNS cord-313312-h607itv2 190 41 [ [ -LRB- cord-313312-h607itv2 190 42 85 85 CD cord-313312-h607itv2 190 43 ] ] -RRB- cord-313312-h607itv2 190 44 . . . cord-313312-h607itv2 191 1 In in IN cord-313312-h607itv2 191 2 addition addition NN cord-313312-h607itv2 191 3 to to IN cord-313312-h607itv2 191 4 the the DT cord-313312-h607itv2 191 5 extended extended JJ cord-313312-h607itv2 191 6 duration duration NN cord-313312-h607itv2 191 7 of of IN cord-313312-h607itv2 191 8 viremia viremia NN cord-313312-h607itv2 191 9 observed observe VBN cord-313312-h607itv2 191 10 in in IN cord-313312-h607itv2 191 11 these these DT cord-313312-h607itv2 191 12 subjects subject NNS cord-313312-h607itv2 191 13 , , , cord-313312-h607itv2 191 14 enhancing enhance VBG cord-313312-h607itv2 191 15 titers titer NNS cord-313312-h607itv2 191 16 of of IN cord-313312-h607itv2 191 17 cross cross JJ cord-313312-h607itv2 191 18 - - JJ cord-313312-h607itv2 191 19 reactive reactive JJ cord-313312-h607itv2 191 20 antibodies antibody NNS cord-313312-h607itv2 191 21 provoked provoke VBD cord-313312-h607itv2 191 22 greater great JJR cord-313312-h607itv2 191 23 pro pro JJ cord-313312-h607itv2 191 24 - - JJ cord-313312-h607itv2 191 25 inflammatory inflammatory JJ cord-313312-h607itv2 191 26 responses response NNS cord-313312-h607itv2 191 27 , , , cord-313312-h607itv2 191 28 including include VBG cord-313312-h607itv2 191 29 increased increase VBN cord-313312-h607itv2 191 30 innate innate JJ cord-313312-h607itv2 191 31 immune immune JJ cord-313312-h607itv2 191 32 responses response NNS cord-313312-h607itv2 191 33 and and CC cord-313312-h607itv2 191 34 the the DT cord-313312-h607itv2 191 35 production production NN cord-313312-h607itv2 191 36 of of IN cord-313312-h607itv2 191 37 pro pro JJ cord-313312-h607itv2 191 38 - - JJ cord-313312-h607itv2 191 39 inflammatory inflammatory JJ cord-313312-h607itv2 191 40 metabolites metabolite NNS cord-313312-h607itv2 191 41 such such JJ cord-313312-h607itv2 191 42 as as IN cord-313312-h607itv2 191 43 arachidonic arachidonic JJ cord-313312-h607itv2 191 44 acid acid NN cord-313312-h607itv2 191 45 , , , cord-313312-h607itv2 191 46 linoleic linoleic JJ cord-313312-h607itv2 191 47 acid acid NN cord-313312-h607itv2 191 48 , , , cord-313312-h607itv2 191 49 and and CC cord-313312-h607itv2 191 50 12-HETE 12-hete CD cord-313312-h607itv2 191 51 that that WDT cord-313312-h607itv2 191 52 promote promote VBP cord-313312-h607itv2 191 53 phagocytosis phagocytosis NN cord-313312-h607itv2 191 54 and and CC cord-313312-h607itv2 191 55 adaptive adaptive JJ cord-313312-h607itv2 191 56 immune immune JJ cord-313312-h607itv2 191 57 responses response NNS cord-313312-h607itv2 191 58 . . . cord-313312-h607itv2 192 1 The the DT cord-313312-h607itv2 192 2 co co NN cord-313312-h607itv2 192 3 - - NN cord-313312-h607itv2 192 4 ligation ligation NN cord-313312-h607itv2 192 5 of of IN cord-313312-h607itv2 192 6 both both DT cord-313312-h607itv2 192 7 FcγRI FcγRI NNP cord-313312-h607itv2 192 8 and and CC cord-313312-h607itv2 192 9 FcγRIIA FcγRIIA NNP cord-313312-h607itv2 192 10 by by IN cord-313312-h607itv2 192 11 virus virus NN cord-313312-h607itv2 192 12 - - HYPH cord-313312-h607itv2 192 13 antibody antibody NN cord-313312-h607itv2 192 14 immune immune JJ cord-313312-h607itv2 192 15 complexes complex NNS cord-313312-h607itv2 192 16 or or CC cord-313312-h607itv2 192 17 cross cross NN cord-313312-h607itv2 192 18 - - NN cord-313312-h607itv2 192 19 linking linking NN cord-313312-h607itv2 192 20 can can MD cord-313312-h607itv2 192 21 also also RB cord-313312-h607itv2 192 22 upregulate upregulate VB cord-313312-h607itv2 192 23 immune immune JJ cord-313312-h607itv2 192 24 semaphorins semaphorin NNS cord-313312-h607itv2 192 25 such such JJ cord-313312-h607itv2 192 26 as as IN cord-313312-h607itv2 192 27 SEMA4A SEMA4A NNP cord-313312-h607itv2 192 28 , , , cord-313312-h607itv2 192 29 SEMA6A SEMA6A NNP cord-313312-h607itv2 192 30 , , , cord-313312-h607itv2 192 31 and and CC cord-313312-h607itv2 192 32 SEMA7A SEMA7A NNP cord-313312-h607itv2 192 33 which which WDT cord-313312-h607itv2 192 34 are be VBP cord-313312-h607itv2 192 35 critical critical JJ cord-313312-h607itv2 192 36 for for IN cord-313312-h607itv2 192 37 antigen antigen NN cord-313312-h607itv2 192 38 - - HYPH cord-313312-h607itv2 192 39 presenting present VBG cord-313312-h607itv2 192 40 cell cell NN cord-313312-h607itv2 192 41 and and CC cord-313312-h607itv2 192 42 T t NN cord-313312-h607itv2 192 43 - - HYPH cord-313312-h607itv2 192 44 cell cell NN cord-313312-h607itv2 192 45 interactions interaction NNS cord-313312-h607itv2 192 46 [ [ -LRB- cord-313312-h607itv2 192 47 85 85 CD cord-313312-h607itv2 192 48 ] ] -RRB- cord-313312-h607itv2 192 49 . . . cord-313312-h607itv2 193 1 While while IN cord-313312-h607itv2 193 2 the the DT cord-313312-h607itv2 193 3 mechanisms mechanism NNS cord-313312-h607itv2 193 4 of of IN cord-313312-h607itv2 193 5 whether whether IN cord-313312-h607itv2 193 6 upregulation upregulation NN cord-313312-h607itv2 193 7 of of IN cord-313312-h607itv2 193 8 immune immune JJ cord-313312-h607itv2 193 9 semaphorins semaphorin NNS cord-313312-h607itv2 193 10 by by IN cord-313312-h607itv2 193 11 immune immune JJ cord-313312-h607itv2 193 12 complexes complex NNS cord-313312-h607itv2 193 13 leads lead VBZ cord-313312-h607itv2 193 14 to to IN cord-313312-h607itv2 193 15 increased increase VBN cord-313312-h607itv2 193 16 T t NN cord-313312-h607itv2 193 17 - - HYPH cord-313312-h607itv2 193 18 cell cell NN cord-313312-h607itv2 193 19 proliferation proliferation NN cord-313312-h607itv2 193 20 and and CC cord-313312-h607itv2 193 21 activation activation NN cord-313312-h607itv2 193 22 in in IN cord-313312-h607itv2 193 23 humans human NNS cord-313312-h607itv2 193 24 remains remain VBZ cord-313312-h607itv2 193 25 to to TO cord-313312-h607itv2 193 26 be be VB cord-313312-h607itv2 193 27 evaluated evaluate VBN cord-313312-h607itv2 193 28 , , , cord-313312-h607itv2 193 29 previous previous JJ cord-313312-h607itv2 193 30 studies study NNS cord-313312-h607itv2 193 31 have have VBP cord-313312-h607itv2 193 32 shown show VBN cord-313312-h607itv2 193 33 that that IN cord-313312-h607itv2 193 34 SEMA4A SEMA4A NNP cord-313312-h607itv2 193 35 can can MD cord-313312-h607itv2 193 36 enhance enhance VB cord-313312-h607itv2 193 37 T T NNP cord-313312-h607itv2 193 38 - - HYPH cord-313312-h607itv2 193 39 cell cell NN cord-313312-h607itv2 193 40 activation activation NN cord-313312-h607itv2 193 41 through through IN cord-313312-h607itv2 193 42 interaction interaction NN cord-313312-h607itv2 193 43 with with IN cord-313312-h607itv2 193 44 Tim-2 Tim-2 NNP cord-313312-h607itv2 193 45 , , , cord-313312-h607itv2 193 46 thereby thereby RB cord-313312-h607itv2 193 47 increasing increase VBG cord-313312-h607itv2 193 48 antigen antigen NN cord-313312-h607itv2 193 49 - - HYPH cord-313312-h607itv2 193 50 specific specific JJ cord-313312-h607itv2 193 51 T t NN cord-313312-h607itv2 193 52 - - HYPH cord-313312-h607itv2 193 53 cell cell NN cord-313312-h607itv2 193 54 and and CC cord-313312-h607itv2 193 55 antibody antibody NN cord-313312-h607itv2 193 56 responses response NNS cord-313312-h607itv2 193 57 against against IN cord-313312-h607itv2 193 58 T t NN cord-313312-h607itv2 193 59 - - HYPH cord-313312-h607itv2 193 60 cell cell NN cord-313312-h607itv2 193 61 dependent dependent JJ cord-313312-h607itv2 193 62 antigens antigen NNS cord-313312-h607itv2 193 63 [ [ -LRB- cord-313312-h607itv2 193 64 114 114 CD cord-313312-h607itv2 193 65 , , , cord-313312-h607itv2 193 66 115 115 CD cord-313312-h607itv2 193 67 ] ] -RRB- cord-313312-h607itv2 193 68 . . . cord-313312-h607itv2 194 1 However however RB cord-313312-h607itv2 194 2 , , , cord-313312-h607itv2 194 3 it -PRON- PRP cord-313312-h607itv2 194 4 is be VBZ cord-313312-h607itv2 194 5 also also RB cord-313312-h607itv2 194 6 noticeable noticeable JJ cord-313312-h607itv2 194 7 that that IN cord-313312-h607itv2 194 8 not not RB cord-313312-h607itv2 194 9 all all DT cord-313312-h607itv2 194 10 subjects subject NNS cord-313312-h607itv2 194 11 within within IN cord-313312-h607itv2 194 12 that that DT cord-313312-h607itv2 194 13 specific specific JJ cord-313312-h607itv2 194 14 window window NN cord-313312-h607itv2 194 15 of of IN cord-313312-h607itv2 194 16 cross cross JJ cord-313312-h607itv2 194 17 - - JJ cord-313312-h607itv2 194 18 reactive reactive JJ cord-313312-h607itv2 194 19 antibody antibody NN cord-313312-h607itv2 194 20 levels level NNS cord-313312-h607itv2 194 21 exhibited exhibit VBD cord-313312-h607itv2 194 22 increased increased JJ cord-313312-h607itv2 194 23 vaccine vaccine NN cord-313312-h607itv2 194 24 immunogenicity immunogenicity NN cord-313312-h607itv2 194 25 , , , cord-313312-h607itv2 194 26 suggesting suggest VBG cord-313312-h607itv2 194 27 that that IN cord-313312-h607itv2 194 28 baseline baseline JJ cord-313312-h607itv2 194 29 variations variation NNS cord-313312-h607itv2 194 30 , , , cord-313312-h607itv2 194 31 such such JJ cord-313312-h607itv2 194 32 as as IN cord-313312-h607itv2 194 33 genetics genetic NNS cord-313312-h607itv2 194 34 , , , cord-313312-h607itv2 194 35 dietary dietary JJ cord-313312-h607itv2 194 36 or or CC cord-313312-h607itv2 194 37 environmental environmental JJ cord-313312-h607itv2 194 38 factors factor NNS cord-313312-h607itv2 194 39 may may MD cord-313312-h607itv2 194 40 also also RB cord-313312-h607itv2 194 41 influence influence VB cord-313312-h607itv2 194 42 the the DT cord-313312-h607itv2 194 43 outcome outcome NN cord-313312-h607itv2 194 44 of of IN cord-313312-h607itv2 194 45 LAV LAV NNP cord-313312-h607itv2 194 46 immunogenicity immunogenicity NN cord-313312-h607itv2 194 47 [ [ -LRB- cord-313312-h607itv2 194 48 85 85 CD cord-313312-h607itv2 194 49 ] ] -RRB- cord-313312-h607itv2 194 50 . . . cord-313312-h607itv2 195 1 Some some DT cord-313312-h607itv2 195 2 recent recent JJ cord-313312-h607itv2 195 3 studies study NNS cord-313312-h607itv2 195 4 hinted hint VBD cord-313312-h607itv2 195 5 at at IN cord-313312-h607itv2 195 6 the the DT cord-313312-h607itv2 195 7 possibility possibility NN cord-313312-h607itv2 195 8 that that IN cord-313312-h607itv2 195 9 baseline baseline JJ cord-313312-h607itv2 195 10 variations variation NNS cord-313312-h607itv2 195 11 in in IN cord-313312-h607itv2 195 12 B b NN cord-313312-h607itv2 195 13 - - HYPH cord-313312-h607itv2 195 14 cell cell NN cord-313312-h607itv2 195 15 signatures signature NNS cord-313312-h607itv2 195 16 and and CC cord-313312-h607itv2 195 17 gene gene NN cord-313312-h607itv2 195 18 regulation regulation NN cord-313312-h607itv2 195 19 could could MD cord-313312-h607itv2 195 20 influence influence VB cord-313312-h607itv2 195 21 LAV LAV NNP cord-313312-h607itv2 195 22 reactogenicity reactogenicity NN cord-313312-h607itv2 195 23 and and CC cord-313312-h607itv2 195 24 immunogenicity immunogenicity NN cord-313312-h607itv2 195 25 , , , cord-313312-h607itv2 195 26 which which WDT cord-313312-h607itv2 195 27 can can MD cord-313312-h607itv2 195 28 be be VB cord-313312-h607itv2 195 29 potential potential JJ cord-313312-h607itv2 195 30 avenues avenue NNS cord-313312-h607itv2 195 31 for for IN cord-313312-h607itv2 195 32 future future JJ cord-313312-h607itv2 195 33 studies study NNS cord-313312-h607itv2 195 34 [ [ -LRB- cord-313312-h607itv2 195 35 116 116 CD cord-313312-h607itv2 195 36 , , , cord-313312-h607itv2 195 37 117 117 CD cord-313312-h607itv2 195 38 ] ] -RRB- cord-313312-h607itv2 195 39 . . . cord-313312-h607itv2 196 1 Viruses virus NNS cord-313312-h607itv2 196 2 2020 2020 CD cord-313312-h607itv2 196 3 , , , cord-313312-h607itv2 196 4 12 12 CD cord-313312-h607itv2 196 5 , , , cord-313312-h607itv2 196 6 x x NN cord-313312-h607itv2 196 7 FOR for IN cord-313312-h607itv2 196 8 PEER peer NN cord-313312-h607itv2 196 9 REVIEW review NN cord-313312-h607itv2 197 1 10 10 CD cord-313312-h607itv2 197 2 of of IN cord-313312-h607itv2 197 3 17 17 CD cord-313312-h607itv2 197 4 cell cell NN cord-313312-h607itv2 197 5 dependent dependent JJ cord-313312-h607itv2 197 6 antigens antigen NNS cord-313312-h607itv2 197 7 [ [ -LRB- cord-313312-h607itv2 197 8 114 114 CD cord-313312-h607itv2 197 9 , , , cord-313312-h607itv2 197 10 115 115 CD cord-313312-h607itv2 197 11 ] ] -RRB- cord-313312-h607itv2 197 12 . . . cord-313312-h607itv2 198 1 However however RB cord-313312-h607itv2 198 2 , , , cord-313312-h607itv2 198 3 it -PRON- PRP cord-313312-h607itv2 198 4 is be VBZ cord-313312-h607itv2 198 5 also also RB cord-313312-h607itv2 198 6 noticeable noticeable JJ cord-313312-h607itv2 198 7 that that IN cord-313312-h607itv2 198 8 not not RB cord-313312-h607itv2 198 9 all all DT cord-313312-h607itv2 198 10 subjects subject NNS cord-313312-h607itv2 198 11 within within IN cord-313312-h607itv2 198 12 that that DT cord-313312-h607itv2 198 13 specific specific JJ cord-313312-h607itv2 198 14 window window NN cord-313312-h607itv2 198 15 of of IN cord-313312-h607itv2 198 16 cross cross JJ cord-313312-h607itv2 198 17 - - JJ cord-313312-h607itv2 198 18 reactive reactive JJ cord-313312-h607itv2 198 19 antibody antibody NN cord-313312-h607itv2 198 20 levels level NNS cord-313312-h607itv2 198 21 exhibited exhibit VBD cord-313312-h607itv2 198 22 increased increased JJ cord-313312-h607itv2 198 23 vaccine vaccine NN cord-313312-h607itv2 198 24 immunogenicity immunogenicity NN cord-313312-h607itv2 198 25 , , , cord-313312-h607itv2 198 26 suggesting suggest VBG cord-313312-h607itv2 198 27 that that IN cord-313312-h607itv2 198 28 baseline baseline JJ cord-313312-h607itv2 198 29 variations variation NNS cord-313312-h607itv2 198 30 , , , cord-313312-h607itv2 198 31 such such JJ cord-313312-h607itv2 198 32 as as IN cord-313312-h607itv2 198 33 genetics genetic NNS cord-313312-h607itv2 198 34 , , , cord-313312-h607itv2 198 35 dietary dietary JJ cord-313312-h607itv2 198 36 or or CC cord-313312-h607itv2 198 37 environmental environmental JJ cord-313312-h607itv2 198 38 factors factor NNS cord-313312-h607itv2 198 39 may may MD cord-313312-h607itv2 198 40 also also RB cord-313312-h607itv2 198 41 influence influence VB cord-313312-h607itv2 198 42 the the DT cord-313312-h607itv2 198 43 outcome outcome NN cord-313312-h607itv2 198 44 of of IN cord-313312-h607itv2 198 45 LAV LAV NNP cord-313312-h607itv2 198 46 immunogenicity immunogenicity NN cord-313312-h607itv2 198 47 [ [ -LRB- cord-313312-h607itv2 198 48 85 85 CD cord-313312-h607itv2 198 49 ] ] -RRB- cord-313312-h607itv2 198 50 . . . cord-313312-h607itv2 199 1 Some some DT cord-313312-h607itv2 199 2 recent recent JJ cord-313312-h607itv2 199 3 studies study NNS cord-313312-h607itv2 199 4 hinted hint VBD cord-313312-h607itv2 199 5 at at IN cord-313312-h607itv2 199 6 the the DT cord-313312-h607itv2 199 7 possibility possibility NN cord-313312-h607itv2 199 8 that that IN cord-313312-h607itv2 199 9 baseline baseline JJ cord-313312-h607itv2 199 10 variations variation NNS cord-313312-h607itv2 199 11 in in IN cord-313312-h607itv2 199 12 B b NN cord-313312-h607itv2 199 13 - - HYPH cord-313312-h607itv2 199 14 cell cell NN cord-313312-h607itv2 199 15 signatures signature NNS cord-313312-h607itv2 199 16 and and CC cord-313312-h607itv2 199 17 gene gene NN cord-313312-h607itv2 199 18 regulation regulation NN cord-313312-h607itv2 199 19 could could MD cord-313312-h607itv2 199 20 influence influence VB cord-313312-h607itv2 199 21 LAV LAV NNP cord-313312-h607itv2 199 22 reactogenicity reactogenicity NN cord-313312-h607itv2 199 23 and and CC cord-313312-h607itv2 199 24 immunogenicity immunogenicity NN cord-313312-h607itv2 199 25 , , , cord-313312-h607itv2 199 26 which which WDT cord-313312-h607itv2 199 27 can can MD cord-313312-h607itv2 199 28 be be VB cord-313312-h607itv2 199 29 potential potential JJ cord-313312-h607itv2 199 30 avenues avenue NNS cord-313312-h607itv2 199 31 for for IN cord-313312-h607itv2 199 32 future future JJ cord-313312-h607itv2 199 33 studies study NNS cord-313312-h607itv2 199 34 [ [ -LRB- cord-313312-h607itv2 199 35 116 116 CD cord-313312-h607itv2 199 36 , , , cord-313312-h607itv2 199 37 117 117 CD cord-313312-h607itv2 199 38 ] ] -RRB- cord-313312-h607itv2 199 39 . . . cord-313312-h607itv2 200 1 Immune immune JJ cord-313312-h607itv2 200 2 complexes complex NNS cord-313312-h607itv2 200 3 formed form VBN cord-313312-h607itv2 200 4 by by IN cord-313312-h607itv2 200 5 pre pre JJ cord-313312-h607itv2 200 6 - - JJ cord-313312-h607itv2 200 7 existing existing JJ cord-313312-h607itv2 200 8 antibodies antibody NNS cord-313312-h607itv2 200 9 and and CC cord-313312-h607itv2 200 10 viruses virus NNS cord-313312-h607itv2 200 11 can can MD cord-313312-h607itv2 200 12 engage engage VB cord-313312-h607itv2 200 13 FcγRs FcγRs NNP cord-313312-h607itv2 200 14 , , , cord-313312-h607itv2 200 15 resulting result VBG cord-313312-h607itv2 200 16 in in IN cord-313312-h607itv2 200 17 increased increase VBN cord-313312-h607itv2 200 18 viral viral JJ cord-313312-h607itv2 200 19 uptake uptake NN cord-313312-h607itv2 200 20 and and CC cord-313312-h607itv2 200 21 fusion fusion NN cord-313312-h607itv2 200 22 through through IN cord-313312-h607itv2 200 23 the the DT cord-313312-h607itv2 200 24 process process NN cord-313312-h607itv2 200 25 of of IN cord-313312-h607itv2 200 26 antibody antibody NN cord-313312-h607itv2 200 27 - - HYPH cord-313312-h607itv2 200 28 dependent dependent JJ cord-313312-h607itv2 200 29 enhancement enhancement NN cord-313312-h607itv2 200 30 that that WDT cord-313312-h607itv2 200 31 leads lead VBZ cord-313312-h607itv2 200 32 to to IN cord-313312-h607itv2 200 33 increased increase VBN cord-313312-h607itv2 200 34 vaccine vaccine NN cord-313312-h607itv2 200 35 viremia viremia NN cord-313312-h607itv2 200 36 and and CC cord-313312-h607itv2 200 37 antigen antigen NN cord-313312-h607itv2 200 38 presentation presentation NN cord-313312-h607itv2 200 39 . . . cord-313312-h607itv2 201 1 Activating activate VBG cord-313312-h607itv2 201 2 FcγR fcγr NN cord-313312-h607itv2 201 3 - - HYPH cord-313312-h607itv2 201 4 signaling signal VBG cord-313312-h607itv2 201 5 , , , cord-313312-h607itv2 201 6 on on IN cord-313312-h607itv2 201 7 the the DT cord-313312-h607itv2 201 8 other other JJ cord-313312-h607itv2 201 9 hand hand NN cord-313312-h607itv2 201 10 , , , cord-313312-h607itv2 201 11 provokes provoke VBZ cord-313312-h607itv2 201 12 greater great JJR cord-313312-h607itv2 201 13 innate innate JJ cord-313312-h607itv2 201 14 immune immune JJ cord-313312-h607itv2 201 15 responses response NNS cord-313312-h607itv2 201 16 and and CC cord-313312-h607itv2 201 17 production production NN cord-313312-h607itv2 201 18 of of IN cord-313312-h607itv2 201 19 pro pro JJ cord-313312-h607itv2 201 20 - - JJ cord-313312-h607itv2 201 21 inflammatory inflammatory JJ cord-313312-h607itv2 201 22 metabolites metabolite NNS cord-313312-h607itv2 201 23 that that WDT cord-313312-h607itv2 201 24 can can MD cord-313312-h607itv2 201 25 enhance enhance VB cord-313312-h607itv2 201 26 innate innate JJ cord-313312-h607itv2 201 27 and and CC cord-313312-h607itv2 201 28 adaptive adaptive JJ cord-313312-h607itv2 201 29 immune immune JJ cord-313312-h607itv2 201 30 responses response NNS cord-313312-h607itv2 201 31 . . . cord-313312-h607itv2 202 1 In in IN cord-313312-h607itv2 202 2 addition addition NN cord-313312-h607itv2 202 3 , , , cord-313312-h607itv2 202 4 the the DT cord-313312-h607itv2 202 5 cross cross NN cord-313312-h607itv2 202 6 - - NN cord-313312-h607itv2 202 7 linking linking NN cord-313312-h607itv2 202 8 of of IN cord-313312-h607itv2 202 9 FcγRs FcγRs NNP cord-313312-h607itv2 202 10 causes cause NNS cord-313312-h607itv2 202 11 increased increase VBN cord-313312-h607itv2 202 12 expression expression NN cord-313312-h607itv2 202 13 of of IN cord-313312-h607itv2 202 14 immune immune JJ cord-313312-h607itv2 202 15 semaphorins semaphorin NNS cord-313312-h607itv2 202 16 , , , cord-313312-h607itv2 202 17 which which WDT cord-313312-h607itv2 202 18 are be VBP cord-313312-h607itv2 202 19 critical critical JJ cord-313312-h607itv2 202 20 for for IN cord-313312-h607itv2 202 21 antigen antigen NN cord-313312-h607itv2 202 22 - - HYPH cord-313312-h607itv2 202 23 presenting present VBG cord-313312-h607itv2 202 24 cell cell NN cord-313312-h607itv2 202 25 and and CC cord-313312-h607itv2 202 26 T t NN cord-313312-h607itv2 202 27 - - HYPH cord-313312-h607itv2 202 28 cell cell NN cord-313312-h607itv2 202 29 interaction interaction NN cord-313312-h607itv2 202 30 . . . cord-313312-h607itv2 203 1 Overall overall RB cord-313312-h607itv2 203 2 , , , cord-313312-h607itv2 203 3 this this DT cord-313312-h607itv2 203 4 leads lead VBZ cord-313312-h607itv2 203 5 to to IN cord-313312-h607itv2 203 6 increased increase VBN cord-313312-h607itv2 203 7 T t NN cord-313312-h607itv2 203 8 - - HYPH cord-313312-h607itv2 203 9 cell cell NN cord-313312-h607itv2 203 10 proliferation proliferation NN cord-313312-h607itv2 203 11 and and CC cord-313312-h607itv2 203 12 activation activation NN cord-313312-h607itv2 203 13 , , , cord-313312-h607itv2 203 14 which which WDT cord-313312-h607itv2 203 15 consequently consequently RB cord-313312-h607itv2 203 16 improves improve VBZ cord-313312-h607itv2 203 17 LAV LAV NNP cord-313312-h607itv2 203 18 immunogenicity immunogenicity NN cord-313312-h607itv2 203 19 . . . cord-313312-h607itv2 204 1 In in IN cord-313312-h607itv2 204 2 this this DT cord-313312-h607itv2 204 3 review review NN cord-313312-h607itv2 204 4 , , , cord-313312-h607itv2 204 5 we -PRON- PRP cord-313312-h607itv2 204 6 have have VBP cord-313312-h607itv2 204 7 highlighted highlight VBN cord-313312-h607itv2 204 8 several several JJ cord-313312-h607itv2 204 9 studies study NNS cord-313312-h607itv2 204 10 that that WDT cord-313312-h607itv2 204 11 have have VBP cord-313312-h607itv2 204 12 shown show VBN cord-313312-h607itv2 204 13 that that IN cord-313312-h607itv2 204 14 the the DT cord-313312-h607itv2 204 15 efficacy efficacy NN cord-313312-h607itv2 204 16 of of IN cord-313312-h607itv2 204 17 some some DT cord-313312-h607itv2 204 18 commonly commonly RB cord-313312-h607itv2 204 19 used use VBN cord-313312-h607itv2 204 20 LAVs lav NNS cord-313312-h607itv2 204 21 , , , cord-313312-h607itv2 204 22 such such JJ cord-313312-h607itv2 204 23 as as IN cord-313312-h607itv2 204 24 measles measles NN cord-313312-h607itv2 204 25 , , , cord-313312-h607itv2 204 26 adenovirus adenovirus NN cord-313312-h607itv2 204 27 , , , cord-313312-h607itv2 204 28 influenza influenza NN cord-313312-h607itv2 204 29 , , , cord-313312-h607itv2 204 30 and and CC cord-313312-h607itv2 204 31 flaviviral flaviviral JJ cord-313312-h607itv2 204 32 vaccines vaccine NNS cord-313312-h607itv2 204 33 , , , cord-313312-h607itv2 204 34 can can MD cord-313312-h607itv2 204 35 be be VB cord-313312-h607itv2 204 36 affected affect VBN cord-313312-h607itv2 204 37 by by IN cord-313312-h607itv2 204 38 these these DT cord-313312-h607itv2 204 39 pre pre JJ cord-313312-h607itv2 204 40 - - JJ cord-313312-h607itv2 204 41 existing existing JJ cord-313312-h607itv2 204 42 adaptive adaptive JJ cord-313312-h607itv2 204 43 immune immune JJ cord-313312-h607itv2 204 44 responses response NNS cord-313312-h607itv2 204 45 . . . cord-313312-h607itv2 205 1 This this DT cord-313312-h607itv2 205 2 knowledge knowledge NN cord-313312-h607itv2 205 3 will will MD cord-313312-h607itv2 205 4 be be VB cord-313312-h607itv2 205 5 critical critical JJ cord-313312-h607itv2 205 6 to to IN cord-313312-h607itv2 205 7 understanding understand VBG cord-313312-h607itv2 205 8 the the DT cord-313312-h607itv2 205 9 limitations limitation NNS cord-313312-h607itv2 205 10 of of IN cord-313312-h607itv2 205 11 administering administer VBG cord-313312-h607itv2 205 12 LAVs lav NNS cord-313312-h607itv2 205 13 in in IN cord-313312-h607itv2 205 14 seropositive seropositive JJ cord-313312-h607itv2 205 15 individuals individual NNS cord-313312-h607itv2 205 16 to to TO cord-313312-h607itv2 205 17 reduce reduce VB cord-313312-h607itv2 205 18 the the DT cord-313312-h607itv2 205 19 incidence incidence NN cord-313312-h607itv2 205 20 of of IN cord-313312-h607itv2 205 21 vaccine vaccine NN cord-313312-h607itv2 205 22 failures failure NNS cord-313312-h607itv2 205 23 , , , cord-313312-h607itv2 205 24 as as RB cord-313312-h607itv2 205 25 well well RB cord-313312-h607itv2 205 26 as as IN cord-313312-h607itv2 205 27 in in IN cord-313312-h607itv2 205 28 future future JJ cord-313312-h607itv2 205 29 designs design NNS cord-313312-h607itv2 205 30 of of IN cord-313312-h607itv2 205 31 clinical clinical JJ cord-313312-h607itv2 205 32 trials trial NNS cord-313312-h607itv2 205 33 to to TO cord-313312-h607itv2 205 34 evaluate evaluate VB cord-313312-h607itv2 205 35 the the DT cord-313312-h607itv2 205 36 efficacy efficacy NN cord-313312-h607itv2 205 37 of of IN cord-313312-h607itv2 205 38 LAVs lav NNS cord-313312-h607itv2 205 39 . . . cord-313312-h607itv2 206 1 Whether whether IN cord-313312-h607itv2 206 2 preexisting preexisting JJ cord-313312-h607itv2 206 3 antibodies antibody NNS cord-313312-h607itv2 206 4 can can MD cord-313312-h607itv2 206 5 inhibit inhibit VB cord-313312-h607itv2 206 6 or or CC cord-313312-h607itv2 206 7 augment augment VB cord-313312-h607itv2 206 8 LAV LAV NNP cord-313312-h607itv2 206 9 immunogenicity immunogenicity NN cord-313312-h607itv2 206 10 depends depend VBZ cord-313312-h607itv2 206 11 on on IN cord-313312-h607itv2 206 12 the the DT cord-313312-h607itv2 206 13 concentration concentration NN cord-313312-h607itv2 206 14 and and CC cord-313312-h607itv2 206 15 the the DT cord-313312-h607itv2 206 16 type type NN cord-313312-h607itv2 206 17 of of IN cord-313312-h607itv2 206 18 antibodies antibody NNS cord-313312-h607itv2 206 19 that that WDT cord-313312-h607itv2 206 20 are be VBP cord-313312-h607itv2 206 21 present present JJ cord-313312-h607itv2 207 1 ( ( -LRB- cord-313312-h607itv2 207 2 Figure figure NN cord-313312-h607itv2 207 3 4 4 CD cord-313312-h607itv2 207 4 ) ) -RRB- cord-313312-h607itv2 207 5 . . . cord-313312-h607itv2 208 1 With with IN cord-313312-h607itv2 208 2 high high JJ cord-313312-h607itv2 208 3 antibody antibody NN cord-313312-h607itv2 208 4 levels level NNS cord-313312-h607itv2 208 5 or or CC cord-313312-h607itv2 208 6 potently potently RB cord-313312-h607itv2 208 7 neutralizing neutralize VBG cord-313312-h607itv2 208 8 antibodies antibody NNS cord-313312-h607itv2 208 9 , , , cord-313312-h607itv2 208 10 pre pre JJ cord-313312-h607itv2 208 11 - - JJ cord-313312-h607itv2 208 12 existing existing JJ cord-313312-h607itv2 208 13 antibodies antibody NNS cord-313312-h607itv2 208 14 can can MD cord-313312-h607itv2 208 15 inhibit inhibit VB cord-313312-h607itv2 208 16 LAV LAV NNP cord-313312-h607itv2 208 17 efficacy efficacy NN cord-313312-h607itv2 208 18 by by IN cord-313312-h607itv2 208 19 virus virus NN cord-313312-h607itv2 208 20 neutralization neutralization NN cord-313312-h607itv2 208 21 or or CC cord-313312-h607itv2 208 22 inhibition inhibition NN cord-313312-h607itv2 208 23 of of IN cord-313312-h607itv2 208 24 Bcell Bcell NNP cord-313312-h607itv2 208 25 responses response NNS cord-313312-h607itv2 208 26 . . . cord-313312-h607itv2 209 1 By by IN cord-313312-h607itv2 209 2 contrast contrast NN cord-313312-h607itv2 209 3 , , , cord-313312-h607itv2 209 4 at at IN cord-313312-h607itv2 209 5 sub sub NN cord-313312-h607itv2 209 6 - - JJ cord-313312-h607itv2 209 7 neutralizing neutralize VBG cord-313312-h607itv2 209 8 titers titer NNS cord-313312-h607itv2 209 9 , , , cord-313312-h607itv2 209 10 pre pre JJ cord-313312-h607itv2 209 11 - - JJ cord-313312-h607itv2 209 12 existing existing JJ cord-313312-h607itv2 209 13 antibodies antibody NNS cord-313312-h607itv2 209 14 can can MD cord-313312-h607itv2 209 15 enable enable VB cord-313312-h607itv2 209 16 viruses virus NNS cord-313312-h607itv2 209 17 to to TO cord-313312-h607itv2 209 18 better well RBR cord-313312-h607itv2 209 19 infect infect VB cord-313312-h607itv2 209 20 cells cell NNS cord-313312-h607itv2 209 21 and and CC cord-313312-h607itv2 209 22 increase increase VB cord-313312-h607itv2 209 23 innate innate JJ cord-313312-h607itv2 209 24 immune immune JJ cord-313312-h607itv2 209 25 responses response NNS cord-313312-h607itv2 209 26 that that WDT cord-313312-h607itv2 209 27 augment augment VBP cord-313312-h607itv2 209 28 LAV LAV NNP cord-313312-h607itv2 209 29 immunogenicity immunogenicity NN cord-313312-h607itv2 209 30 . . . cord-313312-h607itv2 210 1 Moreover moreover RB cord-313312-h607itv2 210 2 , , , cord-313312-h607itv2 210 3 pre pre JJ cord-313312-h607itv2 210 4 - - JJ cord-313312-h607itv2 210 5 existing existing JJ cord-313312-h607itv2 210 6 immunity immunity NN cord-313312-h607itv2 210 7 can can MD cord-313312-h607itv2 210 8 prime prime JJ cord-313312-h607itv2 210 9 dendritic dendritic JJ cord-313312-h607itv2 210 10 cells cell NNS cord-313312-h607itv2 210 11 and and CC cord-313312-h607itv2 210 12 memory memory NN cord-313312-h607itv2 210 13 T t NN cord-313312-h607itv2 210 14 - - HYPH cord-313312-h607itv2 210 15 cells cell NNS cord-313312-h607itv2 210 16 to to TO cord-313312-h607itv2 210 17 enhance enhance VB cord-313312-h607itv2 210 18 protection protection NN cord-313312-h607itv2 210 19 during during IN cord-313312-h607itv2 210 20 secondary secondary JJ cord-313312-h607itv2 210 21 infection infection NN cord-313312-h607itv2 210 22 with with IN cord-313312-h607itv2 210 23 an an DT cord-313312-h607itv2 210 24 antigenically antigenically RB cord-313312-h607itv2 210 25 related relate VBN cord-313312-h607itv2 210 26 virus virus NN cord-313312-h607itv2 210 27 [ [ -LRB- cord-313312-h607itv2 210 28 83 83 CD cord-313312-h607itv2 210 29 ] ] -RRB- cord-313312-h607itv2 210 30 . . . cord-313312-h607itv2 211 1 We -PRON- PRP cord-313312-h607itv2 211 2 believe believe VBP cord-313312-h607itv2 211 3 that that IN cord-313312-h607itv2 211 4 a a DT cord-313312-h607itv2 211 5 deeper deep JJR cord-313312-h607itv2 211 6 understanding understanding NN cord-313312-h607itv2 211 7 of of IN cord-313312-h607itv2 211 8 the the DT cord-313312-h607itv2 211 9 underlying underlie VBG cord-313312-h607itv2 211 10 mechanisms mechanism NNS cord-313312-h607itv2 211 11 involved involve VBN cord-313312-h607itv2 211 12 will will MD cord-313312-h607itv2 211 13 help help VB cord-313312-h607itv2 211 14 us -PRON- PRP cord-313312-h607itv2 211 15 better well RBR cord-313312-h607itv2 211 16 understand understand VB cord-313312-h607itv2 211 17 the the DT cord-313312-h607itv2 211 18 circumstances circumstance NNS cord-313312-h607itv2 211 19 that that WDT cord-313312-h607itv2 211 20 can can MD cord-313312-h607itv2 211 21 allow allow VB cord-313312-h607itv2 211 22 us -PRON- PRP cord-313312-h607itv2 211 23 to to TO cord-313312-h607itv2 211 24 manage manage VB cord-313312-h607itv2 211 25 immunization immunization NN cord-313312-h607itv2 211 26 in in IN cord-313312-h607itv2 211 27 the the DT cord-313312-h607itv2 211 28 presence presence NN cord-313312-h607itv2 211 29 of of IN cord-313312-h607itv2 211 30 pre pre JJ cord-313312-h607itv2 211 31 - - JJ cord-313312-h607itv2 211 32 existing existing JJ cord-313312-h607itv2 211 33 antibodies antibody NNS cord-313312-h607itv2 211 34 , , , cord-313312-h607itv2 211 35 and and CC cord-313312-h607itv2 211 36 even even RB cord-313312-h607itv2 211 37 explore explore VB cord-313312-h607itv2 211 38 the the DT cord-313312-h607itv2 211 39 possibilities possibility NNS cord-313312-h607itv2 211 40 of of IN cord-313312-h607itv2 211 41 exploiting exploit VBG cord-313312-h607itv2 211 42 pre pre JJ cord-313312-h607itv2 211 43 - - JJ cord-313312-h607itv2 211 44 existing existing JJ cord-313312-h607itv2 211 45 antibodies antibody NNS cord-313312-h607itv2 211 46 to to TO cord-313312-h607itv2 211 47 promote promote VB cord-313312-h607itv2 211 48 vaccine vaccine NN cord-313312-h607itv2 211 49 immunogenicity immunogenicity NN cord-313312-h607itv2 211 50 and and CC cord-313312-h607itv2 211 51 efficacy efficacy NN cord-313312-h607itv2 211 52 . . . cord-313312-h607itv2 212 1 It -PRON- PRP cord-313312-h607itv2 212 2 would would MD cord-313312-h607itv2 212 3 also also RB cord-313312-h607itv2 212 4 be be VB cord-313312-h607itv2 212 5 interesting interesting JJ cord-313312-h607itv2 212 6 to to TO cord-313312-h607itv2 212 7 determine determine VB cord-313312-h607itv2 212 8 if if IN cord-313312-h607itv2 212 9 cross cross JJ cord-313312-h607itv2 212 10 - - JJ cord-313312-h607itv2 212 11 reactive reactive JJ cord-313312-h607itv2 212 12 antibodies antibody NNS cord-313312-h607itv2 212 13 Immune Immune NNP cord-313312-h607itv2 212 14 complexes complex NNS cord-313312-h607itv2 212 15 formed form VBN cord-313312-h607itv2 212 16 by by IN cord-313312-h607itv2 212 17 pre pre JJ cord-313312-h607itv2 212 18 - - JJ cord-313312-h607itv2 212 19 existing existing JJ cord-313312-h607itv2 212 20 antibodies antibody NNS cord-313312-h607itv2 212 21 and and CC cord-313312-h607itv2 212 22 viruses virus NNS cord-313312-h607itv2 212 23 can can MD cord-313312-h607itv2 212 24 engage engage VB cord-313312-h607itv2 212 25 FcγRs FcγRs NNP cord-313312-h607itv2 212 26 , , , cord-313312-h607itv2 212 27 resulting result VBG cord-313312-h607itv2 212 28 in in IN cord-313312-h607itv2 212 29 increased increase VBN cord-313312-h607itv2 212 30 viral viral JJ cord-313312-h607itv2 212 31 uptake uptake NN cord-313312-h607itv2 212 32 and and CC cord-313312-h607itv2 212 33 fusion fusion NN cord-313312-h607itv2 212 34 through through IN cord-313312-h607itv2 212 35 the the DT cord-313312-h607itv2 212 36 process process NN cord-313312-h607itv2 212 37 of of IN cord-313312-h607itv2 212 38 antibody antibody NN cord-313312-h607itv2 212 39 - - HYPH cord-313312-h607itv2 212 40 dependent dependent JJ cord-313312-h607itv2 212 41 enhancement enhancement NN cord-313312-h607itv2 212 42 that that WDT cord-313312-h607itv2 212 43 leads lead VBZ cord-313312-h607itv2 212 44 to to IN cord-313312-h607itv2 212 45 increased increase VBN cord-313312-h607itv2 212 46 vaccine vaccine NN cord-313312-h607itv2 212 47 viremia viremia NN cord-313312-h607itv2 212 48 and and CC cord-313312-h607itv2 212 49 antigen antigen NN cord-313312-h607itv2 212 50 presentation presentation NN cord-313312-h607itv2 212 51 . . . cord-313312-h607itv2 213 1 Activating activate VBG cord-313312-h607itv2 213 2 FcγR fcγr NN cord-313312-h607itv2 213 3 - - HYPH cord-313312-h607itv2 213 4 signaling signal VBG cord-313312-h607itv2 213 5 , , , cord-313312-h607itv2 213 6 on on IN cord-313312-h607itv2 213 7 the the DT cord-313312-h607itv2 213 8 other other JJ cord-313312-h607itv2 213 9 hand hand NN cord-313312-h607itv2 213 10 , , , cord-313312-h607itv2 213 11 provokes provoke VBZ cord-313312-h607itv2 213 12 greater great JJR cord-313312-h607itv2 213 13 innate innate JJ cord-313312-h607itv2 213 14 immune immune JJ cord-313312-h607itv2 213 15 responses response NNS cord-313312-h607itv2 213 16 and and CC cord-313312-h607itv2 213 17 production production NN cord-313312-h607itv2 213 18 of of IN cord-313312-h607itv2 213 19 pro pro JJ cord-313312-h607itv2 213 20 - - JJ cord-313312-h607itv2 213 21 inflammatory inflammatory JJ cord-313312-h607itv2 213 22 metabolites metabolite NNS cord-313312-h607itv2 213 23 that that WDT cord-313312-h607itv2 213 24 can can MD cord-313312-h607itv2 213 25 enhance enhance VB cord-313312-h607itv2 213 26 innate innate JJ cord-313312-h607itv2 213 27 and and CC cord-313312-h607itv2 213 28 adaptive adaptive JJ cord-313312-h607itv2 213 29 immune immune JJ cord-313312-h607itv2 213 30 responses response NNS cord-313312-h607itv2 213 31 . . . cord-313312-h607itv2 214 1 In in IN cord-313312-h607itv2 214 2 addition addition NN cord-313312-h607itv2 214 3 , , , cord-313312-h607itv2 214 4 the the DT cord-313312-h607itv2 214 5 cross cross NN cord-313312-h607itv2 214 6 - - NN cord-313312-h607itv2 214 7 linking linking NN cord-313312-h607itv2 214 8 of of IN cord-313312-h607itv2 214 9 FcγRs FcγRs NNP cord-313312-h607itv2 214 10 causes cause NNS cord-313312-h607itv2 214 11 increased increase VBN cord-313312-h607itv2 214 12 expression expression NN cord-313312-h607itv2 214 13 of of IN cord-313312-h607itv2 214 14 immune immune JJ cord-313312-h607itv2 214 15 semaphorins semaphorin NNS cord-313312-h607itv2 214 16 , , , cord-313312-h607itv2 214 17 which which WDT cord-313312-h607itv2 214 18 are be VBP cord-313312-h607itv2 214 19 critical critical JJ cord-313312-h607itv2 214 20 for for IN cord-313312-h607itv2 214 21 antigen antigen NN cord-313312-h607itv2 214 22 - - HYPH cord-313312-h607itv2 214 23 presenting present VBG cord-313312-h607itv2 214 24 cell cell NN cord-313312-h607itv2 214 25 and and CC cord-313312-h607itv2 214 26 T t NN cord-313312-h607itv2 214 27 - - HYPH cord-313312-h607itv2 214 28 cell cell NN cord-313312-h607itv2 214 29 interaction interaction NN cord-313312-h607itv2 214 30 . . . cord-313312-h607itv2 215 1 Overall overall RB cord-313312-h607itv2 215 2 , , , cord-313312-h607itv2 215 3 this this DT cord-313312-h607itv2 215 4 leads lead VBZ cord-313312-h607itv2 215 5 to to IN cord-313312-h607itv2 215 6 increased increase VBN cord-313312-h607itv2 215 7 T t NN cord-313312-h607itv2 215 8 - - HYPH cord-313312-h607itv2 215 9 cell cell NN cord-313312-h607itv2 215 10 proliferation proliferation NN cord-313312-h607itv2 215 11 and and CC cord-313312-h607itv2 215 12 activation activation NN cord-313312-h607itv2 215 13 , , , cord-313312-h607itv2 215 14 which which WDT cord-313312-h607itv2 215 15 consequently consequently RB cord-313312-h607itv2 215 16 improves improve VBZ cord-313312-h607itv2 215 17 LAV LAV NNP cord-313312-h607itv2 215 18 immunogenicity immunogenicity NN cord-313312-h607itv2 215 19 . . . cord-313312-h607itv2 216 1 In in IN cord-313312-h607itv2 216 2 this this DT cord-313312-h607itv2 216 3 review review NN cord-313312-h607itv2 216 4 , , , cord-313312-h607itv2 216 5 we -PRON- PRP cord-313312-h607itv2 216 6 have have VBP cord-313312-h607itv2 216 7 highlighted highlight VBN cord-313312-h607itv2 216 8 several several JJ cord-313312-h607itv2 216 9 studies study NNS cord-313312-h607itv2 216 10 that that WDT cord-313312-h607itv2 216 11 have have VBP cord-313312-h607itv2 216 12 shown show VBN cord-313312-h607itv2 216 13 that that IN cord-313312-h607itv2 216 14 the the DT cord-313312-h607itv2 216 15 efficacy efficacy NN cord-313312-h607itv2 216 16 of of IN cord-313312-h607itv2 216 17 some some DT cord-313312-h607itv2 216 18 commonly commonly RB cord-313312-h607itv2 216 19 used use VBN cord-313312-h607itv2 216 20 LAVs lav NNS cord-313312-h607itv2 216 21 , , , cord-313312-h607itv2 216 22 such such JJ cord-313312-h607itv2 216 23 as as IN cord-313312-h607itv2 216 24 measles measles NN cord-313312-h607itv2 216 25 , , , cord-313312-h607itv2 216 26 adenovirus adenovirus NN cord-313312-h607itv2 216 27 , , , cord-313312-h607itv2 216 28 influenza influenza NN cord-313312-h607itv2 216 29 , , , cord-313312-h607itv2 216 30 and and CC cord-313312-h607itv2 216 31 flaviviral flaviviral JJ cord-313312-h607itv2 216 32 vaccines vaccine NNS cord-313312-h607itv2 216 33 , , , cord-313312-h607itv2 216 34 can can MD cord-313312-h607itv2 216 35 be be VB cord-313312-h607itv2 216 36 affected affect VBN cord-313312-h607itv2 216 37 by by IN cord-313312-h607itv2 216 38 these these DT cord-313312-h607itv2 216 39 pre pre JJ cord-313312-h607itv2 216 40 - - JJ cord-313312-h607itv2 216 41 existing existing JJ cord-313312-h607itv2 216 42 adaptive adaptive JJ cord-313312-h607itv2 216 43 immune immune JJ cord-313312-h607itv2 216 44 responses response NNS cord-313312-h607itv2 216 45 . . . cord-313312-h607itv2 217 1 This this DT cord-313312-h607itv2 217 2 knowledge knowledge NN cord-313312-h607itv2 217 3 will will MD cord-313312-h607itv2 217 4 be be VB cord-313312-h607itv2 217 5 critical critical JJ cord-313312-h607itv2 217 6 to to IN cord-313312-h607itv2 217 7 understanding understand VBG cord-313312-h607itv2 217 8 the the DT cord-313312-h607itv2 217 9 limitations limitation NNS cord-313312-h607itv2 217 10 of of IN cord-313312-h607itv2 217 11 administering administer VBG cord-313312-h607itv2 217 12 LAVs lav NNS cord-313312-h607itv2 217 13 in in IN cord-313312-h607itv2 217 14 seropositive seropositive JJ cord-313312-h607itv2 217 15 individuals individual NNS cord-313312-h607itv2 217 16 to to TO cord-313312-h607itv2 217 17 reduce reduce VB cord-313312-h607itv2 217 18 the the DT cord-313312-h607itv2 217 19 incidence incidence NN cord-313312-h607itv2 217 20 of of IN cord-313312-h607itv2 217 21 vaccine vaccine NN cord-313312-h607itv2 217 22 failures failure NNS cord-313312-h607itv2 217 23 , , , cord-313312-h607itv2 217 24 as as RB cord-313312-h607itv2 217 25 well well RB cord-313312-h607itv2 217 26 as as IN cord-313312-h607itv2 217 27 in in IN cord-313312-h607itv2 217 28 future future JJ cord-313312-h607itv2 217 29 designs design NNS cord-313312-h607itv2 217 30 of of IN cord-313312-h607itv2 217 31 clinical clinical JJ cord-313312-h607itv2 217 32 trials trial NNS cord-313312-h607itv2 217 33 to to TO cord-313312-h607itv2 217 34 evaluate evaluate VB cord-313312-h607itv2 217 35 the the DT cord-313312-h607itv2 217 36 efficacy efficacy NN cord-313312-h607itv2 217 37 of of IN cord-313312-h607itv2 217 38 LAVs lav NNS cord-313312-h607itv2 217 39 . . . cord-313312-h607itv2 218 1 Whether whether IN cord-313312-h607itv2 218 2 pre pre JJ cord-313312-h607itv2 218 3 - - JJ cord-313312-h607itv2 218 4 existing existing JJ cord-313312-h607itv2 218 5 antibodies antibody NNS cord-313312-h607itv2 218 6 can can MD cord-313312-h607itv2 218 7 inhibit inhibit VB cord-313312-h607itv2 218 8 or or CC cord-313312-h607itv2 218 9 augment augment VB cord-313312-h607itv2 218 10 LAV LAV NNP cord-313312-h607itv2 218 11 immunogenicity immunogenicity NN cord-313312-h607itv2 218 12 depends depend VBZ cord-313312-h607itv2 218 13 on on IN cord-313312-h607itv2 218 14 the the DT cord-313312-h607itv2 218 15 concentration concentration NN cord-313312-h607itv2 218 16 and and CC cord-313312-h607itv2 218 17 the the DT cord-313312-h607itv2 218 18 type type NN cord-313312-h607itv2 218 19 of of IN cord-313312-h607itv2 218 20 antibodies antibody NNS cord-313312-h607itv2 218 21 that that WDT cord-313312-h607itv2 218 22 are be VBP cord-313312-h607itv2 218 23 present present JJ cord-313312-h607itv2 219 1 ( ( -LRB- cord-313312-h607itv2 219 2 Figure figure NN cord-313312-h607itv2 219 3 4 4 CD cord-313312-h607itv2 219 4 ) ) -RRB- cord-313312-h607itv2 219 5 . . . cord-313312-h607itv2 220 1 With with IN cord-313312-h607itv2 220 2 high high JJ cord-313312-h607itv2 220 3 antibody antibody NN cord-313312-h607itv2 220 4 levels level NNS cord-313312-h607itv2 220 5 or or CC cord-313312-h607itv2 220 6 potently potently RB cord-313312-h607itv2 220 7 neutralizing neutralize VBG cord-313312-h607itv2 220 8 antibodies antibody NNS cord-313312-h607itv2 220 9 , , , cord-313312-h607itv2 220 10 pre pre JJ cord-313312-h607itv2 220 11 - - JJ cord-313312-h607itv2 220 12 existing existing JJ cord-313312-h607itv2 220 13 antibodies antibody NNS cord-313312-h607itv2 220 14 can can MD cord-313312-h607itv2 220 15 inhibit inhibit VB cord-313312-h607itv2 220 16 LAV LAV NNP cord-313312-h607itv2 220 17 efficacy efficacy NN cord-313312-h607itv2 220 18 by by IN cord-313312-h607itv2 220 19 virus virus NN cord-313312-h607itv2 220 20 neutralization neutralization NN cord-313312-h607itv2 220 21 or or CC cord-313312-h607itv2 220 22 inhibition inhibition NN cord-313312-h607itv2 220 23 of of IN cord-313312-h607itv2 220 24 B b NN cord-313312-h607itv2 220 25 - - HYPH cord-313312-h607itv2 220 26 cell cell NN cord-313312-h607itv2 220 27 responses response NNS cord-313312-h607itv2 220 28 . . . cord-313312-h607itv2 221 1 By by IN cord-313312-h607itv2 221 2 contrast contrast NN cord-313312-h607itv2 221 3 , , , cord-313312-h607itv2 221 4 at at IN cord-313312-h607itv2 221 5 sub sub NN cord-313312-h607itv2 221 6 - - JJ cord-313312-h607itv2 221 7 neutralizing neutralize VBG cord-313312-h607itv2 221 8 titers titer NNS cord-313312-h607itv2 221 9 , , , cord-313312-h607itv2 221 10 pre pre JJ cord-313312-h607itv2 221 11 - - JJ cord-313312-h607itv2 221 12 existing existing JJ cord-313312-h607itv2 221 13 antibodies antibody NNS cord-313312-h607itv2 221 14 can can MD cord-313312-h607itv2 221 15 enable enable VB cord-313312-h607itv2 221 16 viruses virus NNS cord-313312-h607itv2 221 17 to to TO cord-313312-h607itv2 221 18 better well RBR cord-313312-h607itv2 221 19 infect infect VB cord-313312-h607itv2 221 20 cells cell NNS cord-313312-h607itv2 221 21 and and CC cord-313312-h607itv2 221 22 increase increase VB cord-313312-h607itv2 221 23 innate innate JJ cord-313312-h607itv2 221 24 immune immune JJ cord-313312-h607itv2 221 25 responses response NNS cord-313312-h607itv2 221 26 that that WDT cord-313312-h607itv2 221 27 augment augment VBP cord-313312-h607itv2 221 28 LAV LAV NNP cord-313312-h607itv2 221 29 immunogenicity immunogenicity NN cord-313312-h607itv2 221 30 . . . cord-313312-h607itv2 222 1 Moreover moreover RB cord-313312-h607itv2 222 2 , , , cord-313312-h607itv2 222 3 pre pre JJ cord-313312-h607itv2 222 4 - - JJ cord-313312-h607itv2 222 5 existing existing JJ cord-313312-h607itv2 222 6 immunity immunity NN cord-313312-h607itv2 222 7 can can MD cord-313312-h607itv2 222 8 prime prime JJ cord-313312-h607itv2 222 9 dendritic dendritic JJ cord-313312-h607itv2 222 10 cells cell NNS cord-313312-h607itv2 222 11 and and CC cord-313312-h607itv2 222 12 memory memory NN cord-313312-h607itv2 222 13 T t NN cord-313312-h607itv2 222 14 - - HYPH cord-313312-h607itv2 222 15 cells cell NNS cord-313312-h607itv2 222 16 to to TO cord-313312-h607itv2 222 17 enhance enhance VB cord-313312-h607itv2 222 18 protection protection NN cord-313312-h607itv2 222 19 during during IN cord-313312-h607itv2 222 20 secondary secondary JJ cord-313312-h607itv2 222 21 infection infection NN cord-313312-h607itv2 222 22 with with IN cord-313312-h607itv2 222 23 an an DT cord-313312-h607itv2 222 24 antigenically antigenically RB cord-313312-h607itv2 222 25 related relate VBN cord-313312-h607itv2 222 26 virus virus NN cord-313312-h607itv2 222 27 [ [ -LRB- cord-313312-h607itv2 222 28 83 83 CD cord-313312-h607itv2 222 29 ] ] -RRB- cord-313312-h607itv2 222 30 . . . cord-313312-h607itv2 223 1 We -PRON- PRP cord-313312-h607itv2 223 2 believe believe VBP cord-313312-h607itv2 223 3 that that IN cord-313312-h607itv2 223 4 a a DT cord-313312-h607itv2 223 5 deeper deep JJR cord-313312-h607itv2 223 6 understanding understanding NN cord-313312-h607itv2 223 7 of of IN cord-313312-h607itv2 223 8 the the DT cord-313312-h607itv2 223 9 underlying underlie VBG cord-313312-h607itv2 223 10 mechanisms mechanism NNS cord-313312-h607itv2 223 11 involved involve VBN cord-313312-h607itv2 223 12 will will MD cord-313312-h607itv2 223 13 help help VB cord-313312-h607itv2 223 14 us -PRON- PRP cord-313312-h607itv2 223 15 better well RBR cord-313312-h607itv2 223 16 understand understand VB cord-313312-h607itv2 223 17 the the DT cord-313312-h607itv2 223 18 circumstances circumstance NNS cord-313312-h607itv2 223 19 that that WDT cord-313312-h607itv2 223 20 can can MD cord-313312-h607itv2 223 21 allow allow VB cord-313312-h607itv2 223 22 us -PRON- PRP cord-313312-h607itv2 223 23 to to TO cord-313312-h607itv2 223 24 manage manage VB cord-313312-h607itv2 223 25 immunization immunization NN cord-313312-h607itv2 223 26 in in IN cord-313312-h607itv2 223 27 the the DT cord-313312-h607itv2 223 28 presence presence NN cord-313312-h607itv2 223 29 of of IN cord-313312-h607itv2 223 30 pre pre JJ cord-313312-h607itv2 223 31 - - JJ cord-313312-h607itv2 223 32 existing existing JJ cord-313312-h607itv2 223 33 antibodies antibody NNS cord-313312-h607itv2 223 34 , , , cord-313312-h607itv2 223 35 and and CC cord-313312-h607itv2 223 36 even even RB cord-313312-h607itv2 223 37 explore explore VB cord-313312-h607itv2 223 38 the the DT cord-313312-h607itv2 223 39 possibilities possibility NNS cord-313312-h607itv2 223 40 of of IN cord-313312-h607itv2 223 41 exploiting exploit VBG cord-313312-h607itv2 223 42 pre pre JJ cord-313312-h607itv2 223 43 - - JJ cord-313312-h607itv2 223 44 existing existing JJ cord-313312-h607itv2 223 45 antibodies antibody NNS cord-313312-h607itv2 223 46 to to TO cord-313312-h607itv2 223 47 promote promote VB cord-313312-h607itv2 223 48 vaccine vaccine NN cord-313312-h607itv2 223 49 immunogenicity immunogenicity NN cord-313312-h607itv2 223 50 and and CC cord-313312-h607itv2 223 51 efficacy efficacy NN cord-313312-h607itv2 223 52 . . . cord-313312-h607itv2 224 1 It -PRON- PRP cord-313312-h607itv2 224 2 would would MD cord-313312-h607itv2 224 3 also also RB cord-313312-h607itv2 224 4 be be VB cord-313312-h607itv2 224 5 interesting interesting JJ cord-313312-h607itv2 224 6 to to TO cord-313312-h607itv2 224 7 determine determine VB cord-313312-h607itv2 224 8 if if IN cord-313312-h607itv2 224 9 cross cross JJ cord-313312-h607itv2 224 10 - - JJ cord-313312-h607itv2 224 11 reactive reactive JJ cord-313312-h607itv2 224 12 antibodies antibody NNS cord-313312-h607itv2 224 13 can can MD cord-313312-h607itv2 224 14 impact impact VB cord-313312-h607itv2 224 15 future future JJ cord-313312-h607itv2 224 16 development development NN cord-313312-h607itv2 224 17 of of IN cord-313312-h607itv2 224 18 LAVs lav NNS cord-313312-h607itv2 224 19 against against IN cord-313312-h607itv2 224 20 newly newly RB cord-313312-h607itv2 224 21 emerging emerge VBG cord-313312-h607itv2 224 22 pandemic pandemic NN cord-313312-h607itv2 224 23 viruses virus NNS cord-313312-h607itv2 224 24 , , , cord-313312-h607itv2 224 25 including include VBG cord-313312-h607itv2 224 26 Ebola Ebola NNP cord-313312-h607itv2 224 27 , , , cord-313312-h607itv2 224 28 Severe severe JJ cord-313312-h607itv2 224 29 Acute acute JJ cord-313312-h607itv2 224 30 Respiratory Respiratory NNP cord-313312-h607itv2 224 31 Syndrome Syndrome NNP cord-313312-h607itv2 224 32 coronavirus-2 coronavirus-2 NNP cord-313312-h607itv2 224 33 ( ( -LRB- cord-313312-h607itv2 224 34 SARS SARS NNP cord-313312-h607itv2 224 35 CoV-2 CoV-2 NNP cord-313312-h607itv2 224 36 ) ) -RRB- cord-313312-h607itv2 224 37 , , , cord-313312-h607itv2 224 38 and and CC cord-313312-h607itv2 224 39 Zika Zika NNP cord-313312-h607itv2 224 40 viruses virus NNS cord-313312-h607itv2 224 41 . . . cord-313312-h607itv2 225 1 can can MD cord-313312-h607itv2 225 2 impact impact VB cord-313312-h607itv2 225 3 future future JJ cord-313312-h607itv2 225 4 development development NN cord-313312-h607itv2 225 5 of of IN cord-313312-h607itv2 225 6 LAVs lav NNS cord-313312-h607itv2 225 7 against against IN cord-313312-h607itv2 225 8 newly newly RB cord-313312-h607itv2 225 9 emerging emerge VBG cord-313312-h607itv2 225 10 pandemic pandemic NN cord-313312-h607itv2 225 11 viruses virus NNS cord-313312-h607itv2 225 12 , , , cord-313312-h607itv2 225 13 including include VBG cord-313312-h607itv2 225 14 Ebola Ebola NNP cord-313312-h607itv2 225 15 , , , cord-313312-h607itv2 225 16 Severe severe JJ cord-313312-h607itv2 225 17 Acute acute JJ cord-313312-h607itv2 225 18 Respiratory Respiratory NNP cord-313312-h607itv2 225 19 Syndrome Syndrome NNP cord-313312-h607itv2 225 20 coronavirus-2 coronavirus-2 NNP cord-313312-h607itv2 225 21 ( ( -LRB- cord-313312-h607itv2 225 22 SARS SARS NNP cord-313312-h607itv2 225 23 CoV-2 CoV-2 NNP cord-313312-h607itv2 225 24 ) ) -RRB- cord-313312-h607itv2 225 25 , , , cord-313312-h607itv2 225 26 and and CC cord-313312-h607itv2 225 27 Zika Zika NNP cord-313312-h607itv2 225 28 viruses virus NNS cord-313312-h607itv2 225 29 . . . cord-313312-h607itv2 226 1 In in IN cord-313312-h607itv2 226 2 the the DT cord-313312-h607itv2 226 3 presence presence NN cord-313312-h607itv2 226 4 of of IN cord-313312-h607itv2 226 5 high high JJ cord-313312-h607itv2 226 6 levels level NNS cord-313312-h607itv2 226 7 of of IN cord-313312-h607itv2 226 8 pre pre JJ cord-313312-h607itv2 226 9 - - JJ cord-313312-h607itv2 226 10 existing existing JJ cord-313312-h607itv2 226 11 antibodies antibody NNS cord-313312-h607itv2 226 12 or or CC cord-313312-h607itv2 226 13 with with IN cord-313312-h607itv2 226 14 potently potently RB cord-313312-h607itv2 226 15 neutralizing neutralize VBG cord-313312-h607itv2 226 16 antibodies antibody NNS cord-313312-h607itv2 226 17 , , , cord-313312-h607itv2 226 18 LAV LAV NNP cord-313312-h607itv2 226 19 immunogenicity immunogenicity NN cord-313312-h607itv2 226 20 is be VBZ cord-313312-h607itv2 226 21 hindered hinder VBN cord-313312-h607itv2 226 22 due due IN cord-313312-h607itv2 226 23 to to IN cord-313312-h607itv2 226 24 immune immune JJ cord-313312-h607itv2 226 25 interference interference NN cord-313312-h607itv2 226 26 from from IN cord-313312-h607itv2 226 27 virus virus NN cord-313312-h607itv2 226 28 neutralization neutralization NN cord-313312-h607itv2 226 29 or or CC cord-313312-h607itv2 226 30 inhibition inhibition NN cord-313312-h607itv2 226 31 of of IN cord-313312-h607itv2 226 32 B b NN cord-313312-h607itv2 226 33 - - HYPH cord-313312-h607itv2 226 34 cell cell NN cord-313312-h607itv2 226 35 responses response NNS cord-313312-h607itv2 226 36 . . . cord-313312-h607itv2 227 1 However however RB cord-313312-h607itv2 227 2 , , , cord-313312-h607itv2 227 3 at at IN cord-313312-h607itv2 227 4 sub sub NN cord-313312-h607itv2 227 5 - - JJ cord-313312-h607itv2 227 6 neutralizing neutralize VBG cord-313312-h607itv2 227 7 antibody antibody NN cord-313312-h607itv2 227 8 titers titer NNS cord-313312-h607itv2 227 9 , , , cord-313312-h607itv2 227 10 there there EX cord-313312-h607itv2 227 11 is be VBZ cord-313312-h607itv2 227 12 a a DT cord-313312-h607itv2 227 13 window window NN cord-313312-h607itv2 227 14 of of IN cord-313312-h607itv2 227 15 augmented augment VBN cord-313312-h607itv2 227 16 vaccine vaccine NN cord-313312-h607itv2 227 17 immunogenicity immunogenicity NN cord-313312-h607itv2 227 18 due due IN cord-313312-h607itv2 227 19 to to IN cord-313312-h607itv2 227 20 increased increase VBN cord-313312-h607itv2 227 21 uptake uptake NN cord-313312-h607itv2 227 22 into into IN cord-313312-h607itv2 227 23 Fc Fc NNP cord-313312-h607itv2 227 24 receptor receptor NN cord-313312-h607itv2 227 25 - - HYPH cord-313312-h607itv2 227 26 bearing bear VBG cord-313312-h607itv2 227 27 cells cell NNS cord-313312-h607itv2 227 28 and and CC cord-313312-h607itv2 227 29 greater great JJR cord-313312-h607itv2 227 30 induction induction NN cord-313312-h607itv2 227 31 of of IN cord-313312-h607itv2 227 32 innate innate JJ cord-313312-h607itv2 227 33 immune immune JJ cord-313312-h607itv2 227 34 responses response NNS cord-313312-h607itv2 227 35 . . . cord-313312-h607itv2 228 1 The the DT cord-313312-h607itv2 228 2 horizontal horizontal JJ cord-313312-h607itv2 228 3 dotted dotted JJ cord-313312-h607itv2 228 4 line line NN cord-313312-h607itv2 228 5 indicates indicate VBZ cord-313312-h607itv2 228 6 LAV LAV NNP cord-313312-h607itv2 228 7 immunogenicity immunogenicity NN cord-313312-h607itv2 228 8 in in IN cord-313312-h607itv2 228 9 the the DT cord-313312-h607itv2 228 10 absence absence NN cord-313312-h607itv2 228 11 of of IN cord-313312-h607itv2 228 12 pre pre JJ cord-313312-h607itv2 228 13 - - JJ cord-313312-h607itv2 228 14 existing existing JJ cord-313312-h607itv2 228 15 antibodies antibody NNS cord-313312-h607itv2 228 16 . . . cord-313312-h607itv2 228 17 _SP cord-313312-h607itv2 229 1 The the DT cord-313312-h607itv2 229 2 First First NNP cord-313312-h607itv2 229 3 Pandemic Pandemic NNP cord-313312-h607itv2 229 4 of of IN cord-313312-h607itv2 229 5 the the DT cord-313312-h607itv2 229 6 21st 21st JJ cord-313312-h607itv2 229 7 Century century NN cord-313312-h607itv2 229 8 : : : cord-313312-h607itv2 229 9 Review Review NNP cord-313312-h607itv2 229 10 of of IN cord-313312-h607itv2 229 11 the the DT cord-313312-h607itv2 229 12 2009 2009 CD cord-313312-h607itv2 229 13 Pandemic Pandemic NNP cord-313312-h607itv2 229 14 Variant Variant NNP cord-313312-h607itv2 229 15 Influenza Influenza NNP cord-313312-h607itv2 229 16 A A NNP cord-313312-h607itv2 229 17 ( ( -LRB- cord-313312-h607itv2 229 18 H1N1 H1N1 NNP cord-313312-h607itv2 229 19 ) ) -RRB- cord-313312-h607itv2 229 20 Virus Virus NNP cord-313312-h607itv2 229 21 Resurgence Resurgence NNP cord-313312-h607itv2 229 22 of of IN cord-313312-h607itv2 229 23 Yellow Yellow NNP cord-313312-h607itv2 229 24 Fever Fever NNP cord-313312-h607itv2 229 25 in in IN cord-313312-h607itv2 229 26 Angola Angola NNP cord-313312-h607itv2 229 27 Transmission Transmission NNP cord-313312-h607itv2 229 28 dynamics dynamic NNS cord-313312-h607itv2 229 29 and and CC cord-313312-h607itv2 229 30 control control NN cord-313312-h607itv2 229 31 of of IN cord-313312-h607itv2 229 32 Ebola Ebola NNP cord-313312-h607itv2 229 33 virus virus NN cord-313312-h607itv2 229 34 disease disease NN cord-313312-h607itv2 229 35 ( ( -LRB- cord-313312-h607itv2 229 36 EVD EVD NNP cord-313312-h607itv2 229 37 ) ) -RRB- cord-313312-h607itv2 229 38 : : : cord-313312-h607itv2 230 1 A a DT cord-313312-h607itv2 230 2 review review NN cord-313312-h607itv2 231 1 Zika Zika NNP cord-313312-h607itv2 231 2 virus virus NN cord-313312-h607itv2 231 3 in in IN cord-313312-h607itv2 231 4 the the DT cord-313312-h607itv2 231 5 Americas- Americas- NNP cord-313312-h607itv2 232 1 Yet yet RB cord-313312-h607itv2 232 2 another another DT cord-313312-h607itv2 232 3 arbovirus arbovirus NN cord-313312-h607itv2 232 4 threat threat NN cord-313312-h607itv2 232 5 Outbreak outbreak NN cord-313312-h607itv2 232 6 of of IN cord-313312-h607itv2 232 7 pneumonia pneumonia NN cord-313312-h607itv2 232 8 of of IN cord-313312-h607itv2 232 9 unknown unknown JJ cord-313312-h607itv2 232 10 etiology etiology NN cord-313312-h607itv2 232 11 in in IN cord-313312-h607itv2 232 12 Wuhan Wuhan NNP cord-313312-h607itv2 232 13 , , , cord-313312-h607itv2 232 14 China China NNP cord-313312-h607itv2 232 15 : : : cord-313312-h607itv2 233 1 The the DT cord-313312-h607itv2 233 2 mystery mystery NN cord-313312-h607itv2 233 3 and and CC cord-313312-h607itv2 233 4 the the DT cord-313312-h607itv2 233 5 miracle miracle NN cord-313312-h607itv2 233 6 Epidemiology epidemiology NN cord-313312-h607itv2 233 7 and and CC cord-313312-h607itv2 233 8 ecology ecology NN cord-313312-h607itv2 233 9 of of IN cord-313312-h607itv2 233 10 yellow yellow JJ cord-313312-h607itv2 233 11 fever fever NN cord-313312-h607itv2 233 12 virus virus NN cord-313312-h607itv2 234 1 A a DT cord-313312-h607itv2 234 2 Decade decade NN cord-313312-h607itv2 234 3 of of IN cord-313312-h607itv2 234 4 Vaccines vaccine NNS cord-313312-h607itv2 234 5 : : : cord-313312-h607itv2 235 1 Integrating integrate VBG cord-313312-h607itv2 235 2 Immunology Immunology NNP cord-313312-h607itv2 235 3 and and CC cord-313312-h607itv2 235 4 Vaccinology Vaccinology NNP cord-313312-h607itv2 235 5 for for IN cord-313312-h607itv2 235 6 Rational Rational NNP cord-313312-h607itv2 235 7 Vaccine Vaccine NNP cord-313312-h607itv2 235 8 Design Design NNP cord-313312-h607itv2 235 9 Declaration Declaration NNP cord-313312-h607itv2 235 10 of of IN cord-313312-h607itv2 235 11 global global JJ cord-313312-h607itv2 235 12 eradication eradication NN cord-313312-h607itv2 235 13 of of IN cord-313312-h607itv2 235 14 smallpox smallpox NN cord-313312-h607itv2 235 15 State State NNP cord-313312-h607itv2 235 16 of of IN cord-313312-h607itv2 235 17 the the DT cord-313312-h607itv2 235 18 World World NNP cord-313312-h607itv2 235 19 's 's POS cord-313312-h607itv2 235 20 Vaccines Vaccines NNPS cord-313312-h607itv2 235 21 and and CC cord-313312-h607itv2 235 22 Immunization Immunization NNP cord-313312-h607itv2 236 1 The the DT cord-313312-h607itv2 236 2 First First NNP cord-313312-h607itv2 236 3 Pandemic Pandemic NNP cord-313312-h607itv2 236 4 of of IN cord-313312-h607itv2 236 5 the the DT cord-313312-h607itv2 236 6 21st 21st JJ cord-313312-h607itv2 236 7 Century century NN cord-313312-h607itv2 236 8 : : : cord-313312-h607itv2 236 9 Review Review NNP cord-313312-h607itv2 236 10 of of IN cord-313312-h607itv2 236 11 the the DT cord-313312-h607itv2 236 12 2009 2009 CD cord-313312-h607itv2 236 13 Pandemic Pandemic NNP cord-313312-h607itv2 236 14 Variant Variant NNP cord-313312-h607itv2 236 15 Influenza Influenza NNP cord-313312-h607itv2 236 16 A A NNP cord-313312-h607itv2 236 17 ( ( -LRB- cord-313312-h607itv2 236 18 H1N1 H1N1 NNP cord-313312-h607itv2 236 19 ) ) -RRB- cord-313312-h607itv2 236 20 Virus Virus NNP cord-313312-h607itv2 236 21 Resurgence Resurgence NNP cord-313312-h607itv2 236 22 of of IN cord-313312-h607itv2 236 23 Yellow Yellow NNP cord-313312-h607itv2 236 24 Fever Fever NNP cord-313312-h607itv2 236 25 in in IN cord-313312-h607itv2 236 26 Angola Angola NNP cord-313312-h607itv2 236 27 Transmission Transmission NNP cord-313312-h607itv2 236 28 dynamics dynamic NNS cord-313312-h607itv2 236 29 and and CC cord-313312-h607itv2 236 30 control control NN cord-313312-h607itv2 236 31 of of IN cord-313312-h607itv2 236 32 Ebola Ebola NNP cord-313312-h607itv2 236 33 virus virus NN cord-313312-h607itv2 236 34 disease disease NN cord-313312-h607itv2 236 35 ( ( -LRB- cord-313312-h607itv2 236 36 EVD EVD NNP cord-313312-h607itv2 236 37 ) ) -RRB- cord-313312-h607itv2 236 38 : : : cord-313312-h607itv2 237 1 A a DT cord-313312-h607itv2 237 2 review review NN cord-313312-h607itv2 238 1 Zika Zika NNP cord-313312-h607itv2 238 2 virus virus NN cord-313312-h607itv2 238 3 in in IN cord-313312-h607itv2 238 4 the the DT cord-313312-h607itv2 238 5 Americas- Americas- NNP cord-313312-h607itv2 239 1 Yet yet RB cord-313312-h607itv2 239 2 another another DT cord-313312-h607itv2 239 3 arbovirus arbovirus NN cord-313312-h607itv2 239 4 threat threat NN cord-313312-h607itv2 239 5 Outbreak outbreak NN cord-313312-h607itv2 239 6 of of IN cord-313312-h607itv2 239 7 pneumonia pneumonia NN cord-313312-h607itv2 239 8 of of IN cord-313312-h607itv2 239 9 unknown unknown JJ cord-313312-h607itv2 239 10 etiology etiology NN cord-313312-h607itv2 239 11 in in IN cord-313312-h607itv2 239 12 Wuhan Wuhan NNP cord-313312-h607itv2 239 13 , , , cord-313312-h607itv2 239 14 China China NNP cord-313312-h607itv2 239 15 : : : cord-313312-h607itv2 240 1 The the DT cord-313312-h607itv2 240 2 mystery mystery NN cord-313312-h607itv2 240 3 and and CC cord-313312-h607itv2 240 4 the the DT cord-313312-h607itv2 240 5 miracle miracle NN cord-313312-h607itv2 240 6 Epidemiology epidemiology NN cord-313312-h607itv2 240 7 and and CC cord-313312-h607itv2 240 8 ecology ecology NN cord-313312-h607itv2 240 9 of of IN cord-313312-h607itv2 240 10 yellow yellow JJ cord-313312-h607itv2 240 11 fever fever NN cord-313312-h607itv2 240 12 virus virus NN cord-313312-h607itv2 241 1 A a DT cord-313312-h607itv2 241 2 Decade decade NN cord-313312-h607itv2 241 3 of of IN cord-313312-h607itv2 241 4 Vaccines vaccine NNS cord-313312-h607itv2 241 5 : : : cord-313312-h607itv2 242 1 Integrating integrate VBG cord-313312-h607itv2 242 2 Immunology Immunology NNP cord-313312-h607itv2 242 3 and and CC cord-313312-h607itv2 242 4 Vaccinology Vaccinology NNP cord-313312-h607itv2 242 5 for for IN cord-313312-h607itv2 242 6 Rational Rational NNP cord-313312-h607itv2 242 7 Vaccine Vaccine NNP cord-313312-h607itv2 242 8 Design Design NNP cord-313312-h607itv2 242 9 Declaration Declaration NNP cord-313312-h607itv2 242 10 of of IN cord-313312-h607itv2 242 11 global global JJ cord-313312-h607itv2 242 12 eradication eradication NN cord-313312-h607itv2 242 13 of of IN cord-313312-h607itv2 242 14 smallpox smallpox NN cord-313312-h607itv2 242 15 State State NNP cord-313312-h607itv2 242 16 of of IN cord-313312-h607itv2 242 17 the the DT cord-313312-h607itv2 242 18 World World NNP cord-313312-h607itv2 242 19 's 's POS cord-313312-h607itv2 242 20 Vaccines Vaccines NNPS cord-313312-h607itv2 242 21 and and CC cord-313312-h607itv2 242 22 Immunization Immunization NNP cord-313312-h607itv2 242 23 , , , cord-313312-h607itv2 242 24 Geneva Geneva NNP cord-313312-h607itv2 242 25 ; ; : cord-313312-h607itv2 242 26 World World NNP cord-313312-h607itv2 242 27 Health Health NNP cord-313312-h607itv2 242 28 Organization Organization NNP cord-313312-h607itv2 242 29 Estimated estimate VBD cord-313312-h607itv2 242 30 economic economic JJ cord-313312-h607itv2 242 31 benefits benefit NNS cord-313312-h607itv2 242 32 during during IN cord-313312-h607itv2 242 33 the the DT cord-313312-h607itv2 242 34 ' ' '' cord-313312-h607itv2 242 35 decade decade NN cord-313312-h607itv2 242 36 of of IN cord-313312-h607itv2 242 37 vaccines vaccine NNS cord-313312-h607itv2 242 38 ' ' '' cord-313312-h607itv2 242 39 include include VBP cord-313312-h607itv2 242 40 treatment treatment NN cord-313312-h607itv2 242 41 savings saving NNS cord-313312-h607itv2 242 42 , , , cord-313312-h607itv2 242 43 gains gain NNS cord-313312-h607itv2 242 44 in in IN cord-313312-h607itv2 242 45 labor labor NN cord-313312-h607itv2 242 46 productivity productivity NN cord-313312-h607itv2 242 47 Anti Anti NNP cord-313312-h607itv2 242 48 - - NNP cord-313312-h607itv2 242 49 Vaccine Vaccine NNP cord-313312-h607itv2 242 50 Decision decision NN cord-313312-h607itv2 242 51 - - HYPH cord-313312-h607itv2 242 52 Making making NN cord-313312-h607itv2 242 53 and and CC cord-313312-h607itv2 242 54 Measles Measles NNP cord-313312-h607itv2 242 55 Resurgence Resurgence NNP cord-313312-h607itv2 242 56 in in IN cord-313312-h607itv2 242 57 the the DT cord-313312-h607itv2 242 58 United United NNP cord-313312-h607itv2 242 59 States States NNP cord-313312-h607itv2 243 1 Recent recent JJ cord-313312-h607itv2 243 2 advances advance NNS cord-313312-h607itv2 243 3 in in IN cord-313312-h607itv2 243 4 antigen antigen NN cord-313312-h607itv2 243 5 processing processing NN cord-313312-h607itv2 243 6 and and CC cord-313312-h607itv2 243 7 presentation presentation NN cord-313312-h607itv2 243 8 Live live VB cord-313312-h607itv2 243 9 attenuated attenuated JJ cord-313312-h607itv2 243 10 vaccines vaccine NNS cord-313312-h607itv2 243 11 : : : cord-313312-h607itv2 243 12 Influenza influenza NN cord-313312-h607itv2 243 13 , , , cord-313312-h607itv2 243 14 rotavirus rotavirus NN cord-313312-h607itv2 243 15 and and CC cord-313312-h607itv2 243 16 varicella varicella NN cord-313312-h607itv2 243 17 zoster zoster NN cord-313312-h607itv2 243 18 virus virus NN cord-313312-h607itv2 243 19 Novel Novel NNP cord-313312-h607itv2 243 20 viral viral JJ cord-313312-h607itv2 243 21 vectors vector NNS cord-313312-h607itv2 243 22 in in IN cord-313312-h607itv2 243 23 infectious infectious JJ cord-313312-h607itv2 243 24 diseases disease NNS cord-313312-h607itv2 244 1 Viral viral JJ cord-313312-h607itv2 244 2 vector vector NN cord-313312-h607itv2 244 3 - - HYPH cord-313312-h607itv2 244 4 based base VBN cord-313312-h607itv2 244 5 therapeutic therapeutic JJ cord-313312-h607itv2 244 6 cancer cancer NN cord-313312-h607itv2 244 7 vaccines vaccine NNS cord-313312-h607itv2 244 8 Safety Safety NNP cord-313312-h607itv2 244 9 and and CC cord-313312-h607itv2 244 10 Efficacy Efficacy NNP cord-313312-h607itv2 244 11 of of IN cord-313312-h607itv2 244 12 Chimeric Chimeric NNP cord-313312-h607itv2 244 13 Yellow Yellow NNP cord-313312-h607itv2 244 14 Fever Fever NNP cord-313312-h607itv2 244 15 - - HYPH cord-313312-h607itv2 244 16 Dengue Dengue NNP cord-313312-h607itv2 244 17 Virus Virus NNP cord-313312-h607itv2 244 18 Tetravalent Tetravalent NNP cord-313312-h607itv2 244 19 Vaccine Vaccine NNP cord-313312-h607itv2 244 20 Formulations Formulations NNPS cord-313312-h607itv2 244 21 in in IN cord-313312-h607itv2 244 22 Nonhuman Nonhuman NNP cord-313312-h607itv2 244 23 Primates Primates NNPS cord-313312-h607itv2 244 24 Efficacy Efficacy NNP cord-313312-h607itv2 244 25 and and CC cord-313312-h607itv2 244 26 long long JJ cord-313312-h607itv2 244 27 - - HYPH cord-313312-h607itv2 244 28 term term NN cord-313312-h607itv2 244 29 safety safety NN cord-313312-h607itv2 244 30 of of IN cord-313312-h607itv2 244 31 a a DT cord-313312-h607itv2 244 32 dengue dengue NN cord-313312-h607itv2 244 33 vaccine vaccine NN cord-313312-h607itv2 244 34 in in IN cord-313312-h607itv2 244 35 regions region NNS cord-313312-h607itv2 244 36 of of IN cord-313312-h607itv2 244 37 endemic endemic JJ cord-313312-h607itv2 244 38 disease disease NN cord-313312-h607itv2 244 39 A a DT cord-313312-h607itv2 244 40 framework framework NN cord-313312-h607itv2 244 41 for for IN cord-313312-h607itv2 244 42 Controlled Controlled NNP cord-313312-h607itv2 244 43 Human Human NNP cord-313312-h607itv2 244 44 Infection Infection NNP cord-313312-h607itv2 244 45 Model Model NNP cord-313312-h607itv2 244 46 ( ( -LRB- cord-313312-h607itv2 244 47 CHIM CHIM NNP cord-313312-h607itv2 244 48 ) ) -RRB- cord-313312-h607itv2 244 49 studies study NNS cord-313312-h607itv2 244 50 in in IN cord-313312-h607itv2 244 51 Malawi Malawi NNP cord-313312-h607itv2 244 52 : : : cord-313312-h607itv2 244 53 Report Report NNP cord-313312-h607itv2 244 54 of of IN cord-313312-h607itv2 244 55 a a DT cord-313312-h607itv2 244 56 Wellcome Wellcome NNP cord-313312-h607itv2 244 57 Trust Trust NNP cord-313312-h607itv2 244 58 workshop workshop NN cord-313312-h607itv2 244 59 on on IN cord-313312-h607itv2 244 60 CHIM CHIM NNP cord-313312-h607itv2 244 61 in in IN cord-313312-h607itv2 244 62 Low Low NNP cord-313312-h607itv2 244 63 Income Income NNP cord-313312-h607itv2 244 64 Countries Countries NNPS cord-313312-h607itv2 244 65 Effect Effect NNP cord-313312-h607itv2 244 66 of of IN cord-313312-h607itv2 244 67 a a DT cord-313312-h607itv2 244 68 prepregnancy prepregnancy NN cord-313312-h607itv2 244 69 pertussis pertussis NN cord-313312-h607itv2 244 70 booster booster NN cord-313312-h607itv2 244 71 dose dose NN cord-313312-h607itv2 244 72 on on IN cord-313312-h607itv2 244 73 maternal maternal JJ cord-313312-h607itv2 244 74 antibody antibody NN cord-313312-h607itv2 244 75 titers titer NNS cord-313312-h607itv2 244 76 in in IN cord-313312-h607itv2 244 77 young young JJ cord-313312-h607itv2 244 78 infants infant NNS cord-313312-h607itv2 245 1 Passive passive JJ cord-313312-h607itv2 245 2 transmission transmission NN cord-313312-h607itv2 245 3 and and CC cord-313312-h607itv2 245 4 persistence persistence NN cord-313312-h607itv2 245 5 of of IN cord-313312-h607itv2 245 6 naturally naturally RB cord-313312-h607itv2 245 7 acquired acquire VBN cord-313312-h607itv2 245 8 or or CC cord-313312-h607itv2 245 9 vaccine vaccine NN cord-313312-h607itv2 245 10 - - HYPH cord-313312-h607itv2 245 11 induced induce VBN cord-313312-h607itv2 245 12 maternal maternal JJ cord-313312-h607itv2 245 13 antibodies antibody NNS cord-313312-h607itv2 245 14 against against IN cord-313312-h607itv2 245 15 measles measle NNS cord-313312-h607itv2 245 16 in in IN cord-313312-h607itv2 245 17 newborns newborn NNS cord-313312-h607itv2 246 1 The the DT cord-313312-h607itv2 246 2 clinical clinical JJ cord-313312-h607itv2 246 3 significance significance NN cord-313312-h607itv2 246 4 of of IN cord-313312-h607itv2 246 5 measles measle NNS cord-313312-h607itv2 246 6 : : : cord-313312-h607itv2 246 7 A a DT cord-313312-h607itv2 246 8 review review NN cord-313312-h607itv2 246 9 Medical medical JJ cord-313312-h607itv2 246 10 importance importance NN cord-313312-h607itv2 246 11 of of IN cord-313312-h607itv2 246 12 measles measle NNS cord-313312-h607itv2 246 13 Observations observation NNS cord-313312-h607itv2 246 14 on on IN cord-313312-h607itv2 246 15 the the DT cord-313312-h607itv2 246 16 seroepidemiology seroepidemiology NN cord-313312-h607itv2 246 17 of of IN cord-313312-h607itv2 246 18 measles measle NNS cord-313312-h607itv2 246 19 Pathological pathological JJ cord-313312-h607itv2 246 20 consequences consequence NNS cord-313312-h607itv2 246 21 of of IN cord-313312-h607itv2 246 22 systemic systemic JJ cord-313312-h607itv2 246 23 measles measle NNS cord-313312-h607itv2 246 24 virus virus NN cord-313312-h607itv2 246 25 infection infection NN cord-313312-h607itv2 247 1 The the DT cord-313312-h607itv2 247 2 first first JJ cord-313312-h607itv2 247 3 measles measles NN cord-313312-h607itv2 247 4 vaccine vaccine NN cord-313312-h607itv2 247 5 Progress Progress NNP cord-313312-h607itv2 247 6 in in IN cord-313312-h607itv2 247 7 global global JJ cord-313312-h607itv2 247 8 measles measle NNS cord-313312-h607itv2 247 9 control control NN cord-313312-h607itv2 247 10 and and CC cord-313312-h607itv2 247 11 mortality mortality NN cord-313312-h607itv2 247 12 reduction reduction NN cord-313312-h607itv2 248 1 The the DT cord-313312-h607itv2 248 2 global global JJ cord-313312-h607itv2 248 3 burden burden NN cord-313312-h607itv2 248 4 of of IN cord-313312-h607itv2 248 5 measles measle NNS cord-313312-h607itv2 248 6 in in IN cord-313312-h607itv2 248 7 the the DT cord-313312-h607itv2 248 8 year year NN cord-313312-h607itv2 248 9 2000-A 2000-a CD cord-313312-h607itv2 248 10 model model NN cord-313312-h607itv2 248 11 that that WDT cord-313312-h607itv2 248 12 uses use VBZ cord-313312-h607itv2 248 13 country country NN cord-313312-h607itv2 248 14 - - HYPH cord-313312-h607itv2 248 15 specific specific JJ cord-313312-h607itv2 248 16 indicators indicator NNS cord-313312-h607itv2 248 17 Estimates estimate NNS cord-313312-h607itv2 248 18 of of IN cord-313312-h607itv2 248 19 case case NN cord-313312-h607itv2 248 20 - - HYPH cord-313312-h607itv2 248 21 fatality fatality NN cord-313312-h607itv2 248 22 ratios ratio NNS cord-313312-h607itv2 248 23 of of IN cord-313312-h607itv2 248 24 measles measle NNS cord-313312-h607itv2 248 25 in in IN cord-313312-h607itv2 248 26 low low JJ cord-313312-h607itv2 248 27 - - HYPH cord-313312-h607itv2 248 28 income income NN cord-313312-h607itv2 248 29 and and CC cord-313312-h607itv2 248 30 middle middle JJ cord-313312-h607itv2 248 31 - - HYPH cord-313312-h607itv2 248 32 income income NN cord-313312-h607itv2 248 33 countries country NNS cord-313312-h607itv2 248 34 : : : cord-313312-h607itv2 249 1 A a DT cord-313312-h607itv2 249 2 systematic systematic JJ cord-313312-h607itv2 249 3 review review NN cord-313312-h607itv2 249 4 and and CC cord-313312-h607itv2 249 5 modelling modelling NN cord-313312-h607itv2 249 6 analysis analysis NN cord-313312-h607itv2 249 7 Propagation propagation NN cord-313312-h607itv2 249 8 in in IN cord-313312-h607itv2 249 9 tissue tissue NN cord-313312-h607itv2 249 10 cultures culture NNS cord-313312-h607itv2 249 11 of of IN cord-313312-h607itv2 249 12 cytopathogenic cytopathogenic JJ cord-313312-h607itv2 249 13 agents agent NNS cord-313312-h607itv2 249 14 from from IN cord-313312-h607itv2 249 15 patients patient NNS cord-313312-h607itv2 249 16 with with IN cord-313312-h607itv2 249 17 measles measle NNS cord-313312-h607itv2 249 18 Measles Measles NNP cord-313312-h607itv2 249 19 vaccines vaccine NNS cord-313312-h607itv2 249 20 : : : cord-313312-h607itv2 250 1 WHO who WP cord-313312-h607itv2 250 2 position position VBP cord-313312-h607itv2 250 3 paper paper NN cord-313312-h607itv2 250 4 Comparative comparative JJ cord-313312-h607itv2 250 5 analysis analysis NN cord-313312-h607itv2 250 6 of of IN cord-313312-h607itv2 250 7 titers titer NNS cord-313312-h607itv2 250 8 of of IN cord-313312-h607itv2 250 9 antibody antibody NN cord-313312-h607itv2 250 10 against against IN cord-313312-h607itv2 250 11 measles measles NNP cord-313312-h607itv2 250 12 virus virus NN cord-313312-h607itv2 250 13 in in IN cord-313312-h607itv2 250 14 sera sera NNP cord-313312-h607itv2 250 15 of of IN cord-313312-h607itv2 250 16 vaccinated vaccinate VBN cord-313312-h607itv2 250 17 and and CC cord-313312-h607itv2 250 18 naturally naturally RB cord-313312-h607itv2 250 19 infected infect VBN cord-313312-h607itv2 250 20 Japanese japanese JJ cord-313312-h607itv2 250 21 individuals individual NNS cord-313312-h607itv2 250 22 of of IN cord-313312-h607itv2 250 23 different different JJ cord-313312-h607itv2 250 24 age age NN cord-313312-h607itv2 250 25 groups group NNS cord-313312-h607itv2 250 26 Persistence persistence NN cord-313312-h607itv2 250 27 of of IN cord-313312-h607itv2 250 28 vaccine vaccine NN cord-313312-h607itv2 250 29 - - HYPH cord-313312-h607itv2 250 30 induced induce VBN cord-313312-h607itv2 250 31 antibody antibody NN cord-313312-h607itv2 250 32 to to IN cord-313312-h607itv2 250 33 measles measle NNS cord-313312-h607itv2 250 34 26 26 CD cord-313312-h607itv2 250 35 - - SYM cord-313312-h607itv2 250 36 33 33 CD cord-313312-h607itv2 250 37 years year NNS cord-313312-h607itv2 250 38 after after IN cord-313312-h607itv2 250 39 vaccination vaccination NN cord-313312-h607itv2 250 40 Relevance relevance NN cord-313312-h607itv2 250 41 of of IN cord-313312-h607itv2 250 42 a a DT cord-313312-h607itv2 250 43 pre pre JJ cord-313312-h607itv2 250 44 - - JJ cord-313312-h607itv2 250 45 existing existing JJ cord-313312-h607itv2 250 46 measles measle NNS cord-313312-h607itv2 250 47 immunity immunity NN cord-313312-h607itv2 250 48 prior prior JJ cord-313312-h607itv2 250 49 immunization immunization NN cord-313312-h607itv2 250 50 with with IN cord-313312-h607itv2 250 51 a a DT cord-313312-h607itv2 250 52 recombinant recombinant JJ cord-313312-h607itv2 250 53 measles measles NN cord-313312-h607itv2 250 54 virus virus NN cord-313312-h607itv2 250 55 vector vector NN cord-313312-h607itv2 250 56 Elevation Elevation NNP cord-313312-h607itv2 250 57 of of IN cord-313312-h607itv2 250 58 cord cord NN cord-313312-h607itv2 250 59 over over IN cord-313312-h607itv2 250 60 maternal maternal JJ cord-313312-h607itv2 250 61 IgG igg NN cord-313312-h607itv2 250 62 immunoglobulin immunoglobulin NN cord-313312-h607itv2 250 63 : : : cord-313312-h607itv2 250 64 Evidence evidence NN cord-313312-h607itv2 250 65 for for IN cord-313312-h607itv2 250 66 an an DT cord-313312-h607itv2 250 67 active active JJ cord-313312-h607itv2 250 68 placental placental JJ cord-313312-h607itv2 250 69 IgG igg NN cord-313312-h607itv2 250 70 transport transport NN cord-313312-h607itv2 250 71 Measles Measles NNP cord-313312-h607itv2 250 72 immunization immunization NN cord-313312-h607itv2 250 73 . . . cord-313312-h607itv2 251 1 Successes success NNS cord-313312-h607itv2 251 2 and and CC cord-313312-h607itv2 251 3 failures failure NNS cord-313312-h607itv2 251 4 Persistence persistence NN cord-313312-h607itv2 251 5 of of IN cord-313312-h607itv2 251 6 maternal maternal JJ cord-313312-h607itv2 251 7 antibody antibody NN cord-313312-h607itv2 251 8 in in IN cord-313312-h607itv2 251 9 infants infant NNS cord-313312-h607itv2 251 10 beyond beyond IN cord-313312-h607itv2 251 11 12 12 CD cord-313312-h607itv2 251 12 months month NNS cord-313312-h607itv2 251 13 : : : cord-313312-h607itv2 251 14 Mechanism mechanism NN cord-313312-h607itv2 251 15 of of IN cord-313312-h607itv2 251 16 measles measle NNS cord-313312-h607itv2 251 17 vaccine vaccine NN cord-313312-h607itv2 251 18 failure failure NN cord-313312-h607itv2 251 19 Clinical clinical JJ cord-313312-h607itv2 251 20 efficacy efficacy NN cord-313312-h607itv2 251 21 of of IN cord-313312-h607itv2 251 22 measles measle NNS cord-313312-h607itv2 251 23 vaccine vaccine NN cord-313312-h607itv2 251 24 during during IN cord-313312-h607itv2 251 25 the the DT cord-313312-h607itv2 251 26 1990 1990 CD cord-313312-h607itv2 251 27 measles measle NNS cord-313312-h607itv2 251 28 epidemic epidemic NN cord-313312-h607itv2 251 29 Appropriate appropriate JJ cord-313312-h607itv2 251 30 age age NN cord-313312-h607itv2 251 31 for for IN cord-313312-h607itv2 251 32 measles measle NNS cord-313312-h607itv2 251 33 vaccination vaccination NN cord-313312-h607itv2 251 34 in in IN cord-313312-h607itv2 251 35 the the DT cord-313312-h607itv2 251 36 United United NNP cord-313312-h607itv2 251 37 States States NNP cord-313312-h607itv2 251 38 Measles Measles NNP cord-313312-h607itv2 251 39 vaccination vaccination NN cord-313312-h607itv2 251 40 in in IN cord-313312-h607itv2 251 41 the the DT cord-313312-h607itv2 251 42 presence presence NN cord-313312-h607itv2 251 43 or or CC cord-313312-h607itv2 251 44 absence absence NN cord-313312-h607itv2 251 45 of of IN cord-313312-h607itv2 251 46 maternal maternal JJ cord-313312-h607itv2 251 47 measles measles NN cord-313312-h607itv2 251 48 antibody antibody NN cord-313312-h607itv2 251 49 : : : cord-313312-h607itv2 251 50 Impact impact NN cord-313312-h607itv2 251 51 on on IN cord-313312-h607itv2 251 52 child child NN cord-313312-h607itv2 251 53 survival survival NN cord-313312-h607itv2 251 54 Protective protective JJ cord-313312-h607itv2 251 55 immunity immunity NN cord-313312-h607itv2 251 56 in in IN cord-313312-h607itv2 251 57 macaques macaque NNS cord-313312-h607itv2 251 58 vaccinated vaccinate VBN cord-313312-h607itv2 251 59 with with IN cord-313312-h607itv2 251 60 live live JJ cord-313312-h607itv2 251 61 attenuated attenuated JJ cord-313312-h607itv2 251 62 , , , cord-313312-h607itv2 251 63 recombinant recombinant JJ cord-313312-h607itv2 251 64 , , , cord-313312-h607itv2 251 65 and and CC cord-313312-h607itv2 251 66 subunit subunit NN cord-313312-h607itv2 251 67 measles measles NN cord-313312-h607itv2 251 68 vaccines vaccine NNS cord-313312-h607itv2 251 69 in in IN cord-313312-h607itv2 251 70 the the DT cord-313312-h607itv2 251 71 presence presence NN cord-313312-h607itv2 251 72 of of IN cord-313312-h607itv2 251 73 passively passively RB cord-313312-h607itv2 251 74 acquired acquire VBN cord-313312-h607itv2 251 75 antibodies antibody NNS cord-313312-h607itv2 251 76 Humoral Humoral NNP cord-313312-h607itv2 251 77 and and CC cord-313312-h607itv2 251 78 cell cell NN cord-313312-h607itv2 251 79 - - HYPH cord-313312-h607itv2 251 80 mediated mediate VBN cord-313312-h607itv2 251 81 immune immune JJ cord-313312-h607itv2 251 82 responses response NNS cord-313312-h607itv2 251 83 to to IN cord-313312-h607itv2 251 84 an an DT cord-313312-h607itv2 251 85 early early JJ cord-313312-h607itv2 251 86 2-dose 2-dose CD cord-313312-h607itv2 251 87 measles measle NNS cord-313312-h607itv2 251 88 vaccination vaccination NN cord-313312-h607itv2 251 89 regimen regimen NN cord-313312-h607itv2 251 90 in in IN cord-313312-h607itv2 251 91 the the DT cord-313312-h607itv2 251 92 United United NNP cord-313312-h607itv2 251 93 States States NNP cord-313312-h607itv2 251 94 Immune Immune NNP cord-313312-h607itv2 251 95 responses response NNS cord-313312-h607itv2 251 96 to to IN cord-313312-h607itv2 251 97 adenovirus adenovirus NN cord-313312-h607itv2 251 98 and and CC cord-313312-h607itv2 251 99 adeno adeno NN cord-313312-h607itv2 251 100 - - HYPH cord-313312-h607itv2 251 101 associated associate VBN cord-313312-h607itv2 251 102 virus virus NN cord-313312-h607itv2 251 103 in in IN cord-313312-h607itv2 251 104 humans human NNS cord-313312-h607itv2 251 105 International international JJ cord-313312-h607itv2 251 106 epidemiology epidemiology NN cord-313312-h607itv2 251 107 of of IN cord-313312-h607itv2 251 108 human human JJ cord-313312-h607itv2 251 109 pre pre JJ cord-313312-h607itv2 251 110 - - JJ cord-313312-h607itv2 251 111 existing existing JJ cord-313312-h607itv2 251 112 adenovirus adenovirus NN cord-313312-h607itv2 251 113 ( ( -LRB- cord-313312-h607itv2 251 114 Ad ad NN cord-313312-h607itv2 251 115 ) ) -RRB- cord-313312-h607itv2 251 116 type-5 type-5 NNP cord-313312-h607itv2 251 117 , , , cord-313312-h607itv2 251 118 type-6 type-6 NNP cord-313312-h607itv2 251 119 , , , cord-313312-h607itv2 251 120 type-26 type-26 CD cord-313312-h607itv2 251 121 and and CC cord-313312-h607itv2 251 122 type-36 type-36 IN cord-313312-h607itv2 251 123 neutralizing neutralize VBG cord-313312-h607itv2 251 124 antibodies antibody NNS cord-313312-h607itv2 251 125 : : : cord-313312-h607itv2 252 1 Correlates correlate NNS cord-313312-h607itv2 252 2 of of IN cord-313312-h607itv2 252 3 high high JJ cord-313312-h607itv2 252 4 Ad5 ad5 CD cord-313312-h607itv2 252 5 titers titer NNS cord-313312-h607itv2 252 6 and and CC cord-313312-h607itv2 252 7 implications implication NNS cord-313312-h607itv2 252 8 for for IN cord-313312-h607itv2 252 9 potential potential JJ cord-313312-h607itv2 252 10 HIV HIV NNP cord-313312-h607itv2 252 11 vaccine vaccine NN cord-313312-h607itv2 252 12 trials trial NNS cord-313312-h607itv2 252 13 Efficacy Efficacy NNP cord-313312-h607itv2 252 14 assessment assessment NN cord-313312-h607itv2 252 15 of of IN cord-313312-h607itv2 252 16 a a DT cord-313312-h607itv2 252 17 cell cell NN cord-313312-h607itv2 252 18 - - HYPH cord-313312-h607itv2 252 19 mediated mediate VBN cord-313312-h607itv2 252 20 immunity immunity NN cord-313312-h607itv2 252 21 HIV-1 HIV-1 NNP cord-313312-h607itv2 252 22 vaccine vaccine NN cord-313312-h607itv2 252 23 ( ( -LRB- cord-313312-h607itv2 252 24 the the DT cord-313312-h607itv2 252 25 Step Step NNP cord-313312-h607itv2 252 26 Study Study NNP cord-313312-h607itv2 252 27 ) ) -RRB- cord-313312-h607itv2 252 28 : : : cord-313312-h607itv2 252 29 A a DT cord-313312-h607itv2 252 30 double double JJ cord-313312-h607itv2 252 31 - - HYPH cord-313312-h607itv2 252 32 blind blind JJ cord-313312-h607itv2 252 33 , , , cord-313312-h607itv2 252 34 randomised randomised JJ cord-313312-h607itv2 252 35 , , , cord-313312-h607itv2 252 36 placebo placebo NN cord-313312-h607itv2 252 37 - - HYPH cord-313312-h607itv2 252 38 controlled control VBN cord-313312-h607itv2 252 39 , , , cord-313312-h607itv2 252 40 test test NN cord-313312-h607itv2 252 41 - - HYPH cord-313312-h607itv2 252 42 of of IN cord-313312-h607itv2 252 43 - - HYPH cord-313312-h607itv2 252 44 concept concept NN cord-313312-h607itv2 252 45 trial trial NN cord-313312-h607itv2 252 46 Overcoming overcome VBG cord-313312-h607itv2 252 47 immunity immunity NN cord-313312-h607itv2 252 48 to to IN cord-313312-h607itv2 252 49 a a DT cord-313312-h607itv2 252 50 viral viral JJ cord-313312-h607itv2 252 51 vaccine vaccine NN cord-313312-h607itv2 252 52 by by IN cord-313312-h607itv2 252 53 DNA dna NN cord-313312-h607itv2 252 54 priming priming NN cord-313312-h607itv2 252 55 before before IN cord-313312-h607itv2 252 56 vector vector NN cord-313312-h607itv2 252 57 boosting boost VBG cord-313312-h607itv2 252 58 Comparative comparative JJ cord-313312-h607itv2 252 59 immunogenicity immunogenicity NN cord-313312-h607itv2 252 60 in in IN cord-313312-h607itv2 252 61 rhesus rhesu NNS cord-313312-h607itv2 252 62 monkeys monkey NNS cord-313312-h607itv2 252 63 of of IN cord-313312-h607itv2 252 64 DNA dna NN cord-313312-h607itv2 252 65 plasmid plasmid NN cord-313312-h607itv2 252 66 , , , cord-313312-h607itv2 252 67 recombinant recombinant JJ cord-313312-h607itv2 252 68 vaccinia vaccinia NN cord-313312-h607itv2 252 69 virus virus NN cord-313312-h607itv2 252 70 , , , cord-313312-h607itv2 252 71 and and CC cord-313312-h607itv2 252 72 replication replication NN cord-313312-h607itv2 252 73 - - HYPH cord-313312-h607itv2 252 74 defective defective JJ cord-313312-h607itv2 252 75 adenovirus adenovirus NN cord-313312-h607itv2 252 76 vectors vector NNS cord-313312-h607itv2 252 77 expressing express VBG cord-313312-h607itv2 253 1 a a DT cord-313312-h607itv2 253 2 human human JJ cord-313312-h607itv2 253 3 immunodeficiency immunodeficiency NN cord-313312-h607itv2 253 4 virus virus NN cord-313312-h607itv2 253 5 type type NN cord-313312-h607itv2 253 6 1 1 CD cord-313312-h607itv2 253 7 gag gag NN cord-313312-h607itv2 253 8 gene gene NN cord-313312-h607itv2 253 9 A a DT cord-313312-h607itv2 253 10 human human JJ cord-313312-h607itv2 253 11 type type NN cord-313312-h607itv2 253 12 5 5 CD cord-313312-h607itv2 253 13 adenovirus adenovirus NN cord-313312-h607itv2 253 14 - - HYPH cord-313312-h607itv2 253 15 based base VBN cord-313312-h607itv2 253 16 tuberculosis tuberculosis NN cord-313312-h607itv2 253 17 vaccine vaccine NN cord-313312-h607itv2 253 18 induces induce VBZ cord-313312-h607itv2 253 19 robust robust JJ cord-313312-h607itv2 253 20 T T NNP cord-313312-h607itv2 253 21 cell cell NN cord-313312-h607itv2 253 22 responses response NNS cord-313312-h607itv2 253 23 in in IN cord-313312-h607itv2 253 24 humans human NNS cord-313312-h607itv2 253 25 despite despite IN cord-313312-h607itv2 253 26 preexisting preexist VBG cord-313312-h607itv2 253 27 anti anti JJ cord-313312-h607itv2 253 28 - - JJ cord-313312-h607itv2 253 29 adenovirus adenovirus JJ cord-313312-h607itv2 253 30 immunity immunity NN cord-313312-h607itv2 253 31 New new JJ cord-313312-h607itv2 253 32 recombinant recombinant JJ cord-313312-h607itv2 253 33 Ad5 ad5 CD cord-313312-h607itv2 253 34 vector vector NN cord-313312-h607itv2 253 35 overcomes overcome VBZ cord-313312-h607itv2 253 36 Ad5 Ad5 NNP cord-313312-h607itv2 253 37 immunity immunity NN cord-313312-h607itv2 253 38 allowing allow VBG cord-313312-h607itv2 253 39 for for IN cord-313312-h607itv2 253 40 multiple multiple JJ cord-313312-h607itv2 253 41 safe safe JJ cord-313312-h607itv2 253 42 , , , cord-313312-h607itv2 253 43 homologous homologous JJ cord-313312-h607itv2 253 44 immunizations immunization NNS cord-313312-h607itv2 253 45 Hexon Hexon NNP cord-313312-h607itv2 253 46 - - HYPH cord-313312-h607itv2 253 47 chimaeric chimaeric JJ cord-313312-h607itv2 253 48 adenovirus adenovirus NN cord-313312-h607itv2 253 49 serotype serotype NN cord-313312-h607itv2 253 50 5 5 CD cord-313312-h607itv2 253 51 vectors vector NNS cord-313312-h607itv2 253 52 circumvent circumvent VBP cord-313312-h607itv2 253 53 pre pre JJ cord-313312-h607itv2 253 54 - - JJ cord-313312-h607itv2 253 55 existing existing JJ cord-313312-h607itv2 253 56 anti anti JJ cord-313312-h607itv2 253 57 - - JJ cord-313312-h607itv2 253 58 vector vector JJ cord-313312-h607itv2 253 59 immunity immunity NN cord-313312-h607itv2 253 60 Extensive extensive JJ cord-313312-h607itv2 253 61 cross cross NN cord-313312-h607itv2 253 62 - - NN cord-313312-h607itv2 253 63 reactivity reactivity NN cord-313312-h607itv2 253 64 of of IN cord-313312-h607itv2 253 65 CD4 CD4 NNP cord-313312-h607itv2 253 66 + + CC cord-313312-h607itv2 253 67 adenovirus adenovirus NN cord-313312-h607itv2 253 68 - - HYPH cord-313312-h607itv2 253 69 specific specific JJ cord-313312-h607itv2 253 70 T t NN cord-313312-h607itv2 253 71 cells cell NNS cord-313312-h607itv2 253 72 : : : cord-313312-h607itv2 253 73 Implications implication NNS cord-313312-h607itv2 253 74 for for IN cord-313312-h607itv2 253 75 immunotherapy immunotherapy NN cord-313312-h607itv2 253 76 and and CC cord-313312-h607itv2 253 77 gene gene NN cord-313312-h607itv2 253 78 therapy therapy NN cord-313312-h607itv2 253 79 Immunogenicity Immunogenicity NNP cord-313312-h607itv2 253 80 of of IN cord-313312-h607itv2 253 81 recombinant recombinant JJ cord-313312-h607itv2 253 82 adenovirus adenovirus NN cord-313312-h607itv2 253 83 serotype serotype NN cord-313312-h607itv2 253 84 35 35 CD cord-313312-h607itv2 253 85 vaccine vaccine NN cord-313312-h607itv2 253 86 in in IN cord-313312-h607itv2 253 87 the the DT cord-313312-h607itv2 253 88 presence presence NN cord-313312-h607itv2 253 89 of of IN cord-313312-h607itv2 253 90 pre pre JJ cord-313312-h607itv2 253 91 - - JJ cord-313312-h607itv2 253 92 existing existing JJ cord-313312-h607itv2 253 93 anti anti JJ cord-313312-h607itv2 253 94 - - JJ cord-313312-h607itv2 253 95 Ad5 ad5 JJ cord-313312-h607itv2 253 96 immunity immunity NN cord-313312-h607itv2 253 97 Immunogenicity Immunogenicity NNP cord-313312-h607itv2 253 98 of of IN cord-313312-h607itv2 253 99 heterologous heterologous JJ cord-313312-h607itv2 253 100 prime prime JJ cord-313312-h607itv2 253 101 - - HYPH cord-313312-h607itv2 253 102 boost boost NN cord-313312-h607itv2 253 103 regimens regimen NNS cord-313312-h607itv2 253 104 involving involve VBG cord-313312-h607itv2 253 105 recombinant recombinant JJ cord-313312-h607itv2 253 106 adenovirus adenovirus NN cord-313312-h607itv2 253 107 serotype serotype NN cord-313312-h607itv2 253 108 11 11 CD cord-313312-h607itv2 253 109 ( ( -LRB- cord-313312-h607itv2 253 110 Ad11 Ad11 NNP cord-313312-h607itv2 253 111 ) ) -RRB- cord-313312-h607itv2 253 112 and and CC cord-313312-h607itv2 253 113 Ad35 Ad35 NNP cord-313312-h607itv2 254 1 vaccine vaccine NN cord-313312-h607itv2 254 2 vectors vector NNS cord-313312-h607itv2 254 3 in in IN cord-313312-h607itv2 254 4 the the DT cord-313312-h607itv2 254 5 presence presence NN cord-313312-h607itv2 254 6 of of IN cord-313312-h607itv2 254 7 anti anti JJ cord-313312-h607itv2 254 8 - - JJ cord-313312-h607itv2 254 9 ad5 ad5 JJ cord-313312-h607itv2 254 10 immunity immunity NN cord-313312-h607itv2 254 11 Estimates estimate NNS cord-313312-h607itv2 254 12 of of IN cord-313312-h607itv2 254 13 global global JJ cord-313312-h607itv2 254 14 seasonal seasonal JJ cord-313312-h607itv2 254 15 influenza influenza NN cord-313312-h607itv2 254 16 - - HYPH cord-313312-h607itv2 254 17 associated associate VBN cord-313312-h607itv2 254 18 respiratory respiratory JJ cord-313312-h607itv2 254 19 mortality mortality NN cord-313312-h607itv2 254 20 : : : cord-313312-h607itv2 254 21 A a DT cord-313312-h607itv2 254 22 modelling modelling NN cord-313312-h607itv2 254 23 study study NN cord-313312-h607itv2 254 24 Prevention Prevention NNP cord-313312-h607itv2 254 25 and and CC cord-313312-h607itv2 254 26 Control Control NNP cord-313312-h607itv2 254 27 of of IN cord-313312-h607itv2 254 28 Seasonal Seasonal NNP cord-313312-h607itv2 254 29 Influenza Influenza NNP cord-313312-h607itv2 254 30 with with IN cord-313312-h607itv2 254 31 Vaccines vaccine NNS cord-313312-h607itv2 254 32 : : : cord-313312-h607itv2 254 33 Recommendations recommendation NNS cord-313312-h607itv2 254 34 of of IN cord-313312-h607itv2 254 35 the the DT cord-313312-h607itv2 254 36 Advisory Advisory NNP cord-313312-h607itv2 254 37 Committee Committee NNP cord-313312-h607itv2 254 38 on on IN cord-313312-h607itv2 254 39 Immunization Immunization NNP cord-313312-h607itv2 254 40 Practices Practices NNPS cord-313312-h607itv2 254 41 -United -unite VBD cord-313312-h607itv2 254 42 States States NNP cord-313312-h607itv2 254 43 , , , cord-313312-h607itv2 254 44 2019 2019 CD cord-313312-h607itv2 254 45 - - SYM cord-313312-h607itv2 254 46 20 20 CD cord-313312-h607itv2 255 1 Influenza Influenza NNP cord-313312-h607itv2 255 2 Season Season NNP cord-313312-h607itv2 255 3 Influenza Influenza NNP cord-313312-h607itv2 255 4 vaccines vaccine NNS cord-313312-h607itv2 255 5 : : : cord-313312-h607itv2 255 6 Challenges challenge NNS cord-313312-h607itv2 255 7 and and CC cord-313312-h607itv2 255 8 solutions solution NNS cord-313312-h607itv2 256 1 The the DT cord-313312-h607itv2 256 2 role role NN cord-313312-h607itv2 256 3 of of IN cord-313312-h607itv2 256 4 nasal nasal NN cord-313312-h607itv2 256 5 IgA IgA NNP cord-313312-h607itv2 256 6 in in IN cord-313312-h607itv2 256 7 children child NNS cord-313312-h607itv2 256 8 vaccinated vaccinate VBN cord-313312-h607itv2 256 9 with with IN cord-313312-h607itv2 256 10 live live JJ cord-313312-h607itv2 256 11 attenuated attenuated JJ cord-313312-h607itv2 256 12 influenza influenza NN cord-313312-h607itv2 256 13 vaccine vaccine NN cord-313312-h607itv2 256 14 Correlation Correlation NNP cord-313312-h607itv2 256 15 of of IN cord-313312-h607itv2 256 16 Cellular Cellular NNP cord-313312-h607itv2 256 17 Immune Immune NNP cord-313312-h607itv2 256 18 Responses Responses NNPS cord-313312-h607itv2 256 19 with with IN cord-313312-h607itv2 256 20 Protection Protection NNP cord-313312-h607itv2 256 21 against against IN cord-313312-h607itv2 256 22 Culture Culture NNP cord-313312-h607itv2 256 23 - - HYPH cord-313312-h607itv2 256 24 Confirmed confirm VBN cord-313312-h607itv2 256 25 Influenza Influenza NNP cord-313312-h607itv2 256 26 Virus Virus NNP cord-313312-h607itv2 256 27 in in IN cord-313312-h607itv2 256 28 Young Young NNP cord-313312-h607itv2 256 29 Children child NNS cord-313312-h607itv2 257 1 The the DT cord-313312-h607itv2 257 2 efficacy efficacy NN cord-313312-h607itv2 257 3 of of IN cord-313312-h607itv2 257 4 intranasal intranasal NN cord-313312-h607itv2 257 5 live live NN cord-313312-h607itv2 257 6 attenuated attenuated JJ cord-313312-h607itv2 257 7 influenza influenza NN cord-313312-h607itv2 257 8 vaccine vaccine NN cord-313312-h607itv2 257 9 in in IN cord-313312-h607itv2 257 10 children child NNS cord-313312-h607itv2 257 11 2 2 CD cord-313312-h607itv2 257 12 through through IN cord-313312-h607itv2 257 13 17 17 CD cord-313312-h607itv2 257 14 years year NNS cord-313312-h607itv2 257 15 of of IN cord-313312-h607itv2 257 16 age age NN cord-313312-h607itv2 257 17 : : : cord-313312-h607itv2 258 1 A a DT cord-313312-h607itv2 258 2 meta meta JJ cord-313312-h607itv2 258 3 - - HYPH cord-313312-h607itv2 258 4 analysis analysis NN cord-313312-h607itv2 258 5 of of IN cord-313312-h607itv2 258 6 8 8 CD cord-313312-h607itv2 258 7 randomized randomized JJ cord-313312-h607itv2 258 8 controlled control VBN cord-313312-h607itv2 258 9 studies study NNS cord-313312-h607itv2 259 1 The the DT cord-313312-h607itv2 259 2 Effect effect NN cord-313312-h607itv2 259 3 of of IN cord-313312-h607itv2 259 4 Preexisting Preexisting NNP cord-313312-h607itv2 259 5 Immunity Immunity NNP cord-313312-h607itv2 259 6 on on IN cord-313312-h607itv2 259 7 Virus Virus NNP cord-313312-h607itv2 259 8 Detection Detection NNP cord-313312-h607itv2 259 9 and and CC cord-313312-h607itv2 259 10 Immune Immune NNP cord-313312-h607itv2 259 11 Responses response NNS cord-313312-h607itv2 259 12 in in IN cord-313312-h607itv2 259 13 a a DT cord-313312-h607itv2 259 14 Phase Phase NNP cord-313312-h607itv2 259 15 II II NNP cord-313312-h607itv2 259 16 , , , cord-313312-h607itv2 259 17 Randomized Randomized NNP cord-313312-h607itv2 259 18 Trial Trial NNP cord-313312-h607itv2 259 19 of of IN cord-313312-h607itv2 259 20 a a DT cord-313312-h607itv2 259 21 Russian Russian NNP cord-313312-h607itv2 259 22 - - HYPH cord-313312-h607itv2 259 23 Backbone backbone NN cord-313312-h607itv2 259 24 , , , cord-313312-h607itv2 259 25 Live live JJ cord-313312-h607itv2 259 26 , , , cord-313312-h607itv2 259 27 Attenuated Attenuated NNP cord-313312-h607itv2 259 28 Influenza Influenza NNP cord-313312-h607itv2 259 29 Vaccine Vaccine NNP cord-313312-h607itv2 259 30 in in IN cord-313312-h607itv2 259 31 Bangladeshi bangladeshi JJ cord-313312-h607itv2 259 32 Children Children NNP cord-313312-h607itv2 259 33 Longevity Longevity NNP cord-313312-h607itv2 259 34 of of IN cord-313312-h607itv2 259 35 B b NN cord-313312-h607itv2 259 36 - - HYPH cord-313312-h607itv2 259 37 cell cell NN cord-313312-h607itv2 259 38 and and CC cord-313312-h607itv2 259 39 T t NN cord-313312-h607itv2 259 40 - - HYPH cord-313312-h607itv2 259 41 cell cell NN cord-313312-h607itv2 259 42 responses response NNS cord-313312-h607itv2 259 43 after after IN cord-313312-h607itv2 259 44 live live JJ cord-313312-h607itv2 259 45 attenuated attenuated JJ cord-313312-h607itv2 259 46 influenza influenza NN cord-313312-h607itv2 259 47 vaccination vaccination NN cord-313312-h607itv2 259 48 in in IN cord-313312-h607itv2 259 49 children child NNS cord-313312-h607itv2 259 50 Boosting boost VBG cord-313312-h607itv2 259 51 of of IN cord-313312-h607itv2 259 52 Cross Cross NNP cord-313312-h607itv2 259 53 - - HYPH cord-313312-h607itv2 259 54 Reactive Reactive NNP cord-313312-h607itv2 259 55 and and CC cord-313312-h607itv2 259 56 Protection Protection NNP cord-313312-h607itv2 259 57 - - HYPH cord-313312-h607itv2 259 58 Associated Associated NNP cord-313312-h607itv2 259 59 T T NNP cord-313312-h607itv2 259 60 Cells cell NNS cord-313312-h607itv2 259 61 in in IN cord-313312-h607itv2 259 62 Children child NNS cord-313312-h607itv2 260 1 After after IN cord-313312-h607itv2 260 2 Live live JJ cord-313312-h607itv2 260 3 Attenuated Attenuated NNP cord-313312-h607itv2 260 4 Influenza Influenza NNP cord-313312-h607itv2 260 5 Vaccination Vaccination NNP cord-313312-h607itv2 260 6 Evaluation Evaluation NNP cord-313312-h607itv2 260 7 of of IN cord-313312-h607itv2 260 8 bivalent bivalent NN cord-313312-h607itv2 261 1 live live VB cord-313312-h607itv2 261 2 attenuated attenuated JJ cord-313312-h607itv2 261 3 influenza influenza NN cord-313312-h607itv2 261 4 A a DT cord-313312-h607itv2 261 5 vaccines vaccine NNS cord-313312-h607itv2 261 6 in in IN cord-313312-h607itv2 261 7 children child NNS cord-313312-h607itv2 261 8 2 2 CD cord-313312-h607itv2 261 9 months month NNS cord-313312-h607itv2 261 10 to to IN cord-313312-h607itv2 261 11 3 3 CD cord-313312-h607itv2 261 12 years year NNS cord-313312-h607itv2 261 13 of of IN cord-313312-h607itv2 261 14 age age NN cord-313312-h607itv2 261 15 : : : cord-313312-h607itv2 261 16 Safety safety NN cord-313312-h607itv2 261 17 , , , cord-313312-h607itv2 261 18 immunogenicity immunogenicity NN cord-313312-h607itv2 261 19 and and CC cord-313312-h607itv2 261 20 dose dose NN cord-313312-h607itv2 261 21 - - HYPH cord-313312-h607itv2 261 22 response response NN cord-313312-h607itv2 261 23 Negative negative JJ cord-313312-h607itv2 261 24 impact impact NN cord-313312-h607itv2 261 25 of of IN cord-313312-h607itv2 261 26 prior prior JJ cord-313312-h607itv2 261 27 influenza influenza NN cord-313312-h607itv2 261 28 vaccination vaccination NN cord-313312-h607itv2 261 29 on on IN cord-313312-h607itv2 261 30 current current JJ cord-313312-h607itv2 261 31 influenza influenza NN cord-313312-h607itv2 261 32 vaccination vaccination NN cord-313312-h607itv2 261 33 among among IN cord-313312-h607itv2 261 34 people people NNS cord-313312-h607itv2 261 35 infected infect VBN cord-313312-h607itv2 261 36 and and CC cord-313312-h607itv2 261 37 not not RB cord-313312-h607itv2 261 38 infected infect VBN cord-313312-h607itv2 261 39 in in IN cord-313312-h607itv2 261 40 prior prior JJ cord-313312-h607itv2 261 41 season season NN cord-313312-h607itv2 261 42 : : : cord-313312-h607itv2 262 1 A a DT cord-313312-h607itv2 262 2 test test NN cord-313312-h607itv2 262 3 - - HYPH cord-313312-h607itv2 262 4 negative negative JJ cord-313312-h607itv2 262 5 case case NN cord-313312-h607itv2 262 6 - - HYPH cord-313312-h607itv2 262 7 control control NN cord-313312-h607itv2 262 8 study study NN cord-313312-h607itv2 262 9 in in IN cord-313312-h607itv2 262 10 Japan Japan NNP cord-313312-h607itv2 262 11 Influence Influence NNP cord-313312-h607itv2 262 12 of of IN cord-313312-h607itv2 262 13 prior prior JJ cord-313312-h607itv2 262 14 influenza influenza NN cord-313312-h607itv2 262 15 vaccination vaccination NN cord-313312-h607itv2 262 16 on on IN cord-313312-h607itv2 262 17 antibody antibody NN cord-313312-h607itv2 262 18 and and CC cord-313312-h607itv2 262 19 B b NN cord-313312-h607itv2 262 20 - - HYPH cord-313312-h607itv2 262 21 cell cell NN cord-313312-h607itv2 262 22 responses response NNS cord-313312-h607itv2 262 23 Development Development NNP cord-313312-h607itv2 262 24 of of IN cord-313312-h607itv2 262 25 live live JJ cord-313312-h607itv2 262 26 attenuated attenuated JJ cord-313312-h607itv2 262 27 influenza influenza NN cord-313312-h607itv2 262 28 vaccines vaccine NNS cord-313312-h607itv2 262 29 against against IN cord-313312-h607itv2 262 30 pandemic pandemic NN cord-313312-h607itv2 262 31 influenza influenza NN cord-313312-h607itv2 262 32 strains strain NNS cord-313312-h607itv2 263 1 An an DT cord-313312-h607itv2 263 2 integrated integrated JJ cord-313312-h607itv2 263 3 multi multi JJ cord-313312-h607itv2 263 4 - - JJ cord-313312-h607itv2 263 5 study study JJ cord-313312-h607itv2 263 6 analysis analysis NN cord-313312-h607itv2 263 7 of of IN cord-313312-h607itv2 263 8 serum serum NN cord-313312-h607itv2 263 9 HAI HAI NNP cord-313312-h607itv2 263 10 antibody antibody NN cord-313312-h607itv2 263 11 responses response NNS cord-313312-h607itv2 263 12 to to IN cord-313312-h607itv2 263 13 Ann Ann NNP cord-313312-h607itv2 263 14 Arbor Arbor NNP cord-313312-h607itv2 263 15 strain strain VB cord-313312-h607itv2 263 16 live live RB cord-313312-h607itv2 263 17 attenuated attenuated JJ cord-313312-h607itv2 263 18 influenza influenza NN cord-313312-h607itv2 263 19 vaccine vaccine NN cord-313312-h607itv2 263 20 in in IN cord-313312-h607itv2 263 21 children child NNS cord-313312-h607itv2 263 22 and and CC cord-313312-h607itv2 263 23 adults adult NNS cord-313312-h607itv2 264 1 A a DT cord-313312-h607itv2 264 2 structural structural JJ cord-313312-h607itv2 264 3 perspective perspective NN cord-313312-h607itv2 264 4 of of IN cord-313312-h607itv2 264 5 the the DT cord-313312-h607itv2 264 6 flavivirus flavivirus NNP cord-313312-h607itv2 264 7 life life NN cord-313312-h607itv2 264 8 cycle cycle NN cord-313312-h607itv2 264 9 Zika Zika NNP cord-313312-h607itv2 264 10 Virus Virus NNP cord-313312-h607itv2 264 11 Infection infection NN cord-313312-h607itv2 264 12 - - : cord-313312-h607itv2 264 13 After after IN cord-313312-h607itv2 264 14 the the DT cord-313312-h607itv2 264 15 Pandemic Pandemic NNP cord-313312-h607itv2 264 16 The the DT cord-313312-h607itv2 264 17 global global JJ cord-313312-h607itv2 264 18 distribution distribution NN cord-313312-h607itv2 264 19 and and CC cord-313312-h607itv2 264 20 burden burden NN cord-313312-h607itv2 264 21 of of IN cord-313312-h607itv2 264 22 dengue dengue NN cord-313312-h607itv2 264 23 Antigenic antigenic JJ cord-313312-h607itv2 264 24 relationships relationship NNS cord-313312-h607itv2 264 25 between between IN cord-313312-h607itv2 264 26 flaviviruses flavivirus NNS cord-313312-h607itv2 264 27 as as IN cord-313312-h607itv2 264 28 determined determine VBN cord-313312-h607itv2 264 29 by by IN cord-313312-h607itv2 264 30 cross cross NN cord-313312-h607itv2 264 31 - - JJ cord-313312-h607itv2 264 32 neutralization neutralization JJ cord-313312-h607itv2 264 33 tests test NNS cord-313312-h607itv2 264 34 with with IN cord-313312-h607itv2 264 35 polyclonal polyclonal JJ cord-313312-h607itv2 264 36 antisera antisera NNP cord-313312-h607itv2 264 37 Cross Cross NNP cord-313312-h607itv2 264 38 - - HYPH cord-313312-h607itv2 264 39 Reactive reactive JJ cord-313312-h607itv2 264 40 Immunity immunity NN cord-313312-h607itv2 264 41 Among among IN cord-313312-h607itv2 264 42 Flaviviruses Flaviviruses NNP cord-313312-h607itv2 264 43 . . . cord-313312-h607itv2 265 1 Front front NN cord-313312-h607itv2 265 2 . . . cord-313312-h607itv2 266 1 Immunol Immunol NNP cord-313312-h607itv2 266 2 . . . cord-313312-h607itv2 267 1 2020 2020 CD cord-313312-h607itv2 267 2 , , , cord-313312-h607itv2 267 3 11 11 CD cord-313312-h607itv2 267 4 Review Review NNP cord-313312-h607itv2 267 5 article article NN cord-313312-h607itv2 267 6 : : : cord-313312-h607itv2 268 1 Research research NN cord-313312-h607itv2 268 2 on on IN cord-313312-h607itv2 268 3 dengue dengue NN cord-313312-h607itv2 268 4 during during IN cord-313312-h607itv2 268 5 World World NNP cord-313312-h607itv2 268 6 War War NNP cord-313312-h607itv2 268 7 II II NNP cord-313312-h607itv2 268 8 revisited revisit VBD cord-313312-h607itv2 268 9 Research Research NNP cord-313312-h607itv2 268 10 on on IN cord-313312-h607itv2 268 11 dengue dengue NN cord-313312-h607itv2 268 12 during during IN cord-313312-h607itv2 268 13 World World NNP cord-313312-h607itv2 268 14 War War NNP cord-313312-h607itv2 268 15 II II NNP cord-313312-h607itv2 268 16 Epidemiologic Epidemiologic NNP cord-313312-h607itv2 268 17 Studies Studies NNPS cord-313312-h607itv2 268 18 on on IN cord-313312-h607itv2 268 19 Dengue Dengue NNP cord-313312-h607itv2 268 20 in in IN cord-313312-h607itv2 268 21 Santiago Santiago NNP cord-313312-h607itv2 268 22 de de NNP cord-313312-h607itv2 268 23 Cuba Cuba NNP cord-313312-h607itv2 268 24 Antibody Antibody NNP cord-313312-h607itv2 268 25 - - HYPH cord-313312-h607itv2 268 26 dependent dependent JJ cord-313312-h607itv2 268 27 enhancement enhancement NN cord-313312-h607itv2 268 28 of of IN cord-313312-h607itv2 268 29 severe severe JJ cord-313312-h607itv2 268 30 dengue dengue NN cord-313312-h607itv2 268 31 disease disease NN cord-313312-h607itv2 268 32 in in IN cord-313312-h607itv2 268 33 humans human NNS cord-313312-h607itv2 268 34 Reconstruction Reconstruction NNP cord-313312-h607itv2 268 35 of of IN cord-313312-h607itv2 268 36 antibody antibody NN cord-313312-h607itv2 268 37 dynamics dynamic NNS cord-313312-h607itv2 268 38 and and CC cord-313312-h607itv2 268 39 infection infection NN cord-313312-h607itv2 268 40 histories history NNS cord-313312-h607itv2 268 41 to to TO cord-313312-h607itv2 268 42 evaluate evaluate VB cord-313312-h607itv2 268 43 dengue dengue NN cord-313312-h607itv2 269 1 risk risk NN cord-313312-h607itv2 269 2 Evidence evidence NN cord-313312-h607itv2 269 3 that that IN cord-313312-h607itv2 269 4 maternal maternal JJ cord-313312-h607itv2 269 5 dengue dengue NN cord-313312-h607itv2 269 6 antibodies antibody NNS cord-313312-h607itv2 269 7 are be VBP cord-313312-h607itv2 269 8 important important JJ cord-313312-h607itv2 269 9 in in IN cord-313312-h607itv2 269 10 the the DT cord-313312-h607itv2 269 11 development development NN cord-313312-h607itv2 269 12 of of IN cord-313312-h607itv2 269 13 dengue dengue NN cord-313312-h607itv2 269 14 hemorrhagic hemorrhagic JJ cord-313312-h607itv2 269 15 fever fever NN cord-313312-h607itv2 269 16 in in IN cord-313312-h607itv2 269 17 infants infant NNS cord-313312-h607itv2 269 18 Efficacy Efficacy NNP cord-313312-h607itv2 269 19 of of IN cord-313312-h607itv2 269 20 a a DT cord-313312-h607itv2 269 21 tetravalent tetravalent NN cord-313312-h607itv2 269 22 dengue dengue NN cord-313312-h607itv2 269 23 vaccine vaccine NN cord-313312-h607itv2 269 24 in in IN cord-313312-h607itv2 269 25 children child NNS cord-313312-h607itv2 269 26 in in IN cord-313312-h607itv2 269 27 Latin Latin NNP cord-313312-h607itv2 269 28 America America NNP cord-313312-h607itv2 269 29 Efficacy Efficacy NNP cord-313312-h607itv2 269 30 of of IN cord-313312-h607itv2 269 31 a a DT cord-313312-h607itv2 269 32 Tetravalent Tetravalent NNP cord-313312-h607itv2 269 33 Dengue Dengue NNP cord-313312-h607itv2 269 34 Vaccine Vaccine NNP cord-313312-h607itv2 269 35 in in IN cord-313312-h607itv2 269 36 Healthy Healthy NNP cord-313312-h607itv2 269 37 Children Children NNPS cord-313312-h607itv2 269 38 and and CC cord-313312-h607itv2 269 39 Adolescents Adolescents NNPS cord-313312-h607itv2 270 1 Flavivirus Flavivirus NNP cord-313312-h607itv2 270 2 serocomplex serocomplex NNP cord-313312-h607itv2 270 3 cross cross JJ cord-313312-h607itv2 270 4 - - JJ cord-313312-h607itv2 270 5 reactive reactive JJ cord-313312-h607itv2 270 6 immunity immunity NN cord-313312-h607itv2 270 7 is be VBZ cord-313312-h607itv2 270 8 protective protective JJ cord-313312-h607itv2 270 9 by by IN cord-313312-h607itv2 270 10 activating activate VBG cord-313312-h607itv2 270 11 heterologous heterologous JJ cord-313312-h607itv2 270 12 memory memory NN cord-313312-h607itv2 270 13 CD4 CD4 NNP cord-313312-h607itv2 270 14 T T NNP cord-313312-h607itv2 270 15 cells cell NNS cord-313312-h607itv2 270 16 Pre pre JJ cord-313312-h607itv2 270 17 - - JJ cord-313312-h607itv2 270 18 existing exist VBG cord-313312-h607itv2 270 19 yellow yellow JJ cord-313312-h607itv2 270 20 fever fever NN cord-313312-h607itv2 270 21 immunity immunity NN cord-313312-h607itv2 270 22 impairs impair VBZ cord-313312-h607itv2 270 23 and and CC cord-313312-h607itv2 270 24 modulates modulate VBZ cord-313312-h607itv2 270 25 the the DT cord-313312-h607itv2 270 26 antibody antibody NN cord-313312-h607itv2 270 27 response response NN cord-313312-h607itv2 270 28 to to TO cord-313312-h607itv2 270 29 tick tick VB cord-313312-h607itv2 270 30 - - HYPH cord-313312-h607itv2 270 31 borne bear VBN cord-313312-h607itv2 270 32 encephalitis encephalitis JJ cord-313312-h607itv2 270 33 vaccination vaccination NN cord-313312-h607itv2 270 34 Cross Cross NNP cord-313312-h607itv2 270 35 - - JJ cord-313312-h607itv2 270 36 reactive reactive JJ cord-313312-h607itv2 270 37 antibodies antibody NNS cord-313312-h607itv2 270 38 enhance enhance VBP cord-313312-h607itv2 270 39 live live JJ cord-313312-h607itv2 270 40 attenuated attenuated JJ cord-313312-h607itv2 270 41 virus virus NN cord-313312-h607itv2 270 42 infection infection NN cord-313312-h607itv2 270 43 for for IN cord-313312-h607itv2 270 44 increased increase VBN cord-313312-h607itv2 270 45 immunogenicity immunogenicity NN cord-313312-h607itv2 270 46 IgG IgG NNP cord-313312-h607itv2 270 47 Fc Fc NNP cord-313312-h607itv2 270 48 Receptors Receptors NNP cord-313312-h607itv2 270 49 Physical Physical NNP cord-313312-h607itv2 270 50 and and CC cord-313312-h607itv2 270 51 functional functional JJ cord-313312-h607itv2 270 52 association association NN cord-313312-h607itv2 270 53 of of IN cord-313312-h607itv2 270 54 Src Src NNP cord-313312-h607itv2 270 55 - - HYPH cord-313312-h607itv2 270 56 related relate VBN cord-313312-h607itv2 270 57 protein protein NN cord-313312-h607itv2 270 58 tyrosine tyrosine NN cord-313312-h607itv2 270 59 kinases kinase NNS cord-313312-h607itv2 270 60 with with IN cord-313312-h607itv2 270 61 Fc Fc NNP cord-313312-h607itv2 270 62 gamma gamma NN cord-313312-h607itv2 270 63 RII RII NNP cord-313312-h607itv2 270 64 in in IN cord-313312-h607itv2 270 65 monocytic monocytic NNP cord-313312-h607itv2 270 66 THP-1 THP-1 NNP cord-313312-h607itv2 270 67 cells cell NNS cord-313312-h607itv2 271 1 A a DT cord-313312-h607itv2 271 2 critical critical JJ cord-313312-h607itv2 271 3 role role NN cord-313312-h607itv2 271 4 for for IN cord-313312-h607itv2 271 5 Syk Syk NNP cord-313312-h607itv2 271 6 in in IN cord-313312-h607itv2 271 7 signal signal NN cord-313312-h607itv2 271 8 transduction transduction NN cord-313312-h607itv2 271 9 and and CC cord-313312-h607itv2 271 10 phagocytosis phagocytosis NN cord-313312-h607itv2 271 11 mediated mediate VBN cord-313312-h607itv2 271 12 by by IN cord-313312-h607itv2 271 13 Fcgamma Fcgamma NNP cord-313312-h607itv2 271 14 receptors receptor NNS cord-313312-h607itv2 271 15 on on IN cord-313312-h607itv2 271 16 macrophages macrophage NNS cord-313312-h607itv2 271 17 FcγRIIb FcγRIIb NNP cord-313312-h607itv2 271 18 controls control VBZ cord-313312-h607itv2 271 19 bone bone NN cord-313312-h607itv2 271 20 marrow marrow NN cord-313312-h607itv2 271 21 plasma plasma NN cord-313312-h607itv2 271 22 cell cell NN cord-313312-h607itv2 271 23 persistence persistence NN cord-313312-h607itv2 271 24 and and CC cord-313312-h607itv2 271 25 apoptosis apoptosis NN cord-313312-h607itv2 271 26 Selective selective JJ cord-313312-h607itv2 271 27 dysregulation dysregulation NN cord-313312-h607itv2 271 28 of of IN cord-313312-h607itv2 271 29 the the DT cord-313312-h607itv2 271 30 FcγIIB FcγIIB NNP cord-313312-h607itv2 271 31 receptor receptor NN cord-313312-h607itv2 271 32 on on IN cord-313312-h607itv2 271 33 memory memory NN cord-313312-h607itv2 271 34 B b NN cord-313312-h607itv2 271 35 cells cell NNS cord-313312-h607itv2 271 36 in in IN cord-313312-h607itv2 271 37 SLE SLE NNP cord-313312-h607itv2 271 38 FcγRIIB fcγriib NN cord-313312-h607itv2 271 39 in in IN cord-313312-h607itv2 271 40 autoimmunity autoimmunity NN cord-313312-h607itv2 271 41 and and CC cord-313312-h607itv2 271 42 infection infection NN cord-313312-h607itv2 271 43 : : : cord-313312-h607itv2 272 1 Evolutionary evolutionary JJ cord-313312-h607itv2 272 2 and and CC cord-313312-h607itv2 272 3 therapeutic therapeutic JJ cord-313312-h607itv2 272 4 implications implication NNS cord-313312-h607itv2 272 5 Dissection dissection NN cord-313312-h607itv2 272 6 of of IN cord-313312-h607itv2 272 7 the the DT cord-313312-h607itv2 272 8 signalling signal VBG cord-313312-h607itv2 272 9 mechanisms mechanism NNS cord-313312-h607itv2 273 1 underlying underlie VBG cord-313312-h607itv2 273 2 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 273 3 - - HYPH cord-313312-h607itv2 273 4 mediated mediate VBN cord-313312-h607itv2 273 5 apoptosis apoptosis NN cord-313312-h607itv2 273 6 of of IN cord-313312-h607itv2 273 7 mature mature JJ cord-313312-h607itv2 273 8 B b NN cord-313312-h607itv2 273 9 - - HYPH cord-313312-h607itv2 273 10 cells cell NNS cord-313312-h607itv2 274 1 The the DT cord-313312-h607itv2 274 2 B b NN cord-313312-h607itv2 274 3 cell cell NN cord-313312-h607itv2 274 4 inhibitory inhibitory JJ cord-313312-h607itv2 274 5 Fc Fc NNP cord-313312-h607itv2 274 6 receptor receptor NN cord-313312-h607itv2 274 7 triggers trigger VBZ cord-313312-h607itv2 274 8 apoptosis apoptosis NN cord-313312-h607itv2 274 9 by by IN cord-313312-h607itv2 274 10 a a DT cord-313312-h607itv2 274 11 novel novel NN cord-313312-h607itv2 274 12 c c NN cord-313312-h607itv2 274 13 - - : cord-313312-h607itv2 274 14 Abl Abl NNP cord-313312-h607itv2 274 15 family family NN cord-313312-h607itv2 274 16 kinase kinase NN cord-313312-h607itv2 274 17 - - HYPH cord-313312-h607itv2 274 18 dependent dependent JJ cord-313312-h607itv2 274 19 pathway pathway NN cord-313312-h607itv2 274 20 Impaired impair VBD cord-313312-h607itv2 274 21 inhibitory inhibitory JJ cord-313312-h607itv2 274 22 Fcγ Fcγ NNP cord-313312-h607itv2 274 23 receptor receptor NN cord-313312-h607itv2 274 24 IIB IIB NNP cord-313312-h607itv2 274 25 expression expression NN cord-313312-h607itv2 274 26 on on IN cord-313312-h607itv2 274 27 B b NN cord-313312-h607itv2 274 28 cells cell NNS cord-313312-h607itv2 274 29 in in IN cord-313312-h607itv2 274 30 chronic chronic JJ cord-313312-h607itv2 274 31 inflammatory inflammatory JJ cord-313312-h607itv2 274 32 demyelinating demyelinating NN cord-313312-h607itv2 274 33 polyneuropathy polyneuropathy NNS cord-313312-h607itv2 275 1 FcγRIIB FcγRIIB NNP cord-313312-h607itv2 275 2 mediates mediate VBZ cord-313312-h607itv2 275 3 antigen antigen NN cord-313312-h607itv2 275 4 - - HYPH cord-313312-h607itv2 275 5 independent independent JJ cord-313312-h607itv2 275 6 inhibition inhibition NN cord-313312-h607itv2 275 7 on on IN cord-313312-h607itv2 275 8 human human JJ cord-313312-h607itv2 275 9 B b NN cord-313312-h607itv2 275 10 lymphocytes lymphocyte NNS cord-313312-h607itv2 275 11 through through IN cord-313312-h607itv2 275 12 Btk Btk NNP cord-313312-h607itv2 275 13 and and CC cord-313312-h607itv2 275 14 p38 p38 NN cord-313312-h607itv2 275 15 MAPK MAPK NNP cord-313312-h607itv2 275 16 Molecular Molecular NNP cord-313312-h607itv2 275 17 mechanisms mechanism NNS cord-313312-h607itv2 275 18 of of IN cord-313312-h607itv2 275 19 antibody antibody NN cord-313312-h607itv2 275 20 - - HYPH cord-313312-h607itv2 275 21 mediated mediate VBN cord-313312-h607itv2 275 22 neutralisation neutralisation NN cord-313312-h607itv2 275 23 of of IN cord-313312-h607itv2 275 24 flavivirus flavivirus JJ cord-313312-h607itv2 275 25 infection infection NN cord-313312-h607itv2 276 1 The the DT cord-313312-h607itv2 276 2 stoichiometry stoichiometry NN cord-313312-h607itv2 276 3 of of IN cord-313312-h607itv2 276 4 antibody antibody NN cord-313312-h607itv2 276 5 - - HYPH cord-313312-h607itv2 276 6 mediated mediate VBN cord-313312-h607itv2 276 7 neutralization neutralization NN cord-313312-h607itv2 276 8 and and CC cord-313312-h607itv2 276 9 enhancement enhancement NN cord-313312-h607itv2 276 10 of of IN cord-313312-h607itv2 276 11 West West NNP cord-313312-h607itv2 276 12 Nile Nile NNP cord-313312-h607itv2 276 13 virus virus NN cord-313312-h607itv2 276 14 infection infection NN cord-313312-h607itv2 276 15 Structural Structural NNP cord-313312-h607itv2 276 16 Insights Insights NNPS cord-313312-h607itv2 276 17 into into IN cord-313312-h607itv2 276 18 the the DT cord-313312-h607itv2 276 19 Mechanisms Mechanisms NNPS cord-313312-h607itv2 276 20 of of IN cord-313312-h607itv2 276 21 Antibody Antibody NNP cord-313312-h607itv2 276 22 - - HYPH cord-313312-h607itv2 276 23 Mediated mediate VBN cord-313312-h607itv2 276 24 Neutralization neutralization NN cord-313312-h607itv2 276 25 of of IN cord-313312-h607itv2 276 26 Flavivirus Flavivirus NNP cord-313312-h607itv2 276 27 Infection infection NN cord-313312-h607itv2 276 28 : : : cord-313312-h607itv2 276 29 Implications implication NNS cord-313312-h607itv2 276 30 for for IN cord-313312-h607itv2 276 31 Vaccine Vaccine NNP cord-313312-h607itv2 276 32 Development Development NNP cord-313312-h607itv2 276 33 Antibody Antibody NNP cord-313312-h607itv2 276 34 - - HYPH cord-313312-h607itv2 276 35 mediated mediate VBN cord-313312-h607itv2 276 36 neutralization neutralization NN cord-313312-h607itv2 276 37 of of IN cord-313312-h607itv2 276 38 flaviviruses flavivirus NNS cord-313312-h607itv2 276 39 : : : cord-313312-h607itv2 276 40 A a DT cord-313312-h607itv2 276 41 reductionist reductionist JJ cord-313312-h607itv2 276 42 view view NN cord-313312-h607itv2 276 43 Structure structure NN cord-313312-h607itv2 276 44 of of IN cord-313312-h607itv2 276 45 the the DT cord-313312-h607itv2 276 46 Fab Fab NNP cord-313312-h607itv2 276 47 - - HYPH cord-313312-h607itv2 276 48 labeled label VBN cord-313312-h607itv2 276 49 " " `` cord-313312-h607itv2 276 50 breathing breathe VBG cord-313312-h607itv2 276 51 " " '' cord-313312-h607itv2 276 52 state state NN cord-313312-h607itv2 276 53 of of IN cord-313312-h607itv2 276 54 native native JJ cord-313312-h607itv2 276 55 poliovirus poliovirus NN cord-313312-h607itv2 276 56 Fc Fc NNP cord-313312-h607itv2 276 57 receptors receptor NNS cord-313312-h607itv2 276 58 and and CC cord-313312-h607itv2 276 59 their -PRON- PRP$ cord-313312-h607itv2 276 60 influence influence NN cord-313312-h607itv2 276 61 on on IN cord-313312-h607itv2 276 62 efficacy efficacy NN cord-313312-h607itv2 276 63 of of IN cord-313312-h607itv2 276 64 therapeutic therapeutic JJ cord-313312-h607itv2 276 65 antibodies antibody NNS cord-313312-h607itv2 276 66 for for IN cord-313312-h607itv2 276 67 treatment treatment NN cord-313312-h607itv2 276 68 of of IN cord-313312-h607itv2 276 69 viral viral JJ cord-313312-h607itv2 276 70 diseases disease NNS cord-313312-h607itv2 276 71 Ligation Ligation NNP cord-313312-h607itv2 276 72 of of IN cord-313312-h607itv2 276 73 Fc Fc NNP cord-313312-h607itv2 276 74 gamma gamma NN cord-313312-h607itv2 276 75 receptor receptor NN cord-313312-h607itv2 277 1 IIB IIB NNP cord-313312-h607itv2 277 2 inhibits inhibit VBZ cord-313312-h607itv2 277 3 antibody antibody NN cord-313312-h607itv2 277 4 - - HYPH cord-313312-h607itv2 277 5 dependent dependent JJ cord-313312-h607itv2 277 6 enhancement enhancement NN cord-313312-h607itv2 277 7 of of IN cord-313312-h607itv2 277 8 dengue dengue NN cord-313312-h607itv2 277 9 virus virus NN cord-313312-h607itv2 277 10 infection infection NN cord-313312-h607itv2 277 11 Pathogenic Pathogenic NNP cord-313312-h607itv2 277 12 Exploitation Exploitation NNP cord-313312-h607itv2 277 13 of of IN cord-313312-h607itv2 277 14 Fc Fc NNP cord-313312-h607itv2 277 15 Activity Activity NNP cord-313312-h607itv2 277 16 FcgammaRIIB FcgammaRIIB NNP cord-313312-h607itv2 277 17 in in IN cord-313312-h607itv2 277 18 IgG IgG NNP cord-313312-h607itv2 277 19 - - HYPH cord-313312-h607itv2 277 20 mediated mediate VBN cord-313312-h607itv2 277 21 suppression suppression NN cord-313312-h607itv2 277 22 of of IN cord-313312-h607itv2 277 23 antibody antibody NN cord-313312-h607itv2 277 24 responses response NNS cord-313312-h607itv2 277 25 : : : cord-313312-h607itv2 278 1 Different different JJ cord-313312-h607itv2 278 2 impact impact NN cord-313312-h607itv2 278 3 in in IN cord-313312-h607itv2 278 4 vivo vivo NN cord-313312-h607itv2 278 5 and and CC cord-313312-h607itv2 279 1 in in FW cord-313312-h607itv2 279 2 vitro vitro FW cord-313312-h607itv2 279 3 Insights Insights NNP cord-313312-h607itv2 279 4 into into IN cord-313312-h607itv2 279 5 the the DT cord-313312-h607itv2 279 6 regulatory regulatory JJ cord-313312-h607itv2 279 7 mechanism mechanism NN cord-313312-h607itv2 279 8 controlling control VBG cord-313312-h607itv2 279 9 the the DT cord-313312-h607itv2 279 10 inhibition inhibition NN cord-313312-h607itv2 279 11 of of IN cord-313312-h607itv2 279 12 vaccine vaccine NN cord-313312-h607itv2 279 13 - - HYPH cord-313312-h607itv2 279 14 induced induce VBN cord-313312-h607itv2 279 15 seroconversion seroconversion NN cord-313312-h607itv2 279 16 by by IN cord-313312-h607itv2 279 17 maternal maternal JJ cord-313312-h607itv2 279 18 antibodies antibody NNS cord-313312-h607itv2 279 19 Protective protective JJ cord-313312-h607itv2 279 20 efficacy efficacy NN cord-313312-h607itv2 279 21 against against IN cord-313312-h607itv2 279 22 respiratory respiratory JJ cord-313312-h607itv2 279 23 syncytial syncytial JJ cord-313312-h607itv2 279 24 virus virus NN cord-313312-h607itv2 279 25 following follow VBG cord-313312-h607itv2 279 26 murine murine JJ cord-313312-h607itv2 279 27 neonatal neonatal JJ cord-313312-h607itv2 279 28 immunization immunization NN cord-313312-h607itv2 279 29 with with IN cord-313312-h607itv2 279 30 BBG2Na BBG2Na NNP cord-313312-h607itv2 279 31 vaccine vaccine NN cord-313312-h607itv2 279 32 : : : cord-313312-h607itv2 279 33 Influence influence NN cord-313312-h607itv2 279 34 of of IN cord-313312-h607itv2 279 35 adjuvants adjuvant NNS cord-313312-h607itv2 279 36 and and CC cord-313312-h607itv2 279 37 maternal maternal JJ cord-313312-h607itv2 279 38 antibodies antibody NNS cord-313312-h607itv2 279 39 Studies Studies NNPS cord-313312-h607itv2 279 40 on on IN cord-313312-h607itv2 279 41 the the DT cord-313312-h607itv2 279 42 Mechanism Mechanism NNP cord-313312-h607itv2 279 43 by by IN cord-313312-h607itv2 279 44 Which which WDT cord-313312-h607itv2 279 45 Antigen Antigen NNP cord-313312-h607itv2 279 46 - - HYPH cord-313312-h607itv2 279 47 Specific specific JJ cord-313312-h607itv2 279 48 IgG igg NN cord-313312-h607itv2 279 49 Suppresses suppress VBZ cord-313312-h607itv2 279 50 Primary Primary NNP cord-313312-h607itv2 279 51 Antibody Antibody NNP cord-313312-h607itv2 279 52 Responses Responses NNPS cord-313312-h607itv2 280 1 : : : cord-313312-h607itv2 280 2 Evidence evidence NN cord-313312-h607itv2 280 3 for for IN cord-313312-h607itv2 280 4 Epitope Epitope NNP cord-313312-h607itv2 280 5 Masking masking NN cord-313312-h607itv2 280 6 and and CC cord-313312-h607itv2 280 7 Decreased Decreased NNP cord-313312-h607itv2 280 8 Localization Localization NNP cord-313312-h607itv2 280 9 of of IN cord-313312-h607itv2 280 10 Antigen Antigen NNP cord-313312-h607itv2 280 11 in in IN cord-313312-h607itv2 280 12 the the DT cord-313312-h607itv2 280 13 Spleen Spleen NNP cord-313312-h607itv2 280 14 Immunoregulation Immunoregulation NNP cord-313312-h607itv2 280 15 by by IN cord-313312-h607itv2 280 16 monoclonal monoclonal JJ cord-313312-h607itv2 280 17 sheep sheep NN cord-313312-h607itv2 280 18 erythrocyte erythrocyte NN cord-313312-h607itv2 280 19 - - HYPH cord-313312-h607itv2 280 20 specific specific JJ cord-313312-h607itv2 280 21 IgG igg NN cord-313312-h607itv2 280 22 antibodies antibody NNS cord-313312-h607itv2 280 23 : : : cord-313312-h607itv2 280 24 Suppression suppression NN cord-313312-h607itv2 280 25 is be VBZ cord-313312-h607itv2 280 26 correlated correlate VBN cord-313312-h607itv2 280 27 to to IN cord-313312-h607itv2 280 28 level level NN cord-313312-h607itv2 280 29 of of IN cord-313312-h607itv2 280 30 antigen antigen NN cord-313312-h607itv2 280 31 binding binding NN cord-313312-h607itv2 280 32 and and CC cord-313312-h607itv2 280 33 not not RB cord-313312-h607itv2 280 34 to to IN cord-313312-h607itv2 280 35 isotype isotype JJ cord-313312-h607itv2 280 36 Intrinsic intrinsic JJ cord-313312-h607itv2 280 37 antibody antibody NN cord-313312-h607itv2 280 38 - - HYPH cord-313312-h607itv2 280 39 dependent dependent JJ cord-313312-h607itv2 280 40 enhancement enhancement NN cord-313312-h607itv2 280 41 of of IN cord-313312-h607itv2 280 42 microbial microbial JJ cord-313312-h607itv2 280 43 infection infection NN cord-313312-h607itv2 280 44 in in IN cord-313312-h607itv2 280 45 macrophages macrophage NNS cord-313312-h607itv2 280 46 : : : cord-313312-h607itv2 280 47 Disease disease NN cord-313312-h607itv2 280 48 regulation regulation NN cord-313312-h607itv2 280 49 by by IN cord-313312-h607itv2 280 50 immune immune JJ cord-313312-h607itv2 280 51 complexes complex NNS cord-313312-h607itv2 280 52 Dengue dengue NN cord-313312-h607itv2 280 53 Virus virus NN cord-313312-h607itv2 280 54 Neutralization neutralization NN cord-313312-h607itv2 280 55 in in IN cord-313312-h607itv2 280 56 Cells cell NNS cord-313312-h607itv2 280 57 Expressing express VBG cord-313312-h607itv2 280 58 Fc Fc NNP cord-313312-h607itv2 280 59 Gamma Gamma NNP cord-313312-h607itv2 280 60 Receptors Receptors NNP cord-313312-h607itv2 280 61 Differential Differential NNP cord-313312-h607itv2 280 62 Enhancement Enhancement NNP cord-313312-h607itv2 280 63 of of IN cord-313312-h607itv2 280 64 Dengue Dengue NNP cord-313312-h607itv2 280 65 Virus Virus NNP cord-313312-h607itv2 280 66 Immune immune VBP cord-313312-h607itv2 280 67 Complex complex JJ cord-313312-h607itv2 280 68 Infectivity infectivity NN cord-313312-h607itv2 280 69 Mediated mediate VBN cord-313312-h607itv2 280 70 by by IN cord-313312-h607itv2 280 71 Signaling signal VBG cord-313312-h607itv2 280 72 - - HYPH cord-313312-h607itv2 280 73 Competent competent JJ cord-313312-h607itv2 280 74 and and CC cord-313312-h607itv2 280 75 Signaling Signaling NNP cord-313312-h607itv2 280 76 - - HYPH cord-313312-h607itv2 280 77 Incompetent Incompetent NNP cord-313312-h607itv2 280 78 Human human JJ cord-313312-h607itv2 280 79 FcγRIA FcγRIA NNS cord-313312-h607itv2 280 80 ( ( -LRB- cord-313312-h607itv2 280 81 CD64 CD64 NNP cord-313312-h607itv2 280 82 ) ) -RRB- cord-313312-h607itv2 280 83 or or CC cord-313312-h607itv2 280 84 FcγRIIA FcγRIIA NNP cord-313312-h607itv2 280 85 ( ( -LRB- cord-313312-h607itv2 280 86 CD32 CD32 NNP cord-313312-h607itv2 280 87 ) ) -RRB- cord-313312-h607itv2 280 88 Differential differential JJ cord-313312-h607itv2 280 89 signal signal NN cord-313312-h607itv2 280 90 transduction transduction NN cord-313312-h607itv2 280 91 , , , cord-313312-h607itv2 280 92 membrane membrane NN cord-313312-h607itv2 280 93 trafficking trafficking NN cord-313312-h607itv2 280 94 , , , cord-313312-h607itv2 280 95 and and CC cord-313312-h607itv2 280 96 immune immune JJ cord-313312-h607itv2 280 97 effector effector NN cord-313312-h607itv2 280 98 functions function NNS cord-313312-h607itv2 280 99 mediated mediate VBN cord-313312-h607itv2 280 100 by by IN cord-313312-h607itv2 280 101 FcγRI FcγRI NNP cord-313312-h607itv2 280 102 versus versus IN cord-313312-h607itv2 280 103 FcγRIIa FcγRIIa NNP cord-313312-h607itv2 280 104 Antibody Antibody NNP cord-313312-h607itv2 280 105 - - HYPH cord-313312-h607itv2 280 106 Dependent Dependent NNP cord-313312-h607itv2 280 107 Enhancement Enhancement NNP cord-313312-h607itv2 280 108 of of IN cord-313312-h607itv2 280 109 Dengue Dengue NNP cord-313312-h607itv2 280 110 Virus Virus NNP cord-313312-h607itv2 280 111 Infection Infection NNP cord-313312-h607itv2 280 112 in in IN cord-313312-h607itv2 280 113 Primary Primary NNP cord-313312-h607itv2 280 114 Human Human NNP cord-313312-h607itv2 280 115 Macrophages Macrophages NNPS cord-313312-h607itv2 280 116 ; ; : cord-313312-h607itv2 280 117 Balancing balance VBG cord-313312-h607itv2 280 118 Higher high JJR cord-313312-h607itv2 280 119 Fusion Fusion NNP cord-313312-h607itv2 280 120 against against IN cord-313312-h607itv2 280 121 Antiviral Antiviral NNP cord-313312-h607itv2 280 122 Responses Responses NNPS cord-313312-h607itv2 280 123 Class Class NNP cord-313312-h607itv2 280 124 IV IV NNP cord-313312-h607itv2 280 125 semaphorin semaphorin NNP cord-313312-h607itv2 280 126 Sema4A Sema4A NNP cord-313312-h607itv2 280 127 enhances enhance VBZ cord-313312-h607itv2 280 128 T t NN cord-313312-h607itv2 280 129 - - HYPH cord-313312-h607itv2 280 130 cell cell NN cord-313312-h607itv2 280 131 activation activation NN cord-313312-h607itv2 280 132 and and CC cord-313312-h607itv2 280 133 interacts interact VBZ cord-313312-h607itv2 280 134 with with IN cord-313312-h607itv2 280 135 Tim-2 Tim-2 NNP cord-313312-h607itv2 280 136 Nonredundant Nonredundant NNP cord-313312-h607itv2 280 137 Roles role NNS cord-313312-h607itv2 280 138 of of IN cord-313312-h607itv2 280 139 Sema4A Sema4A NNP cord-313312-h607itv2 280 140 in in IN cord-313312-h607itv2 280 141 the the DT cord-313312-h607itv2 280 142 Immune Immune NNP cord-313312-h607itv2 280 143 System System NNP cord-313312-h607itv2 280 144 : : : cord-313312-h607itv2 280 145 Defective defective JJ cord-313312-h607itv2 280 146 T t NN cord-313312-h607itv2 280 147 Cell cell NN cord-313312-h607itv2 280 148 Priming Priming NNP cord-313312-h607itv2 280 149 and and CC cord-313312-h607itv2 280 150 Th1 th1 NN cord-313312-h607itv2 280 151 / / SYM cord-313312-h607itv2 280 152 Th2 th2 CD cord-313312-h607itv2 280 153 Regulation regulation NN cord-313312-h607itv2 280 154 in in IN cord-313312-h607itv2 280 155 Sema4A Sema4A NNP cord-313312-h607itv2 280 156 - - HYPH cord-313312-h607itv2 280 157 Deficient deficient JJ cord-313312-h607itv2 280 158 Mice mouse NNS cord-313312-h607itv2 280 159 Metabolic metabolic JJ cord-313312-h607itv2 280 160 perturbations perturbation NNS cord-313312-h607itv2 280 161 and and CC cord-313312-h607itv2 280 162 cellular cellular JJ cord-313312-h607itv2 280 163 stress stress NN cord-313312-h607itv2 280 164 underpin underpin VBP cord-313312-h607itv2 280 165 susceptibility susceptibility NN cord-313312-h607itv2 280 166 to to IN cord-313312-h607itv2 280 167 symptomatic symptomatic JJ cord-313312-h607itv2 280 168 live live RB cord-313312-h607itv2 280 169 - - HYPH cord-313312-h607itv2 280 170 attenuated attenuate VBN cord-313312-h607itv2 280 171 yellow yellow JJ cord-313312-h607itv2 280 172 fever fever NN cord-313312-h607itv2 280 173 infection infection NN cord-313312-h607itv2 281 1 Broad broad JJ cord-313312-h607itv2 281 2 immune immune JJ cord-313312-h607itv2 281 3 activation activation NN cord-313312-h607itv2 281 4 underlies underlie VBZ cord-313312-h607itv2 281 5 shared share VBN cord-313312-h607itv2 281 6 set set NN cord-313312-h607itv2 281 7 point point NN cord-313312-h607itv2 281 8 signatures signature NNS cord-313312-h607itv2 281 9 for for IN cord-313312-h607itv2 281 10 vaccine vaccine NN cord-313312-h607itv2 281 11 responsiveness responsiveness NN cord-313312-h607itv2 281 12 in in IN cord-313312-h607itv2 281 13 healthy healthy JJ cord-313312-h607itv2 281 14 individuals individual NNS cord-313312-h607itv2 281 15 and and CC cord-313312-h607itv2 281 16 disease disease NN cord-313312-h607itv2 281 17 activity activity NN cord-313312-h607itv2 281 18 in in IN cord-313312-h607itv2 281 19 patients patient NNS cord-313312-h607itv2 281 20 with with IN cord-313312-h607itv2 281 21 lupus lupus NN cord-313312-h607itv2 282 1 This this DT cord-313312-h607itv2 282 2 article article NN cord-313312-h607itv2 282 3 is be VBZ cord-313312-h607itv2 282 4 an an DT cord-313312-h607itv2 282 5 open open JJ cord-313312-h607itv2 282 6 access access NN cord-313312-h607itv2 282 7 article article NN cord-313312-h607itv2 282 8 distributed distribute VBN cord-313312-h607itv2 282 9 under under IN cord-313312-h607itv2 282 10 the the DT cord-313312-h607itv2 282 11 terms term NNS cord-313312-h607itv2 282 12 and and CC cord-313312-h607itv2 282 13 conditions condition NNS cord-313312-h607itv2 282 14 of of IN cord-313312-h607itv2 282 15 the the DT cord-313312-h607itv2 282 16 Creative Creative NNP cord-313312-h607itv2 282 17 Commons Commons NNP cord-313312-h607itv2 282 18 Attribution Attribution NNP cord-313312-h607itv2 282 19 ( ( -LRB- cord-313312-h607itv2 282 20 CC CC NNP cord-313312-h607itv2 282 21 BY by IN cord-313312-h607itv2 282 22 ) ) -RRB- cord-313312-h607itv2 282 23 license license NN cord-313312-h607itv2 283 1 The the DT cord-313312-h607itv2 283 2 authors author NNS cord-313312-h607itv2 283 3 declare declare VBP cord-313312-h607itv2 283 4 no no DT cord-313312-h607itv2 283 5 conflict conflict NN cord-313312-h607itv2 283 6 of of IN cord-313312-h607itv2 283 7 interest interest NN cord-313312-h607itv2 283 8 . . .